,loading,Input,Match type,Approved symbol,Approved name,HGNC ID,Location
HMGA2,0.022848939,HMGA2,Approved symbol,HMGA2,high mobility group AT-hook 2,HGNC:5009,12q14.3
BBIP1,-0.022789308,BBIP1,Approved symbol,BBIP1,BBSome interacting protein 1,HGNC:28093,10q25.2
CTDSPL,0.022651701,CTDSPL,Approved symbol,CTDSPL,CTD small phosphatase like,HGNC:16890,3p22.2
SMPDL3B,0.022586797,SMPDL3B,Approved symbol,SMPDL3B,sphingomyelin phosphodiesterase acid like 3B,HGNC:21416,1p35.3
TMEM38A,0.022540112,TMEM38A,Approved symbol,TMEM38A,transmembrane protein 38A,HGNC:28462,19p13.11
TMEM59,0.0222905,TMEM59,Approved symbol,TMEM59,transmembrane protein 59,HGNC:1239,1p32.3
RP11-677M14.3,0.022211023,RP11-677M14.3,Unmatched,RP11-677M14.3,,,
APBA1,0.022206448,APBA1,Approved symbol,APBA1,amyloid beta precursor protein binding family A member 1,HGNC:578,9q21.12
ACVR1B,0.022081506,ACVR1B,Approved symbol,ACVR1B,activin A receptor type 1B,HGNC:172,12q13.13
CLDN2,-0.022073068,CLDN2,Approved symbol,CLDN2,claudin 2,HGNC:2041,Xq22.3
CA1,0.022055238,CA1,Approved symbol,CA1,carbonic anhydrase 1,HGNC:1368,8q21.2
ELOVL5,-0.022045367,ELOVL5,Approved symbol,ELOVL5,ELOVL fatty acid elongase 5,HGNC:21308,6p12.1
CTD-2555C10.3,-0.022018707,CTD-2555C10.3,Unmatched,CTD-2555C10.3,,,
NDRG2,0.02195575,NDRG2,Approved symbol,NDRG2,NDRG family member 2,HGNC:14460,14q11.2
HEPACAM2,0.021928193,HEPACAM2,Approved symbol,HEPACAM2,HEPACAM family member 2,HGNC:27364,7q21.2
IL4,-0.021899686,IL4,Approved symbol,IL4,interleukin 4,HGNC:6014,5q31.1
GPR125,0.021855813,GPR125,Previous symbol,ADGRA3,adhesion G protein-coupled receptor A3,HGNC:13839,4p15.2
RAB4A,0.021772353,RAB4A,Approved symbol,RAB4A,"RAB4A, member RAS oncogene family",HGNC:9781,1q42.13
UGT2B10,0.021765832,UGT2B10,Approved symbol,UGT2B10,UDP glucuronosyltransferase family 2 member B10,HGNC:12544,4q13.2
CAPN14,-0.021758142,CAPN14,Approved symbol,CAPN14,calpain 14,HGNC:16664,2p23.1
CD44,-0.021719157,CD44,Approved symbol,CD44,CD44 molecule (Indian blood group),HGNC:1681,11p13
ACAT1,0.021672197,ACAT1,Approved symbol,ACAT1,acetyl-CoA acetyltransferase 1,HGNC:93,11q22.3
RP11-1090M7.1,0.021653292,RP11-1090M7.1,Unmatched,RP11-1090M7.1,,,
PPP1R1B,0.021647782,PPP1R1B,Approved symbol,PPP1R1B,protein phosphatase 1 regulatory inhibitor subunit 1B,HGNC:9287,17q12
EPHB1,-0.021637117,EPHB1,Approved symbol,EPHB1,EPH receptor B1,HGNC:3392,3q22.2
LA16c-380H5.5,0.021618076,LA16c-380H5.5,Unmatched,LA16c-380H5.5,,,
TRABD2A,0.021617896,TRABD2A,Approved symbol,TRABD2A,TraB domain containing 2A,HGNC:27013,2p11.2
RAB40B,0.021608367,RAB40B,Approved symbol,RAB40B,"RAB40B, member RAS oncogene family",HGNC:18284,17q25.3
PHF11,-0.02159249,PHF11,Approved symbol,PHF11,PHD finger protein 11,HGNC:17024,13q14.2
CPA6,0.021559292,CPA6,Approved symbol,CPA6,carboxypeptidase A6,HGNC:17245,8q13.2
KRT7,-0.021551624,KRT7,Approved symbol,KRT7,keratin 7,HGNC:6445,12q13.13
TMEM192,0.021541367,TMEM192,Approved symbol,TMEM192,transmembrane protein 192,HGNC:26775,4q32.3
GABRP,-0.021524414,GABRP,Approved symbol,GABRP,gamma-aminobutyric acid type A receptor subunit pi,HGNC:4089,5q35.1
TCEA3,0.021491538,TCEA3,Approved symbol,TCEA3,transcription elongation factor A3,HGNC:11615,1p36.12
AC147651.4,-0.021491118,AC147651.4,Unmatched,AC147651.4,,,
CAMK1D,0.0214726,CAMK1D,Approved symbol,CAMK1D,calcium/calmodulin dependent protein kinase ID,HGNC:19341,10p13
TMEM98,0.021467066,TMEM98,Approved symbol,TMEM98,transmembrane protein 98,HGNC:24529,17q11.2
COG1,0.021466484,COG1,Approved symbol,COG1,component of oligomeric golgi complex 1,HGNC:6545,17q25.1
CTLA4,-0.021460882,CTLA4,Approved symbol,CTLA4,cytotoxic T-lymphocyte associated protein 4,HGNC:2505,2q33.2
ENDOD1,0.021447909,ENDOD1,Approved symbol,ENDOD1,endonuclease domain containing 1,HGNC:29129,11q21
HRH2,-0.021442989,HRH2,Approved symbol,HRH2,histamine receptor H2,HGNC:5183,5q35.2
ILDR1,0.02144147,ILDR1,Approved symbol,ILDR1,immunoglobulin like domain containing receptor 1,HGNC:28741,3q13.33
ATPAF1,0.021430711,ATPAF1,Approved symbol,ATPAF1,ATP synthase mitochondrial F1 complex assembly factor 1,HGNC:18803,1p33
USP30,0.021419401,USP30,Approved symbol,USP30,ubiquitin specific peptidase 30,HGNC:20065,12q24.11
MMP12,-0.021407874,MMP12,Approved symbol,MMP12,matrix metallopeptidase 12,HGNC:7158,11q22.2
SGSM1,0.021383768,SGSM1,Approved symbol,SGSM1,small G protein signaling modulator 1,HGNC:29410,22q11.23
CHRDL2,-0.021382361,CHRDL2,Approved symbol,CHRDL2,chordin like 2,HGNC:24168,11q13.4
ZFYVE9,0.02137375,ZFYVE9,Approved symbol,ZFYVE9,zinc finger FYVE-type containing 9,HGNC:6775,1p32.3
ADA,-0.021314172,ADA,Approved symbol,ADA,adenosine deaminase,HGNC:186,20q13.12
IGF2BP2,0.021271304,IGF2BP2,Approved symbol,IGF2BP2,insulin like growth factor 2 mRNA binding protein 2,HGNC:28867,3q27.2
MMP1,-0.021271236,MMP1,Approved symbol,MMP1,matrix metallopeptidase 1,HGNC:7155,11q22.2
DTX4,0.021269828,DTX4,Approved symbol,DTX4,deltex E3 ubiquitin ligase 4,HGNC:29151,11q12.1
CCL17,-0.021246668,CCL17,Approved symbol,CCL17,C-C motif chemokine ligand 17,HGNC:10615,16q21
NRARP,0.021244499,NRARP,Approved symbol,NRARP,NOTCH regulated ankyrin repeat protein,HGNC:33843,9q34.3
FOXD2,0.021230872,FOXD2,Approved symbol,FOXD2,forkhead box D2,HGNC:3803,1p33
TDO2,-0.021228192,TDO2,Approved symbol,TDO2,"tryptophan 2,3-dioxygenase",HGNC:11708,4q32.1
CNNM2,0.021200029,CNNM2,Approved symbol,CNNM2,cyclin and CBS domain divalent metal cation transport mediator 2,HGNC:103,10q24.32
UBASH3B,-0.021197195,UBASH3B,Approved symbol,UBASH3B,ubiquitin associated and SH3 domain containing B,HGNC:29884,11q24.1
WNK4,0.021175723,WNK4,Approved symbol,WNK4,WNK lysine deficient protein kinase 4,HGNC:14544,17q21.2
CTB-134H23.3,0.021168178,CTB-134H23.3,Unmatched,CTB-134H23.3,,,
PIK3R2,0.021161437,PIK3R2,Approved symbol,PIK3R2,phosphoinositide-3-kinase regulatory subunit 2,HGNC:8980,19p13.11
MMP7,-0.021158924,MMP7,Approved symbol,MMP7,matrix metallopeptidase 7,HGNC:7174,11q22.2
C17orf96,-0.021151651,C17orf96,Previous symbol,EPOP,elongin BC and polycomb repressive complex 2 associated protein,HGNC:34493,17q12
OSBPL3,-0.021144829,OSBPL3,Approved symbol,OSBPL3,oxysterol binding protein like 3,HGNC:16370,7p15.3
RP11-357H14.17,0.021135125,RP11-357H14.17,Unmatched,RP11-357H14.17,,,
FAM162A,0.02113363,FAM162A,Approved symbol,FAM162A,family with sequence similarity 162 member A,HGNC:17865,3q21.1
PSKH1,0.021117407,PSKH1,Approved symbol,PSKH1,protein serine kinase H1,HGNC:9529,16q22.1
AC093415.2,0.021107675,AC093415.2,Unmatched,AC093415.2,,,
XRCC6BP1,0.021088955,XRCC6BP1,Previous symbol,ATP23,ATP23 metallopeptidase and ATP synthase assembly factor homolog,HGNC:29452,12q14.1
STAT5A,-0.021084197,STAT5A,Approved symbol,STAT5A,signal transducer and activator of transcription 5A,HGNC:11366,17q21.2
MPND,0.021081016,MPND,Approved symbol,MPND,MPN domain containing,HGNC:25934,19p13.3
HPCA,0.021062663,HPCA,Approved symbol,HPCA,hippocalcin,HGNC:5144,1p35.1
CCR8,-0.021050452,CCR8,Approved symbol,CCR8,C-C motif chemokine receptor 8,HGNC:1609,3p22.1
PHF19,-0.021049054,PHF19,Approved symbol,PHF19,PHD finger protein 19,HGNC:24566,9q33.2
GHR,0.021037447,GHR,Approved symbol,GHR,growth hormone receptor,HGNC:4263,5p13.1-p12
IFI16,-0.021033685,IFI16,Approved symbol,IFI16,interferon gamma inducible protein 16,HGNC:5395,1q23.1
TACSTD2,-0.021028646,TACSTD2,Approved symbol,TACSTD2,tumor associated calcium signal transducer 2,HGNC:11530,1p32.1
PDPN,-0.020984244,PDPN,Approved symbol,PDPN,podoplanin,HGNC:29602,1p36.21
SLC6A6,-0.0209841,SLC6A6,Approved symbol,SLC6A6,solute carrier family 6 member 6,HGNC:11052,3p25.1
SHANK2,0.020976828,SHANK2,Approved symbol,SHANK2,SH3 and multiple ankyrin repeat domains 2,HGNC:14295,11q13.3-q13.4
FGR,-0.020974883,FGR,Approved symbol,FGR,"FGR proto-oncogene, Src family tyrosine kinase",HGNC:3697,1p35.3
RP11-333O1.1,-0.020933418,RP11-333O1.1,Unmatched,RP11-333O1.1,,,
DSCAML1,0.020915795,DSCAML1,Approved symbol,DSCAML1,DS cell adhesion molecule like 1,HGNC:14656,11q23.3
EMR2,-0.020912396,EMR2,Previous symbol,ADGRE2,adhesion G protein-coupled receptor E2,HGNC:3337,19p13.12
SPR,0.02091228,SPR,Approved symbol,SPR,sepiapterin reductase,HGNC:11257,2p13.2
IL18R1,-0.020899899,IL18R1,Approved symbol,IL18R1,interleukin 18 receptor 1,HGNC:5988,2q12.1
LRRN2,0.020899749,LRRN2,Approved symbol,LRRN2,leucine rich repeat neuronal 2,HGNC:16914,1q32.1
RAPGEFL1,0.020869759,RAPGEFL1,Approved symbol,RAPGEFL1,Rap guanine nucleotide exchange factor like 1,HGNC:17428,17q21.1
FOXD2-AS1,0.020868726,FOXD2-AS1,Approved symbol,FOXD2-AS1,FOXD2 adjacent opposite strand RNA 1,HGNC:44256,1p33
RHEBL1,-0.020864105,RHEBL1,Approved symbol,RHEBL1,RHEB like 1,HGNC:21166,12q13.12
NABP1,-0.020856605,NABP1,Approved symbol,NABP1,nucleic acid binding protein 1,HGNC:26232,2q32.3
STARD10,0.020854489,STARD10,Approved symbol,STARD10,StAR related lipid transfer domain containing 10,HGNC:10666,11q13.4
MED9,0.020842182,MED9,Approved symbol,MED9,mediator complex subunit 9,HGNC:25487,17p11.2
ATP11A,-0.020829477,ATP11A,Approved symbol,ATP11A,ATPase phospholipid transporting 11A,HGNC:13552,13q34
SLC41A1,-0.020827995,SLC41A1,Approved symbol,SLC41A1,solute carrier family 41 member 1,HGNC:19429,1q32.1
FBXO25,0.020826598,FBXO25,Approved symbol,FBXO25,F-box protein 25,HGNC:13596,8p23.3
NFKB2,-0.020814669,NFKB2,Approved symbol,NFKB2,nuclear factor kappa B subunit 2,HGNC:7795,10q24.32
TNFRSF9,-0.020811753,TNFRSF9,Approved symbol,TNFRSF9,TNF receptor superfamily member 9,HGNC:11924,1p36.23
CCDC109B,-0.020808476,CCDC109B,Previous symbol,MCUB,mitochondrial calcium uniporter dominant negative subunit beta,HGNC:26076,4q25
PRDX6,0.02079792,PRDX6,Approved symbol,PRDX6,peroxiredoxin 6,HGNC:16753,1q25.1
RFX5,-0.020797356,RFX5,Approved symbol,RFX5,regulatory factor X5,HGNC:9986,1q21.3
HAPLN3,-0.020772458,HAPLN3,Approved symbol,HAPLN3,hyaluronan and proteoglycan link protein 3,HGNC:21446,15q26.1
POFUT1,0.020767388,POFUT1,Approved symbol,POFUT1,protein O-fucosyltransferase 1,HGNC:14988,20q11.21
IL27RA,-0.020765486,IL27RA,Approved symbol,IL27RA,interleukin 27 receptor subunit alpha,HGNC:17290,19p13.12
RP11-247L20.4,0.020751147,RP11-247L20.4,Unmatched,RP11-247L20.4,,,
IFT57,0.020745987,IFT57,Approved symbol,IFT57,intraflagellar transport 57,HGNC:17367,3q13.12-q13.13
LCMT1,0.020744687,LCMT1,Approved symbol,LCMT1,leucine carboxyl methyltransferase 1,HGNC:17557,16p12.1
CALN1,0.020725258,CALN1,Approved symbol,CALN1,calneuron 1,HGNC:13248,7q11.22
MIR155HG,-0.020720837,MIR155HG,Approved symbol,MIR155HG,MIR155 host gene,HGNC:35460,21q21.3
LAMP3,-0.020717766,LAMP3,Approved symbol,LAMP3,lysosomal associated membrane protein 3,HGNC:14582,3q27.1
SLC22A23,0.020712301,SLC22A23,Approved symbol,SLC22A23,solute carrier family 22 member 23,HGNC:21106,6p25.2
CEACAM4,-0.020711353,CEACAM4,Approved symbol,CEACAM4,CEA cell adhesion molecule 4,HGNC:1816,19q13.2
PVT1,-0.020709648,PVT1,Approved symbol,PVT1,Pvt1 oncogene,HGNC:9709,8q24.21
PRPS1,-0.020706984,PRPS1,Approved symbol,PRPS1,phosphoribosyl pyrophosphate synthetase 1,HGNC:9462,Xq22.3
ARNTL2,-0.020695702,ARNTL2,Approved symbol,ARNTL2,aryl hydrocarbon receptor nuclear translocator like 2,HGNC:18984,12p11.23
ZNF613,0.020691901,ZNF613,Approved symbol,ZNF613,zinc finger protein 613,HGNC:25827,19q13.41
CSTA,-0.020689276,CSTA,Approved symbol,CSTA,cystatin A,HGNC:2481,3q21.1
MFSD4,0.020685834,MFSD4,Previous symbol,MFSD4A,major facilitator superfamily domain containing 4A,HGNC:25433,1q32.1
TRIB2,-0.020677164,TRIB2,Approved symbol,TRIB2,tribbles pseudokinase 2,HGNC:30809,2p24.3
ESM1,-0.020673476,ESM1,Approved symbol,ESM1,endothelial cell specific molecule 1,HGNC:3466,5q11.2
LILRA1,-0.020671227,LILRA1,Approved symbol,LILRA1,leukocyte immunoglobulin like receptor A1,HGNC:6602,19q13.42
EXPH5,0.020645287,EXPH5,Approved symbol,EXPH5,exophilin 5,HGNC:30578,11q22.3
BCAT2,0.020640513,BCAT2,Approved symbol,BCAT2,branched chain amino acid transaminase 2,HGNC:977,19q13.33
RN7SKP127,0.020627773,RN7SKP127,Approved symbol,RN7SKP127,RN7SK pseudogene 127,HGNC:45851,16p11.2
RELT,-0.02062652,RELT,Approved symbol,RELT,RELT TNF receptor,HGNC:13764,11q13.4
WISP1,-0.020625815,WISP1,Previous symbol,CCN4,cellular communication network factor 4,HGNC:12769,8q24.22
TMEM9B,0.020617613,TMEM9B,Approved symbol,TMEM9B,TMEM9 domain family member B,HGNC:1168,11p15.4
S1PR1,-0.020606311,S1PR1,Approved symbol,S1PR1,sphingosine-1-phosphate receptor 1,HGNC:3165,1p21.2
ICOS,-0.020605681,ICOS,Approved symbol,ICOS,inducible T cell costimulator,HGNC:5351,2q33.2
CPT2,0.020602423,CPT2,Approved symbol,CPT2,carnitine palmitoyltransferase 2,HGNC:2330,1p32.3
ROBO1,-0.020602185,ROBO1,Approved symbol,ROBO1,roundabout guidance receptor 1,HGNC:10249,3p12.3
FAM110C,0.020580205,FAM110C,Approved symbol,FAM110C,family with sequence similarity 110 member C,HGNC:33340,2p25.3
MX2,-0.020574044,MX2,Approved symbol,MX2,MX dynamin like GTPase 2,HGNC:7533,21q22.3
KLHL5,-0.020569423,KLHL5,Approved symbol,KLHL5,kelch like family member 5,HGNC:6356,4p14
NKX3-1,-0.020568553,NKX3-1,Approved symbol,NKX3-1,NK3 homeobox 1,HGNC:7838,8p21.2
PTGIR,-0.020563149,PTGIR,Approved symbol,PTGIR,prostaglandin I2 receptor,HGNC:9602,19q13.32
FAM219A,-0.020562934,FAM219A,Approved symbol,FAM219A,family with sequence similarity 219 member A,HGNC:19920,9p13.3
CXCL17,-0.020551028,CXCL17,Approved symbol,CXCL17,C-X-C motif chemokine ligand 17,HGNC:19232,19q13.2
HNRNPA1P21,-0.020544197,HNRNPA1P21,Approved symbol,HNRNPA1P21,heterogeneous nuclear ribonucleoprotein A1 pseudogene 21,HGNC:39539,3p22.1
CHST2,-0.02052772,CHST2,Approved symbol,CHST2,carbohydrate sulfotransferase 2,HGNC:1970,3q24
KSR1,-0.020521573,KSR1,Approved symbol,KSR1,kinase suppressor of ras 1,HGNC:6465,17q11.2
CAMK2N1,0.020515376,CAMK2N1,Approved symbol,CAMK2N1,calcium/calmodulin dependent protein kinase II inhibitor 1,HGNC:24190,1p36.12
SELENBP1,0.020504755,SELENBP1,Approved symbol,SELENBP1,selenium binding protein 1,HGNC:10719,1q21.3
SH2D2A,-0.020493422,SH2D2A,Approved symbol,SH2D2A,SH2 domain containing 2A,HGNC:10821,1q23.1
SELP,-0.020492241,SELP,Approved symbol,SELP,selectin P,HGNC:10721,1q24.2
FMO3,-0.020491405,FMO3,Approved symbol,FMO3,flavin containing dimethylaniline monoxygenase 3,HGNC:3771,1q24.3
CBFB,-0.020458378,CBFB,Approved symbol,CBFB,core-binding factor subunit beta,HGNC:1539,16q22.1
LAIR2,-0.020455985,LAIR2,Approved symbol,LAIR2,leukocyte associated immunoglobulin like receptor 2,HGNC:6478,19q13.42
TRAF1,-0.020445682,TRAF1,Approved symbol,TRAF1,TNF receptor associated factor 1,HGNC:12031,9q33.2
CD40,-0.02044485,CD40,Approved symbol,CD40,CD40 molecule,HGNC:11919,20q13.12
LINC00940,0.020435817,LINC00940,Approved symbol,LINC00940,long intergenic non-protein coding RNA 940,HGNC:48634,12p13.33
ZDHHC7,0.020431624,ZDHHC7,Approved symbol,ZDHHC7,zinc finger DHHC-type palmitoyltransferase 7,HGNC:18459,16q24.1
CDX1,0.02041623,CDX1,Approved symbol,CDX1,caudal type homeobox 1,HGNC:1805,5q32
CACNA2D2,0.020394995,CACNA2D2,Approved symbol,CACNA2D2,calcium voltage-gated channel auxiliary subunit alpha2delta 2,HGNC:1400,3p21.31
DGUOK-AS1,0.02036657,DGUOK-AS1,Approved symbol,DGUOK-AS1,DGUOK antisense RNA 1,HGNC:43441,2p13.1
MIR223,-0.020364489,MIR223,Approved symbol,MIR223,microRNA 223,HGNC:31603,Xq12
C8orf47,0.020361349,C8orf47,Previous symbol,ERICH5,glutamate rich 5,HGNC:26823,8q22.2
CD80,-0.020352105,CD80,Approved symbol,CD80,CD80 molecule,HGNC:1700,3q13.33
REC8,-0.020352069,REC8,Approved symbol,REC8,REC8 meiotic recombination protein,HGNC:16879,14q12
BATF3,-0.020349245,BATF3,Approved symbol,BATF3,basic leucine zipper ATF-like transcription factor 3,HGNC:28915,1q32.3
KLF5,0.020328084,KLF5,Approved symbol,KLF5,Kruppel like factor 5,HGNC:6349,13q22.1
SGIP1,-0.020326273,SGIP1,Approved symbol,SGIP1,SH3GL interacting endocytic adaptor 1,HGNC:25412,1p31.3
ZNF385D,-0.020313343,ZNF385D,Approved symbol,ZNF385D,zinc finger protein 385D,HGNC:26191,3p24.3
SERPINB7,-0.020294846,SERPINB7,Approved symbol,SERPINB7,serpin family B member 7,HGNC:13902,18q21.33
MYBL2,-0.020291253,MYBL2,Approved symbol,MYBL2,MYB proto-oncogene like 2,HGNC:7548,20q13.12
IL13RA2,-0.02028773,IL13RA2,Approved symbol,IL13RA2,interleukin 13 receptor subunit alpha 2,HGNC:5975,Xq23
DGCR2,0.020286144,DGCR2,Approved symbol,DGCR2,DiGeorge syndrome critical region gene 2,HGNC:2845,22q11.21
FXYD3,0.020279664,FXYD3,Approved symbol,FXYD3,FXYD domain containing ion transport regulator 3,HGNC:4027,19q13.12
PARS2,0.020272965,PARS2,Approved symbol,PARS2,"prolyl-tRNA synthetase 2, mitochondrial",HGNC:30563,1p32.3
KYNU,-0.02026436,KYNU,Approved symbol,KYNU,kynureninase,HGNC:6469,2q22.2
HNF1B,0.020259083,HNF1B,Approved symbol,HNF1B,HNF1 homeobox B,HGNC:11630,17q12
RP11-649G15.2,0.020243827,RP11-649G15.2,Unmatched,RP11-649G15.2,,,
F2RL2,-0.020243699,F2RL2,Approved symbol,F2RL2,coagulation factor II thrombin receptor like 2,HGNC:3539,5q13.3
ATP13A4,0.02023773,ATP13A4,Approved symbol,ATP13A4,ATPase 13A4,HGNC:25422,3q29
ITGAX,-0.020233456,ITGAX,Approved symbol,ITGAX,integrin subunit alpha X,HGNC:6152,16p11.2
RP11-298O21.2,-0.020226573,RP11-298O21.2,Unmatched,RP11-298O21.2,,,
SEMA7A,-0.020224858,SEMA7A,Approved symbol,SEMA7A,semaphorin 7A (John Milton Hagen blood group),HGNC:10741,15q24.1
FAM101A,0.020212831,FAM101A,Previous symbol,RFLNA,refilin A,HGNC:27051,12q24.31
EPB41L1,0.020198883,EPB41L1,Approved symbol,EPB41L1,erythrocyte membrane protein band 4.1 like 1,HGNC:3378,20q11.23
SAMSN1,-0.020193049,SAMSN1,Approved symbol,SAMSN1,"SAM domain, SH3 domain and nuclear localization signals 1",HGNC:10528,21q11.2
JAK3,-0.020190798,JAK3,Approved symbol,JAK3,Janus kinase 3,HGNC:6193,19p13.11
FAM171A1,0.020187483,FAM171A1,Approved symbol,FAM171A1,family with sequence similarity 171 member A1,HGNC:23522,10p13
PXMP2,0.020185407,PXMP2,Approved symbol,PXMP2,peroxisomal membrane protein 2,HGNC:9716,12q24.33
CLDN8,0.020179156,CLDN8,Approved symbol,CLDN8,claudin 8,HGNC:2050,21q22.11
BATF,-0.020178034,BATF,Approved symbol,BATF,basic leucine zipper ATF-like transcription factor,HGNC:958,14q24.3
PIF1,-0.020170795,PIF1,Approved symbol,PIF1,PIF1 5'-to-3' DNA helicase,HGNC:26220,15q22.31
NCF2,-0.020151361,NCF2,Approved symbol,NCF2,neutrophil cytosolic factor 2,HGNC:7661,1q25.3
FILIP1L,-0.020147056,FILIP1L,Approved symbol,FILIP1L,filamin A interacting protein 1 like,HGNC:24589,3q12.1
AKAP1,0.020141519,AKAP1,Approved symbol,AKAP1,A-kinase anchoring protein 1,HGNC:367,17q22
PADI2,0.020141053,PADI2,Approved symbol,PADI2,peptidyl arginine deiminase 2,HGNC:18341,1p36.13
RIPK2,-0.020138257,RIPK2,Approved symbol,RIPK2,receptor interacting serine/threonine kinase 2,HGNC:10020,8q21.3
MSN,-0.020135851,MSN,Approved symbol,MSN,moesin,HGNC:7373,Xq12
IL33,-0.020130502,IL33,Approved symbol,IL33,interleukin 33,HGNC:16028,9p24.1
MB21D1,-0.020121211,MB21D1,Previous symbol,CGAS,cyclic GMP-AMP synthase,HGNC:21367,6q13
AUTS2,0.020120579,AUTS2,Approved symbol,AUTS2,activator of transcription and developmental regulator AUTS2,HGNC:14262,7q11.22
WNK2,0.02011911,WNK2,Approved symbol,WNK2,WNK lysine deficient protein kinase 2,HGNC:14542,9q22.31
EMR3,-0.020117805,EMR3,Previous symbol,ADGRE3,adhesion G protein-coupled receptor E3,HGNC:23647,19p13.12
FAM20A,-0.020115109,FAM20A,Approved symbol,FAM20A,FAM20A golgi associated secretory pathway pseudokinase,HGNC:23015,17q24.2
ADARB1,-0.020112521,ADARB1,Approved symbol,ADARB1,adenosine deaminase RNA specific B1,HGNC:226,21q22.3
RP11-81H14.2,-0.020111848,RP11-81H14.2,Unmatched,RP11-81H14.2,,,
FUT8,-0.020111612,FUT8,Approved symbol,FUT8,fucosyltransferase 8,HGNC:4019,14q23.3
LILRB1,-0.020096553,LILRB1,Approved symbol,LILRB1,leukocyte immunoglobulin like receptor B1,HGNC:6605,19q13.42
NDUFA5,0.020089704,NDUFA5,Approved symbol,NDUFA5,NADH:ubiquinone oxidoreductase subunit A5,HGNC:7688,7q31.32
KMO,-0.020086448,KMO,Approved symbol,KMO,kynurenine 3-monooxygenase,HGNC:6381,1q43
RP11-346I3.4,0.020086097,RP11-346I3.4,Unmatched,RP11-346I3.4,,,
ORC6,-0.020084937,ORC6,Approved symbol,ORC6,origin recognition complex subunit 6,HGNC:17151,16q11.2
WNT2,-0.020077209,WNT2,Approved symbol,WNT2,Wnt family member 2,HGNC:12780,7q31.2
ENTPD5,0.0200716,ENTPD5,Approved symbol,ENTPD5,ectonucleoside triphosphate diphosphohydrolase 5 (inactive),HGNC:3367,14q24.3
ZNF629,0.020070285,ZNF629,Approved symbol,ZNF629,zinc finger protein 629,HGNC:29008,16p11.2
MAPK11,-0.020066012,MAPK11,Approved symbol,MAPK11,mitogen-activated protein kinase 11,HGNC:6873,22q13.33
DSG3,-0.020062403,DSG3,Approved symbol,DSG3,desmoglein 3,HGNC:3050,18q12.1
ACOT13,0.020061168,ACOT13,Approved symbol,ACOT13,acyl-CoA thioesterase 13,HGNC:20999,6p22.3
SYBU,0.020057123,SYBU,Approved symbol,SYBU,syntabulin,HGNC:26011,8q23.2
SRGN,-0.020056861,SRGN,Approved symbol,SRGN,serglycin,HGNC:9361,10q22.1
CTD-2319I12.1,-0.020056433,CTD-2319I12.1,Unmatched,CTD-2319I12.1,,,
COTL1,-0.020055116,COTL1,Approved symbol,COTL1,coactosin like F-actin binding protein 1,HGNC:18304,16q24.1
ZC2HC1C,0.020053458,ZC2HC1C,Approved symbol,ZC2HC1C,zinc finger C2HC-type containing 1C,HGNC:20354,14q24.3
CCDC115,0.02005313,CCDC115,Approved symbol,CCDC115,coiled-coil domain containing 115,HGNC:28178,2q21.1
SHCBP1,-0.020051102,SHCBP1,Approved symbol,SHCBP1,SHC binding and spindle associated 1,HGNC:29547,16q11.2
RP11-326F20.5,0.02005071,RP11-326F20.5,Unmatched,RP11-326F20.5,,,
KLK3,0.020049658,KLK3,Approved symbol,KLK3,kallikrein related peptidase 3,HGNC:6364,19q13.33
PDCD4,0.020044786,PDCD4,Approved symbol,PDCD4,programmed cell death 4,HGNC:8763,10q25.2
VAV3,0.020044672,VAV3,Approved symbol,VAV3,vav guanine nucleotide exchange factor 3,HGNC:12659,1p13.3
PEX19,0.020043958,PEX19,Approved symbol,PEX19,peroxisomal biogenesis factor 19,HGNC:9713,1q23.2
GPR97,-0.020041189,GPR97,Previous symbol,ADGRG3,adhesion G protein-coupled receptor G3,HGNC:13728,16q21
SLC26A2,0.02003961,SLC26A2,Approved symbol,SLC26A2,solute carrier family 26 member 2,HGNC:10994,5q32
PPARGC1A,0.020039555,PPARGC1A,Approved symbol,PPARGC1A,PPARG coactivator 1 alpha,HGNC:9237,4p15.2
RP11-284F21.9,0.020035047,RP11-284F21.9,Unmatched,RP11-284F21.9,,,
TMEM206,-0.020027211,TMEM206,Previous symbol,PACC1,proton activated chloride channel 1,HGNC:25593,1q32.3
TMEM8B,0.020025026,TMEM8B,Approved symbol,TMEM8B,transmembrane protein 8B,HGNC:21427,9p13.3
VSIG1,-0.020022641,VSIG1,Approved symbol,VSIG1,V-set and immunoglobulin domain containing 1,HGNC:28675,Xq22.3
GPR85,-0.020022416,GPR85,Approved symbol,GPR85,G protein-coupled receptor 85,HGNC:4536,7q31.1
MT1E,0.02001513,MT1E,Approved symbol,MT1E,metallothionein 1E,HGNC:7397,16q13
SPATA2,0.01999692,SPATA2,Approved symbol,SPATA2,spermatogenesis associated 2,HGNC:14681,20q13.13
ANGPT2,-0.019990174,ANGPT2,Approved symbol,ANGPT2,angiopoietin 2,HGNC:485,8p23.1
WDFY2,-0.019987554,WDFY2,Approved symbol,WDFY2,WD repeat and FYVE domain containing 2,HGNC:20482,13q14.3
CSF2RB,-0.019981954,CSF2RB,Approved symbol,CSF2RB,colony stimulating factor 2 receptor subunit beta,HGNC:2436,22q12.3
FOXP3,-0.019981037,FOXP3,Approved symbol,FOXP3,forkhead box P3,HGNC:6106,Xp11.23
SEMA4G,0.019975112,SEMA4G,Approved symbol,SEMA4G,semaphorin 4G,HGNC:10735,10q24.31
MMP3,-0.019972253,MMP3,Approved symbol,MMP3,matrix metallopeptidase 3,HGNC:7173,11q22.2
SYT13,0.019970739,SYT13,Approved symbol,SYT13,synaptotagmin 13,HGNC:14962,11p11.2
KCNJ2-AS1,0.019956522,KCNJ2-AS1,Approved symbol,KCNJ2-AS1,KCNJ2 antisense RNA 1,HGNC:43720,17q24.3
CSGALNACT2,-0.019956201,CSGALNACT2,Approved symbol,CSGALNACT2,chondroitin sulfate N-acetylgalactosaminyltransferase 2,HGNC:24292,10q11.21
MKRN1,0.019954719,MKRN1,Approved symbol,MKRN1,makorin ring finger protein 1,HGNC:7112,7q34
CCDC167,-0.019936722,CCDC167,Approved symbol,CCDC167,coiled-coil domain containing 167,HGNC:21239,6p21.2
GGT7,0.019931326,GGT7,Approved symbol,GGT7,gamma-glutamyltransferase 7,HGNC:4259,20q11.22
RHBDF2,-0.019926775,RHBDF2,Approved symbol,RHBDF2,rhomboid 5 homolog 2,HGNC:20788,17q25.1
MAD2L2,-0.019918135,MAD2L2,Approved symbol,MAD2L2,mitotic arrest deficient 2 like 2,HGNC:6764,1p36.22
RIMS4,0.019910542,RIMS4,Approved symbol,RIMS4,regulating synaptic membrane exocytosis 4,HGNC:16183,20q13.12
LRP8,-0.019908596,LRP8,Approved symbol,LRP8,LDL receptor related protein 8,HGNC:6700,1p32.3
C11orf1,0.019891245,C11orf1,Approved symbol,C11orf1,chromosome 11 open reading frame 1,HGNC:1163,11q23.1
RP11-61A14.1,0.019890033,RP11-61A14.1,Unmatched,RP11-61A14.1,,,
CTD-2269F5.1,0.019888628,CTD-2269F5.1,Unmatched,CTD-2269F5.1,,,
RECQL,-0.019888133,RECQL,Approved symbol,RECQL,RecQ like helicase,HGNC:9948,12p12.1
IHH,0.019884931,IHH,Approved symbol,IHH,Indian hedgehog signaling molecule,HGNC:5956,2q35
PLAU,-0.019877258,PLAU,Approved symbol,PLAU,"plasminogen activator, urokinase",HGNC:9052,10q22.2
OAF,0.019876702,OAF,Approved symbol,OAF,out at first homolog,HGNC:28752,11q23.3
RP5-1024G6.8,-0.019875462,RP5-1024G6.8,Unmatched,RP5-1024G6.8,,,
CPNE2,0.019874401,CPNE2,Approved symbol,CPNE2,copine 2,HGNC:2315,16q13
APLN,-0.019862472,APLN,Approved symbol,APLN,apelin,HGNC:16665,Xq26.1
SAMD13,0.019860329,SAMD13,Approved symbol,SAMD13,sterile alpha motif domain containing 13,HGNC:24582,1p31.1
GNB5,-0.019854009,GNB5,Approved symbol,GNB5,G protein subunit beta 5,HGNC:4401,15q21.2
ABCC1,-0.019852495,ABCC1,Approved symbol,ABCC1,ATP binding cassette subfamily C member 1,HGNC:51,16p13.11
TNFRSF8,-0.019852044,TNFRSF8,Approved symbol,TNFRSF8,TNF receptor superfamily member 8,HGNC:11923,1p36.22
OAS2,-0.019848166,OAS2,Approved symbol,OAS2,2'-5'-oligoadenylate synthetase 2,HGNC:8087,12q24.13
ENTPD1,-0.019842309,ENTPD1,Approved symbol,ENTPD1,ectonucleoside triphosphate diphosphohydrolase 1,HGNC:3363,10q24.1
ZDHHC23,0.019838565,ZDHHC23,Approved symbol,ZDHHC23,zinc finger DHHC-type palmitoyltransferase 23,HGNC:28654,3q13.31
MIAT,-0.019834381,MIAT,Approved symbol,MIAT,myocardial infarction associated transcript,HGNC:33425,22q12.1
MAZ,0.019834005,MAZ,Approved symbol,MAZ,MYC associated zinc finger protein,HGNC:6914,16p11.2
FCN3,-0.019814461,FCN3,Approved symbol,FCN3,ficolin 3,HGNC:3625,1p36.11
IL2RA,-0.019813657,IL2RA,Approved symbol,IL2RA,interleukin 2 receptor subunit alpha,HGNC:6008,10p15.1
SLC43A3,-0.019803655,SLC43A3,Approved symbol,SLC43A3,solute carrier family 43 member 3,HGNC:17466,11q12.1
TGFBI,-0.019792706,TGFBI,Approved symbol,TGFBI,transforming growth factor beta induced,HGNC:11771,5q31.1
TMEM63C,0.019790811,TMEM63C,Approved symbol,TMEM63C,transmembrane protein 63C,HGNC:23787,14q24.3
IFITM2,-0.019784154,IFITM2,Approved symbol,IFITM2,interferon induced transmembrane protein 2,HGNC:5413,11p15.5
TIMP1,-0.019782353,TIMP1,Approved symbol,TIMP1,TIMP metallopeptidase inhibitor 1,HGNC:11820,Xp11.3
ACSL4,-0.019780692,ACSL4,Approved symbol,ACSL4,acyl-CoA synthetase long chain family member 4,HGNC:3571,Xq23
PTAFR,-0.01976513,PTAFR,Approved symbol,PTAFR,platelet activating factor receptor,HGNC:9582,1p35.3
TNF,-0.019755527,TNF,Approved symbol,TNF,tumor necrosis factor,HGNC:11892,6p21.33
DAPP1,-0.019753617,DAPP1,Approved symbol,DAPP1,dual adaptor of phosphotyrosine and 3-phosphoinositides 1,HGNC:16500,4q23
CLCN4,-0.019753153,CLCN4,Approved symbol,CLCN4,chloride voltage-gated channel 4,HGNC:2022,Xp22.2
BCL2A1,-0.019746829,BCL2A1,Approved symbol,BCL2A1,BCL2 related protein A1,HGNC:991,15q25.1
LGI2,-0.019745633,LGI2,Approved symbol,LGI2,leucine rich repeat LGI family member 2,HGNC:18710,4p15.2
IL21R,-0.01973654,IL21R,Approved symbol,IL21R,interleukin 21 receptor,HGNC:6006,16p12.1
ASAP1,-0.019731596,ASAP1,Approved symbol,ASAP1,"ArfGAP with SH3 domain, ankyrin repeat and PH domain 1",HGNC:2720,8q24.21-q24.22
MT1M,0.019730459,MT1M,Approved symbol,MT1M,metallothionein 1M,HGNC:14296,16q13
TNC,-0.019729469,TNC,Approved symbol,TNC,tenascin C,HGNC:5318,9q33.1
FCRL5,-0.019727358,FCRL5,Approved symbol,FCRL5,Fc receptor like 5,HGNC:18508,1q23.1
STRA6,-0.019725447,STRA6,Approved symbol,STRA6,signaling receptor and transporter of retinol STRA6,HGNC:30650,15q24.1
PLEKHG2,-0.019717919,PLEKHG2,Approved symbol,PLEKHG2,pleckstrin homology and RhoGEF domain containing G2,HGNC:29515,19q13.2
THRB,0.019717266,THRB,Approved symbol,THRB,thyroid hormone receptor beta,HGNC:11799,3p24.2
NNMT,-0.019709019,NNMT,Approved symbol,NNMT,nicotinamide N-methyltransferase,HGNC:7861,11q23.2
ZADH2,0.01969549,ZADH2,Approved symbol,ZADH2,zinc binding alcohol dehydrogenase domain containing 2,HGNC:28697,18q22.3
IL1RL1,-0.0196931,IL1RL1,Approved symbol,IL1RL1,interleukin 1 receptor like 1,HGNC:5998,2q12.1
HSPD1P6,-0.019693099,HSPD1P6,Approved symbol,HSPD1P6,heat shock protein family D (Hsp60) member 1 pseudogene 6,HGNC:5267,3p22.2
ATP10D,-0.019688777,ATP10D,Approved symbol,ATP10D,ATPase phospholipid transporting 10D (putative),HGNC:13549,4p12
FMN2,0.019686117,FMN2,Approved symbol,FMN2,formin 2,HGNC:14074,1q43
SLC26A6,0.019684184,SLC26A6,Approved symbol,SLC26A6,solute carrier family 26 member 6,HGNC:14472,3p21.31
AC017002.1,-0.019683047,AC017002.1,Unmatched,AC017002.1,,,
PHLPP1,0.019677665,PHLPP1,Approved symbol,PHLPP1,PH domain and leucine rich repeat protein phosphatase 1,HGNC:20610,18q21.33
C21orf33,0.019676315,C21orf33,Previous symbol,GATD3A,glutamine amidotransferase like class 1 domain containing 3A,HGNC:1273,21q22.3
LCP2,-0.019676162,LCP2,Approved symbol,LCP2,lymphocyte cytosolic protein 2,HGNC:6529,5q35.1
CIITA,-0.019672485,CIITA,Approved symbol,CIITA,class II major histocompatibility complex transactivator,HGNC:7067,16p13.13
SRGAP2,-0.0196696,SRGAP2,Approved symbol,SRGAP2,SLIT-ROBO Rho GTPase activating protein 2,HGNC:19751,1q32.1
SCGN,0.019667489,SCGN,Approved symbol,SCGN,"secretagogin, EF-hand calcium binding protein",HGNC:16941,6p22.2
CTD-2008P7.9,0.019659289,CTD-2008P7.9,Unmatched,CTD-2008P7.9,,,
ZNF704,0.019652819,ZNF704,Approved symbol,ZNF704,zinc finger protein 704,HGNC:32291,8q21.13
F2R,-0.019650169,F2R,Approved symbol,F2R,coagulation factor II thrombin receptor,HGNC:3537,5q13.3
FITM2,0.019647224,FITM2,Approved symbol,FITM2,fat storage inducing transmembrane protein 2,HGNC:16135,20q13.12
SWAP70,-0.019640248,SWAP70,Approved symbol,SWAP70,switching B cell complex subunit SWAP70,HGNC:17070,11p15.4
AQP9,-0.019638311,AQP9,Approved symbol,AQP9,aquaporin 9,HGNC:643,15q21.3
UBD,-0.019637703,UBD,Approved symbol,UBD,ubiquitin D,HGNC:18795,6p22.1
ICAM1,-0.019637169,ICAM1,Approved symbol,ICAM1,intercellular adhesion molecule 1,HGNC:5344,19p13.2
GPR132,-0.019632825,GPR132,Approved symbol,GPR132,G protein-coupled receptor 132,HGNC:17482,14q32.33
SLC2A3,-0.019630095,SLC2A3,Approved symbol,SLC2A3,solute carrier family 2 member 3,HGNC:11007,12p13.31
OSMR,-0.019629699,OSMR,Approved symbol,OSMR,oncostatin M receptor,HGNC:8507,5p13.1
IGHG3,-0.019627891,IGHG3,Approved symbol,IGHG3,immunoglobulin heavy constant gamma 3 (G3m marker),HGNC:5527,14q32.33
IL23A,-0.019627575,IL23A,Approved symbol,IL23A,interleukin 23 subunit alpha,HGNC:15488,12q13.3
SERPINB3,-0.019623896,SERPINB3,Approved symbol,SERPINB3,serpin family B member 3,HGNC:10569,18q21.33
LIMS1,-0.019613183,LIMS1,Approved symbol,LIMS1,LIM zinc finger domain containing 1,HGNC:6616,2q12.3
TMX3,-0.019607137,TMX3,Approved symbol,TMX3,thioredoxin related transmembrane protein 3,HGNC:24718,18q22.1
TAPSAR1,-0.019606006,TAPSAR1,Previous symbol,PSMB8-AS1,PSMB8 antisense RNA 1 (head to head),HGNC:39758,6p21.32
AC106876.2,0.01960266,AC106876.2,Unmatched,AC106876.2,,,
CSRP2,-0.019598829,CSRP2,Approved symbol,CSRP2,cysteine and glycine rich protein 2,HGNC:2470,12q21.2
IFI44,-0.019598642,IFI44,Approved symbol,IFI44,interferon induced protein 44,HGNC:16938,1p31.1
SPECC1L,0.019598634,SPECC1L,Approved symbol,SPECC1L,sperm antigen with calponin homology and coiled-coil domains 1 like,HGNC:29022,22q11.23
MMP9,-0.01959764,MMP9,Approved symbol,MMP9,matrix metallopeptidase 9,HGNC:7176,20q13.12
MOSPD1,0.019594466,MOSPD1,Approved symbol,MOSPD1,motile sperm domain containing 1,HGNC:25235,Xq26.3
ABCC6P2,0.019592569,ABCC6P2,Approved symbol,ABCC6P2,ATP binding cassette subfamily C member 6 pseudogene 2,HGNC:33353,16p13.11
PLXNA2,0.019588967,PLXNA2,Approved symbol,PLXNA2,plexin A2,HGNC:9100,1q32.2
ADAM8,-0.019583951,ADAM8,Approved symbol,ADAM8,ADAM metallopeptidase domain 8,HGNC:215,10q26.3
FPR1,-0.019571234,FPR1,Approved symbol,FPR1,formyl peptide receptor 1,HGNC:3826,19q13.41
SPPL3,0.019569644,SPPL3,Approved symbol,SPPL3,signal peptide peptidase like 3,HGNC:30424,12q24.31
PPP2R3A,0.019568587,PPP2R3A,Approved symbol,PPP2R3A,protein phosphatase 2 regulatory subunit B''alpha,HGNC:9307,3q22.2-q22.3
RXFP4,0.019568469,RXFP4,Approved symbol,RXFP4,relaxin family peptide/INSL5 receptor 4,HGNC:14666,1q22
PLA2G12A,0.019564926,PLA2G12A,Approved symbol,PLA2G12A,phospholipase A2 group XIIA,HGNC:18554,4q25
UCK2,0.019561217,UCK2,Approved symbol,UCK2,uridine-cytidine kinase 2,HGNC:12562,1q24.1
LPCAT1,-0.019560863,LPCAT1,Approved symbol,LPCAT1,lysophosphatidylcholine acyltransferase 1,HGNC:25718,5p15.33
RP11-316P17.2,-0.019559924,RP11-316P17.2,Unmatched,RP11-316P17.2,,,
BGN,-0.019559425,BGN,Approved symbol,BGN,biglycan,HGNC:1044,Xq28
RPL10L,0.019559401,RPL10L,Approved symbol,RPL10L,ribosomal protein L10 like,HGNC:17976,14q21.2
IMPA2,0.019559304,IMPA2,Approved symbol,IMPA2,inositol monophosphatase 2,HGNC:6051,18p11.21
EFNA4,0.019556951,EFNA4,Approved symbol,EFNA4,ephrin A4,HGNC:3224,1q21.3
MTL5,0.01955233,MTL5,Previous symbol,TESMIN,testis expressed metallothionein like protein,HGNC:7446,11q13.3
C1orf172,0.019551179,C1orf172,Previous symbol,KDF1,keratinocyte differentiation factor 1,HGNC:26624,1p36.11
LCNL1,-0.019550532,LCNL1,Approved symbol,LCNL1,lipocalin like 1,HGNC:34436,9q34.3
TREM1,-0.019548456,TREM1,Approved symbol,TREM1,triggering receptor expressed on myeloid cells 1,HGNC:17760,6p21.1
VSIG10,0.019543758,VSIG10,Approved symbol,VSIG10,V-set and immunoglobulin domain containing 10,HGNC:26078,12q24.23
RARB,-0.019528862,RARB,Approved symbol,RARB,retinoic acid receptor beta,HGNC:9865,3p24.2
C1orf216,-0.019525644,C1orf216,Approved symbol,C1orf216,chromosome 1 open reading frame 216,HGNC:26800,1p34.3
ZBTB32,-0.019524236,ZBTB32,Approved symbol,ZBTB32,zinc finger and BTB domain containing 32,HGNC:16763,19q13.12
RP5-837J1.2,0.019513904,RP5-837J1.2,Unmatched,RP5-837J1.2,,,
MSC,-0.019512312,MSC,Approved symbol,MSC,musculin,HGNC:7321,8q13.3
USP35,-0.019511502,USP35,Approved symbol,USP35,ubiquitin specific peptidase 35,HGNC:20061,11q14.1
EPB41L4B,0.019509772,EPB41L4B,Approved symbol,EPB41L4B,erythrocyte membrane protein band 4.1 like 4B,HGNC:19818,9q31.3
AC010149.4,-0.019502856,AC010149.4,Unmatched,AC010149.4,,,
ADAMTS4,-0.019501533,ADAMTS4,Approved symbol,ADAMTS4,ADAM metallopeptidase with thrombospondin type 1 motif 4,HGNC:220,1q23.3
HSH2D,-0.019501518,HSH2D,Approved symbol,HSH2D,hematopoietic SH2 domain containing,HGNC:24920,19p13.11
C2orf54,0.019493061,C2orf54,Previous symbol,MAB21L4,mab-21 like 4,HGNC:26216,2q37.3
RHOQ,-0.01949124,RHOQ,Approved symbol,RHOQ,ras homolog family member Q,HGNC:17736,2p21
ASIC2,0.019470492,ASIC2,Approved symbol,ASIC2,acid sensing ion channel subunit 2,HGNC:99,17q11.2-q12
PDE4B,-0.01946878,PDE4B,Approved symbol,PDE4B,phosphodiesterase 4B,HGNC:8781,1p31.3
RP11-303E16.2,-0.019457447,RP11-303E16.2,Unmatched,RP11-303E16.2,,,
GPN2,0.019454736,GPN2,Approved symbol,GPN2,GPN-loop GTPase 2,HGNC:25513,1p36.11
PPP1R26-AS1,0.019450165,PPP1R26-AS1,Approved symbol,PPP1R26-AS1,PPP1R26 antisense RNA 1,HGNC:48717,9q34.3
CTC-241F20.3,-0.019449081,CTC-241F20.3,Unmatched,CTC-241F20.3,,,
FAM210B,0.019448669,FAM210B,Approved symbol,FAM210B,family with sequence similarity 210 member B,HGNC:16102,20q13.2
LEPRE1,-0.019445757,LEPRE1,Previous symbol,P3H1,prolyl 3-hydroxylase 1,HGNC:19316,1p34.2
MAML3,0.019444939,MAML3,Approved symbol,MAML3,mastermind like transcriptional coactivator 3,HGNC:16272,4q31.1
RP11-396O20.2,0.019444905,RP11-396O20.2,Unmatched,RP11-396O20.2,,,
THEMIS2,-0.019444096,THEMIS2,Approved symbol,THEMIS2,thymocyte selection associated family member 2,HGNC:16839,1p35.3
FANCA,-0.019431706,FANCA,Approved symbol,FANCA,FA complementation group A,HGNC:3582,16q24.3
RASSF5,-0.019431329,RASSF5,Approved symbol,RASSF5,Ras association domain family member 5,HGNC:17609,1q32.1
OLFM4,-0.019431058,OLFM4,Approved symbol,OLFM4,olfactomedin 4,HGNC:17190,13q14.3
TSPAN7,0.019430243,TSPAN7,Approved symbol,TSPAN7,tetraspanin 7,HGNC:11854,Xp11.4
IL21,-0.019428335,IL21,Approved symbol,IL21,interleukin 21,HGNC:6005,4q27
ZMYND15,-0.019427863,ZMYND15,Approved symbol,ZMYND15,zinc finger MYND-type containing 15,HGNC:20997,17p13.2
MVB12B,0.019426497,MVB12B,Approved symbol,MVB12B,multivesicular body subunit 12B,HGNC:23368,9q33.3
ST3GAL5,-0.019411997,ST3GAL5,Approved symbol,ST3GAL5,"ST3 beta-galactoside alpha-2,3-sialyltransferase 5",HGNC:10872,2p11.2
GPR65,-0.019404443,GPR65,Approved symbol,GPR65,G protein-coupled receptor 65,HGNC:4517,14q31.3
FAM92A1,-0.019395054,FAM92A1,Previous symbol,CIBAR1,CBY1 interacting BAR domain containing 1,HGNC:30452,8q22.1
FJX1,-0.019394438,FJX1,Approved symbol,FJX1,four-jointed box kinase 1,HGNC:17166,11p13
KIAA1737,0.019388713,KIAA1737,Previous symbol,CIPC,CLOCK interacting pacemaker,HGNC:20365,14q24.3
RP11-536O18.2,-0.019388256,RP11-536O18.2,Unmatched,RP11-536O18.2,,,
CHI3L1,-0.019387889,CHI3L1,Approved symbol,CHI3L1,chitinase 3 like 1,HGNC:1932,1q32.1
OTOP2,0.019386848,OTOP2,Approved symbol,OTOP2,otopetrin 2,HGNC:19657,17q25.1
TNFAIP2,-0.019385551,TNFAIP2,Approved symbol,TNFAIP2,TNF alpha induced protein 2,HGNC:11895,14q32.32
RP11-526F3.1,0.019382422,RP11-526F3.1,Unmatched,RP11-526F3.1,,,
IKBIP,-0.019381655,IKBIP,Approved symbol,IKBIP,IKBKB interacting protein,HGNC:26430,12q23.1
FRAT2,0.019380477,FRAT2,Approved symbol,FRAT2,FRAT regulator of WNT signaling pathway 2,HGNC:16048,10q24.1
AC066593.1,0.019380455,AC066593.1,Unmatched,AC066593.1,,,
INTS3,-0.019374761,INTS3,Approved symbol,INTS3,integrator complex subunit 3,HGNC:26153,1q21.3
CTA-384D8.34,-0.019374527,CTA-384D8.34,Unmatched,CTA-384D8.34,,,
OR7E12P,-0.019373098,OR7E12P,Approved symbol,OR7E12P,olfactory receptor family 7 subfamily E member 12 pseudogene,HGNC:8383,11p15.4
STAT4,-0.019372374,STAT4,Approved symbol,STAT4,signal transducer and activator of transcription 4,HGNC:11365,2q32.2-q32.3
PPP1R18,-0.019368151,PPP1R18,Approved symbol,PPP1R18,protein phosphatase 1 regulatory subunit 18,HGNC:29413,6p21.33
TESC,-0.019367544,TESC,Approved symbol,TESC,tescalcin,HGNC:26065,12q24.22
CLDN18,-0.019364285,CLDN18,Approved symbol,CLDN18,claudin 18,HGNC:2039,3q22.3
CDH3,-0.019363561,CDH3,Approved symbol,CDH3,cadherin 3,HGNC:1762,16q22.1
PNKD,0.019360145,PNKD,Approved symbol,PNKD,PNKD metallo-beta-lactamase domain containing,HGNC:9153,2q35
GZMB,-0.019359631,GZMB,Approved symbol,GZMB,granzyme B,HGNC:4709,14q12
LCP1,-0.019357683,LCP1,Approved symbol,LCP1,lymphocyte cytosolic protein 1,HGNC:6528,13q14.13
ADCY6,0.019357051,ADCY6,Approved symbol,ADCY6,adenylate cyclase 6,HGNC:237,12q13.12
SLC25A5-AS1,0.019352967,SLC25A5-AS1,Approved symbol,SLC25A5-AS1,SLC25A5 antisense RNA 1,HGNC:43438,Xq24
DOK3,-0.019351113,DOK3,Approved symbol,DOK3,docking protein 3,HGNC:24583,5q35.3
CTD-2521M24.9,-0.019349011,CTD-2521M24.9,Unmatched,CTD-2521M24.9,,,
ISX,0.019343603,ISX,Approved symbol,ISX,intestine specific homeobox,HGNC:28084,22q12.3
CBX2,-0.019337998,CBX2,Approved symbol,CBX2,chromobox 2,HGNC:1552,17q25.3
BCL6,-0.01933291,BCL6,Approved symbol,BCL6,BCL6 transcription repressor,HGNC:1001,3q27.3
TENM4,-0.019332658,TENM4,Approved symbol,TENM4,teneurin transmembrane protein 4,HGNC:29945,11q14.1
CYSLTR2,-0.01932768,CYSLTR2,Approved symbol,CYSLTR2,cysteinyl leukotriene receptor 2,HGNC:18274,13q14.2
EFCAB5,0.019324428,EFCAB5,Approved symbol,EFCAB5,EF-hand calcium binding domain 5,HGNC:24801,17q11.2
GAB1,0.019316162,GAB1,Approved symbol,GAB1,GRB2 associated binding protein 1,HGNC:4066,4q31.21
CLYBL,0.019309707,CLYBL,Approved symbol,CLYBL,citramalyl-CoA lyase,HGNC:18355,13q32.3
PIGZ,0.019307102,PIGZ,Approved symbol,PIGZ,phosphatidylinositol glycan anchor biosynthesis class Z,HGNC:30596,3q29
ARHGAP5-AS1,0.019305984,ARHGAP5-AS1,Approved symbol,ARHGAP5-AS1,ARHGAP5 antisense RNA 1 (head to head),HGNC:20279,14q12
MIR4454,-0.01930246,MIR4454,Approved symbol,MIR4454,microRNA 4454,HGNC:41553,4q32.2
RP4-758J24.5,0.019297302,RP4-758J24.5,Unmatched,RP4-758J24.5,,,
BICD1,-0.019295499,BICD1,Approved symbol,BICD1,BICD cargo adaptor 1,HGNC:1049,12p11.21
CEP135,-0.019288579,CEP135,Approved symbol,CEP135,centrosomal protein 135,HGNC:29086,4q12
EGR3,-0.019287026,EGR3,Approved symbol,EGR3,early growth response 3,HGNC:3240,8p21.3
ADAMTS6,-0.019277959,ADAMTS6,Approved symbol,ADAMTS6,ADAM metallopeptidase with thrombospondin type 1 motif 6,HGNC:222,5q12.3
NDUFA10,0.019277615,NDUFA10,Approved symbol,NDUFA10,NADH:ubiquinone oxidoreductase subunit A10,HGNC:7684,2q37.3
AMT,0.019273775,AMT,Approved symbol,AMT,aminomethyltransferase,HGNC:473,3p21.31
IL26,-0.019271833,IL26,Approved symbol,IL26,interleukin 26,HGNC:17119,12q15
ZC3H14,0.019271782,ZC3H14,Approved symbol,ZC3H14,zinc finger CCCH-type containing 14,HGNC:20509,14q31.3
RP11-33O4.1,0.01926523,RP11-33O4.1,Unmatched,RP11-33O4.1,,,
RNF185,0.019262873,RNF185,Approved symbol,RNF185,ring finger protein 185,HGNC:26783,22q12.2
ZNF844,0.019262684,ZNF844,Approved symbol,ZNF844,zinc finger protein 844,HGNC:25932,19p13.2
PDE10A,-0.019251101,PDE10A,Approved symbol,PDE10A,phosphodiesterase 10A,HGNC:8772,6q27
CDX2,0.019248935,CDX2,Approved symbol,CDX2,caudal type homeobox 2,HGNC:1806,13q12.2
MMD,-0.019248143,MMD,Approved symbol,MMD,monocyte to macrophage differentiation associated,HGNC:7153,17q22
EMR1,-0.019247068,EMR1,Previous symbol,ADGRE1,adhesion G protein-coupled receptor E1,HGNC:3336,19p13.3-p13.2
DUSP14,-0.01924669,DUSP14,Approved symbol,DUSP14,dual specificity phosphatase 14,HGNC:17007,17q12
SCAP,0.019242854,SCAP,Approved symbol,SCAP,SREBF chaperone,HGNC:30634,3p21.31
BMP3,0.019241269,BMP3,Approved symbol,BMP3,bone morphogenetic protein 3,HGNC:1070,4q21.21
UNC5CL,-0.01923508,UNC5CL,Approved symbol,UNC5CL,unc-5 family C-terminal like,HGNC:21203,6p21.1
CHST11,-0.019233448,CHST11,Approved symbol,CHST11,carbohydrate sulfotransferase 11,HGNC:17422,12q23.3
FER1L4,-0.019232508,FER1L4,Approved symbol,FER1L4,fer-1 like family member 4 (pseudogene),HGNC:15801,20q11.22
GRK5,-0.019229919,GRK5,Approved symbol,GRK5,G protein-coupled receptor kinase 5,HGNC:4544,10q26.11
SLC7A5,-0.019228415,SLC7A5,Approved symbol,SLC7A5,solute carrier family 7 member 5,HGNC:11063,16q24.2
LGALS12,-0.019228117,LGALS12,Approved symbol,LGALS12,galectin 12,HGNC:15788,11q12.3
MSNP1,-0.01922786,MSNP1,Approved symbol,MSNP1,moesin pseudogene 1,HGNC:7374,5p14.1
PPFIBP2,0.019222944,PPFIBP2,Approved symbol,PPFIBP2,PPFIA binding protein 2,HGNC:9250,11p15.4
EAPP,0.019221078,EAPP,Approved symbol,EAPP,E2F associated phosphoprotein,HGNC:19312,14q13.1
KRT80,-0.019218532,KRT80,Approved symbol,KRT80,keratin 80,HGNC:27056,12q13.13
CHP2,0.019217738,CHP2,Approved symbol,CHP2,calcineurin like EF-hand protein 2,HGNC:24927,16p12.2
CDC7,-0.019214122,CDC7,Approved symbol,CDC7,cell division cycle 7,HGNC:1745,1p22.1
EHD3,-0.019210457,EHD3,Approved symbol,EHD3,EH domain containing 3,HGNC:3244,2p23.1
TNFAIP8,-0.019207454,TNFAIP8,Approved symbol,TNFAIP8,TNF alpha induced protein 8,HGNC:17260,5q23.1
PRR15,0.019201153,PRR15,Approved symbol,PRR15,proline rich 15,HGNC:22310,7p14.3
LAMTOR4,0.019200721,LAMTOR4,Approved symbol,LAMTOR4,"late endosomal/lysosomal adaptor, MAPK and MTOR activator 4",HGNC:33772,7q22.1
CEP164,-0.019198807,CEP164,Approved symbol,CEP164,centrosomal protein 164,HGNC:29182,11q23.3
PHEX,-0.019194331,PHEX,Approved symbol,PHEX,phosphate regulating endopeptidase homolog X-linked,HGNC:8918,Xp22.11
DUSP10,-0.019193604,DUSP10,Approved symbol,DUSP10,dual specificity phosphatase 10,HGNC:3065,1q41
SNX20,-0.019191941,SNX20,Approved symbol,SNX20,sorting nexin 20,HGNC:30390,16q12.1
FMNL1,-0.019191314,FMNL1,Approved symbol,FMNL1,formin like 1,HGNC:1212,17q21.31
CENPP,-0.019185533,CENPP,Approved symbol,CENPP,centromere protein P,HGNC:32933,9q22.31
ADAM19,-0.019184568,ADAM19,Approved symbol,ADAM19,ADAM metallopeptidase domain 19,HGNC:197,5q33.3
SLA,-0.019181354,SLA,Approved symbol,SLA,Src like adaptor,HGNC:10902,8q24.22
CXCR2,-0.019178904,CXCR2,Approved symbol,CXCR2,C-X-C motif chemokine receptor 2,HGNC:6027,2q35
TAGAP,-0.019177212,TAGAP,Approved symbol,TAGAP,T cell activation RhoGTPase activating protein,HGNC:15669,6q25.3
DAZL,-0.019169054,DAZL,Approved symbol,DAZL,deleted in azoospermia like,HGNC:2685,3p24.3
ALOXE3,-0.019166895,ALOXE3,Approved symbol,ALOXE3,arachidonate lipoxygenase 3,HGNC:13743,17p13.1
CHRNA1,0.019165527,CHRNA1,Approved symbol,CHRNA1,cholinergic receptor nicotinic alpha 1 subunit,HGNC:1955,2q31.1
LINC00152,-0.019164241,LINC00152,Previous symbol,CYTOR,cytoskeleton regulator RNA,HGNC:28717,2p11.2
C9orf139,-0.019163301,C9orf139,Approved symbol,C9orf139,chromosome 9 putative open reading frame 139,HGNC:31426,9q34.3
4-Mar,0.019163246,4-Mar,Unmatched,4-Mar,,,
GJA5,-0.019161665,GJA5,Approved symbol,GJA5,gap junction protein alpha 5,HGNC:4279,1q21.2
AMER3,0.019158672,AMER3,Approved symbol,AMER3,APC membrane recruitment protein 3,HGNC:26771,2q21.1
FPR2,-0.019151795,FPR2,Approved symbol,FPR2,formyl peptide receptor 2,HGNC:3827,19q13.41
LILRA5,-0.019139383,LILRA5,Approved symbol,LILRA5,leukocyte immunoglobulin like receptor A5,HGNC:16309,19q13.42
RASSF1,-0.019137532,RASSF1,Approved symbol,RASSF1,Ras association domain family member 1,HGNC:9882,3p21.31
CDHR1,0.01913635,CDHR1,Approved symbol,CDHR1,cadherin related family member 1,HGNC:14550,10q23.1
FZD8,0.019132996,FZD8,Approved symbol,FZD8,frizzled class receptor 8,HGNC:4046,10p11.21
MYO1G,-0.019124479,MYO1G,Approved symbol,MYO1G,myosin IG,HGNC:13880,7p13
COQ9,0.019124388,COQ9,Approved symbol,COQ9,coenzyme Q9,HGNC:25302,16q21
GUCY1B3,-0.019122939,GUCY1B3,Previous symbol,GUCY1B1,guanylate cyclase 1 soluble subunit beta 1,HGNC:4687,4q32.1
ITGA5,-0.019122907,ITGA5,Approved symbol,ITGA5,integrin subunit alpha 5,HGNC:6141,12q13.13
HOXD-AS1,0.019122799,HOXD-AS1,Previous symbol,HAGLR,HOXD antisense growth-associated long non-coding RNA,HGNC:43755,2q31.1
PPARGC1B,0.019121762,PPARGC1B,Approved symbol,PPARGC1B,PPARG coactivator 1 beta,HGNC:30022,5q32
GPCPD1,-0.019121236,GPCPD1,Approved symbol,GPCPD1,glycerophosphocholine phosphodiesterase 1,HGNC:26957,20p12.3
BLVRA,-0.019117189,BLVRA,Approved symbol,BLVRA,biliverdin reductase A,HGNC:1062,7p13
APOL3,-0.019116176,APOL3,Approved symbol,APOL3,apolipoprotein L3,HGNC:14868,22q12.3
TMEM255B,-0.019114741,TMEM255B,Approved symbol,TMEM255B,transmembrane protein 255B,HGNC:28297,13q34
RP11-532F12.5,0.019113666,RP11-532F12.5,Alias symbol,SPINT1-AS1,SPINT1 antisense RNA 1,HGNC:53162,15q15.1
ALDH5A1,0.019110578,ALDH5A1,Approved symbol,ALDH5A1,aldehyde dehydrogenase 5 family member A1,HGNC:408,6p22.3
PGAP3,0.019110298,PGAP3,Approved symbol,PGAP3,post-GPI attachment to proteins phospholipase 3,HGNC:23719,17q12
MMP10,-0.019109703,MMP10,Approved symbol,MMP10,matrix metallopeptidase 10,HGNC:7156,11q22.2
FAM134A,0.019104366,FAM134A,Previous symbol,RETREG2,reticulophagy regulator family member 2,HGNC:28450,2q35
STAT2,-0.01910336,STAT2,Approved symbol,STAT2,signal transducer and activator of transcription 2,HGNC:11363,12q13.3
AFG3L2,0.019085725,AFG3L2,Approved symbol,AFG3L2,AFG3 like matrix AAA peptidase subunit 2,HGNC:315,18p11.21
ACADSB,0.019085134,ACADSB,Approved symbol,ACADSB,acyl-CoA dehydrogenase short/branched chain,HGNC:91,10q26.13
ARHGAP36,0.01907736,ARHGAP36,Approved symbol,ARHGAP36,Rho GTPase activating protein 36,HGNC:26388,Xq26.1
RGS5,-0.019076535,RGS5,Approved symbol,RGS5,regulator of G protein signaling 5,HGNC:10001,1q23.3
PTPRF,0.019075573,PTPRF,Approved symbol,PTPRF,protein tyrosine phosphatase receptor type F,HGNC:9670,1p34.2
KCNJ15,-0.019069305,KCNJ15,Approved symbol,KCNJ15,potassium inwardly rectifying channel subfamily J member 15,HGNC:6261,21q22.13-q22.2
DONSON,-0.019068853,DONSON,Approved symbol,DONSON,DNA replication fork stabilization factor DONSON,HGNC:2993,21q22.11
KPTN,-0.019063806,KPTN,Approved symbol,KPTN,"kaptin, actin binding protein",HGNC:6404,19q13.32
GPR176,-0.019054915,GPR176,Approved symbol,GPR176,G protein-coupled receptor 176,HGNC:32370,15q14-q15.1
SH3BP5,-0.01905052,SH3BP5,Approved symbol,SH3BP5,SH3 domain binding protein 5,HGNC:10827,3p25.1
RP1-229K20.5,-0.019046489,RP1-229K20.5,Unmatched,RP1-229K20.5,,,
IL4I1,-0.019046316,IL4I1,Approved symbol,IL4I1,interleukin 4 induced 1,HGNC:19094,19q13.33
TOMM20,0.019043453,TOMM20,Approved symbol,TOMM20,translocase of outer mitochondrial membrane 20,HGNC:20947,1q42.3
CKB,0.019036211,CKB,Approved symbol,CKB,creatine kinase B,HGNC:1991,14q32.33
AAMDC,0.01902678,AAMDC,Approved symbol,AAMDC,adipogenesis associated Mth938 domain containing,HGNC:30205,11q14.1
GATA6,0.019026048,GATA6,Approved symbol,GATA6,GATA binding protein 6,HGNC:4174,18q11.2
SELL,-0.019020267,SELL,Approved symbol,SELL,selectin L,HGNC:10720,1q24.2
PDCD1,-0.019017667,PDCD1,Approved symbol,PDCD1,programmed cell death 1,HGNC:8760,2q37.3
PLEKHO1,-0.019016069,PLEKHO1,Approved symbol,PLEKHO1,pleckstrin homology domain containing O1,HGNC:24310,1q21.2
KIAA1191,0.019015732,KIAA1191,Approved symbol,KIAA1191,KIAA1191,HGNC:29209,5q35.2
RP11-876N24.5,-0.019008099,RP11-876N24.5,Unmatched,RP11-876N24.5,,,
RNF152,0.019001904,RNF152,Approved symbol,RNF152,ring finger protein 152,HGNC:26811,18q21.33
CD93,-0.019001703,CD93,Approved symbol,CD93,CD93 molecule,HGNC:15855,20p11.21
KIFC3,-0.018998479,KIFC3,Approved symbol,KIFC3,kinesin family member C3,HGNC:6326,16q21
TPBGL,-0.01899574,TPBGL,Approved symbol,TPBGL,trophoblast glycoprotein like,HGNC:44159,11q13.4
CNTN3,0.018992771,CNTN3,Approved symbol,CNTN3,contactin 3,HGNC:2173,3p12.3
IL17A,-0.018989836,IL17A,Approved symbol,IL17A,interleukin 17A,HGNC:5981,6p12.2
RBPMS-AS1,-0.018989042,RBPMS-AS1,Approved symbol,RBPMS-AS1,RBPMS antisense RNA 1,HGNC:48721,8p12
TACC3,-0.018987061,TACC3,Approved symbol,TACC3,transforming acidic coiled-coil containing protein 3,HGNC:11524,4p16.3
FAIM2,-0.018984124,FAIM2,Approved symbol,FAIM2,Fas apoptotic inhibitory molecule 2,HGNC:17067,12q13.12
BZW2,0.018972731,BZW2,Approved symbol,BZW2,basic leucine zipper and W2 domains 2,HGNC:18808,7p21.1
RCHY1,0.018969456,RCHY1,Approved symbol,RCHY1,ring finger and CHY zinc finger domain containing 1,HGNC:17479,4q21.1
TMEM14C,0.018962555,TMEM14C,Approved symbol,TMEM14C,transmembrane protein 14C,HGNC:20952,6p24.2
ITPKA,0.018953393,ITPKA,Approved symbol,ITPKA,inositol-trisphosphate 3-kinase A,HGNC:6178,15q15.1
WDR66,-0.018953221,WDR66,Previous symbol,CFAP251,cilia and flagella associated protein 251,HGNC:28506,12q24.31
SP110,-0.018953203,SP110,Approved symbol,SP110,SP110 nuclear body protein,HGNC:5401,2q37.1
MMP13,-0.018953115,MMP13,Approved symbol,MMP13,matrix metallopeptidase 13,HGNC:7159,11q22.2
CSGALNACT1,-0.018951052,CSGALNACT1,Approved symbol,CSGALNACT1,chondroitin sulfate N-acetylgalactosaminyltransferase 1,HGNC:24290,8p21.3
RP11-15H20.5,0.018950403,RP11-15H20.5,Unmatched,RP11-15H20.5,,,
HOXB7,0.018949608,HOXB7,Approved symbol,HOXB7,homeobox B7,HGNC:5118,17q21.32
SERPINB9,-0.018948628,SERPINB9,Approved symbol,SERPINB9,serpin family B member 9,HGNC:8955,6p25.2
PLEK,-0.018947464,PLEK,Approved symbol,PLEK,pleckstrin,HGNC:9070,2p14
DNMT1,-0.018947421,DNMT1,Approved symbol,DNMT1,DNA methyltransferase 1,HGNC:2976,19p13.2
FGD2,-0.018946989,FGD2,Approved symbol,FGD2,"FYVE, RhoGEF and PH domain containing 2",HGNC:3664,6p21.2
VIPR1,0.018944861,VIPR1,Approved symbol,VIPR1,vasoactive intestinal peptide receptor 1,HGNC:12694,3p22.1
MDFI,-0.018944442,MDFI,Approved symbol,MDFI,MyoD family inhibitor,HGNC:6967,6p21.1
HAUS1,-0.018938249,HAUS1,Approved symbol,HAUS1,HAUS augmin like complex subunit 1,HGNC:25174,18q21.1
AC011526.1,-0.018938059,AC011526.1,Unmatched,AC011526.1,,,
MRAS,-0.018937786,MRAS,Approved symbol,MRAS,muscle RAS oncogene homolog,HGNC:7227,3q22.3
RP3-406A7.7,0.018935521,RP3-406A7.7,Unmatched,RP3-406A7.7,,,
PIM2,-0.018934808,PIM2,Approved symbol,PIM2,"Pim-2 proto-oncogene, serine/threonine kinase",HGNC:8987,Xp11.23
FN3K,0.018934296,FN3K,Approved symbol,FN3K,fructosamine 3 kinase,HGNC:24822,17q25.3
SPP1,-0.018934175,SPP1,Approved symbol,SPP1,secreted phosphoprotein 1,HGNC:11255,4q22.1
LOXL2,-0.018932983,LOXL2,Approved symbol,LOXL2,lysyl oxidase like 2,HGNC:6666,8p21.3
ANK1,-0.018930102,ANK1,Approved symbol,ANK1,ankyrin 1,HGNC:492,8p11.21
RP11-22C11.2,0.018925579,RP11-22C11.2,Unmatched,RP11-22C11.2,,,
ZNF350,0.018925349,ZNF350,Approved symbol,ZNF350,zinc finger protein 350,HGNC:16656,19q13.41
CLSTN3,-0.018923014,CLSTN3,Approved symbol,CLSTN3,calsyntenin 3,HGNC:18371,12p13.31
CYTH4,-0.018922577,CYTH4,Approved symbol,CYTH4,cytohesin 4,HGNC:9505,22q13.1
CSF3R,-0.018921713,CSF3R,Approved symbol,CSF3R,colony stimulating factor 3 receptor,HGNC:2439,1p34.3
VLDLR,0.018918997,VLDLR,Approved symbol,VLDLR,very low density lipoprotein receptor,HGNC:12698,9p24.2
GSTO2,0.018914754,GSTO2,Approved symbol,GSTO2,glutathione S-transferase omega 2,HGNC:23064,10q25.1
CXCR1,-0.018912685,CXCR1,Approved symbol,CXCR1,C-X-C motif chemokine receptor 1,HGNC:6026,2q35
SSTR1,0.018911255,SSTR1,Approved symbol,SSTR1,somatostatin receptor 1,HGNC:11330,14q13
S100A9,-0.01890284,S100A9,Approved symbol,S100A9,S100 calcium binding protein A9,HGNC:10499,1q21.3
RP5-1057J7.7,0.018894618,RP5-1057J7.7,Unmatched,RP5-1057J7.7,,,
AJUBA,-0.018893943,AJUBA,Approved symbol,AJUBA,ajuba LIM protein,HGNC:20250,14q11.2
C6orf136,0.018891345,C6orf136,Approved symbol,C6orf136,chromosome 6 open reading frame 136,HGNC:21301,6p21.33
RP1-228P16.5,0.018890076,RP1-228P16.5,Unmatched,RP1-228P16.5,,,
TREML2,-0.018889577,TREML2,Approved symbol,TREML2,triggering receptor expressed on myeloid cells like 2,HGNC:21092,6p21.1
THBD,-0.018886871,THBD,Approved symbol,THBD,thrombomodulin,HGNC:11784,20p11.21
RNGTT,-0.018881217,RNGTT,Approved symbol,RNGTT,RNA guanylyltransferase and 5'-phosphatase,HGNC:10073,6q15
RP4-550H1.4,0.018872605,RP4-550H1.4,Unmatched,RP4-550H1.4,,,
FAM101B,-0.018867564,FAM101B,Previous symbol,RFLNB,refilin B,HGNC:28705,17p13.3
SRGAP1,0.018863368,SRGAP1,Approved symbol,SRGAP1,SLIT-ROBO Rho GTPase activating protein 1,HGNC:17382,12q14.2
ACSF2,0.018852853,ACSF2,Approved symbol,ACSF2,acyl-CoA synthetase family member 2,HGNC:26101,17q21.33
HNF1A-AS1,0.018851981,HNF1A-AS1,Approved symbol,HNF1A-AS1,HNF1A antisense RNA 1,HGNC:26785,12q24.31
AGBL5,0.018850914,AGBL5,Approved symbol,AGBL5,ATP/GTP binding protein like 5,HGNC:26147,2p23.3
PGAP2,0.018850703,PGAP2,Approved symbol,PGAP2,post-GPI attachment to proteins 2,HGNC:17893,11p15.4
RP11-214O1.2,-0.018844243,RP11-214O1.2,Unmatched,RP11-214O1.2,,,
RP11-150O12.3,0.018839887,RP11-150O12.3,Unmatched,RP11-150O12.3,,,
IL12RB1,-0.018837616,IL12RB1,Approved symbol,IL12RB1,interleukin 12 receptor subunit beta 1,HGNC:5971,19p13.11
TMCO1,0.018834482,TMCO1,Approved symbol,TMCO1,transmembrane and coiled-coil domains 1,HGNC:18188,1q24.1
SGK2,0.01883358,SGK2,Approved symbol,SGK2,serum/glucocorticoid regulated kinase 2,HGNC:13900,20q13.12
CD1B,-0.018832174,CD1B,Approved symbol,CD1B,CD1b molecule,HGNC:1635,1q23.1
RP11-428J1.4,-0.018818584,RP11-428J1.4,Unmatched,RP11-428J1.4,,,
SOCS3,-0.01881735,SOCS3,Approved symbol,SOCS3,suppressor of cytokine signaling 3,HGNC:19391,17q25.3
ZKSCAN1,0.018816704,ZKSCAN1,Approved symbol,ZKSCAN1,zinc finger with KRAB and SCAN domains 1,HGNC:13101,7q22.1
MT1F,0.018811849,MT1F,Approved symbol,MT1F,metallothionein 1F,HGNC:7398,16q13
ZNF703,0.018810927,ZNF703,Approved symbol,ZNF703,zinc finger protein 703,HGNC:25883,8p11.23
NBEAL2,-0.018800118,NBEAL2,Approved symbol,NBEAL2,neurobeachin like 2,HGNC:31928,3p21.31
ADAMTS9,-0.018799199,ADAMTS9,Approved symbol,ADAMTS9,ADAM metallopeptidase with thrombospondin type 1 motif 9,HGNC:13202,3p14.1
LRRC46,-0.018799139,LRRC46,Approved symbol,LRRC46,leucine rich repeat containing 46,HGNC:25047,17q21.32
SRSF8,0.018797558,SRSF8,Approved symbol,SRSF8,serine and arginine rich splicing factor 8,HGNC:16988,11q21
DPP10,0.018790479,DPP10,Approved symbol,DPP10,dipeptidyl peptidase like 10,HGNC:20823,2q14.1
COL5A3,-0.018787816,COL5A3,Approved symbol,COL5A3,collagen type V alpha 3 chain,HGNC:14864,19p13.2
KRT6B,-0.018785908,KRT6B,Approved symbol,KRT6B,keratin 6B,HGNC:6444,12q13.13
CARD17,-0.018785253,CARD17,Approved symbol,CARD17,caspase recruitment domain family member 17,HGNC:33827,11q22.3
LSM11,0.018784384,LSM11,Approved symbol,LSM11,"LSM11, U7 small nuclear RNA associated",HGNC:30860,5q33.3
DCLK3,-0.018782043,DCLK3,Approved symbol,DCLK3,doublecortin like kinase 3,HGNC:19005,3p22.2
AC116366.5,-0.018779724,AC116366.5,Unmatched,AC116366.5,,,
CD300LF,-0.018777796,CD300LF,Approved symbol,CD300LF,CD300 molecule like family member f,HGNC:29883,17q25.1
HHAT,0.018777085,HHAT,Approved symbol,HHAT,hedgehog acyltransferase,HGNC:18270,1q32.2
NDUFC2,0.018774188,NDUFC2,Approved symbol,NDUFC2,NADH:ubiquinone oxidoreductase subunit C2,HGNC:7706,11q14.1
WDR54,-0.018771391,WDR54,Approved symbol,WDR54,WD repeat domain 54,HGNC:25770,2p13.1
OLFML2B,-0.01877048,OLFML2B,Approved symbol,OLFML2B,olfactomedin like 2B,HGNC:24558,1q23.3
CD300E,-0.018769835,CD300E,Approved symbol,CD300E,CD300e molecule,HGNC:28874,17q25.1
ATF7IP2,-0.018764625,ATF7IP2,Approved symbol,ATF7IP2,activating transcription factor 7 interacting protein 2,HGNC:20397,16p13.2-p13.13
MPV17,-0.018764506,MPV17,Approved symbol,MPV17,mitochondrial inner membrane protein MPV17,HGNC:7224,2p23.3
IGHGP,-0.018761558,IGHGP,Approved symbol,IGHGP,immunoglobulin heavy constant gamma P (non-functional),HGNC:5529,14q32.33
LPL,-0.018761412,LPL,Approved symbol,LPL,lipoprotein lipase,HGNC:6677,8p21.3
EFCAB14,0.018758996,EFCAB14,Approved symbol,EFCAB14,EF-hand calcium binding domain 14,HGNC:29051,1p33
RUNX1,-0.018756909,RUNX1,Approved symbol,RUNX1,RUNX family transcription factor 1,HGNC:10471,21q22.12
RP11-350J20.12,-0.018756146,RP11-350J20.12,Unmatched,RP11-350J20.12,,,
ALG1L13P,-0.018752883,ALG1L13P,Approved symbol,ALG1L13P,"ALG1 like 13, pseudogene",HGNC:44382,8p23.1
MAP4K4,-0.01875209,MAP4K4,Approved symbol,MAP4K4,mitogen-activated protein kinase kinase kinase kinase 4,HGNC:6866,2q11.2
NAAA,0.018746014,NAAA,Approved symbol,NAAA,N-acylethanolamine acid amidase,HGNC:736,4q21.1
SIRPB2,-0.018740965,SIRPB2,Approved symbol,SIRPB2,signal regulatory protein beta 2,HGNC:16247,20p13
RP11-536O18.1,-0.018738859,RP11-536O18.1,Unmatched,RP11-536O18.1,,,
FAM72D,-0.018737648,FAM72D,Approved symbol,FAM72D,family with sequence similarity 72 member D,HGNC:33593,1q21.1
AP000439.3,0.018736194,AP000439.3,Unmatched,AP000439.3,,,
TRPV2,-0.018734182,TRPV2,Approved symbol,TRPV2,transient receptor potential cation channel subfamily V member 2,HGNC:18082,17p11.2
RP11-76E17.3,-0.018733175,RP11-76E17.3,Unmatched,RP11-76E17.3,,,
SLC4A11,-0.018725093,SLC4A11,Approved symbol,SLC4A11,solute carrier family 4 member 11,HGNC:16438,20p13
SEMA4D,-0.018724977,SEMA4D,Approved symbol,SEMA4D,semaphorin 4D,HGNC:10732,9q22.2
MIR503HG,-0.018722271,MIR503HG,Approved symbol,MIR503HG,MIR503 host gene,HGNC:28258,Xq26.3
ERG,-0.018721854,ERG,Approved symbol,ERG,ETS transcription factor ERG,HGNC:3446,21q22.2
AC007879.7,-0.01872045,AC007879.7,Unmatched,AC007879.7,,,
C14orf159,0.018719401,C14orf159,Previous symbol,DGLUCY,D-glutamate cyclase,HGNC:20498,14q32.11
CCL4,-0.018712398,CCL4,Approved symbol,CCL4,C-C motif chemokine ligand 4,HGNC:10630,17q12
GPR4,-0.018706507,GPR4,Approved symbol,GPR4,G protein-coupled receptor 4,HGNC:4497,19q13.32
FRZB,0.018700504,FRZB,Approved symbol,FRZB,frizzled related protein,HGNC:3959,2q32.1
NOTCH4,-0.018699695,NOTCH4,Approved symbol,NOTCH4,notch receptor 4,HGNC:7884,6p21.32
AC013283.1,0.01869907,AC013283.1,Unmatched,AC013283.1,,,
LILRA3,-0.018691726,LILRA3,Approved symbol,LILRA3,leukocyte immunoglobulin like receptor A3,HGNC:6604,19q13.4 alternate reference locus
ARID5A,-0.018685044,ARID5A,Approved symbol,ARID5A,AT-rich interaction domain 5A,HGNC:17361,2q11.2
CCR1,-0.018681163,CCR1,Approved symbol,CCR1,C-C motif chemokine receptor 1,HGNC:1602,3p21.31
RP11-977G19.11,0.018679836,RP11-977G19.11,Unmatched,RP11-977G19.11,,,
ADPRH,-0.018675312,ADPRH,Approved symbol,ADPRH,ADP-ribosylarginine hydrolase,HGNC:269,3q13.33
IDO2,-0.018672865,IDO2,Approved symbol,IDO2,"indoleamine 2,3-dioxygenase 2",HGNC:27269,8p11.21
TEX30,-0.01866472,TEX30,Approved symbol,TEX30,testis expressed 30,HGNC:25188,13q33.1
GLYATL3,0.018660268,GLYATL3,Approved symbol,GLYATL3,glycine-N-acyltransferase like 3,HGNC:21349,6p12.3
FAM200B,0.018657567,FAM200B,Approved symbol,FAM200B,family with sequence similarity 200 member B,HGNC:27740,4p15.32
REPIN1,0.018657234,REPIN1,Approved symbol,REPIN1,replication initiator 1,HGNC:17922,7q36.1
ERMP1,0.018654712,ERMP1,Approved symbol,ERMP1,endoplasmic reticulum metallopeptidase 1,HGNC:23703,9p24.1
CDKL2,0.018654481,CDKL2,Approved symbol,CDKL2,cyclin dependent kinase like 2,HGNC:1782,4q21.1
SERPINE1,-0.018652159,SERPINE1,Approved symbol,SERPINE1,serpin family E member 1,HGNC:8583,7q22.1
CARD6,-0.018648539,CARD6,Approved symbol,CARD6,caspase recruitment domain family member 6,HGNC:16394,5p13.1
WSCD1,0.018642829,WSCD1,Approved symbol,WSCD1,WSC domain containing 1,HGNC:29060,17p13.2
COL23A1,-0.018642773,COL23A1,Approved symbol,COL23A1,collagen type XXIII alpha 1 chain,HGNC:22990,5q35.3
SLC1A3,-0.018642539,SLC1A3,Approved symbol,SLC1A3,solute carrier family 1 member 3,HGNC:10941,5p13.2
S1PR5,-0.018640262,S1PR5,Approved symbol,S1PR5,sphingosine-1-phosphate receptor 5,HGNC:14299,19p13.2
PTPN21,0.018640227,PTPN21,Approved symbol,PTPN21,protein tyrosine phosphatase non-receptor type 21,HGNC:9651,14q31.3
COX4I1,0.018635105,COX4I1,Approved symbol,COX4I1,cytochrome c oxidase subunit 4I1,HGNC:2265,16q24.1
EVA1A,-0.018632709,EVA1A,Approved symbol,EVA1A,"eva-1 homolog A, regulator of programmed cell death",HGNC:25816,2p12
CYP1B1-AS1,0.018632205,CYP1B1-AS1,Approved symbol,CYP1B1-AS1,CYP1B1 antisense RNA 1,HGNC:28543,2p22.2
XAF1,-0.01863103,XAF1,Approved symbol,XAF1,XIAP associated factor 1,HGNC:30932,17p13.2
CLEC4A,-0.018630796,CLEC4A,Approved symbol,CLEC4A,C-type lectin domain family 4 member A,HGNC:13257,12p13.31
FAM49A,-0.018628498,FAM49A,Previous symbol,CYRIA,CYFIP related Rac1 interactor A,HGNC:25373,2p24.2
GAREML,0.018620813,GAREML,Previous symbol,GAREM2,GRB2 associated regulator of MAPK1 subtype 2,HGNC:27172,2p23.3
FHDC1,0.018611482,FHDC1,Approved symbol,FHDC1,FH2 domain containing 1,HGNC:29363,4q31.3
IGSF9,0.018601876,IGSF9,Approved symbol,IGSF9,immunoglobulin superfamily member 9,HGNC:18132,1q23.2
MIR4435-1HG,-0.0186008,MIR4435-1HG,Previous symbol,MIR4435-2HG,MIR4435-2 host gene,HGNC:35163,2q13
SLAMF1,-0.018599028,SLAMF1,Approved symbol,SLAMF1,signaling lymphocytic activation molecule family member 1,HGNC:10903,1q23.3
RP11-229P13.20,-0.018597164,RP11-229P13.20,Unmatched,RP11-229P13.20,,,
AAED1,-0.018594841,AAED1,Previous symbol,PRXL2C,peroxiredoxin like 2C,HGNC:16881,9q22.33
FAM168B,0.018593978,FAM168B,Approved symbol,FAM168B,family with sequence similarity 168 member B,HGNC:27016,2q21.1
FAM65C,-0.018592341,FAM65C,Previous symbol,RIPOR3,RIPOR family member 3,HGNC:16168,20q13.13
SLC25A4,0.018591844,SLC25A4,Approved symbol,SLC25A4,solute carrier family 25 member 4,HGNC:10990,4q35.1
AC112721.2,-0.018590798,AC112721.2,Unmatched,AC112721.2,,,
GALNT14,-0.018589813,GALNT14,Approved symbol,GALNT14,polypeptide N-acetylgalactosaminyltransferase 14,HGNC:22946,2p23.1
INHBA,-0.01858884,INHBA,Approved symbol,INHBA,inhibin subunit beta A,HGNC:6066,7p14.1
UNC13D,-0.018586621,UNC13D,Approved symbol,UNC13D,unc-13 homolog D,HGNC:23147,17q25.3
HRH4,-0.018582781,HRH4,Approved symbol,HRH4,histamine receptor H4,HGNC:17383,18q11.2
CHST15,-0.018577449,CHST15,Approved symbol,CHST15,carbohydrate sulfotransferase 15,HGNC:18137,10q26.13
RP11-326C3.12,-0.018577084,RP11-326C3.12,Unmatched,RP11-326C3.12,,,
TMEM71,-0.018577051,TMEM71,Approved symbol,TMEM71,transmembrane protein 71,HGNC:26572,8q24.22
CTD-2541M15.1,0.018576825,CTD-2541M15.1,Unmatched,CTD-2541M15.1,,,
GSG2,-0.018575922,GSG2,Previous symbol,HASPIN,histone H3 associated protein kinase,HGNC:19682,17p13.2
TNFSF14,-0.018571626,TNFSF14,Approved symbol,TNFSF14,TNF superfamily member 14,HGNC:11930,19p13.3
SLC9B2,-0.018570317,SLC9B2,Approved symbol,SLC9B2,solute carrier family 9 member B2,HGNC:25143,4q24
AUH,0.018566252,AUH,Approved symbol,AUH,AU RNA binding methylglutaconyl-CoA hydratase,HGNC:890,9q22.31
MGAT4B,0.018566049,MGAT4B,Approved symbol,MGAT4B,"alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B",HGNC:7048,5q35.3
SMCO2,-0.018561618,SMCO2,Approved symbol,SMCO2,single-pass membrane protein with coiled-coil domains 2,HGNC:34448,12p11.23
FANCB,-0.018560471,FANCB,Approved symbol,FANCB,FA complementation group B,HGNC:3583,Xp22.2
AGT,-0.018558662,AGT,Approved symbol,AGT,angiotensinogen,HGNC:333,1q42.2
TLR2,-0.018558023,TLR2,Approved symbol,TLR2,toll like receptor 2,HGNC:11848,4q31.3
C4BPB,-0.018558004,C4BPB,Approved symbol,C4BPB,complement component 4 binding protein beta,HGNC:1328,1q32.1
CDK2,-0.018557499,CDK2,Approved symbol,CDK2,cyclin dependent kinase 2,HGNC:1771,12q13.2
CRLS1,0.018557207,CRLS1,Approved symbol,CRLS1,cardiolipin synthase 1,HGNC:16148,20p12.3
USP19,0.018557094,USP19,Approved symbol,USP19,ubiquitin specific peptidase 19,HGNC:12617,3p21.31
TYMP,-0.01855605,TYMP,Approved symbol,TYMP,thymidine phosphorylase,HGNC:3148,22q13.33
CLEC7A,-0.018555457,CLEC7A,Approved symbol,CLEC7A,C-type lectin domain containing 7A,HGNC:14558,12p13.2
FCGR3B,-0.018551169,FCGR3B,Approved symbol,FCGR3B,Fc fragment of IgG receptor IIIb,HGNC:3620,1q23.3
TRPM6,0.018551053,TRPM6,Approved symbol,TRPM6,transient receptor potential cation channel subfamily M member 6,HGNC:17995,9q21.13
PRDX1,-0.018550803,PRDX1,Approved symbol,PRDX1,peroxiredoxin 1,HGNC:9352,1p34.1
LRFN2,0.018543523,LRFN2,Approved symbol,LRFN2,leucine rich repeat and fibronectin type III domain containing 2,HGNC:21226,6p21.2-p21.1
SCIMP,-0.018542935,SCIMP,Approved symbol,SCIMP,SLP adaptor and CSK interacting membrane protein,HGNC:33504,17p13.2
STX11,-0.018542372,STX11,Approved symbol,STX11,syntaxin 11,HGNC:11429,6q24.2
RP11-80H8.4,-0.018541013,RP11-80H8.4,Unmatched,RP11-80H8.4,,,
PLXNA1,-0.018538619,PLXNA1,Approved symbol,PLXNA1,plexin A1,HGNC:9099,3q21.3
SMAP2,-0.018534687,SMAP2,Approved symbol,SMAP2,small ArfGAP2,HGNC:25082,1p34.2
LINC00238,0.018530664,LINC00238,Previous symbol,CCDC196,coiled-coil domain containing 196,HGNC:20100,14q23.3
BST2,-0.018525662,BST2,Approved symbol,BST2,bone marrow stromal cell antigen 2,HGNC:1119,19p13.11
AP001046.5,-0.018522876,AP001046.5,Unmatched,AP001046.5,,,
COL4A1,-0.018522621,COL4A1,Approved symbol,COL4A1,collagen type IV alpha 1 chain,HGNC:2202,13q34
C6orf223,-0.018522506,C6orf223,Approved symbol,C6orf223,chromosome 6 open reading frame 223,HGNC:28692,6p21.1
HCAR2,-0.018519888,HCAR2,Approved symbol,HCAR2,hydroxycarboxylic acid receptor 2,HGNC:24827,12q24.31
AC069363.1,-0.018516478,AC069363.1,Unmatched,AC069363.1,,,
MTMR7,0.018515386,MTMR7,Approved symbol,MTMR7,myotubularin related protein 7,HGNC:7454,8p22
ATHL1,-0.018515287,ATHL1,Previous symbol,PGGHG,protein-glucosylgalactosylhydroxylysine glucosidase,HGNC:26210,11p15.5
ELTD1,-0.018511688,ELTD1,Previous symbol,ADGRL4,adhesion G protein-coupled receptor L4,HGNC:20822,1p31.1
LAG3,-0.018506182,LAG3,Approved symbol,LAG3,lymphocyte activating 3,HGNC:6476,12p13.31
PTGS2,-0.018502921,PTGS2,Approved symbol,PTGS2,prostaglandin-endoperoxide synthase 2,HGNC:9605,1q31.1
IL17F,-0.018498314,IL17F,Approved symbol,IL17F,interleukin 17F,HGNC:16404,6p12.2
PLEKHO2,-0.018497509,PLEKHO2,Approved symbol,PLEKHO2,pleckstrin homology domain containing O2,HGNC:30026,15q22.31
AC097468.4,0.018494626,AC097468.4,Unmatched,AC097468.4,,,
KIF21B,-0.018493062,KIF21B,Approved symbol,KIF21B,kinesin family member 21B,HGNC:29442,1q32.1
SGTB,-0.018482042,SGTB,Approved symbol,SGTB,small glutamine rich tetratricopeptide repeat containing beta,HGNC:23567,5q12.3
ACKR4,-0.018479383,ACKR4,Approved symbol,ACKR4,atypical chemokine receptor 4,HGNC:1611,3q22.1
EZH2,-0.018472829,EZH2,Approved symbol,EZH2,enhancer of zeste 2 polycomb repressive complex 2 subunit,HGNC:3527,7q36.1
LPIN1,-0.018472428,LPIN1,Approved symbol,LPIN1,lipin 1,HGNC:13345,2p25.1
IRF2BP2,0.018472295,IRF2BP2,Approved symbol,IRF2BP2,interferon regulatory factor 2 binding protein 2,HGNC:21729,1q42.3
APOH,0.018471738,APOH,Approved symbol,APOH,apolipoprotein H,HGNC:616,17q24.2
RGS16,-0.01846757,RGS16,Approved symbol,RGS16,regulator of G protein signaling 16,HGNC:9997,1q25.3
C16orf93,-0.018465968,C16orf93,Previous symbol,CCDC189,coiled-coil domain containing 189,HGNC:28078,16p11.2
HGF,-0.018464529,HGF,Approved symbol,HGF,hepatocyte growth factor,HGNC:4893,7q21.11
ANKMY2,0.018464128,ANKMY2,Approved symbol,ANKMY2,ankyrin repeat and MYND domain containing 2,HGNC:25370,7p21.1
ELK3,-0.018462001,ELK3,Approved symbol,ELK3,ETS transcription factor ELK3,HGNC:3325,12q23.1
SERPINB4,-0.018452101,SERPINB4,Approved symbol,SERPINB4,serpin family B member 4,HGNC:10570,18q21.33
SNX30,0.018450182,SNX30,Approved symbol,SNX30,sorting nexin family member 30,HGNC:23685,9q32
RP11-91J19.4,0.018447767,RP11-91J19.4,Unmatched,RP11-91J19.4,,,
RP11-120K24.3,0.018445908,RP11-120K24.3,Unmatched,RP11-120K24.3,,,
IL5RA,-0.018444895,IL5RA,Approved symbol,IL5RA,interleukin 5 receptor subunit alpha,HGNC:6017,3p26.2
FAM211A,0.018441776,FAM211A,Previous symbol,LRRC75A,leucine rich repeat containing 75A,HGNC:32403,17p11.2
PWWP2A,0.01843862,PWWP2A,Approved symbol,PWWP2A,PWWP domain containing 2A,HGNC:29406,5q33.3
GEM,-0.018438504,GEM,Approved symbol,GEM,GTP binding protein overexpressed in skeletal muscle,HGNC:4234,8q22.1
RP5-1071N3.1,-0.018438202,RP5-1071N3.1,Unmatched,RP5-1071N3.1,,,
MAP3K8,-0.018434548,MAP3K8,Approved symbol,MAP3K8,mitogen-activated protein kinase kinase kinase 8,HGNC:6860,10p11.23
DTHD1,-0.018427348,DTHD1,Approved symbol,DTHD1,death domain containing 1,HGNC:37261,4p14
CDKN2B,0.018425599,CDKN2B,Approved symbol,CDKN2B,cyclin dependent kinase inhibitor 2B,HGNC:1788,9p21.3
WARS,-0.018422332,WARS,Previous symbol,WARS1,tryptophanyl-tRNA synthetase 1,HGNC:12729,14q32.2
RP11-293P20.2,0.018420352,RP11-293P20.2,Unmatched,RP11-293P20.2,,,
C19orf66,-0.018413731,C19orf66,Previous symbol,SHFL,shiftless antiviral inhibitor of ribosomal frameshifting,HGNC:25649,19p13.2
CPXM1,-0.018410219,CPXM1,Approved symbol,CPXM1,"carboxypeptidase X, M14 family member 1",HGNC:15771,20p13
ZNF768,0.018406108,ZNF768,Approved symbol,ZNF768,zinc finger protein 768,HGNC:26273,16p11.2
C3,-0.018405878,C3,Approved symbol,C3,complement C3,HGNC:1318,19p13.3
CDH5,-0.018404907,CDH5,Approved symbol,CDH5,cadherin 5,HGNC:1764,16q21
UGT1A6,-0.018404484,UGT1A6,Approved symbol,UGT1A6,UDP glucuronosyltransferase family 1 member A6,HGNC:12538,2q37.1
RRN3,0.01840415,RRN3,Approved symbol,RRN3,"RRN3 homolog, RNA polymerase I transcription factor",HGNC:30346,16p13.11
DBF4B,-0.018403636,DBF4B,Approved symbol,DBF4B,DBF4 zinc finger B,HGNC:17883,17q21.31
RAMP3,-0.01840242,RAMP3,Approved symbol,RAMP3,receptor activity modifying protein 3,HGNC:9845,7p13
QPRT,0.018398604,QPRT,Approved symbol,QPRT,quinolinate phosphoribosyltransferase,HGNC:9755,16p11.2
GSDMC,-0.018389215,GSDMC,Approved symbol,GSDMC,gasdermin C,HGNC:7151,8q24.21
FGFR3,0.018384844,FGFR3,Approved symbol,FGFR3,fibroblast growth factor receptor 3,HGNC:3690,4p16.3
CX3CL1,-0.018381588,CX3CL1,Approved symbol,CX3CL1,C-X3-C motif chemokine ligand 1,HGNC:10647,16q21
PTGDS,-0.018378995,PTGDS,Approved symbol,PTGDS,prostaglandin D2 synthase,HGNC:9592,9q34.3
SYTL3,-0.018375252,SYTL3,Approved symbol,SYTL3,synaptotagmin like 3,HGNC:15587,6q25.3
COX5A,0.018373364,COX5A,Approved symbol,COX5A,cytochrome c oxidase subunit 5A,HGNC:2267,15q24.2
MARCKS,0.018372487,MARCKS,Approved symbol,MARCKS,myristoylated alanine rich protein kinase C substrate,HGNC:6759,6q21
NMNAT3,0.018372397,NMNAT3,Approved symbol,NMNAT3,nicotinamide nucleotide adenylyltransferase 3,HGNC:20989,3q23
EGR2,-0.018372223,EGR2,Approved symbol,EGR2,early growth response 2,HGNC:3239,10q21.3
RP11-1070N10.3,-0.018369608,RP11-1070N10.3,Unmatched,RP11-1070N10.3,,,
GPR116,-0.018368933,GPR116,Previous symbol,ADGRF5,adhesion G protein-coupled receptor F5,HGNC:19030,6p12.3
ZBED2,-0.018367326,ZBED2,Approved symbol,ZBED2,zinc finger BED-type containing 2,HGNC:20710,3q13.13
TTR,0.0183639,TTR,Approved symbol,TTR,transthyretin,HGNC:12405,18q12.1
LILRB2,-0.018363727,LILRB2,Approved symbol,LILRB2,leukocyte immunoglobulin like receptor B2,HGNC:6606,19q13.4
ITPRIPL1,-0.018363309,ITPRIPL1,Approved symbol,ITPRIPL1,ITPRIP like 1,HGNC:29371,2q11.2
ATXN7L3B,0.018359241,ATXN7L3B,Approved symbol,ATXN7L3B,ataxin 7 like 3B,HGNC:37931,12q21.1
LINC00938,0.018354495,LINC00938,Approved symbol,LINC00938,long intergenic non-protein coding RNA 938,HGNC:48630,12q12
RAVER2,0.018353863,RAVER2,Approved symbol,RAVER2,"ribonucleoprotein, PTB binding 2",HGNC:25577,1p31.3
C9orf3,-0.018352774,C9orf3,Previous symbol,AOPEP,aminopeptidase O (putative),HGNC:1361,9q22.32
MADCAM1,-0.018352698,MADCAM1,Approved symbol,MADCAM1,mucosal vascular addressin cell adhesion molecule 1,HGNC:6765,19p13.3
SELE,-0.018347495,SELE,Approved symbol,SELE,selectin E,HGNC:10718,1q24.2
LYN,-0.018347029,LYN,Approved symbol,LYN,"LYN proto-oncogene, Src family tyrosine kinase",HGNC:6735,8q12.1
CFI,-0.018344085,CFI,Approved symbol,CFI,complement factor I,HGNC:5394,4q25
RFX6,0.018340974,RFX6,Approved symbol,RFX6,regulatory factor X6,HGNC:21478,6q22.1
MED29,0.018337568,MED29,Approved symbol,MED29,mediator complex subunit 29,HGNC:23074,19q13.2
SORBS3,0.018333467,SORBS3,Approved symbol,SORBS3,sorbin and SH3 domain containing 3,HGNC:30907,8p21.3
CLEC1A,-0.018327447,CLEC1A,Approved symbol,CLEC1A,C-type lectin domain family 1 member A,HGNC:24355,12p13.2
CCDC64,-0.018326854,CCDC64,Previous symbol,BICDL1,BICD family like cargo adaptor 1,HGNC:28095,12q24.23
PACS1,-0.018322307,PACS1,Approved symbol,PACS1,phosphofurin acidic cluster sorting protein 1,HGNC:30032,11q13.1-q13.2
FUT7,-0.018320273,FUT7,Approved symbol,FUT7,fucosyltransferase 7,HGNC:4018,9q34.3
MYO1F,-0.018318045,MYO1F,Approved symbol,MYO1F,myosin IF,HGNC:7600,19p13.2
RILPL2,-0.018310292,RILPL2,Approved symbol,RILPL2,Rab interacting lysosomal protein like 2,HGNC:28787,12q24.31
SMPDL3A,0.018309606,SMPDL3A,Approved symbol,SMPDL3A,sphingomyelin phosphodiesterase acid like 3A,HGNC:17389,6q22.31
ZNF649,0.018306669,ZNF649,Approved symbol,ZNF649,zinc finger protein 649,HGNC:25741,19q13.41
LST1,-0.018306539,LST1,Approved symbol,LST1,leukocyte specific transcript 1,HGNC:14189,6p21.33
TINCR,0.018304429,TINCR,Approved symbol,TINCR,TINCR ubiquitin domain containing,HGNC:14607,19p13.3
LDLRAD3,-0.018304338,LDLRAD3,Approved symbol,LDLRAD3,low density lipoprotein receptor class A domain containing 3,HGNC:27046,11p13
GBP4,-0.018304257,GBP4,Approved symbol,GBP4,guanylate binding protein 4,HGNC:20480,1p22.2
VAV1,-0.018301024,VAV1,Approved symbol,VAV1,vav guanine nucleotide exchange factor 1,HGNC:12657,19p13.3
NME7,-0.01829825,NME7,Approved symbol,NME7,NME/NM23 family member 7,HGNC:20461,1q24.2
PMAIP1,-0.01829741,PMAIP1,Approved symbol,PMAIP1,phorbol-12-myristate-13-acetate-induced protein 1,HGNC:9108,18q21.32
CTSC,-0.018297329,CTSC,Approved symbol,CTSC,cathepsin C,HGNC:2528,11q14.2
NFS1,0.018293555,NFS1,Approved symbol,NFS1,NFS1 cysteine desulfurase,HGNC:15910,20q11.22
HDAC7,-0.018273501,HDAC7,Approved symbol,HDAC7,histone deacetylase 7,HGNC:14067,12q13.11
ADPRHL1,0.0182728,ADPRHL1,Approved symbol,ADPRHL1,ADP-ribosylhydrolase like 1,HGNC:21303,13q34
TMEM158,-0.018272504,TMEM158,Approved symbol,TMEM158,transmembrane protein 158,HGNC:30293,3p21.31
TMEM108,-0.0182714,TMEM108,Approved symbol,TMEM108,transmembrane protein 108,HGNC:28451,3q22.1
BTF3,0.018271151,BTF3,Approved symbol,BTF3,basic transcription factor 3,HGNC:1125,5q13.2
DNAAF1,-0.018270107,DNAAF1,Approved symbol,DNAAF1,dynein axonemal assembly factor 1,HGNC:30539,16q24.1
MT1G,0.018265124,MT1G,Approved symbol,MT1G,metallothionein 1G,HGNC:7399,16q13
ITGAM,-0.018260738,ITGAM,Approved symbol,ITGAM,integrin subunit alpha M,HGNC:6149,16p11.2
AC005152.2,0.018258231,AC005152.2,Unmatched,AC005152.2,,,
LRRK2,-0.018257763,LRRK2,Approved symbol,LRRK2,leucine rich repeat kinase 2,HGNC:18618,12q12
CHSY1,-0.018248115,CHSY1,Approved symbol,CHSY1,chondroitin sulfate synthase 1,HGNC:17198,15q26.3
RP11-290F20.3,-0.018247992,RP11-290F20.3,Unmatched,RP11-290F20.3,,,
RFC2,-0.01824572,RFC2,Approved symbol,RFC2,replication factor C subunit 2,HGNC:9970,7q11.23
BTN2A2,-0.018243115,BTN2A2,Approved symbol,BTN2A2,butyrophilin subfamily 2 member A2,HGNC:1137,6p22.2
FADS1,-0.018240657,FADS1,Approved symbol,FADS1,fatty acid desaturase 1,HGNC:3574,11q12.2
CREM,-0.018240216,CREM,Approved symbol,CREM,cAMP responsive element modulator,HGNC:2352,10p11.21
CTD-2196E14.4,0.018239639,CTD-2196E14.4,Unmatched,CTD-2196E14.4,,,
GAL3ST4,0.01823779,GAL3ST4,Approved symbol,GAL3ST4,galactose-3-O-sulfotransferase 4,HGNC:24145,7q22.1
HOXA11-AS,0.018226839,HOXA11-AS,Approved symbol,HOXA11-AS,HOXA11 antisense RNA,HGNC:24957,7p15.2
EPHX2,0.018223829,EPHX2,Approved symbol,EPHX2,epoxide hydrolase 2,HGNC:3402,8p21.2-p21.1
PLEKHN1,-0.018223377,PLEKHN1,Approved symbol,PLEKHN1,pleckstrin homology domain containing N1,HGNC:25284,1p36.33
SPHK1,-0.018221566,SPHK1,Approved symbol,SPHK1,sphingosine kinase 1,HGNC:11240,17q25.1
CXCL5,-0.018220575,CXCL5,Approved symbol,CXCL5,C-X-C motif chemokine ligand 5,HGNC:10642,4q13.3
FAM115C,-0.018218596,FAM115C,Previous symbol,TCAF2,TRPM8 channel associated factor 2,HGNC:26878,7q35
ZNF233,0.018216748,ZNF233,Approved symbol,ZNF233,zinc finger protein 233,HGNC:30946,19q13.31
STC1,-0.018215176,STC1,Approved symbol,STC1,stanniocalcin 1,HGNC:11373,8p21.2
TTLL4,-0.018206838,TTLL4,Approved symbol,TTLL4,tubulin tyrosine ligase like 4,HGNC:28976,2q35
RP11-499E18.1,0.018203886,RP11-499E18.1,Unmatched,RP11-499E18.1,,,
LTBP2,-0.018203601,LTBP2,Approved symbol,LTBP2,latent transforming growth factor beta binding protein 2,HGNC:6715,14q24.3
AC061992.2,-0.018203437,AC061992.2,Unmatched,AC061992.2,,,
IGFBP5,-0.018197544,IGFBP5,Approved symbol,IGFBP5,insulin like growth factor binding protein 5,HGNC:5474,2q35
MRPS33,0.018193887,MRPS33,Approved symbol,MRPS33,mitochondrial ribosomal protein S33,HGNC:16634,7q34
LIMK1,-0.018190599,LIMK1,Approved symbol,LIMK1,LIM domain kinase 1,HGNC:6613,7q11.23
SIRPB1,-0.018182509,SIRPB1,Approved symbol,SIRPB1,signal regulatory protein beta 1,HGNC:15928,20p13
RP11-563J2.2,-0.018181909,RP11-563J2.2,Unmatched,RP11-563J2.2,,,
AC073316.1,-0.018180797,AC073316.1,Unmatched,AC073316.1,,,
TSPO2,-0.018179237,TSPO2,Approved symbol,TSPO2,translocator protein 2,HGNC:21256,6p21.1
STEAP4,-0.018176668,STEAP4,Approved symbol,STEAP4,STEAP4 metalloreductase,HGNC:21923,7q21.12
FHL3,-0.018174564,FHL3,Approved symbol,FHL3,four and a half LIM domains 3,HGNC:3704,1p34.3
VEGFC,-0.0181677,VEGFC,Approved symbol,VEGFC,vascular endothelial growth factor C,HGNC:12682,4q34.3
ARHGEF9,0.018166344,ARHGEF9,Approved symbol,ARHGEF9,Cdc42 guanine nucleotide exchange factor 9,HGNC:14561,Xq11.1
PROK2,-0.018166231,PROK2,Approved symbol,PROK2,prokineticin 2,HGNC:18455,3p13
MNX1,0.018164423,MNX1,Approved symbol,MNX1,motor neuron and pancreas homeobox 1,HGNC:4979,7q36.3
SSBP3,0.018160834,SSBP3,Approved symbol,SSBP3,single stranded DNA binding protein 3,HGNC:15674,1p32.3
S100A8,-0.018160161,S100A8,Approved symbol,S100A8,S100 calcium binding protein A8,HGNC:10498,1q21.3
KCTD20,-0.01815681,KCTD20,Approved symbol,KCTD20,potassium channel tetramerization domain containing 20,HGNC:21052,6p21.31
CACNA1C,-0.018146057,CACNA1C,Approved symbol,CACNA1C,calcium voltage-gated channel subunit alpha1 C,HGNC:1390,12p13.33
PML,-0.018144173,PML,Approved symbol,PML,PML nuclear body scaffold,HGNC:9113,15q24.1
RP11-589N15.2,-0.018142349,RP11-589N15.2,Unmatched,RP11-589N15.2,,,
ZNRF3,0.018137783,ZNRF3,Approved symbol,ZNRF3,zinc and ring finger 3,HGNC:18126,22q12.1
THG1L,0.018134115,THG1L,Approved symbol,THG1L,tRNA-histidine guanylyltransferase 1 like,HGNC:26053,5q33.3
NKX2-2,0.018132858,NKX2-2,Approved symbol,NKX2-2,NK2 homeobox 2,HGNC:7835,20p11.22
STX2,-0.018132659,STX2,Approved symbol,STX2,syntaxin 2,HGNC:3403,12q24.33
RNF5,0.018132395,RNF5,Approved symbol,RNF5,ring finger protein 5,HGNC:10068,6p21.32
MTHFD1L,-0.01813135,MTHFD1L,Approved symbol,MTHFD1L,methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like,HGNC:21055,6q25.1
DRAM1,-0.018128989,DRAM1,Approved symbol,DRAM1,DNA damage regulated autophagy modulator 1,HGNC:25645,12q23.2
CCNF,-0.01811808,CCNF,Approved symbol,CCNF,cyclin F,HGNC:1591,16p13.3
CETP,-0.018117974,CETP,Approved symbol,CETP,cholesteryl ester transfer protein,HGNC:1869,16q13
MEGF8,0.018117021,MEGF8,Approved symbol,MEGF8,multiple EGF like domains 8,HGNC:3233,19q13.2
CTHRC1,-0.018115656,CTHRC1,Approved symbol,CTHRC1,collagen triple helix repeat containing 1,HGNC:18831,8q22.3
AP000695.4,-0.018112248,AP000695.4,Unmatched,AP000695.4,,,
STOM,-0.018104462,STOM,Approved symbol,STOM,stomatin,HGNC:3383,9q33.2
FAM105B,-0.018097903,FAM105B,Previous symbol,OTULIN,OTU deubiquitinase with linear linkage specificity,HGNC:25118,5p15.2
TBX21,-0.018091281,TBX21,Approved symbol,TBX21,T-box transcription factor 21,HGNC:11599,17q21.32
HBD,-0.018090423,HBD,Approved symbol,HBD,hemoglobin subunit delta,HGNC:4829,11p15.4
RAD54L,-0.018088051,RAD54L,Approved symbol,RAD54L,RAD54 like,HGNC:9826,1p34.1
NXPE3,-0.018086608,NXPE3,Approved symbol,NXPE3,neurexophilin and PC-esterase domain family member 3,HGNC:28238,3q12.3
NFYC,0.018069599,NFYC,Approved symbol,NFYC,nuclear transcription factor Y subunit gamma,HGNC:7806,1p34.2
NEU4,0.018068944,NEU4,Approved symbol,NEU4,neuraminidase 4,HGNC:21328,2q37.3
SH3PXD2B,-0.018068334,SH3PXD2B,Approved symbol,SH3PXD2B,SH3 and PX domains 2B,HGNC:29242,5q35.1
GNA15,-0.018067373,GNA15,Approved symbol,GNA15,G protein subunit alpha 15,HGNC:4383,19p13.3
MAOA,0.01806374,MAOA,Approved symbol,MAOA,monoamine oxidase A,HGNC:6833,Xp11.3
SLC2A10,0.018061548,SLC2A10,Approved symbol,SLC2A10,solute carrier family 2 member 10,HGNC:13444,20q13.12
RBM24,0.018058231,RBM24,Approved symbol,RBM24,RNA binding motif protein 24,HGNC:21539,6p22.3
C11orf82,-0.018056566,C11orf82,Previous symbol,DDIAS,DNA damage induced apoptosis suppressor,HGNC:26351,11q14.1
TTC9,-0.018055678,TTC9,Approved symbol,TTC9,tetratricopeptide repeat domain 9,HGNC:20267,14q24.2
RNF213,-0.018052887,RNF213,Approved symbol,RNF213,ring finger protein 213,HGNC:14539,17q25.3
LILRA2,-0.018050819,LILRA2,Approved symbol,LILRA2,leukocyte immunoglobulin like receptor A2,HGNC:6603,19q13.4
CTB-43E15.4,-0.018049554,CTB-43E15.4,Unmatched,CTB-43E15.4,,,
CCL24,-0.018047865,CCL24,Approved symbol,CCL24,C-C motif chemokine ligand 24,HGNC:10623,7q11.23
LINC01088,0.018040945,LINC01088,Approved symbol,LINC01088,long intergenic non-protein coding RNA 1088,HGNC:49148,4q21.21
MNX1-AS1,0.018040142,MNX1-AS1,Approved symbol,MNX1-AS1,MNX1 antisense RNA 1 (head to head),HGNC:48954,7q36.3
AC108463.2,-0.018037625,AC108463.2,Unmatched,AC108463.2,,,
TIMELESS,-0.018035219,TIMELESS,Approved symbol,TIMELESS,timeless circadian regulator,HGNC:11813,12q13.3
IP6K2,0.018027533,IP6K2,Approved symbol,IP6K2,inositol hexakisphosphate kinase 2,HGNC:17313,3p21.31
CTB-83J4.2,-0.018020877,CTB-83J4.2,Unmatched,CTB-83J4.2,,,
GBP5,-0.018015243,GBP5,Approved symbol,GBP5,guanylate binding protein 5,HGNC:19895,1p22.2
NBPF1,0.018010589,NBPF1,Approved symbol,NBPF1,NBPF member 1,HGNC:26088,1p36.13
NR5A2,0.018009512,NR5A2,Approved symbol,NR5A2,nuclear receptor subfamily 5 group A member 2,HGNC:7984,1q32.1
ROPN1,0.018005198,ROPN1,Approved symbol,ROPN1,rhophilin associated tail protein 1,HGNC:17692,3q21.1
NRD1,-0.018004459,NRD1,Previous symbol,NRDC,nardilysin convertase,HGNC:7995,1p32.3
PRUNE,0.018004296,PRUNE,Previous symbol,PRUNE1,prune exopolyphosphatase 1,HGNC:13420,1q21.3
RP11-468E2.9,0.0180037,RP11-468E2.9,Unmatched,RP11-468E2.9,,,
SERPINI1,-0.018002722,SERPINI1,Approved symbol,SERPINI1,serpin family I member 1,HGNC:8943,3q26.1
RP11-356O9.2,0.018001825,RP11-356O9.2,Unmatched,RP11-356O9.2,,,
PLA1A,-0.018000988,PLA1A,Approved symbol,PLA1A,phospholipase A1 member A,HGNC:17661,3q13.33
FSCN1,-0.017997494,FSCN1,Approved symbol,FSCN1,fascin actin-bundling protein 1,HGNC:11148,7p22.1
MNDA,-0.017996173,MNDA,Approved symbol,MNDA,myeloid cell nuclear differentiation antigen,HGNC:7183,1q23.1
HK3,-0.017991096,HK3,Approved symbol,HK3,hexokinase 3,HGNC:4925,5q35.2
SLFN5,-0.01799069,SLFN5,Approved symbol,SLFN5,schlafen family member 5,HGNC:28286,17q12
CEP128,-0.01798936,CEP128,Approved symbol,CEP128,centrosomal protein 128,HGNC:20359,14q31.1
ERBB2,0.017987948,ERBB2,Approved symbol,ERBB2,erb-b2 receptor tyrosine kinase 2,HGNC:3430,17q12
CASS4,-0.017979609,CASS4,Approved symbol,CASS4,Cas scaffold protein family member 4,HGNC:15878,20q13.31
CDC25B,-0.017978108,CDC25B,Approved symbol,CDC25B,cell division cycle 25B,HGNC:1726,20p13
POLA2,-0.017977072,POLA2,Approved symbol,POLA2,"DNA polymerase alpha 2, accessory subunit",HGNC:30073,11q13.1
GALNT18,-0.01796837,GALNT18,Approved symbol,GALNT18,polypeptide N-acetylgalactosaminyltransferase 18,HGNC:30488,11p15.4
THSD4,0.01796825,THSD4,Approved symbol,THSD4,thrombospondin type 1 domain containing 4,HGNC:25835,15q23
ANO5,0.017968088,ANO5,Approved symbol,ANO5,anoctamin 5,HGNC:27337,11p14.3
HEG1,-0.017959551,HEG1,Approved symbol,HEG1,heart development protein with EGF like domains 1,HGNC:29227,3q21.2
FAM49B,-0.017958345,FAM49B,Previous symbol,CYRIB,CYFIP related Rac1 interactor B,HGNC:25216,8q24.21
VWF,-0.01795778,VWF,Approved symbol,VWF,von Willebrand factor,HGNC:12726,12p13.31
CDHR3,0.01795698,CDHR3,Approved symbol,CDHR3,cadherin related family member 3,HGNC:26308,7q22.3
RP4-813F11.4,0.017955645,RP4-813F11.4,Unmatched,RP4-813F11.4,,,
IGHG1,-0.01795451,IGHG1,Approved symbol,IGHG1,immunoglobulin heavy constant gamma 1 (G1m marker),HGNC:5525,14q32.33
CFP,-0.017952301,CFP,Approved symbol,CFP,complement factor properdin,HGNC:8864,Xp11.23
MCF2L-AS1,0.01795177,MCF2L-AS1,Approved symbol,MCF2L-AS1,MCF2L antisense RNA 1,HGNC:39825,13q34
IGF2BP3,-0.017942702,IGF2BP3,Approved symbol,IGF2BP3,insulin like growth factor 2 mRNA binding protein 3,HGNC:28868,7p15.3
TMIGD1,0.017940305,TMIGD1,Approved symbol,TMIGD1,transmembrane and immunoglobulin domain containing 1,HGNC:32431,17q11.2
DNAAF2,0.017938544,DNAAF2,Approved symbol,DNAAF2,dynein axonemal assembly factor 2,HGNC:20188,14q21.3
CD86,-0.017936612,CD86,Approved symbol,CD86,CD86 molecule,HGNC:1705,3q13.33
MCAM,-0.017936611,MCAM,Approved symbol,MCAM,melanoma cell adhesion molecule,HGNC:6934,11q23.3
SH3GL2,0.017933576,SH3GL2,Approved symbol,SH3GL2,"SH3 domain containing GRB2 like 2, endophilin A1",HGNC:10831,9p22.2
C4orf36,0.017932663,C4orf36,Approved symbol,C4orf36,chromosome 4 open reading frame 36,HGNC:28386,4q21.3
PNPLA3,-0.017930763,PNPLA3,Approved symbol,PNPLA3,patatin like phospholipase domain containing 3,HGNC:18590,22q13.31
TNFRSF10C,-0.017929659,TNFRSF10C,Approved symbol,TNFRSF10C,TNF receptor superfamily member 10c,HGNC:11906,8p21.3
KIAA0040,-0.017927562,KIAA0040,Approved symbol,KIAA0040,KIAA0040,HGNC:28950,1q25.1
RBPMS,-0.017923665,RBPMS,Approved symbol,RBPMS,"RNA binding protein, mRNA processing factor",HGNC:19097,8p12
CXorf36,-0.017923429,CXorf36,Previous symbol,DIPK2B,divergent protein kinase domain 2B,HGNC:25866,Xp11.3
RPS6KA2,-0.017918795,RPS6KA2,Approved symbol,RPS6KA2,ribosomal protein S6 kinase A2,HGNC:10431,6q27
PRADC1,0.017917874,PRADC1,Approved symbol,PRADC1,protease associated domain containing 1,HGNC:16047,2p13.2
RP11-37B2.1,-0.017917371,RP11-37B2.1,Unmatched,RP11-37B2.1,,,
SERPINB5,-0.017914805,SERPINB5,Approved symbol,SERPINB5,serpin family B member 5,HGNC:8949,18q21.33
RFX8,-0.017914114,RFX8,Approved symbol,RFX8,"RFX family member 8, lacking RFX DNA binding domain",HGNC:37253,2q11.2
MINOS1,0.017905038,MINOS1,Previous symbol,MICOS10,mitochondrial contact site and cristae organizing system subunit 10,HGNC:32068,1p36.13
KIF5C,0.017899676,KIF5C,Approved symbol,KIF5C,kinesin family member 5C,HGNC:6325,2q23.1-q23.2
LRRC8C,-0.01789173,LRRC8C,Approved symbol,LRRC8C,leucine rich repeat containing 8 VRAC subunit C,HGNC:25075,1p22.2
KSR2,0.017891165,KSR2,Approved symbol,KSR2,kinase suppressor of ras 2,HGNC:18610,12q24.22-q24.23
CDC45,-0.01789083,CDC45,Approved symbol,CDC45,cell division cycle 45,HGNC:1739,22q11.21
BCL6B,-0.017890343,BCL6B,Approved symbol,BCL6B,BCL6B transcription repressor,HGNC:1002,17p13.1
FAN1,0.017888316,FAN1,Approved symbol,FAN1,FANCD2 and FANCI associated nuclease 1,HGNC:29170,15q13.3
CASP1P2,-0.017887513,CASP1P2,Approved symbol,CASP1P2,caspase 1 pseudogene 2,HGNC:43776,11q22.3
ZNF684,0.017886747,ZNF684,Approved symbol,ZNF684,zinc finger protein 684,HGNC:28418,1p34.2
C4orf32,-0.01788465,C4orf32,Previous symbol,FAM241A,family with sequence similarity 241 member A,HGNC:26813,4q25
NFE2,-0.017884183,NFE2,Approved symbol,NFE2,"nuclear factor, erythroid 2",HGNC:7780,12q13.13
RP11-138A9.2,0.01788358,RP11-138A9.2,Unmatched,RP11-138A9.2,,,
RP3-407E4.4,0.017881402,RP3-407E4.4,Unmatched,RP3-407E4.4,,,
DUSP4,-0.017877658,DUSP4,Approved symbol,DUSP4,dual specificity phosphatase 4,HGNC:3070,8p12
RP11-728F11.4,0.017876484,RP11-728F11.4,Unmatched,RP11-728F11.4,,,
ADORA1,-0.017871054,ADORA1,Approved symbol,ADORA1,adenosine A1 receptor,HGNC:262,1q32.1
LYSMD2,-0.017867586,LYSMD2,Approved symbol,LYSMD2,LysM domain containing 2,HGNC:28571,15q21.2
GJC1,-0.017865732,GJC1,Approved symbol,GJC1,gap junction protein gamma 1,HGNC:4280,17q21.31
LBP,-0.017860671,LBP,Approved symbol,LBP,lipopolysaccharide binding protein,HGNC:6517,20q11.23
C17orf62,-0.017858104,C17orf62,Previous symbol,CYBC1,cytochrome b-245 chaperone 1,HGNC:28672,17q25.3
C2CD2,-0.017856541,C2CD2,Approved symbol,C2CD2,C2 calcium dependent domain containing 2,HGNC:1266,21q22.3
TRAK2,0.017856512,TRAK2,Approved symbol,TRAK2,trafficking kinesin protein 2,HGNC:13206,2q33.1
CD300A,-0.017856382,CD300A,Approved symbol,CD300A,CD300a molecule,HGNC:19319,17q25.1
ITPRIP,-0.017854663,ITPRIP,Approved symbol,ITPRIP,"inositol 1,4,5-trisphosphate receptor interacting protein",HGNC:29370,10q25.1
CERS6,0.017854362,CERS6,Approved symbol,CERS6,ceramide synthase 6,HGNC:23826,2q24.3
RP3-477M7.5,-0.017851293,RP3-477M7.5,Unmatched,RP3-477M7.5,,,
ZRANB2-AS2,0.01785083,ZRANB2-AS2,Approved symbol,ZRANB2-AS2,ZRANB2 antisense RNA 2 (head to head),HGNC:43595,1p31.1
IFITM3,-0.017849557,IFITM3,Approved symbol,IFITM3,interferon induced transmembrane protein 3,HGNC:5414,11p15.5
DYSF,-0.017845916,DYSF,Approved symbol,DYSF,dysferlin,HGNC:3097,2p13.2
OSM,-0.01783969,OSM,Approved symbol,OSM,oncostatin M,HGNC:8506,22q12.2
RXRA,0.01783638,RXRA,Approved symbol,RXRA,retinoid X receptor alpha,HGNC:10477,9q34.2
AF064860.7,0.017834314,AF064860.7,Unmatched,AF064860.7,,,
FSTL4,0.017834078,FSTL4,Approved symbol,FSTL4,follistatin like 4,HGNC:21389,5q31.1
KRT17,-0.017830002,KRT17,Approved symbol,KRT17,keratin 17,HGNC:6427,17q21.2
DUSP2,-0.01782962,DUSP2,Approved symbol,DUSP2,dual specificity phosphatase 2,HGNC:3068,2q11.2
NFAM1,-0.017819417,NFAM1,Approved symbol,NFAM1,NFAT activating protein with ITAM motif 1,HGNC:29872,22q13.2
ZNF816,0.01781877,ZNF816,Approved symbol,ZNF816,zinc finger protein 816,HGNC:26995,19q13.41
CEP19,-0.017818408,CEP19,Approved symbol,CEP19,centrosomal protein 19,HGNC:28209,3q29
PLEKHG6,0.017814196,PLEKHG6,Approved symbol,PLEKHG6,pleckstrin homology and RhoGEF domain containing G6,HGNC:25562,12p13.31
GPRIN2,0.017814044,GPRIN2,Approved symbol,GPRIN2,G protein regulated inducer of neurite outgrowth 2,HGNC:23730,10q11.22
FCGRT,0.017812168,FCGRT,Approved symbol,FCGRT,Fc fragment of IgG receptor and transporter,HGNC:3621,19q13.33
ULBP2,-0.017807452,ULBP2,Approved symbol,ULBP2,UL16 binding protein 2,HGNC:14894,6q25.1
SRPX2,-0.017806221,SRPX2,Approved symbol,SRPX2,sushi repeat containing protein X-linked 2,HGNC:30668,Xq22.1
TMEM170A,0.017801715,TMEM170A,Approved symbol,TMEM170A,transmembrane protein 170A,HGNC:29577,16q23.1
GUCA2A,0.017800423,GUCA2A,Approved symbol,GUCA2A,guanylate cyclase activator 2A,HGNC:4682,1p34.2
PER2,0.017797613,PER2,Approved symbol,PER2,period circadian regulator 2,HGNC:8846,2q37.3
IRAK2,-0.017797221,IRAK2,Approved symbol,IRAK2,interleukin 1 receptor associated kinase 2,HGNC:6113,3p25.3
KCP,-0.017797052,KCP,Approved symbol,KCP,kielin cysteine rich BMP regulator,HGNC:17585,7q32.1
NOL4,0.017796577,NOL4,Approved symbol,NOL4,nucleolar protein 4,HGNC:7870,18q12.1
ANP32E,-0.017795543,ANP32E,Approved symbol,ANP32E,acidic nuclear phosphoprotein 32 family member E,HGNC:16673,1q21.2
CHI3L2,-0.017795487,CHI3L2,Approved symbol,CHI3L2,chitinase 3 like 2,HGNC:1933,1p13.2
AMACR,0.01779356,AMACR,Approved symbol,AMACR,alpha-methylacyl-CoA racemase,HGNC:451,5p13.2
TCN1,-0.017792921,TCN1,Approved symbol,TCN1,transcobalamin 1,HGNC:11652,11q12.1
FAM161B,0.017792619,FAM161B,Approved symbol,FAM161B,FAM161 centrosomal protein B,HGNC:19854,14q24.3
CREB3L2,-0.017790852,CREB3L2,Approved symbol,CREB3L2,cAMP responsive element binding protein 3 like 2,HGNC:23720,7q33
ZFHX3,0.017790468,ZFHX3,Approved symbol,ZFHX3,zinc finger homeobox 3,HGNC:777,16q22.2-q22.3
AIM2,-0.017790263,AIM2,Approved symbol,AIM2,absent in melanoma 2,HGNC:357,1q23.1-q23.2
MMP19,-0.017789698,MMP19,Approved symbol,MMP19,matrix metallopeptidase 19,HGNC:7165,12q13.2
CD55,-0.017788316,CD55,Approved symbol,CD55,CD55 molecule (Cromer blood group),HGNC:2665,1q32.2
SLC9A7,-0.017787704,SLC9A7,Approved symbol,SLC9A7,solute carrier family 9 member A7,HGNC:17123,Xp11.3
TKTL1,-0.017787516,TKTL1,Approved symbol,TKTL1,transketolase like 1,HGNC:11835,Xq28
TROAP,-0.017785421,TROAP,Approved symbol,TROAP,trophinin associated protein,HGNC:12327,12q13.12
RP11-134G8.7,0.017784981,RP11-134G8.7,Unmatched,RP11-134G8.7,,,
LILRB4,-0.017779342,LILRB4,Approved symbol,LILRB4,leukocyte immunoglobulin like receptor B4,HGNC:6608,19q13.42
FBXL13,-0.017773785,FBXL13,Approved symbol,FBXL13,F-box and leucine rich repeat protein 13,HGNC:21658,7q22.1
PKDCC,0.017769353,PKDCC,Approved symbol,PKDCC,"protein kinase domain containing, cytoplasmic",HGNC:25123,2p21
ZBTB10,0.017766448,ZBTB10,Approved symbol,ZBTB10,zinc finger and BTB domain containing 10,HGNC:30953,8q21.13
HCAR3,-0.017764159,HCAR3,Approved symbol,HCAR3,hydroxycarboxylic acid receptor 3,HGNC:16824,12q24.31
SHROOM2,0.017760928,SHROOM2,Approved symbol,SHROOM2,shroom family member 2,HGNC:630,Xp22.2
NR2F6,0.017754946,NR2F6,Approved symbol,NR2F6,nuclear receptor subfamily 2 group F member 6,HGNC:7977,19p13.11
TNNC2,0.017744646,TNNC2,Approved symbol,TNNC2,"troponin C2, fast skeletal type",HGNC:11944,20q13.12
GPR137B,-0.017741155,GPR137B,Approved symbol,GPR137B,G protein-coupled receptor 137B,HGNC:11862,1q42.3
NR4A3,-0.017736684,NR4A3,Approved symbol,NR4A3,nuclear receptor subfamily 4 group A member 3,HGNC:7982,9q22
BLCAP,0.017735641,BLCAP,Approved symbol,BLCAP,BLCAP apoptosis inducing factor,HGNC:1055,20q11.23
ADAMTS7,-0.017735069,ADAMTS7,Approved symbol,ADAMTS7,ADAM metallopeptidase with thrombospondin type 1 motif 7,HGNC:223,15q25.1
BDNF-AS,0.017734971,BDNF-AS,Approved symbol,BDNF-AS,BDNF antisense RNA,HGNC:20608,11p14.1
ZEB1,-0.017733311,ZEB1,Approved symbol,ZEB1,zinc finger E-box binding homeobox 1,HGNC:11642,10p11.22
CEBPA-AS1,0.017731003,CEBPA-AS1,Previous symbol,CEBPA-DT,CEBPA divergent transcript,HGNC:25710,19q13.11
VNN2,-0.017729754,VNN2,Approved symbol,VNN2,vanin 2,HGNC:12706,6q23.2
CDC42SE1,-0.017729582,CDC42SE1,Approved symbol,CDC42SE1,CDC42 small effector 1,HGNC:17719,1q21.3
HLA-DMA,-0.017727102,HLA-DMA,Approved symbol,HLA-DMA,"major histocompatibility complex, class II, DM alpha",HGNC:4934,6p21.32
TP63,-0.017726563,TP63,Approved symbol,TP63,tumor protein p63,HGNC:15979,3q28
LUCAT1,-0.017718841,LUCAT1,Approved symbol,LUCAT1,lung cancer associated transcript 1,HGNC:48498,5q14.3
RNF122,-0.017718784,RNF122,Approved symbol,RNF122,ring finger protein 122,HGNC:21147,8p12
PRKAR2B,-0.017718256,PRKAR2B,Approved symbol,PRKAR2B,protein kinase cAMP-dependent type II regulatory subunit beta,HGNC:9392,7q22.3
HPS5,-0.017715903,HPS5,Approved symbol,HPS5,HPS5 biogenesis of lysosomal organelles complex 2 subunit 2,HGNC:17022,11p15.1
EGFL6,-0.017714922,EGFL6,Approved symbol,EGFL6,EGF like domain multiple 6,HGNC:3235,Xp22.2
BLM,-0.017714478,BLM,Approved symbol,BLM,BLM RecQ like helicase,HGNC:1058,15q26.1
EPHX1,0.017711409,EPHX1,Approved symbol,EPHX1,epoxide hydrolase 1,HGNC:3401,1q42.12
MKKS,0.017711159,MKKS,Approved symbol,MKKS,McKusick-Kaufman syndrome,HGNC:7108,20p12.2
CTC-537E7.2,0.017706904,CTC-537E7.2,Unmatched,CTC-537E7.2,,,
RGMB,0.017703465,RGMB,Approved symbol,RGMB,repulsive guidance molecule BMP co-receptor b,HGNC:26896,5q15
NLRP12,-0.017703077,NLRP12,Approved symbol,NLRP12,NLR family pyrin domain containing 12,HGNC:22938,19q13.42
RP11-296O14.3,0.017700791,RP11-296O14.3,Unmatched,RP11-296O14.3,,,
NTN4,0.017696999,NTN4,Approved symbol,NTN4,netrin 4,HGNC:13658,12q22
LYST,-0.017696494,LYST,Approved symbol,LYST,lysosomal trafficking regulator,HGNC:1968,1q42.3
AC073283.4,0.017695834,AC073283.4,Unmatched,AC073283.4,,,
IL8,-0.017695051,IL8,Previous symbol,CXCL8,C-X-C motif chemokine ligand 8,HGNC:6025,4q13.3
EAF2,-0.017693029,EAF2,Approved symbol,EAF2,ELL associated factor 2,HGNC:23115,3q13.33
GCKR,-0.017690573,GCKR,Approved symbol,GCKR,glucokinase regulator,HGNC:4196,2p23.3
RP11-4O1.2,0.017679771,RP11-4O1.2,Unmatched,RP11-4O1.2,,,
C19orf59,-0.017677371,C19orf59,Previous symbol,MCEMP1,mast cell expressed membrane protein 1,HGNC:27291,19p13.2
TPRG1L,0.017676862,TPRG1L,Approved symbol,TPRG1L,tumor protein p63 regulated 1 like,HGNC:27007,1p36.32
KIAA2013,0.017675876,KIAA2013,Approved symbol,KIAA2013,KIAA2013,HGNC:28513,1p36.22
RABGAP1,0.017674617,RABGAP1,Approved symbol,RABGAP1,RAB GTPase activating protein 1,HGNC:17155,9q33.2-q33.3
EIF3L,0.017673453,EIF3L,Approved symbol,EIF3L,eukaryotic translation initiation factor 3 subunit L,HGNC:18138,22q13.1
SLC39A5,0.017672876,SLC39A5,Approved symbol,SLC39A5,solute carrier family 39 member 5,HGNC:20502,12q13.3
CMTM2,-0.017671045,CMTM2,Approved symbol,CMTM2,CKLF like MARVEL transmembrane domain containing 2,HGNC:19173,16q21
FOXO4,0.017670274,FOXO4,Approved symbol,FOXO4,forkhead box O4,HGNC:7139,Xq13.1
AGTR1,0.017669271,AGTR1,Approved symbol,AGTR1,angiotensin II receptor type 1,HGNC:336,3q24
SLC36A1,0.017666219,SLC36A1,Approved symbol,SLC36A1,solute carrier family 36 member 1,HGNC:18761,5q33.1
TUBB,-0.017664061,TUBB,Approved symbol,TUBB,tubulin beta class I,HGNC:20778,6p21.33
KLHL3,-0.017659207,KLHL3,Approved symbol,KLHL3,kelch like family member 3,HGNC:6354,5q31.2
FBXW7,-0.017654687,FBXW7,Approved symbol,FBXW7,F-box and WD repeat domain containing 7,HGNC:16712,4q31.3
CTSK,-0.017653539,CTSK,Approved symbol,CTSK,cathepsin K,HGNC:2536,1q21.3
CDK5R2,0.017649192,CDK5R2,Approved symbol,CDK5R2,cyclin dependent kinase 5 regulatory subunit 2,HGNC:1776,2q35
SPAG16,0.017641484,SPAG16,Approved symbol,SPAG16,sperm associated antigen 16,HGNC:23225,2q34
FAM169B,-0.017640643,FAM169B,Approved symbol,FAM169B,family with sequence similarity 169 member B,HGNC:26835,15q26.3
SCN9A,0.01763963,SCN9A,Approved symbol,SCN9A,sodium voltage-gated channel alpha subunit 9,HGNC:10597,2q24.3
CXCL1,-0.017637239,CXCL1,Approved symbol,CXCL1,C-X-C motif chemokine ligand 1,HGNC:4602,4q13.3
PHOSPHO1,-0.017629203,PHOSPHO1,Approved symbol,PHOSPHO1,phosphoethanolamine/phosphocholine phosphatase 1,HGNC:16815,17q21.32
TDRD3,0.017624208,TDRD3,Approved symbol,TDRD3,tudor domain containing 3,HGNC:20612,13q21.2
MEOX1,-0.017624133,MEOX1,Approved symbol,MEOX1,mesenchyme homeobox 1,HGNC:7013,17q21.31
FAM184B,0.017617331,FAM184B,Approved symbol,FAM184B,family with sequence similarity 184 member B,HGNC:29235,4p15.32-p15.31
CDC42EP2,-0.017616282,CDC42EP2,Approved symbol,CDC42EP2,CDC42 effector protein 2,HGNC:16263,11q13.1
MARVELD1,0.017614362,MARVELD1,Approved symbol,MARVELD1,MARVEL domain containing 1,HGNC:28674,10q24.2
CEP170,-0.017612173,CEP170,Approved symbol,CEP170,centrosomal protein 170,HGNC:28920,1q43
SFT2D3,0.017611276,SFT2D3,Approved symbol,SFT2D3,SFT2 domain containing 3,HGNC:28767,2q14.3
RALGDS,-0.017609205,RALGDS,Approved symbol,RALGDS,ral guanine nucleotide dissociation stimulator,HGNC:9842,9q34.13-q34.2
C2,-0.017607515,C2,Approved symbol,C2,complement C2,HGNC:1248,6p21.33
AF165138.7,-0.017605846,AF165138.7,Unmatched,AF165138.7,,,
PCDH17,-0.017605397,PCDH17,Approved symbol,PCDH17,protocadherin 17,HGNC:14267,13q21.1
LMCD1,-0.017603676,LMCD1,Approved symbol,LMCD1,LIM and cysteine rich domains 1,HGNC:6633,3p25.3
KCNJ12,0.01760106,KCNJ12,Approved symbol,KCNJ12,potassium inwardly rectifying channel subfamily J member 12,HGNC:6258,17p11.2
KIAA1199,-0.017600378,KIAA1199,Previous symbol,CEMIP,cell migration inducing hyaluronidase 1,HGNC:29213,15q25.1
WDR62,-0.017599087,WDR62,Approved symbol,WDR62,WD repeat domain 62,HGNC:24502,19q13.12
ORAI2,-0.017597237,ORAI2,Approved symbol,ORAI2,ORAI calcium release-activated calcium modulator 2,HGNC:21667,7q22.1
C21orf88,0.017597218,C21orf88,Previous symbol,B3GALT5-AS1,B3GALT5 antisense RNA 1,HGNC:16424,21q22.2
ECH1,0.017594664,ECH1,Approved symbol,ECH1,enoyl-CoA hydratase 1,HGNC:3149,19q13.2
SLC26A7,0.017589892,SLC26A7,Approved symbol,SLC26A7,solute carrier family 26 member 7,HGNC:14467,8q21.3
SIGLEC5,-0.017589687,SIGLEC5,Approved symbol,SIGLEC5,sialic acid binding Ig like lectin 5,HGNC:10874,19q13.41
IL6ST,-0.017586909,IL6ST,Approved symbol,IL6ST,interleukin 6 signal transducer,HGNC:6021,5q11.2
IFNAR2,-0.017583543,IFNAR2,Approved symbol,IFNAR2,interferon alpha and beta receptor subunit 2,HGNC:5433,21q22.11
SUCLG1,0.017580768,SUCLG1,Approved symbol,SUCLG1,succinate-CoA ligase GDP/ADP-forming subunit alpha,HGNC:11449,2p11.2
FAM72A,-0.017579391,FAM72A,Approved symbol,FAM72A,family with sequence similarity 72 member A,HGNC:24044,1q32.1
RTEL1-TNFRSF6B,-0.017576387,RTEL1-TNFRSF6B,Approved symbol,RTEL1-TNFRSF6B,RTEL1-TNFRSF6B readthrough (NMD candidate),HGNC:44095,20q13.33
LPCAT3,0.017575141,LPCAT3,Approved symbol,LPCAT3,lysophosphatidylcholine acyltransferase 3,HGNC:30244,12p13.31
STK10,-0.0175745,STK10,Approved symbol,STK10,serine/threonine kinase 10,HGNC:11388,5q35.1
RRM2,-0.017570992,RRM2,Approved symbol,RRM2,ribonucleotide reductase regulatory subunit M2,HGNC:10452,2p25.1
THRA,0.017569969,THRA,Approved symbol,THRA,thyroid hormone receptor alpha,HGNC:11796,17q21.1
RORC,0.017558375,RORC,Approved symbol,RORC,RAR related orphan receptor C,HGNC:10260,1q21
TTC40,-0.017557751,TTC40,Previous symbol,CFAP46,cilia and flagella associated protein 46,HGNC:25247,10q26.3
MAK,-0.017554545,MAK,Approved symbol,MAK,male germ cell associated kinase,HGNC:6816,6p24.2
GNAI2,-0.01755437,GNAI2,Approved symbol,GNAI2,G protein subunit alpha i2,HGNC:4385,3p21.31
NDE1,-0.017553146,NDE1,Approved symbol,NDE1,nudE neurodevelopment protein 1,HGNC:17619,16p13.11
CXCL11,-0.017548753,CXCL11,Approved symbol,CXCL11,C-X-C motif chemokine ligand 11,HGNC:10638,4q21.1
TRIP13,-0.017541564,TRIP13,Approved symbol,TRIP13,thyroid hormone receptor interactor 13,HGNC:12307,5p15.33
SCN2A,-0.017541249,SCN2A,Approved symbol,SCN2A,sodium voltage-gated channel alpha subunit 2,HGNC:10588,2q24.3
CTB-111H14.1,-0.017540221,CTB-111H14.1,Unmatched,CTB-111H14.1,,,
THY1,-0.017539366,THY1,Approved symbol,THY1,Thy-1 cell surface antigen,HGNC:11801,11q23.3
MEFV,-0.017537574,MEFV,Approved symbol,MEFV,"MEFV innate immuity regulator, pyrin",HGNC:6998,16p13.3
TRIM22,-0.017536794,TRIM22,Approved symbol,TRIM22,tripartite motif containing 22,HGNC:16379,11p15.4
INSL4,-0.017536016,INSL4,Approved symbol,INSL4,insulin like 4,HGNC:6087,9p24.1
AC112229.7,0.017535896,AC112229.7,Unmatched,AC112229.7,,,
FEV,0.017535606,FEV,Approved symbol,FEV,"FEV transcription factor, ETS family member",HGNC:18562,2q35
ATP9A,0.017533894,ATP9A,Approved symbol,ATP9A,ATPase phospholipid transporting 9A (putative),HGNC:13540,20q13.2
RP11-327F22.2,-0.017529248,RP11-327F22.2,Unmatched,RP11-327F22.2,,,
CXCL2,-0.017524224,CXCL2,Approved symbol,CXCL2,C-X-C motif chemokine ligand 2,HGNC:4603,4q13.3
LETM2,-0.017521814,LETM2,Approved symbol,LETM2,leucine zipper and EF-hand containing transmembrane protein 2,HGNC:14648,8p11.23
CHKA,0.017519849,CHKA,Approved symbol,CHKA,choline kinase alpha,HGNC:1937,11q13.2
UGT2B11,0.017517789,UGT2B11,Approved symbol,UGT2B11,UDP glucuronosyltransferase family 2 member B11,HGNC:12545,4q13.2
RP11-511I2.2,0.017516736,RP11-511I2.2,Unmatched,RP11-511I2.2,,,
ZBED1,0.017515095,ZBED1,Approved symbol,ZBED1,zinc finger BED-type containing 1,HGNC:447,Xp22.33 and Yp11
F3,-0.017514308,F3,Approved symbol,F3,"coagulation factor III, tissue factor",HGNC:3541,1p21.3
RP11-1267H10.4,0.017513304,RP11-1267H10.4,Unmatched,RP11-1267H10.4,,,
IFI44L,-0.017498466,IFI44L,Approved symbol,IFI44L,interferon induced protein 44 like,HGNC:17817,1p31.1
CD38,-0.017493229,CD38,Approved symbol,CD38,CD38 molecule,HGNC:1667,4p15.32
MOAP1,0.017491346,MOAP1,Approved symbol,MOAP1,modulator of apoptosis 1,HGNC:16658,14q32.12
RP11-672L10.6,0.0174878,RP11-672L10.6,Unmatched,RP11-672L10.6,,,
SLC22A5,0.017485284,SLC22A5,Approved symbol,SLC22A5,solute carrier family 22 member 5,HGNC:10969,5q31.1
OVOL2,0.017485159,OVOL2,Approved symbol,OVOL2,ovo like zinc finger 2,HGNC:15804,20p11.23
LINC00963,-0.017482114,LINC00963,Approved symbol,LINC00963,long intergenic non-protein coding RNA 963,HGNC:48716,9q34.11
S100A2,-0.017478986,S100A2,Approved symbol,S100A2,S100 calcium binding protein A2,HGNC:10492,1q21.3
DHRS11,0.017475784,DHRS11,Approved symbol,DHRS11,dehydrogenase/reductase 11,HGNC:28639,17q12
SYT17,0.017474742,SYT17,Approved symbol,SYT17,synaptotagmin 17,HGNC:24119,16p12.3
HCK,-0.017469567,HCK,Approved symbol,HCK,"HCK proto-oncogene, Src family tyrosine kinase",HGNC:4840,20q11.21
KIAA0930,-0.017467848,KIAA0930,Approved symbol,KIAA0930,KIAA0930,HGNC:1314,22q13.31
CFB,-0.017466071,CFB,Approved symbol,CFB,complement factor B,HGNC:1037,6p21.33
DGKG,-0.017462909,DGKG,Approved symbol,DGKG,diacylglycerol kinase gamma,HGNC:2853,3q27.2-q27.3
NEURL1B,0.017457551,NEURL1B,Approved symbol,NEURL1B,neuralized E3 ubiquitin protein ligase 1B,HGNC:35422,5q35.1
RP11-61L23.2,-0.01745375,RP11-61L23.2,Unmatched,RP11-61L23.2,,,
RP11-395P17.11,0.017449822,RP11-395P17.11,Unmatched,RP11-395P17.11,,,
TPST1,-0.017444412,TPST1,Approved symbol,TPST1,tyrosylprotein sulfotransferase 1,HGNC:12020,7q11.21
CAPN13,0.017441172,CAPN13,Approved symbol,CAPN13,calpain 13,HGNC:16663,2p23.1
CLEC4E,-0.017440409,CLEC4E,Approved symbol,CLEC4E,C-type lectin domain family 4 member E,HGNC:14555,12p13.31
SEMA6A,0.017438156,SEMA6A,Approved symbol,SEMA6A,semaphorin 6A,HGNC:10738,5q23.1
PLA2G3,-0.017436873,PLA2G3,Approved symbol,PLA2G3,phospholipase A2 group III,HGNC:17934,22q12.2
RAB31,-0.017436449,RAB31,Approved symbol,RAB31,"RAB31, member RAS oncogene family",HGNC:9771,18p11.22
ALPL,-0.017433725,ALPL,Approved symbol,ALPL,"alkaline phosphatase, biomineralization associated",HGNC:438,1p36.12
RP11-797A18.4,0.017433167,RP11-797A18.4,Unmatched,RP11-797A18.4,,,
SLC28A3,-0.017429696,SLC28A3,Approved symbol,SLC28A3,solute carrier family 28 member 3,HGNC:16484,9q21.32-q21.33
EDA,0.017427429,EDA,Approved symbol,EDA,ectodysplasin A,HGNC:3157,Xq13.1
CHN1,-0.017426529,CHN1,Approved symbol,CHN1,chimerin 1,HGNC:1943,2q31.1
RP11-15H20.6,0.017424067,RP11-15H20.6,Unmatched,RP11-15H20.6,,,
RP11-680A11.5,-0.017423855,RP11-680A11.5,Unmatched,RP11-680A11.5,,,
IL6,-0.017422553,IL6,Approved symbol,IL6,interleukin 6,HGNC:6018,7p15.3
HJURP,-0.017421934,HJURP,Approved symbol,HJURP,Holliday junction recognition protein,HGNC:25444,2q37.1
JAKMIP1,-0.017417795,JAKMIP1,Approved symbol,JAKMIP1,janus kinase and microtubule interacting protein 1,HGNC:26460,4p16.1
NECAB3,0.017415863,NECAB3,Approved symbol,NECAB3,N-terminal EF-hand calcium binding protein 3,HGNC:15851,20q11.22
UHRF1,-0.017415391,UHRF1,Approved symbol,UHRF1,ubiquitin like with PHD and ring finger domains 1,HGNC:12556,19p13.3
TRBV7-6,-0.017414943,TRBV7-6,Approved symbol,TRBV7-6,T cell receptor beta variable 7-6,HGNC:12240,7q34
ZNF44,0.017411955,ZNF44,Approved symbol,ZNF44,zinc finger protein 44,HGNC:13110,19p13.2
RASSF8-AS1,-0.017408017,RASSF8-AS1,Approved symbol,RASSF8-AS1,RASSF8 antisense RNA 1,HGNC:48637,12p12.1
FAP,-0.017406649,FAP,Approved symbol,FAP,fibroblast activation protein alpha,HGNC:3590,2q24.2
SH3RF3-AS1,-0.017406295,SH3RF3-AS1,Approved symbol,SH3RF3-AS1,SH3RF3 antisense RNA 1,HGNC:44168,2q13
RP11-76C10.5,0.017405054,RP11-76C10.5,Unmatched,RP11-76C10.5,,,
CTA-384D8.35,-0.017403873,CTA-384D8.35,Unmatched,CTA-384D8.35,,,
FAM189A1,0.017403422,FAM189A1,Approved symbol,FAM189A1,family with sequence similarity 189 member A1,HGNC:29075,15q13.1
CCDC147-AS1,-0.01740108,CCDC147-AS1,Previous symbol,CFAP58-DT,CFAP58 divergent transcript,HGNC:45243,10q25.1
ZNF204P,0.017399786,ZNF204P,Approved symbol,ZNF204P,"zinc finger protein 204, pseudogene",HGNC:12995,6p22.1
DSE,-0.017395613,DSE,Approved symbol,DSE,dermatan sulfate epimerase,HGNC:21144,6q22.1
SKA1,-0.017390106,SKA1,Approved symbol,SKA1,spindle and kinetochore associated complex subunit 1,HGNC:28109,18q21.1
RP11-511B23.2,0.017389628,RP11-511B23.2,Unmatched,RP11-511B23.2,,,
SIK2,0.017388621,SIK2,Approved symbol,SIK2,salt inducible kinase 2,HGNC:21680,11q23.1
HOXA10,0.01738667,HOXA10,Approved symbol,HOXA10,homeobox A10,HGNC:5100,7p15.2
CXCL6,-0.017384013,CXCL6,Approved symbol,CXCL6,C-X-C motif chemokine ligand 6,HGNC:10643,4q13.3
IP6K3,-0.017382568,IP6K3,Approved symbol,IP6K3,inositol hexakisphosphate kinase 3,HGNC:17269,6p21.31
DDHD1,-0.017382563,DDHD1,Approved symbol,DDHD1,DDHD domain containing 1,HGNC:19714,14q22.1
GNA12,-0.017382401,GNA12,Approved symbol,GNA12,G protein subunit alpha 12,HGNC:4380,7p22.3-p22.2
GAS6,0.01737981,GAS6,Approved symbol,GAS6,growth arrest specific 6,HGNC:4168,13q34
IGKJ5,-0.017379507,IGKJ5,Approved symbol,IGKJ5,immunoglobulin kappa joining 5,HGNC:5723,2p11.2
CCDC122,0.017378396,CCDC122,Approved symbol,CCDC122,coiled-coil domain containing 122,HGNC:26478,13q14.11
ARHGAP29,-0.017377445,ARHGAP29,Approved symbol,ARHGAP29,Rho GTPase activating protein 29,HGNC:30207,1p22.1
APOL1,-0.017368276,APOL1,Approved symbol,APOL1,apolipoprotein L1,HGNC:618,22q12.3
SLC18B1,0.017364184,SLC18B1,Approved symbol,SLC18B1,solute carrier family 18 member B1,HGNC:21573,6q23.2
CCDC69,-0.017358369,CCDC69,Approved symbol,CCDC69,coiled-coil domain containing 69,HGNC:24487,5q33.1
LDLRAD2,-0.017356346,LDLRAD2,Approved symbol,LDLRAD2,low density lipoprotein receptor class A domain containing 2,HGNC:32071,1p36.12
SIX4,-0.017354115,SIX4,Approved symbol,SIX4,SIX homeobox 4,HGNC:10890,14q23.1
TNFAIP8L1,-0.017353007,TNFAIP8L1,Approved symbol,TNFAIP8L1,TNF alpha induced protein 8 like 1,HGNC:28279,19p13.3
IL18RAP,-0.017352105,IL18RAP,Approved symbol,IL18RAP,interleukin 18 receptor accessory protein,HGNC:5989,2q12.1
MALT1,-0.017349378,MALT1,Approved symbol,MALT1,MALT1 paracaspase,HGNC:6819,18q21.32
MUM1L1,0.017347058,MUM1L1,Previous symbol,PWWP3B,PWWP domain containing 3B,HGNC:26583,Xq22.3
APOBEC3G,-0.017345797,APOBEC3G,Approved symbol,APOBEC3G,apolipoprotein B mRNA editing enzyme catalytic subunit 3G,HGNC:17357,22q13.1
FCAR,-0.01734139,FCAR,Approved symbol,FCAR,Fc fragment of IgA receptor,HGNC:3608,19q13.42
RNF183,-0.017341094,RNF183,Approved symbol,RNF183,ring finger protein 183,HGNC:28721,9q32
RP11-360F5.3,-0.017332787,RP11-360F5.3,Unmatched,RP11-360F5.3,,,
RP11-83A24.2,0.017331764,RP11-83A24.2,Unmatched,RP11-83A24.2,,,
DCC,-0.017331275,DCC,Approved symbol,DCC,DCC netrin 1 receptor,HGNC:2701,18q21.2
SERPINF2,-0.017329744,SERPINF2,Approved symbol,SERPINF2,serpin family F member 2,HGNC:9075,17p13.3
ARG2,-0.017325537,ARG2,Approved symbol,ARG2,arginase 2,HGNC:664,14q24.1
IFFO2,-0.017325388,IFFO2,Approved symbol,IFFO2,intermediate filament family orphan 2,HGNC:27006,1p36.13
GTSE1,-0.017321634,GTSE1,Approved symbol,GTSE1,G2 and S-phase expressed 1,HGNC:13698,22q13.31
CDKN2B-AS1,0.017317924,CDKN2B-AS1,Approved symbol,CDKN2B-AS1,CDKN2B antisense RNA 1,HGNC:34341,9p21.3
CST7,-0.017315864,CST7,Approved symbol,CST7,cystatin F,HGNC:2479,20p11.21
KIAA0101,-0.017315616,KIAA0101,Previous symbol,PCLAF,PCNA clamp associated factor,HGNC:28961,15q22.31
PADI4,-0.01731405,PADI4,Approved symbol,PADI4,peptidyl arginine deiminase 4,HGNC:18368,1p36.13
MICB,-0.017307952,MICB,Approved symbol,MICB,MHC class I polypeptide-related sequence B,HGNC:7091,6p21.33
CCR3,-0.017301448,CCR3,Approved symbol,CCR3,C-C motif chemokine receptor 3,HGNC:1604,3p21.31
FMO5,0.017295848,FMO5,Approved symbol,FMO5,flavin containing dimethylaniline monoxygenase 5,HGNC:3773,1q21.1
RP11-379K17.12,0.017294862,RP11-379K17.12,Unmatched,RP11-379K17.12,,,
ZSCAN16,0.017291918,ZSCAN16,Approved symbol,ZSCAN16,zinc finger and SCAN domain containing 16,HGNC:20813,6p22.1
SNAI1,-0.017290962,SNAI1,Approved symbol,SNAI1,snail family transcriptional repressor 1,HGNC:11128,20q13.13
SSTR2,0.017288958,SSTR2,Approved symbol,SSTR2,somatostatin receptor 2,HGNC:11331,17q25.1
NRIP3,-0.017287695,NRIP3,Approved symbol,NRIP3,nuclear receptor interacting protein 3,HGNC:1167,11p15.4
NFKBIE,-0.017287246,NFKBIE,Approved symbol,NFKBIE,NFKB inhibitor epsilon,HGNC:7799,6p21.1
ABCA12,-0.017284432,ABCA12,Approved symbol,ABCA12,ATP binding cassette subfamily A member 12,HGNC:14637,2q35
B3GNT8,0.017283266,B3GNT8,Approved symbol,B3GNT8,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8",HGNC:24139,19q13.2
PCBP3,-0.017282666,PCBP3,Approved symbol,PCBP3,poly(rC) binding protein 3,HGNC:8651,21q22.3
DSN1,-0.01728202,DSN1,Approved symbol,DSN1,DSN1 component of MIS12 kinetochore complex,HGNC:16165,20q11.23
SLFN11,-0.017280404,SLFN11,Approved symbol,SLFN11,schlafen family member 11,HGNC:26633,17q12
SLC25A37,-0.017278415,SLC25A37,Approved symbol,SLC25A37,solute carrier family 25 member 37,HGNC:29786,8p21.2
PANX2,-0.017277774,PANX2,Approved symbol,PANX2,pannexin 2,HGNC:8600,22q13.33
RP11-598F7.5,-0.017277254,RP11-598F7.5,Unmatched,RP11-598F7.5,,,
RERE,0.017272381,RERE,Approved symbol,RERE,arginine-glutamic acid dipeptide repeats,HGNC:9965,1p36.23
NCOA7,-0.017271233,NCOA7,Approved symbol,NCOA7,nuclear receptor coactivator 7,HGNC:21081,6q22.31-q22.32
DENND5A,-0.017269386,DENND5A,Approved symbol,DENND5A,DENN domain containing 5A,HGNC:19344,11p15.4
INSM1,0.017261442,INSM1,Approved symbol,INSM1,INSM transcriptional repressor 1,HGNC:6090,20p11.23
C5orf63,0.017258136,C5orf63,Approved symbol,C5orf63,chromosome 5 open reading frame 63,HGNC:40051,5q23.2
IRAK3,-0.017255385,IRAK3,Approved symbol,IRAK3,interleukin 1 receptor associated kinase 3,HGNC:17020,12q14.3
TPH1,0.017252605,TPH1,Approved symbol,TPH1,tryptophan hydroxylase 1,HGNC:12008,11p15.1
TUBB3,-0.017247061,TUBB3,Approved symbol,TUBB3,tubulin beta 3 class III,HGNC:20772,16q24.3
GPR84,-0.017245909,GPR84,Approved symbol,GPR84,G protein-coupled receptor 84,HGNC:4535,12q13.13
SP140L,-0.017243715,SP140L,Approved symbol,SP140L,SP140 nuclear body protein like,HGNC:25105,2q37.1
IL1RN,-0.017242995,IL1RN,Approved symbol,IL1RN,interleukin 1 receptor antagonist,HGNC:6000,2q14.1
RP11-611O2.5,0.017242079,RP11-611O2.5,Unmatched,RP11-611O2.5,,,
COL6A3,-0.017236937,COL6A3,Approved symbol,COL6A3,collagen type VI alpha 3 chain,HGNC:2213,2q37.3
SHMT2,-0.017231649,SHMT2,Approved symbol,SHMT2,serine hydroxymethyltransferase 2,HGNC:10852,12q13.3
VENTX,-0.017230507,VENTX,Approved symbol,VENTX,VENT homeobox,HGNC:13639,10q26.3
SULF1,-0.017229863,SULF1,Approved symbol,SULF1,sulfatase 1,HGNC:20391,8q13.2-q13.3
C4A,-0.017229253,C4A,Approved symbol,C4A,complement C4A (Rodgers blood group),HGNC:1323,6p21.33
CHRNB2,0.017227544,CHRNB2,Approved symbol,CHRNB2,cholinergic receptor nicotinic beta 2 subunit,HGNC:1962,1q21.3
ANKRD27,0.017226141,ANKRD27,Approved symbol,ANKRD27,ankyrin repeat domain 27,HGNC:25310,19q13.11
CTB-61M7.2,-0.017224296,CTB-61M7.2,Unmatched,CTB-61M7.2,,,
CREB5,-0.017222149,CREB5,Approved symbol,CREB5,cAMP responsive element binding protein 5,HGNC:16844,7p15.1-p14.3
CCDC71L,-0.01722199,CCDC71L,Approved symbol,CCDC71L,coiled-coil domain containing 71 like,HGNC:26685,7q22.3
PPBP,-0.017221698,PPBP,Approved symbol,PPBP,pro-platelet basic protein,HGNC:9240,4q13.3
TM4SF1,-0.017211985,TM4SF1,Approved symbol,TM4SF1,transmembrane 4 L six family member 1,HGNC:11853,3q25.1
C17orf53,-0.017204441,C17orf53,Previous symbol,HROB,homologous recombination factor with OB-fold,HGNC:28460,17q21.31
TRPM3,0.017203888,TRPM3,Approved symbol,TRPM3,transient receptor potential cation channel subfamily M member 3,HGNC:17992,9q21.12-q21.13
AC110619.1,0.017199131,AC110619.1,Unmatched,AC110619.1,,,
PRRX1,-0.017185746,PRRX1,Approved symbol,PRRX1,paired related homeobox 1,HGNC:9142,1q24.2
FRAS1,0.017184775,FRAS1,Approved symbol,FRAS1,Fraser extracellular matrix complex subunit 1,HGNC:19185,4q21.21
IL17REL,-0.017179906,IL17REL,Approved symbol,IL17REL,interleukin 17 receptor E like,HGNC:33808,22q13.33
FAM83A,-0.017175307,FAM83A,Approved symbol,FAM83A,family with sequence similarity 83 member A,HGNC:28210,8q24.13
LY6E,-0.017169908,LY6E,Approved symbol,LY6E,lymphocyte antigen 6 family member E,HGNC:6727,8q24.3
HRASLS5,-0.017166562,HRASLS5,Previous symbol,PLAAT5,phospholipase A and acyltransferase 5,HGNC:24978,11q12.3
POU2AF1,-0.017166388,POU2AF1,Approved symbol,POU2AF1,POU class 2 homeobox associating factor 1,HGNC:9211,11q23.1
FCGR1C,-0.017161466,FCGR1C,Previous symbol,FCGR1CP,"Fc fragment of IgG receptor Ic, pseudogene",HGNC:3615,1q21.1
SPIRE2,0.017160684,SPIRE2,Approved symbol,SPIRE2,spire type actin nucleation factor 2,HGNC:30623,16q24.3
SVOP,0.01716048,SVOP,Approved symbol,SVOP,SV2 related protein,HGNC:25417,12q24.11
PTPN13,-0.017157567,PTPN13,Approved symbol,PTPN13,protein tyrosine phosphatase non-receptor type 13,HGNC:9646,4q21.3
EBF3,-0.017157505,EBF3,Approved symbol,EBF3,EBF transcription factor 3,HGNC:19087,10q26.3
AP000230.1,0.017156679,AP000230.1,Unmatched,AP000230.1,,,
IDO1,-0.017154482,IDO1,Approved symbol,IDO1,"indoleamine 2,3-dioxygenase 1",HGNC:6059,8p11.21
RQCD1,-0.017153114,RQCD1,Previous symbol,CNOT9,CCR4-NOT transcription complex subunit 9,HGNC:10445,2q35
KLHDC7B,-0.017151941,KLHDC7B,Approved symbol,KLHDC7B,kelch domain containing 7B,HGNC:25145,22q13.33
SLAMF8,-0.017150772,SLAMF8,Approved symbol,SLAMF8,SLAM family member 8,HGNC:21391,1q23.2
MME,-0.017150496,MME,Approved symbol,MME,membrane metalloendopeptidase,HGNC:7154,3q25.2
TMTC1,-0.017150392,TMTC1,Approved symbol,TMTC1,transmembrane O-mannosyltransferase targeting cadherins 1,HGNC:24099,12p11.22
LTK,0.017145066,LTK,Approved symbol,LTK,leukocyte receptor tyrosine kinase,HGNC:6721,15q15.1
STRIP2,-0.017143622,STRIP2,Approved symbol,STRIP2,striatin interacting protein 2,HGNC:22209,7q32.1
PHTF1,-0.017137544,PHTF1,Approved symbol,PHTF1,putative homeodomain transcription factor 1,HGNC:8939,1p13.2
PKM,-0.01713529,PKM,Approved symbol,PKM,pyruvate kinase M1/2,HGNC:9021,15q23
RBMS1,-0.017132032,RBMS1,Approved symbol,RBMS1,RNA binding motif single stranded interacting protein 1,HGNC:9907,2q24.2
ANXA1,-0.017126135,ANXA1,Approved symbol,ANXA1,annexin A1,HGNC:533,9q21.13
DARC,-0.017120185,DARC,Previous symbol,ACKR1,atypical chemokine receptor 1 (Duffy blood group),HGNC:4035,1q23.2
REG1A,-0.017115127,REG1A,Approved symbol,REG1A,regenerating family member 1 alpha,HGNC:9951,2p12
PHLDB1,0.017114077,PHLDB1,Approved symbol,PHLDB1,pleckstrin homology like domain family B member 1,HGNC:23697,11q23.3
RP11-13K12.1,0.017105867,RP11-13K12.1,Unmatched,RP11-13K12.1,,,
EMB,-0.017093117,EMB,Approved symbol,EMB,embigin,HGNC:30465,5q11.1
RGS18,-0.017092762,RGS18,Approved symbol,RGS18,regulator of G protein signaling 18,HGNC:14261,1q31.2
PORCN,-0.017089572,PORCN,Approved symbol,PORCN,porcupine O-acyltransferase,HGNC:17652,Xp11.23
LINC00840,-0.017089492,LINC00840,Approved symbol,LINC00840,long intergenic non-protein coding RNA 840,HGNC:44987,10q11.21
PDK2,0.017089315,PDK2,Approved symbol,PDK2,pyruvate dehydrogenase kinase 2,HGNC:8810,17q21.33
CXCR6,-0.017089146,CXCR6,Approved symbol,CXCR6,C-X-C motif chemokine receptor 6,HGNC:16647,3p21.31
ACAD10,0.017086802,ACAD10,Approved symbol,ACAD10,acyl-CoA dehydrogenase family member 10,HGNC:21597,12q24.12
MYBPH,-0.017085648,MYBPH,Approved symbol,MYBPH,myosin binding protein H,HGNC:7552,1q32.1
RP1-249H1.4,0.017078555,RP1-249H1.4,Unmatched,RP1-249H1.4,,,
GREM1,-0.01707336,GREM1,Approved symbol,GREM1,"gremlin 1, DAN family BMP antagonist",HGNC:2001,15q13.3
FCN1,-0.017071968,FCN1,Approved symbol,FCN1,ficolin 1,HGNC:3623,9q34.3
RP4-584D14.5,0.017065966,RP4-584D14.5,Unmatched,RP4-584D14.5,,,
FFAR3,-0.017053693,FFAR3,Approved symbol,FFAR3,free fatty acid receptor 3,HGNC:4499,19q13.12
TNFRSF10B,-0.017050651,TNFRSF10B,Approved symbol,TNFRSF10B,TNF receptor superfamily member 10b,HGNC:11905,8p21.3
ETV7,-0.017045067,ETV7,Approved symbol,ETV7,ETS variant transcription factor 7,HGNC:18160,6p21.31
C15orf54,-0.017043593,C15orf54,Approved symbol,C15orf54,chromosome 15 putative open reading frame 54,HGNC:33797,15q14
SLC16A6,-0.017042328,SLC16A6,Approved symbol,SLC16A6,solute carrier family 16 member 6,HGNC:10927,17q24.2
TNFAIP3,-0.017042016,TNFAIP3,Approved symbol,TNFAIP3,TNF alpha induced protein 3,HGNC:11896,6q23.3
TRERF1,-0.017037249,TRERF1,Approved symbol,TRERF1,transcriptional regulating factor 1,HGNC:18273,6p21.1
ZNF267,-0.017036515,ZNF267,Approved symbol,ZNF267,zinc finger protein 267,HGNC:13060,16p11.2
PITPNC1,-0.01703437,PITPNC1,Approved symbol,PITPNC1,phosphatidylinositol transfer protein cytoplasmic 1,HGNC:21045,17q24.2
CHGA,0.017033699,CHGA,Approved symbol,CHGA,chromogranin A,HGNC:1929,14q32.12
CTD-2171N6.1,-0.017033225,CTD-2171N6.1,Alias symbol,LINC01929,long intergenic non-protein coding RNA 1929,HGNC:52751,18q21.2
CTB-114C7.4,-0.017033102,CTB-114C7.4,Unmatched,CTB-114C7.4,,,
FEN1,-0.017027671,FEN1,Approved symbol,FEN1,flap structure-specific endonuclease 1,HGNC:3650,11q12.2
DIO3,0.01702745,DIO3,Approved symbol,DIO3,iodothyronine deiodinase 3,HGNC:2885,14q32.31
HIVEP2,-0.017024743,HIVEP2,Approved symbol,HIVEP2,HIVEP zinc finger 2,HGNC:4921,6q24.2
C1QTNF1-AS1,0.017024078,C1QTNF1-AS1,Approved symbol,C1QTNF1-AS1,C1QTNF1 antisense RNA 1,HGNC:44351,17q25.3
FAM132B,-0.017023152,FAM132B,Previous symbol,ERFE,erythroferrone,HGNC:26727,2q37.3
TEAD4,-0.017022627,TEAD4,Approved symbol,TEAD4,TEA domain transcription factor 4,HGNC:11717,12p13.33
C14orf93,0.017021333,C14orf93,Approved symbol,C14orf93,chromosome 14 open reading frame 93,HGNC:20162,14q11.2
CCDC181,0.017021153,CCDC181,Approved symbol,CCDC181,coiled-coil domain containing 181,HGNC:28051,1q24.2
RP11-347C12.10,0.017020086,RP11-347C12.10,Unmatched,RP11-347C12.10,,,
REG1B,-0.017018722,REG1B,Approved symbol,REG1B,regenerating family member 1 beta,HGNC:9952,2p12
GLOD4,0.017014435,GLOD4,Approved symbol,GLOD4,glyoxalase domain containing 4,HGNC:14111,17p13.3
ADM2,-0.017012596,ADM2,Approved symbol,ADM2,adrenomedullin 2,HGNC:28898,22q13.33
INHBB,-0.017012147,INHBB,Approved symbol,INHBB,inhibin subunit beta B,HGNC:6067,2q14.2
AC127496.1,0.017009331,AC127496.1,Unmatched,AC127496.1,,,
PCK1,0.017008325,PCK1,Approved symbol,PCK1,phosphoenolpyruvate carboxykinase 1,HGNC:8724,20q13.31
AURKB,-0.016995866,AURKB,Approved symbol,AURKB,aurora kinase B,HGNC:11390,17p13.1
P2RY13,-0.016993681,P2RY13,Approved symbol,P2RY13,purinergic receptor P2Y13,HGNC:4537,3q25.1
APOL2,-0.016993675,APOL2,Approved symbol,APOL2,apolipoprotein L2,HGNC:619,22q12.3
BTN3A3,-0.016992346,BTN3A3,Approved symbol,BTN3A3,butyrophilin subfamily 3 member A3,HGNC:1140,6p22.2
ZNF365,-0.016992143,ZNF365,Approved symbol,ZNF365,zinc finger protein 365,HGNC:18194,10q21.2
COL22A1,-0.016992053,COL22A1,Approved symbol,COL22A1,collagen type XXII alpha 1 chain,HGNC:22989,8q24.23-q24.3
CRYBA2,0.016990254,CRYBA2,Approved symbol,CRYBA2,crystallin beta A2,HGNC:2395,2q35
FAM114A2,-0.016990123,FAM114A2,Approved symbol,FAM114A2,family with sequence similarity 114 member A2,HGNC:1333,5q33.2
SLC39A6,-0.016989254,SLC39A6,Approved symbol,SLC39A6,solute carrier family 39 member 6,HGNC:18607,18q12.2
TLR8,-0.016984124,TLR8,Approved symbol,TLR8,toll like receptor 8,HGNC:15632,Xp22.2
DNAH5,-0.016983647,DNAH5,Approved symbol,DNAH5,dynein axonemal heavy chain 5,HGNC:2950,5p15.2
UBTF,0.01698233,UBTF,Approved symbol,UBTF,upstream binding transcription factor,HGNC:12511,17q21.31
C11orf73,-0.016980958,C11orf73,Previous symbol,HIKESHI,heat shock protein nuclear import factor hikeshi,HGNC:26938,11q14.2
C19orf38,-0.016980309,C19orf38,Approved symbol,C19orf38,chromosome 19 open reading frame 38,HGNC:34073,19p13.2
SCG3,0.016978971,SCG3,Approved symbol,SCG3,secretogranin III,HGNC:13707,15q21.2
ADCY4,-0.016977707,ADCY4,Approved symbol,ADCY4,adenylate cyclase 4,HGNC:235,14q12
NT5DC2,-0.01697615,NT5DC2,Approved symbol,NT5DC2,5'-nucleotidase domain containing 2,HGNC:25717,3p21.1
CISD3,0.01697521,CISD3,Approved symbol,CISD3,CDGSH iron sulfur domain 3,HGNC:27578,17q12
SNX5,0.016973894,SNX5,Approved symbol,SNX5,sorting nexin 5,HGNC:14969,20p11.23
NKG7,-0.016962509,NKG7,Approved symbol,NKG7,natural killer cell granule protein 7,HGNC:7830,19q13.41
ZNF576,0.016962489,ZNF576,Approved symbol,ZNF576,zinc finger protein 576,HGNC:28357,19q13.31
RP11-221J22.2,-0.016959135,RP11-221J22.2,Unmatched,RP11-221J22.2,,,
SLC16A4,-0.016958571,SLC16A4,Approved symbol,SLC16A4,solute carrier family 16 member 4,HGNC:10925,1p13.3
TTC26,-0.016958093,TTC26,Approved symbol,TTC26,tetratricopeptide repeat domain 26,HGNC:21882,7q34
RP13-188A5.1,0.016953769,RP13-188A5.1,Unmatched,RP13-188A5.1,,,
RP11-383C5.4,0.016952704,RP11-383C5.4,Unmatched,RP11-383C5.4,,,
SCG2,0.016950647,SCG2,Approved symbol,SCG2,secretogranin II,HGNC:10575,2q36.1
CGRRF1,0.016950444,CGRRF1,Approved symbol,CGRRF1,cell growth regulator with ring finger domain 1,HGNC:15528,14q22.2
GMPR,-0.016948153,GMPR,Approved symbol,GMPR,guanosine monophosphate reductase,HGNC:4376,6p22.3
HOXB5,0.016947677,HOXB5,Approved symbol,HOXB5,homeobox B5,HGNC:5116,17q21.32
SUCNR1,-0.016947598,SUCNR1,Approved symbol,SUCNR1,succinate receptor 1,HGNC:4542,3q25.1
PGF,-0.016944122,PGF,Approved symbol,PGF,placental growth factor,HGNC:8893,14q24.3
CXCL3,-0.016939632,CXCL3,Approved symbol,CXCL3,C-X-C motif chemokine ligand 3,HGNC:4604,4q13.3
C1orf167,-0.016935913,C1orf167,Approved symbol,C1orf167,chromosome 1 open reading frame 167,HGNC:25262,1p36.22
EDN3,0.016931052,EDN3,Approved symbol,EDN3,endothelin 3,HGNC:3178,20q13.32
ODF3B,-0.016930367,ODF3B,Approved symbol,ODF3B,outer dense fiber of sperm tails 3B,HGNC:34388,22q13.33
AC022182.3,-0.016926804,AC022182.3,Unmatched,AC022182.3,,,
GAL,-0.016923947,GAL,Approved symbol,GAL,galanin and GMAP prepropeptide,HGNC:4114,11q13.2
AC005235.1,0.016922398,AC005235.1,Unmatched,AC005235.1,,,
RP11-219G17.4,-0.016922334,RP11-219G17.4,Unmatched,RP11-219G17.4,,,
ANO2,-0.016921064,ANO2,Approved symbol,ANO2,anoctamin 2,HGNC:1183,12p13.31
HLA-DPA3,-0.016920144,HLA-DPA3,Approved symbol,HLA-DPA3,"major histocompatibility complex, class II, DP alpha 3 (pseudogene)",HGNC:19393,6p21.32
FMO1,-0.016919651,FMO1,Approved symbol,FMO1,flavin containing dimethylaniline monoxygenase 1,HGNC:3769,1q24.3
CTC-297N7.8,0.016917725,CTC-297N7.8,Unmatched,CTC-297N7.8,,,
ZNF606,0.016917451,ZNF606,Approved symbol,ZNF606,zinc finger protein 606,HGNC:25879,19q13.43
MIS12,-0.016915898,MIS12,Approved symbol,MIS12,MIS12 kinetochore complex component,HGNC:24967,17p13.2
DSTNP2,-0.016911866,DSTNP2,Approved symbol,DSTNP2,DSTN pseudogene 2,HGNC:34546,12p13.31
LGR6,0.016910557,LGR6,Approved symbol,LGR6,leucine rich repeat containing G protein-coupled receptor 6,HGNC:19719,1q32.1
NEUROD1,0.016909336,NEUROD1,Approved symbol,NEUROD1,neuronal differentiation 1,HGNC:7762,2q31.3
IGLON5,-0.016903295,IGLON5,Approved symbol,IGLON5,IgLON family member 5,HGNC:34550,19q13.41
MMP25,-0.016903227,MMP25,Approved symbol,MMP25,matrix metallopeptidase 25,HGNC:14246,16p13.3
MIEF2,0.016903075,MIEF2,Approved symbol,MIEF2,mitochondrial elongation factor 2,HGNC:17920,17p11.2
CELF3,0.016899154,CELF3,Approved symbol,CELF3,CUGBP Elav-like family member 3,HGNC:11967,1q21.3
TMEM141,0.016895869,TMEM141,Approved symbol,TMEM141,transmembrane protein 141,HGNC:28211,9q34.3
ECSCR,-0.016894663,ECSCR,Approved symbol,ECSCR,endothelial cell surface expressed chemotaxis and apoptosis regulator,HGNC:35454,5q31.2
COL7A1,-0.016892479,COL7A1,Approved symbol,COL7A1,collagen type VII alpha 1 chain,HGNC:2214,3p21.31
FKBP11,-0.016890022,FKBP11,Approved symbol,FKBP11,FKBP prolyl isomerase 11,HGNC:18624,12q13.12
PRR16,-0.016889843,PRR16,Approved symbol,PRR16,proline rich 16,HGNC:29654,5q23.1
LRP6,0.016888927,LRP6,Approved symbol,LRP6,LDL receptor related protein 6,HGNC:6698,12p13.2
GPR12,0.016885957,GPR12,Approved symbol,GPR12,G protein-coupled receptor 12,HGNC:4466,13q12.13
ITGB2,-0.016878371,ITGB2,Approved symbol,ITGB2,integrin subunit beta 2,HGNC:6155,21q22.3
DNAJB5,-0.016876034,DNAJB5,Approved symbol,DNAJB5,DnaJ heat shock protein family (Hsp40) member B5,HGNC:14887,9p13.3
VWA5B1,0.016874579,VWA5B1,Approved symbol,VWA5B1,von Willebrand factor A domain containing 5B1,HGNC:26538,1p36.12
BLOC1S6,-0.016874269,BLOC1S6,Approved symbol,BLOC1S6,biogenesis of lysosomal organelles complex 1 subunit 6,HGNC:8549,15q21.1
C2CD4A,-0.01687046,C2CD4A,Approved symbol,C2CD4A,C2 calcium dependent domain containing 4A,HGNC:33627,15q22.2
RP11-625L16.3,-0.016861573,RP11-625L16.3,Unmatched,RP11-625L16.3,,,
FANCG,-0.016859493,FANCG,Approved symbol,FANCG,FA complementation group G,HGNC:3588,9p13.3
RP11-355B11.2,0.016856843,RP11-355B11.2,Unmatched,RP11-355B11.2,,,
RP11-47I22.2,-0.016856363,RP11-47I22.2,Unmatched,RP11-47I22.2,,,
DENND3,-0.016855751,DENND3,Approved symbol,DENND3,DENN domain containing 3,HGNC:29134,8q24.3
FAM26F,-0.016855317,FAM26F,Previous symbol,CALHM6,calcium homeostasis modulator family member 6,HGNC:33391,6q22.1
AHR,-0.016854386,AHR,Approved symbol,AHR,aryl hydrocarbon receptor,HGNC:348,7p21.1
RP11-654D12.2,0.016853914,RP11-654D12.2,Unmatched,RP11-654D12.2,,,
C1R,-0.016850653,C1R,Approved symbol,C1R,complement C1r,HGNC:1246,12p13.31
IL1R1,-0.016849073,IL1R1,Approved symbol,IL1R1,interleukin 1 receptor type 1,HGNC:5993,2q11.2-q12.1
TUBB6,-0.016848798,TUBB6,Approved symbol,TUBB6,tubulin beta 6 class V,HGNC:20776,18p11.21
NOVA2,-0.016845793,NOVA2,Approved symbol,NOVA2,NOVA alternative splicing regulator 2,HGNC:7887,19q13.32
CTPS1,-0.016844758,CTPS1,Approved symbol,CTPS1,CTP synthase 1,HGNC:2519,1p34.2
HS3ST6,0.016843499,HS3ST6,Approved symbol,HS3ST6,heparan sulfate-glucosamine 3-sulfotransferase 6,HGNC:14178,16p13.3
RHOU,0.016841908,RHOU,Approved symbol,RHOU,ras homolog family member U,HGNC:17794,1q42.13
C11orf91,-0.016838961,C11orf91,Approved symbol,C11orf91,chromosome 11 open reading frame 91,HGNC:34444,11p13
TBXAS1,-0.016836625,TBXAS1,Approved symbol,TBXAS1,thromboxane A synthase 1,HGNC:11609,7q34
DYRK3,-0.016832296,DYRK3,Approved symbol,DYRK3,dual specificity tyrosine phosphorylation regulated kinase 3,HGNC:3094,1q32.1
IGFBP7,-0.016831996,IGFBP7,Approved symbol,IGFBP7,insulin like growth factor binding protein 7,HGNC:5476,4q12
GJD3,-0.016825561,GJD3,Approved symbol,GJD3,gap junction protein delta 3,HGNC:19147,17q21.2
TNFRSF4,-0.016822846,TNFRSF4,Approved symbol,TNFRSF4,TNF receptor superfamily member 4,HGNC:11918,1p36.33
SMIM19,0.016821865,SMIM19,Approved symbol,SMIM19,small integral membrane protein 19,HGNC:25166,8p11.21
FLT4,-0.016821776,FLT4,Approved symbol,FLT4,fms related receptor tyrosine kinase 4,HGNC:3767,5q35.3
SLC30A10,0.01681914,SLC30A10,Approved symbol,SLC30A10,solute carrier family 30 member 10,HGNC:25355,1q41
FAAH,0.016818881,FAAH,Approved symbol,FAAH,fatty acid amide hydrolase,HGNC:3553,1p33
TAP2,-0.016818757,TAP2,Approved symbol,TAP2,"transporter 2, ATP binding cassette subfamily B member",HGNC:44,6p21.32
PHLPP2,0.016816134,PHLPP2,Approved symbol,PHLPP2,PH domain and leucine rich repeat protein phosphatase 2,HGNC:29149,16q22.2
AC105402.2,0.016814562,AC105402.2,Unmatched,AC105402.2,,,
GPR160,0.016812628,GPR160,Approved symbol,GPR160,G protein-coupled receptor 160,HGNC:23693,3q26.2
PGD,-0.01681238,PGD,Approved symbol,PGD,phosphogluconate dehydrogenase,HGNC:8891,1p36.22
PIWIL2,0.016811105,PIWIL2,Approved symbol,PIWIL2,piwi like RNA-mediated gene silencing 2,HGNC:17644,8p21.3
RP11-1008C21.1,-0.016809967,RP11-1008C21.1,Unmatched,RP11-1008C21.1,,,
UBE2L6,-0.016809433,UBE2L6,Approved symbol,UBE2L6,ubiquitin conjugating enzyme E2 L6,HGNC:12490,11q12.1
TLE2,0.01680775,TLE2,Approved symbol,TLE2,"TLE family member 2, transcriptional corepressor",HGNC:11838,19p13.3
MARK3,-0.01680385,MARK3,Approved symbol,MARK3,microtubule affinity regulating kinase 3,HGNC:6897,14q32.32-q32.33
CCL13,-0.01680343,CCL13,Approved symbol,CCL13,C-C motif chemokine ligand 13,HGNC:10611,17q12
CRTC3,-0.016801037,CRTC3,Approved symbol,CRTC3,CREB regulated transcription coactivator 3,HGNC:26148,15q26.1
C4orf50,-0.016800805,C4orf50,Approved symbol,C4orf50,chromosome 4 open reading frame 50,HGNC:33766,4p16.2-p16.1
GNG12-AS1,0.016800583,GNG12-AS1,Approved symbol,GNG12-AS1,"GNG12, DIRAS3 and WLS antisense RNA 1",HGNC:43938,1p31.3
FCGR3A,-0.016800401,FCGR3A,Approved symbol,FCGR3A,Fc fragment of IgG receptor IIIa,HGNC:3619,1q23.3
PALMD,-0.016795053,PALMD,Approved symbol,PALMD,palmdelphin,HGNC:15846,1p21.2
SLCO1B3,-0.016792487,SLCO1B3,Approved symbol,SLCO1B3,solute carrier organic anion transporter family member 1B3,HGNC:10961,12p12.2
DUSP5,-0.016787781,DUSP5,Approved symbol,DUSP5,dual specificity phosphatase 5,HGNC:3071,10q25.2
SNX10,-0.016784219,SNX10,Approved symbol,SNX10,sorting nexin 10,HGNC:14974,7p15.2
CDC20,-0.016783268,CDC20,Approved symbol,CDC20,cell division cycle 20,HGNC:1723,1p34.2
EIF4EBP2,0.016782714,EIF4EBP2,Approved symbol,EIF4EBP2,eukaryotic translation initiation factor 4E binding protein 2,HGNC:3289,10q22.1
TRAM2,-0.016770909,TRAM2,Approved symbol,TRAM2,translocation associated membrane protein 2,HGNC:16855,6p12.2
RELL2,-0.016769946,RELL2,Approved symbol,RELL2,RELT like 2,HGNC:26902,5q31.3
FANCI,-0.016769161,FANCI,Approved symbol,FANCI,FA complementation group I,HGNC:25568,15q26.1
STMN3,-0.016766343,STMN3,Approved symbol,STMN3,stathmin 3,HGNC:15926,20q13.33
TRPV4,-0.01676605,TRPV4,Approved symbol,TRPV4,transient receptor potential cation channel subfamily V member 4,HGNC:18083,12q24.11
CBR3,-0.016762935,CBR3,Approved symbol,CBR3,carbonyl reductase 3,HGNC:1549,21q22.12
RP11-44N21.1,0.016756946,RP11-44N21.1,Unmatched,RP11-44N21.1,,,
SAMHD1,-0.016754112,SAMHD1,Approved symbol,SAMHD1,SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1,HGNC:15925,20q11.23
IL15,-0.016752512,IL15,Approved symbol,IL15,interleukin 15,HGNC:5977,4q31.21
TMEM128,0.016750007,TMEM128,Approved symbol,TMEM128,transmembrane protein 128,HGNC:28201,4p16.3
PNOC,-0.016749026,PNOC,Approved symbol,PNOC,prepronociceptin,HGNC:9163,8p21.1
LIAS,0.016747572,LIAS,Approved symbol,LIAS,lipoic acid synthetase,HGNC:16429,4p14
CENPN,-0.016740445,CENPN,Approved symbol,CENPN,centromere protein N,HGNC:30873,16q23.2
CYP7B1,-0.016739602,CYP7B1,Approved symbol,CYP7B1,cytochrome P450 family 7 subfamily B member 1,HGNC:2652,8q12.3
SENP1,-0.016734516,SENP1,Approved symbol,SENP1,SUMO specific peptidase 1,HGNC:17927,12q13.11
THNSL1,0.016734494,THNSL1,Approved symbol,THNSL1,threonine synthase like 1,HGNC:26160,10p12.1
NMT2,0.016733339,NMT2,Approved symbol,NMT2,N-myristoyltransferase 2,HGNC:7858,10p13
ANGPTL2,-0.016730621,ANGPTL2,Approved symbol,ANGPTL2,angiopoietin like 2,HGNC:490,9q33.3
IFITM1,-0.01672976,IFITM1,Approved symbol,IFITM1,interferon induced transmembrane protein 1,HGNC:5412,11p15.5
CDCA2,-0.016726226,CDCA2,Approved symbol,CDCA2,cell division cycle associated 2,HGNC:14623,8p21.2
GPR126,-0.016725004,GPR126,Previous symbol,ADGRG6,adhesion G protein-coupled receptor G6,HGNC:13841,6q24.2
FAM219B,0.016724041,FAM219B,Approved symbol,FAM219B,family with sequence similarity 219 member B,HGNC:24695,15q24.1-q24.2
S100A3,-0.016723882,S100A3,Approved symbol,S100A3,S100 calcium binding protein A3,HGNC:10493,1q21.3
VANGL2,0.01672363,VANGL2,Approved symbol,VANGL2,VANGL planar cell polarity protein 2,HGNC:15511,1q23.2
TUSC1,0.016722751,TUSC1,Approved symbol,TUSC1,tumor suppressor candidate 1,HGNC:31010,9p21.2
PDCD1LG2,-0.01672215,PDCD1LG2,Approved symbol,PDCD1LG2,programmed cell death 1 ligand 2,HGNC:18731,9p24.1
NLRP3,-0.016719431,NLRP3,Approved symbol,NLRP3,NLR family pyrin domain containing 3,HGNC:16400,1q44
AC006042.8,-0.016718369,AC006042.8,Unmatched,AC006042.8,,,
ZNF443,0.016715249,ZNF443,Approved symbol,ZNF443,zinc finger protein 443,HGNC:20878,19p13.2
RP11-439E19.10,0.016714828,RP11-439E19.10,Unmatched,RP11-439E19.10,,,
HELB,-0.016714675,HELB,Approved symbol,HELB,DNA helicase B,HGNC:17196,12q14.3
PHYH,0.016714393,PHYH,Approved symbol,PHYH,phytanoyl-CoA 2-hydroxylase,HGNC:8940,10p13
FANCD2,-0.016711207,FANCD2,Approved symbol,FANCD2,FA complementation group D2,HGNC:3585,3p25.3
SEC14L5,0.016706225,SEC14L5,Approved symbol,SEC14L5,SEC14 like lipid binding 5,HGNC:29032,16p13.3
FAM167B,-0.016702019,FAM167B,Approved symbol,FAM167B,family with sequence similarity 167 member B,HGNC:28133,1p35.2
TLN1,-0.016699073,TLN1,Approved symbol,TLN1,talin 1,HGNC:11845,9p13.3
LINC00307,0.016693825,LINC00307,Approved symbol,LINC00307,long intergenic non-protein coding RNA 307,HGNC:16727,21q22.11
LAX1,-0.016691394,LAX1,Approved symbol,LAX1,lymphocyte transmembrane adaptor 1,HGNC:26005,1q32.1
TMEM260,0.016687058,TMEM260,Approved symbol,TMEM260,transmembrane protein 260,HGNC:20185,14q22.3
SURF6,0.016685588,SURF6,Approved symbol,SURF6,surfeit 6,HGNC:11478,9q34.2
CDCA5,-0.016683975,CDCA5,Approved symbol,CDCA5,cell division cycle associated 5,HGNC:14626,11q13.1
MLYCD,0.016683628,MLYCD,Approved symbol,MLYCD,malonyl-CoA decarboxylase,HGNC:7150,16q23.3
NPHP4,-0.016682131,NPHP4,Approved symbol,NPHP4,nephrocystin 4,HGNC:19104,1p36.31
MLKL,-0.016680845,MLKL,Approved symbol,MLKL,mixed lineage kinase domain like pseudokinase,HGNC:26617,16q23.1
MCM10,-0.016677769,MCM10,Approved symbol,MCM10,minichromosome maintenance 10 replication initiation factor,HGNC:18043,10p13
CCDC3,-0.016673729,CCDC3,Approved symbol,CCDC3,coiled-coil domain containing 3,HGNC:23813,10p13
MTFR2,-0.016672564,MTFR2,Approved symbol,MTFR2,mitochondrial fission regulator 2,HGNC:21115,6q23.3
DGKD,0.016669826,DGKD,Approved symbol,DGKD,diacylglycerol kinase delta,HGNC:2851,2q37.1
ACOT9,-0.016664068,ACOT9,Approved symbol,ACOT9,acyl-CoA thioesterase 9,HGNC:17152,Xp22.11
CD300LB,-0.01666185,CD300LB,Approved symbol,CD300LB,CD300 molecule like family member b,HGNC:30811,17q25.1
SLC35A1,0.01666152,SLC35A1,Approved symbol,SLC35A1,solute carrier family 35 member A1,HGNC:11021,6q15
COL4A2,-0.016658493,COL4A2,Approved symbol,COL4A2,collagen type IV alpha 2 chain,HGNC:2203,13q34
CXCL9,-0.016658091,CXCL9,Approved symbol,CXCL9,C-X-C motif chemokine ligand 9,HGNC:7098,4q21.1
KAT8,0.016657719,KAT8,Approved symbol,KAT8,lysine acetyltransferase 8,HGNC:17933,16p11.2
CCL3,-0.016656769,CCL3,Approved symbol,CCL3,C-C motif chemokine ligand 3,HGNC:10627,17q12
FSTL1,-0.016653607,FSTL1,Approved symbol,FSTL1,follistatin like 1,HGNC:3972,3q13.33
PFKFB3,-0.016650148,PFKFB3,Approved symbol,PFKFB3,"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3",HGNC:8874,10p15.1
PROC,0.016647555,PROC,Approved symbol,PROC,"protein C, inactivator of coagulation factors Va and VIIIa",HGNC:9451,2q14.3
MOV10L1,-0.016641851,MOV10L1,Approved symbol,MOV10L1,Mov10 like RISC complex RNA helicase 1,HGNC:7201,22q13.33
IMPDH1,-0.016636358,IMPDH1,Approved symbol,IMPDH1,inosine monophosphate dehydrogenase 1,HGNC:6052,7q32.1
C16orf70,0.01663635,C16orf70,Approved symbol,C16orf70,chromosome 16 open reading frame 70,HGNC:29564,16q22.1
IQCG,-0.01663575,IQCG,Approved symbol,IQCG,IQ motif containing G,HGNC:25251,3q29
KLHDC9,0.016631756,KLHDC9,Approved symbol,KLHDC9,kelch domain containing 9,HGNC:28489,1q23.3
RP11-806H10.4,-0.016631322,RP11-806H10.4,Unmatched,RP11-806H10.4,,,
ARHGEF15,-0.016630257,ARHGEF15,Approved symbol,ARHGEF15,Rho guanine nucleotide exchange factor 15,HGNC:15590,17p13.1
C8orf4,-0.016627704,C8orf4,Previous symbol,TCIM,transcriptional and immune response regulator,HGNC:1357,8p11.21
DHX58,-0.016626963,DHX58,Approved symbol,DHX58,DExH-box helicase 58,HGNC:29517,17q21.2
ITGA2B,-0.016626906,ITGA2B,Approved symbol,ITGA2B,integrin subunit alpha 2b,HGNC:6138,17q21.31
OIT3,-0.016622343,OIT3,Approved symbol,OIT3,oncoprotein induced transcript 3,HGNC:29953,10q22.1
C15orf62,-0.01662203,C15orf62,Approved symbol,C15orf62,chromosome 15 open reading frame 62,HGNC:34489,15q15.1
TGFBR2,-0.01661541,TGFBR2,Approved symbol,TGFBR2,transforming growth factor beta receptor 2,HGNC:11773,3p24.1
XIRP1,-0.016614637,XIRP1,Approved symbol,XIRP1,xin actin binding repeat containing 1,HGNC:14301,3p22.2
SPINK4,-0.016613615,SPINK4,Approved symbol,SPINK4,serine peptidase inhibitor Kazal type 4,HGNC:16646,9p13.3
CFDP1,0.016607371,CFDP1,Approved symbol,CFDP1,craniofacial development protein 1,HGNC:1873,16q23.1
FCGR1A,-0.01660353,FCGR1A,Approved symbol,FCGR1A,Fc fragment of IgG receptor Ia,HGNC:3613,1q21.2
ADAMTS2,-0.016603304,ADAMTS2,Approved symbol,ADAMTS2,ADAM metallopeptidase with thrombospondin type 1 motif 2,HGNC:218,5q35.3
SLCO5A1,-0.016602993,SLCO5A1,Approved symbol,SLCO5A1,solute carrier organic anion transporter family member 5A1,HGNC:19046,8q13.3
HSBP1L1,0.016596599,HSBP1L1,Approved symbol,HSBP1L1,heat shock factor binding protein 1 like 1,HGNC:37243,18q23
SMIM7,0.016595885,SMIM7,Approved symbol,SMIM7,small integral membrane protein 7,HGNC:28419,19p13.11
SLC6A20,-0.016594786,SLC6A20,Approved symbol,SLC6A20,solute carrier family 6 member 20,HGNC:30927,3p21.31
ADAMTS3,-0.016594729,ADAMTS3,Approved symbol,ADAMTS3,ADAM metallopeptidase with thrombospondin type 1 motif 3,HGNC:219,4q13.3
C15orf26,-0.016593042,C15orf26,Previous symbol,CFAP161,cilia and flagella associated protein 161,HGNC:26782,15q25.1
COL12A1,-0.016591832,COL12A1,Approved symbol,COL12A1,collagen type XII alpha 1 chain,HGNC:2188,6q13-q14.1
CLEC6A,-0.016586906,CLEC6A,Approved symbol,CLEC6A,C-type lectin domain containing 6A,HGNC:14556,12p13.31
ZNF281,-0.016585512,ZNF281,Approved symbol,ZNF281,zinc finger protein 281,HGNC:13075,1q32.1
FFAR2,-0.016583111,FFAR2,Approved symbol,FFAR2,free fatty acid receptor 2,HGNC:4501,19q13.12
DOC2B,-0.016581472,DOC2B,Approved symbol,DOC2B,double C2 domain beta,HGNC:2986,17p13.3
C5AR1,-0.016574675,C5AR1,Approved symbol,C5AR1,complement C5a receptor 1,HGNC:1338,19q13.32
PHLDA1,-0.016573501,PHLDA1,Approved symbol,PHLDA1,pleckstrin homology like domain family A member 1,HGNC:8933,12q21.2
ALOX15,-0.016571116,ALOX15,Approved symbol,ALOX15,arachidonate 15-lipoxygenase,HGNC:433,17p13.2
NOTCH3,-0.016569031,NOTCH3,Approved symbol,NOTCH3,notch receptor 3,HGNC:7883,19p13.12
ABCC9,-0.016569017,ABCC9,Approved symbol,ABCC9,ATP binding cassette subfamily C member 9,HGNC:60,12p12.1
INSC,-0.016567033,INSC,Approved symbol,INSC,INSC spindle orientation adaptor protein,HGNC:33116,11p15.2
PEA15,-0.016566923,PEA15,Approved symbol,PEA15,proliferation and apoptosis adaptor protein 15,HGNC:8822,1q23.2
CLDN1,-0.016565372,CLDN1,Approved symbol,CLDN1,claudin 1,HGNC:2032,3q28
GPR19,-0.016560962,GPR19,Approved symbol,GPR19,G protein-coupled receptor 19,HGNC:4473,12p13.1
SLC35G1,0.016555587,SLC35G1,Approved symbol,SLC35G1,solute carrier family 35 member G1,HGNC:26607,10q23.33
CYP2B7P1,0.016552456,CYP2B7P1,Previous symbol,CYP2B7P,"cytochrome P450 family 2 subfamily B member 7, pseudogene",HGNC:2616,19q13.2
CYP2W1,0.016551926,CYP2W1,Approved symbol,CYP2W1,cytochrome P450 family 2 subfamily W member 1,HGNC:20243,7p22.3
EIF3J-AS1,0.016551796,EIF3J-AS1,Previous symbol,EIF3J-DT,EIF3J divergent transcript,HGNC:48616,15q21.1
RP11-434H14.1,0.016548962,RP11-434H14.1,Unmatched,RP11-434H14.1,,,
ADAM12,-0.016546669,ADAM12,Approved symbol,ADAM12,ADAM metallopeptidase domain 12,HGNC:190,10q26.2
RP11-539L10.3,0.016545543,RP11-539L10.3,Unmatched,RP11-539L10.3,,,
RP11-65J3.1,-0.016540279,RP11-65J3.1,Alias symbol,LINC01503,long intergenic non-protein coding RNA 1503,HGNC:51184,9q34.11
CTD-2555A7.3,-0.016538215,CTD-2555A7.3,Unmatched,CTD-2555A7.3,,,
AC007255.8,0.016536629,AC007255.8,Unmatched,AC007255.8,,,
FAM155A,-0.016535261,FAM155A,Approved symbol,FAM155A,family with sequence similarity 155 member A,HGNC:33877,13q33.3
PKN3,-0.016533136,PKN3,Approved symbol,PKN3,protein kinase N3,HGNC:17999,9q34.11
TICRR,-0.016531831,TICRR,Approved symbol,TICRR,TOPBP1 interacting checkpoint and replication regulator,HGNC:28704,15q26.1
MARCO,-0.016531012,MARCO,Approved symbol,MARCO,macrophage receptor with collagenous structure,HGNC:6895,2q14.2
ZNRF1,0.016529626,ZNRF1,Approved symbol,ZNRF1,zinc and ring finger 1,HGNC:18452,16q23.1
TTC7B,-0.016527539,TTC7B,Approved symbol,TTC7B,tetratricopeptide repeat domain 7B,HGNC:19858,14q32.11
RMDN2,0.016526453,RMDN2,Approved symbol,RMDN2,regulator of microtubule dynamics 2,HGNC:26567,2p22.2
RNF24,-0.016525214,RNF24,Approved symbol,RNF24,ring finger protein 24,HGNC:13779,20p13
GPR68,-0.016524327,GPR68,Approved symbol,GPR68,G protein-coupled receptor 68,HGNC:4519,14q32.11
GJA4,-0.016523796,GJA4,Approved symbol,GJA4,gap junction protein alpha 4,HGNC:4278,1p34.3
EXOSC8,-0.016523539,EXOSC8,Approved symbol,EXOSC8,exosome component 8,HGNC:17035,13q13.3
LCN15,0.016519921,LCN15,Approved symbol,LCN15,lipocalin 15,HGNC:33777,9q34.3
MYLIP,0.016511411,MYLIP,Approved symbol,MYLIP,myosin regulatory light chain interacting protein,HGNC:21155,6p22.3
DENND2D,-0.016510876,DENND2D,Approved symbol,DENND2D,DENN domain containing 2D,HGNC:26192,1p13.3-p13.2
CTB-167B5.2,-0.016509562,CTB-167B5.2,Unmatched,CTB-167B5.2,,,
NCBP2-AS2,0.016509348,NCBP2-AS2,Previous symbol,NCBP2AS2,NCBP2 antisense 2 (head to head),HGNC:25121,3q29
RP11-108P20.4,-0.016509018,RP11-108P20.4,Unmatched,RP11-108P20.4,,,
LRTM2,0.016507724,LRTM2,Approved symbol,LRTM2,leucine rich repeats and transmembrane domains 2,HGNC:32443,12p13.33
SCDP1,-0.016507566,SCDP1,Approved symbol,SCDP1,stearoyl-CoA desaturase pseudogene 1,HGNC:10572,17p11.2
SMOX,-0.016504131,SMOX,Approved symbol,SMOX,spermine oxidase,HGNC:15862,20p13
IGHV3OR16-6,-0.01650368,IGHV3OR16-6,Approved symbol,IGHV3OR16-6,immunoglobulin heavy variable 3/OR16-6 (pseudogene),HGNC:5641,16p11.2
AC008984.2,-0.01650291,AC008984.2,Unmatched,AC008984.2,,,
PARVB,-0.016498456,PARVB,Approved symbol,PARVB,parvin beta,HGNC:14653,22q13.31
ZNF91,0.016497851,ZNF91,Approved symbol,ZNF91,zinc finger protein 91,HGNC:13166,19p12
HAS2-AS1,0.01649691,HAS2-AS1,Approved symbol,HAS2-AS1,HAS2 antisense RNA 1,HGNC:34340,8q24.13
IL12RB2,-0.016495186,IL12RB2,Approved symbol,IL12RB2,interleukin 12 receptor subunit beta 2,HGNC:5972,1p31.3
REM2,-0.016491628,REM2,Approved symbol,REM2,RRAD and GEM like GTPase 2,HGNC:20248,14q11.2
DUOXA2,-0.016490728,DUOXA2,Approved symbol,DUOXA2,dual oxidase maturation factor 2,HGNC:32698,15q21.1
PLOD1,-0.016490325,PLOD1,Approved symbol,PLOD1,"procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",HGNC:9081,1p36.22
PDK1,-0.016487642,PDK1,Approved symbol,PDK1,pyruvate dehydrogenase kinase 1,HGNC:8809,2q31.1
XKR9,-0.016487632,XKR9,Approved symbol,XKR9,XK related 9,HGNC:20937,8q13.3
CRELD2,-0.016484101,CRELD2,Approved symbol,CRELD2,cysteine rich with EGF like domains 2,HGNC:28150,22q13.33
DMBT1,-0.016482982,DMBT1,Approved symbol,DMBT1,deleted in malignant brain tumors 1,HGNC:2926,10q26.13
CHST3,-0.016482877,CHST3,Approved symbol,CHST3,carbohydrate sulfotransferase 3,HGNC:1971,10q22.1
KNTC1,-0.016482608,KNTC1,Approved symbol,KNTC1,kinetochore associated 1,HGNC:17255,12q24.31
FIBIN,-0.016481487,FIBIN,Approved symbol,FIBIN,fin bud initiation factor homolog,HGNC:33747,11p14.2
PRF1,-0.016479965,PRF1,Approved symbol,PRF1,perforin 1,HGNC:9360,10q22.1
LIPG,-0.016478165,LIPG,Approved symbol,LIPG,"lipase G, endothelial type",HGNC:6623,18q21.1
SLC46A1,0.016477517,SLC46A1,Approved symbol,SLC46A1,solute carrier family 46 member 1,HGNC:30521,17q11.2
C4B,-0.016475738,C4B,Approved symbol,C4B,complement C4B (Chido blood group),HGNC:1324,6p21.33
SAMD9L,-0.016471106,SAMD9L,Approved symbol,SAMD9L,sterile alpha motif domain containing 9 like,HGNC:1349,7q21.2
MACROD1,0.016469721,MACROD1,Approved symbol,MACROD1,mono-ADP ribosylhydrolase 1,HGNC:29598,11q13.1
AOC2,-0.016462533,AOC2,Approved symbol,AOC2,amine oxidase copper containing 2,HGNC:549,17q21.31
KLHL29,-0.016455369,KLHL29,Approved symbol,KLHL29,kelch like family member 29,HGNC:29404,2p24.1
SRGAP2B,-0.016451868,SRGAP2B,Approved symbol,SRGAP2B,SLIT-ROBO Rho GTPase activating protein 2B,HGNC:35237,1q21.1
COX4I2,-0.016450525,COX4I2,Approved symbol,COX4I2,cytochrome c oxidase subunit 4I2,HGNC:16232,20q11.21
DNAJC19,0.016450005,DNAJC19,Approved symbol,DNAJC19,DnaJ heat shock protein family (Hsp40) member C19,HGNC:30528,3q26.33
DPYSL3,-0.01644791,DPYSL3,Approved symbol,DPYSL3,dihydropyrimidinase like 3,HGNC:3015,5q32
TTL,-0.016447626,TTL,Approved symbol,TTL,tubulin tyrosine ligase,HGNC:21586,2q14.1
NFE4,-0.016447614,NFE4,Approved symbol,NFE4,"nuclear factor, erythroid 4",HGNC:29902,7q22.1
RP11-701P16.5,-0.016442299,RP11-701P16.5,Unmatched,RP11-701P16.5,,,
CCL11,-0.01643964,CCL11,Approved symbol,CCL11,C-C motif chemokine ligand 11,HGNC:10610,17q12
IL15RA,-0.016438956,IL15RA,Approved symbol,IL15RA,interleukin 15 receptor subunit alpha,HGNC:5978,10p15.1
HECW2,-0.016438568,HECW2,Approved symbol,HECW2,"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2",HGNC:29853,2q32.3
CDK18,0.016436488,CDK18,Approved symbol,CDK18,cyclin dependent kinase 18,HGNC:8751,1q32.1
RP11-792A8.4,0.01643607,RP11-792A8.4,Unmatched,RP11-792A8.4,,,
TEX264,0.016429857,TEX264,Approved symbol,TEX264,"testis expressed 264, ER-phagy receptor",HGNC:30247,3p21.2
C7orf31,0.016424113,C7orf31,Approved symbol,C7orf31,chromosome 7 open reading frame 31,HGNC:21722,7p15.3
TGFB2,-0.016416719,TGFB2,Approved symbol,TGFB2,transforming growth factor beta 2,HGNC:11768,1q41
ENO1,-0.016408543,ENO1,Approved symbol,ENO1,enolase 1,HGNC:3350,1p36.23
HCN4,0.016407342,HCN4,Approved symbol,HCN4,hyperpolarization activated cyclic nucleotide gated potassium channel 4,HGNC:16882,15q24.1
NOX4,-0.016401503,NOX4,Approved symbol,NOX4,NADPH oxidase 4,HGNC:7891,11q14.3
GIMAP2,-0.016401102,GIMAP2,Approved symbol,GIMAP2,"GTPase, IMAP family member 2",HGNC:21789,7q36.1
NDUFB10,0.016398852,NDUFB10,Approved symbol,NDUFB10,NADH:ubiquinone oxidoreductase subunit B10,HGNC:7696,16p13.3
BIRC5,-0.016397969,BIRC5,Approved symbol,BIRC5,baculoviral IAP repeat containing 5,HGNC:593,17q25.3
KIAA1462,-0.016394134,KIAA1462,Previous symbol,JCAD,junctional cadherin 5 associated,HGNC:29283,10p11.23
ADCK3,0.016390406,ADCK3,Previous symbol,COQ8A,coenzyme Q8A,HGNC:16812,1q42.13
SNCAIP,-0.016389494,SNCAIP,Approved symbol,SNCAIP,synuclein alpha interacting protein,HGNC:11139,5q23.2
RP5-903G2.2,0.016386499,RP5-903G2.2,Unmatched,RP5-903G2.2,,,
RP11-7O14.1,0.016382642,RP11-7O14.1,Unmatched,RP11-7O14.1,,,
BAIAP3,0.016378207,BAIAP3,Approved symbol,BAIAP3,BAI1 associated protein 3,HGNC:948,16p13.3
SAP30,-0.016376859,SAP30,Approved symbol,SAP30,Sin3A associated protein 30,HGNC:10532,4q34.1
ADAMTS12,-0.01637446,ADAMTS12,Approved symbol,ADAMTS12,ADAM metallopeptidase with thrombospondin type 1 motif 12,HGNC:14605,5p13.3-p13.2
MS4A3,-0.016372739,MS4A3,Approved symbol,MS4A3,membrane spanning 4-domains A3,HGNC:7317,11q12.1
SLC17A4,0.016370699,SLC17A4,Approved symbol,SLC17A4,solute carrier family 17 member 4,HGNC:10932,6p22.2
VASH1,-0.016370431,VASH1,Approved symbol,VASH1,vasohibin 1,HGNC:19964,14q24.3
SCARA3,-0.016369072,SCARA3,Approved symbol,SCARA3,scavenger receptor class A member 3,HGNC:19000,8p21.1
LMX1A,0.01636656,LMX1A,Approved symbol,LMX1A,LIM homeobox transcription factor 1 alpha,HGNC:6653,1q23.3
MAFG-AS1,-0.01636505,MAFG-AS1,Previous symbol,MAFG-DT,MAFG divergent transcript,HGNC:43649,17q25.3
IL1A,-0.016364307,IL1A,Approved symbol,IL1A,interleukin 1 alpha,HGNC:5991,2q14.1
ROBO4,-0.016359351,ROBO4,Approved symbol,ROBO4,roundabout guidance receptor 4,HGNC:17985,11q24.2
KIF14,-0.016358909,KIF14,Approved symbol,KIF14,kinesin family member 14,HGNC:19181,1q32.1
CYBB,-0.016356435,CYBB,Approved symbol,CYBB,cytochrome b-245 beta chain,HGNC:2578,Xp21.1-p11.4
TFR2,-0.016354551,TFR2,Approved symbol,TFR2,transferrin receptor 2,HGNC:11762,7q22.1
PCBD2,0.016353826,PCBD2,Approved symbol,PCBD2,pterin-4 alpha-carbinolamine dehydratase 2,HGNC:24474,5q31.1
ZBP1,-0.016352132,ZBP1,Approved symbol,ZBP1,Z-DNA binding protein 1,HGNC:16176,20q13.31
LIPN,-0.01634726,LIPN,Approved symbol,LIPN,lipase family member N,HGNC:23452,10q23.31
SLC6A15,0.016346789,SLC6A15,Approved symbol,SLC6A15,solute carrier family 6 member 15,HGNC:13621,12q21.31
GUCY2C,0.01634673,GUCY2C,Approved symbol,GUCY2C,guanylate cyclase 2C,HGNC:4688,12p12.3
IGSF3,0.016344728,IGSF3,Approved symbol,IGSF3,immunoglobulin superfamily member 3,HGNC:5950,1p13.1
KIF18A,-0.016344527,KIF18A,Approved symbol,KIF18A,kinesin family member 18A,HGNC:29441,11p14.1
KIAA1524,-0.016340444,KIAA1524,Previous symbol,CIP2A,cellular inhibitor of PP2A,HGNC:29302,3q13.13
RP6-65G23.1,-0.016338587,RP6-65G23.1,Unmatched,RP6-65G23.1,,,
SLC11A1,-0.016335228,SLC11A1,Approved symbol,SLC11A1,solute carrier family 11 member 1,HGNC:10907,2q35
CTB-118N6.2,0.016324463,CTB-118N6.2,Unmatched,CTB-118N6.2,,,
PPP1R3B,0.016322652,PPP1R3B,Approved symbol,PPP1R3B,protein phosphatase 1 regulatory subunit 3B,HGNC:14942,8p23.1
ZNF747,0.01632229,ZNF747,Approved symbol,ZNF747,zinc finger protein 747,HGNC:28350,16p11.2
ENG,-0.016320868,ENG,Approved symbol,ENG,endoglin,HGNC:3349,9q34.11
RP11-536C5.2,0.016318523,RP11-536C5.2,Unmatched,RP11-536C5.2,,,
CARD14,-0.016314893,CARD14,Approved symbol,CARD14,caspase recruitment domain family member 14,HGNC:16446,17q25.3
AFAP1L1,-0.016313774,AFAP1L1,Approved symbol,AFAP1L1,actin filament associated protein 1 like 1,HGNC:26714,5q32
PLEKHS1,-0.016310204,PLEKHS1,Approved symbol,PLEKHS1,pleckstrin homology domain containing S1,HGNC:26285,10q25.3
GPR98,0.016310153,GPR98,Previous symbol,ADGRV1,adhesion G protein-coupled receptor V1,HGNC:17416,5q14.3
GLRX,-0.016309878,GLRX,Approved symbol,GLRX,glutaredoxin,HGNC:4330,5q15
FKBP4,0.016304564,FKBP4,Approved symbol,FKBP4,FKBP prolyl isomerase 4,HGNC:3720,12p13.33
PRKAG2-AS1,0.016304188,PRKAG2-AS1,Approved symbol,PRKAG2-AS1,PRKAG2 antisense RNA 1,HGNC:40468,7q36.1
LINC00525,-0.016301013,LINC00525,Approved symbol,LINC00525,long intergenic non-protein coding RNA 525,HGNC:40290,7p12.3
HSD17B11,0.016299943,HSD17B11,Approved symbol,HSD17B11,hydroxysteroid 17-beta dehydrogenase 11,HGNC:22960,4q22.1
CHAF1B,-0.016298771,CHAF1B,Approved symbol,CHAF1B,chromatin assembly factor 1 subunit B,HGNC:1911,21q22.12-q22.13
KPNA2,-0.016297109,KPNA2,Approved symbol,KPNA2,karyopherin subunit alpha 2,HGNC:6395,17q24.2
SMKR1,-0.016294614,SMKR1,Approved symbol,SMKR1,small lysine rich protein 1,HGNC:43561,7q32.1
GPRC5B,-0.016286734,GPRC5B,Approved symbol,GPRC5B,G protein-coupled receptor class C group 5 member B,HGNC:13308,16p12.3
CXCR3,-0.016286536,CXCR3,Approved symbol,CXCR3,C-X-C motif chemokine receptor 3,HGNC:4540,Xq13.1
TIE1,-0.016278125,TIE1,Approved symbol,TIE1,tyrosine kinase with immunoglobulin like and EGF like domains 1,HGNC:11809,1p34.2
EPHX4,-0.016276966,EPHX4,Approved symbol,EPHX4,epoxide hydrolase 4,HGNC:23758,1p22.1
ZYX,-0.016276296,ZYX,Approved symbol,ZYX,zyxin,HGNC:13200,7q34
MCTP1,-0.016275999,MCTP1,Approved symbol,MCTP1,multiple C2 and transmembrane domain containing 1,HGNC:26183,5q15
ERCC6L,-0.016274904,ERCC6L,Approved symbol,ERCC6L,"ERCC excision repair 6 like, spindle assembly checkpoint helicase",HGNC:20794,Xq13.1
TESK2,0.016273396,TESK2,Approved symbol,TESK2,testis associated actin remodelling kinase 2,HGNC:11732,1p34.1
CSF2,-0.016273137,CSF2,Approved symbol,CSF2,colony stimulating factor 2,HGNC:2434,5q31.1
ASCC1,-0.016271989,ASCC1,Approved symbol,ASCC1,activating signal cointegrator 1 complex subunit 1,HGNC:24268,10q22.1
SLC16A9,0.016271431,SLC16A9,Approved symbol,SLC16A9,solute carrier family 16 member 9,HGNC:23520,10q21.2
SPI1,-0.016270566,SPI1,Approved symbol,SPI1,Spi-1 proto-oncogene,HGNC:11241,11p11.2
DOK2,-0.01626828,DOK2,Approved symbol,DOK2,docking protein 2,HGNC:2991,8p21.3
CENPK,-0.016267278,CENPK,Approved symbol,CENPK,centromere protein K,HGNC:29479,5q12.3
SLC38A5,-0.016261167,SLC38A5,Approved symbol,SLC38A5,solute carrier family 38 member 5,HGNC:18070,Xp11.23
AC025171.1,-0.016261086,AC025171.1,Unmatched,AC025171.1,,,
KIAA0895,-0.016255931,KIAA0895,Approved symbol,KIAA0895,KIAA0895,HGNC:22206,7p14.2
FAM72B,-0.016250841,FAM72B,Approved symbol,FAM72B,family with sequence similarity 72 member B,HGNC:24805,1p11.2
IL10,-0.016246262,IL10,Approved symbol,IL10,interleukin 10,HGNC:5962,1q32.1
RP11-274B18.2,-0.016243611,RP11-274B18.2,Unmatched,RP11-274B18.2,,,
TGM2,-0.016243073,TGM2,Approved symbol,TGM2,transglutaminase 2,HGNC:11778,20q11.23
IL1B,-0.016242992,IL1B,Approved symbol,IL1B,interleukin 1 beta,HGNC:5992,2q14.1
CASC5,-0.016241964,CASC5,Previous symbol,KNL1,kinetochore scaffold 1,HGNC:24054,15q15.1
CDKN2C,-0.016238912,CDKN2C,Approved symbol,CDKN2C,cyclin dependent kinase inhibitor 2C,HGNC:1789,1p32.3
MSTO1,-0.01623707,MSTO1,Approved symbol,MSTO1,misato mitochondrial distribution and morphology regulator 1,HGNC:29678,1q22
HSD11B1,-0.016231396,HSD11B1,Approved symbol,HSD11B1,hydroxysteroid 11-beta dehydrogenase 1,HGNC:5208,1q32.2
SCLT1,-0.016224972,SCLT1,Approved symbol,SCLT1,sodium channel and clathrin linker 1,HGNC:26406,4q28.2
CALU,-0.016224089,CALU,Approved symbol,CALU,calumenin,HGNC:1458,7q32.1
MIR196A1,0.016217593,MIR196A1,Approved symbol,MIR196A1,microRNA 196a-1,HGNC:31567,17q21.32
RP11-575I8.1,0.016216635,RP11-575I8.1,Unmatched,RP11-575I8.1,,,
PARK2,0.016216178,PARK2,Previous symbol,PRKN,parkin RBR E3 ubiquitin protein ligase,HGNC:8607,6q26
BIRC3,-0.016215401,BIRC3,Approved symbol,BIRC3,baculoviral IAP repeat containing 3,HGNC:591,11q22.2
TEX14,-0.016213678,TEX14,Approved symbol,TEX14,"testis expressed 14, intercellular bridge forming factor",HGNC:11737,17q22
LYZ,-0.016209968,LYZ,Approved symbol,LYZ,lysozyme,HGNC:6740,12q15
NAP1L1P1,-0.016208237,NAP1L1P1,Approved symbol,NAP1L1P1,nucleosome assembly protein 1 like 1 pseudogene 1,HGNC:38004,11q24.2
AC140481.7,0.016207043,AC140481.7,Unmatched,AC140481.7,,,
SPAG5,-0.016206862,SPAG5,Approved symbol,SPAG5,sperm associated antigen 5,HGNC:13452,17q11.2
MEP1A,0.016198943,MEP1A,Approved symbol,MEP1A,meprin A subunit alpha,HGNC:7015,6p12.3
RP1-239B22.5,0.016195896,RP1-239B22.5,Unmatched,RP1-239B22.5,,,
BTN3A1,-0.016190207,BTN3A1,Approved symbol,BTN3A1,butyrophilin subfamily 3 member A1,HGNC:1138,6p22.2
GFPT2,-0.016186482,GFPT2,Approved symbol,GFPT2,glutamine-fructose-6-phosphate transaminase 2,HGNC:4242,5q35.3
NOD2,-0.016186246,NOD2,Approved symbol,NOD2,nucleotide binding oligomerization domain containing 2,HGNC:5331,16q12.1
TIFA,-0.016185596,TIFA,Approved symbol,TIFA,TRAF interacting protein with forkhead associated domain,HGNC:19075,4q25
DBF4,-0.016182835,DBF4,Approved symbol,DBF4,DBF4 zinc finger,HGNC:17364,7q21.12
FGF1,-0.016182607,FGF1,Approved symbol,FGF1,fibroblast growth factor 1,HGNC:3665,5q31.3
GUCY1A3,-0.016179093,GUCY1A3,Previous symbol,GUCY1A1,guanylate cyclase 1 soluble subunit alpha 1,HGNC:4685,4q32.1
PXDN,-0.016177496,PXDN,Approved symbol,PXDN,peroxidasin,HGNC:14966,2p25.3
BRCA2,-0.016170858,BRCA2,Approved symbol,BRCA2,BRCA2 DNA repair associated,HGNC:1101,13q13.1
HIP1,-0.016169842,HIP1,Approved symbol,HIP1,huntingtin interacting protein 1,HGNC:4913,7q11.23
SEPHS2,0.016169154,SEPHS2,Approved symbol,SEPHS2,selenophosphate synthetase 2,HGNC:19686,16p11.2
CCDC108,0.016162395,CCDC108,Previous symbol,CFAP65,cilia and flagella associated protein 65,HGNC:25325,2q35
BNIP3,-0.01616133,BNIP3,Approved symbol,BNIP3,BCL2 interacting protein 3,HGNC:1084,10q26.3
MKNK2,0.016160169,MKNK2,Approved symbol,MKNK2,MAPK interacting serine/threonine kinase 2,HGNC:7111,19p13.3
SFR1,-0.016155067,SFR1,Approved symbol,SFR1,SWI5 dependent homologous recombination repair protein 1,HGNC:29574,10q25.1
NUF2,-0.016148979,NUF2,Approved symbol,NUF2,NUF2 component of NDC80 kinetochore complex,HGNC:14621,1q23.3
FAM92A1P1,-0.016148546,FAM92A1P1,Previous symbol,CIBAR1P1,CIBAR1 pseudogene 1,HGNC:32278,15q15.1
CHIA,-0.016145344,CHIA,Approved symbol,CHIA,chitinase acidic,HGNC:17432,1p13.2
PIK3R3,-0.016143315,PIK3R3,Approved symbol,PIK3R3,phosphoinositide-3-kinase regulatory subunit 3,HGNC:8981,1p34.1
KIAA0125,-0.016141032,KIAA0125,Previous symbol,FAM30A,family with sequence similarity 30 member A,HGNC:19955,14q32.33
OLFM1,-0.016140634,OLFM1,Approved symbol,OLFM1,olfactomedin 1,HGNC:17187,9q34.3
NHSL1,0.016139625,NHSL1,Approved symbol,NHSL1,NHS like 1,HGNC:21021,6q24.1
VNN3,-0.016138799,VNN3,Approved symbol,VNN3,vanin 3,HGNC:16431,6q23.2
C7orf73,0.01613788,C7orf73,Previous symbol,STMP1,short transmembrane mitochondrial protein 1,HGNC:41909,7q33
PRKCSH,0.016137817,PRKCSH,Approved symbol,PRKCSH,protein kinase C substrate 80K-H,HGNC:9411,19p13.2
MT1H,0.016132489,MT1H,Approved symbol,MT1H,metallothionein 1H,HGNC:7400,16q13
NDC80,-0.016131191,NDC80,Approved symbol,NDC80,NDC80 kinetochore complex component,HGNC:16909,18p11.32
ISCA1,0.016125015,ISCA1,Approved symbol,ISCA1,iron-sulfur cluster assembly 1,HGNC:28660,9q21.33
AC006978.6,0.016122166,AC006978.6,Unmatched,AC006978.6,,,
RP11-689B22.2,-0.016122026,RP11-689B22.2,Unmatched,RP11-689B22.2,,,
RIMBP2,0.016120173,RIMBP2,Approved symbol,RIMBP2,RIMS binding protein 2,HGNC:30339,12q24.33
ARHGAP23,-0.01611858,ARHGAP23,Approved symbol,ARHGAP23,Rho GTPase activating protein 23,HGNC:29293,17q12
KIF2C,-0.016113872,KIF2C,Approved symbol,KIF2C,kinesin family member 2C,HGNC:6393,1p34.1
ALAD,0.01611231,ALAD,Approved symbol,ALAD,aminolevulinate dehydratase,HGNC:395,9q32
CSF3,-0.016109431,CSF3,Approved symbol,CSF3,colony stimulating factor 3,HGNC:2438,17q21.1
RP11-693N9.2,-0.016102815,RP11-693N9.2,Unmatched,RP11-693N9.2,,,
CDC27,-0.016101991,CDC27,Approved symbol,CDC27,cell division cycle 27,HGNC:1728,17q21.32
SESN1,0.016101625,SESN1,Approved symbol,SESN1,sestrin 1,HGNC:21595,6q21
RETNLB,0.016101034,RETNLB,Approved symbol,RETNLB,resistin like beta,HGNC:20388,3q13.13
AP000344.3,0.016097909,AP000344.3,Unmatched,AP000344.3,,,
CHAD,0.016092144,CHAD,Approved symbol,CHAD,chondroadherin,HGNC:1909,17q21.33
RP4-575N6.4,-0.016091168,RP4-575N6.4,Unmatched,RP4-575N6.4,,,
AP3S2,0.016090781,AP3S2,Approved symbol,AP3S2,adaptor related protein complex 3 subunit sigma 2,HGNC:571,15q26.1
STARD8,-0.016089729,STARD8,Approved symbol,STARD8,StAR related lipid transfer domain containing 8,HGNC:19161,Xq13.1
PLK3,-0.01608808,PLK3,Approved symbol,PLK3,polo like kinase 3,HGNC:2154,1p34.1
PARP9,-0.016085975,PARP9,Approved symbol,PARP9,poly(ADP-ribose) polymerase family member 9,HGNC:24118,3q21.1
AC073133.1,0.016084909,AC073133.1,Unmatched,AC073133.1,,,
ZNF3,0.016083157,ZNF3,Approved symbol,ZNF3,zinc finger protein 3,HGNC:13089,7q22.1
LZTS1,-0.01607611,LZTS1,Approved symbol,LZTS1,leucine zipper tumor suppressor 1,HGNC:13861,8p21.3
PLA2G16,-0.01607335,PLA2G16,Previous symbol,PLAAT3,phospholipase A and acyltransferase 3,HGNC:17825,11q12.3-q13.1
KB-1507C5.4,-0.016073054,KB-1507C5.4,Unmatched,KB-1507C5.4,,,
TRIM29,-0.016070803,TRIM29,Approved symbol,TRIM29,tripartite motif containing 29,HGNC:17274,11q23.3
AC002331.1,-0.016070149,AC002331.1,Unmatched,AC002331.1,,,
RPL22L1,-0.016066487,RPL22L1,Approved symbol,RPL22L1,ribosomal protein L22 like 1,HGNC:27610,3q26.2
SORCS2,-0.016066109,SORCS2,Approved symbol,SORCS2,sortilin related VPS10 domain containing receptor 2,HGNC:16698,4p16.1
PLK1,-0.016065826,PLK1,Approved symbol,PLK1,polo like kinase 1,HGNC:9077,16p12.2
COL18A1,-0.016062085,COL18A1,Approved symbol,COL18A1,collagen type XVIII alpha 1 chain,HGNC:2195,21q22.3
RSPO1,-0.016060975,RSPO1,Approved symbol,RSPO1,R-spondin 1,HGNC:21679,1p34.3
CDH11,-0.016060442,CDH11,Approved symbol,CDH11,cadherin 11,HGNC:1750,16q21
RGCC,-0.016058268,RGCC,Approved symbol,RGCC,regulator of cell cycle,HGNC:20369,13q14.11
OCEL1,0.016056604,OCEL1,Approved symbol,OCEL1,occludin/ELL domain containing 1,HGNC:26221,19p13.11
CTC-497E21.3,0.016056132,CTC-497E21.3,Unmatched,CTC-497E21.3,,,
VAMP5,-0.016053227,VAMP5,Approved symbol,VAMP5,vesicle associated membrane protein 5,HGNC:12646,2p11.2
ACKR2,0.016050724,ACKR2,Approved symbol,ACKR2,atypical chemokine receptor 2,HGNC:1565,3p22.1
BDNF,-0.01604983,BDNF,Approved symbol,BDNF,brain derived neurotrophic factor,HGNC:1033,11p14.1
DCAF4,0.016046883,DCAF4,Approved symbol,DCAF4,DDB1 and CUL4 associated factor 4,HGNC:20229,14q24.2
EXOSC9,-0.016045042,EXOSC9,Approved symbol,EXOSC9,exosome component 9,HGNC:9137,4q27
CTB-25B13.12,0.01604031,CTB-25B13.12,Unmatched,CTB-25B13.12,,,
EME1,-0.016039284,EME1,Approved symbol,EME1,essential meiotic structure-specific endonuclease 1,HGNC:24965,17q21.33
DLC1,-0.016036877,DLC1,Approved symbol,DLC1,DLC1 Rho GTPase activating protein,HGNC:2897,8p22
ADD3,0.016036473,ADD3,Approved symbol,ADD3,adducin 3,HGNC:245,10q25.1-q25.2
ABCA2,0.016032228,ABCA2,Approved symbol,ABCA2,ATP binding cassette subfamily A member 2,HGNC:32,9q34.3
ZFP3,0.016026974,ZFP3,Approved symbol,ZFP3,ZFP3 zinc finger protein,HGNC:12861,17p13.2
TMEM132A,-0.016024688,TMEM132A,Approved symbol,TMEM132A,transmembrane protein 132A,HGNC:31092,11q12.2
CEP55,-0.016017252,CEP55,Approved symbol,CEP55,centrosomal protein 55,HGNC:1161,10q23.33
KIAA1984,0.016015793,KIAA1984,Previous symbol,CCDC183,coiled-coil domain containing 183,HGNC:28236,9q34.3
LY96,-0.016012997,LY96,Approved symbol,LY96,lymphocyte antigen 96,HGNC:17156,8q21.11
STK17A,-0.016012959,STK17A,Approved symbol,STK17A,serine/threonine kinase 17a,HGNC:11395,7p13
RP11-383H13.1,-0.016012458,RP11-383H13.1,Unmatched,RP11-383H13.1,,,
EOGT,-0.016011671,EOGT,Approved symbol,EOGT,EGF domain specific O-linked N-acetylglucosamine transferase,HGNC:28526,3p14.1
DSCC1,-0.016009845,DSCC1,Approved symbol,DSCC1,DNA replication and sister chromatid cohesion 1,HGNC:24453,8q24.12
AUNIP,-0.016007134,AUNIP,Approved symbol,AUNIP,aurora kinase A and ninein interacting protein,HGNC:28363,1p36.11
FTSJ1,-0.016004854,FTSJ1,Approved symbol,FTSJ1,FtsJ RNA 2'-O-methyltransferase 1,HGNC:13254,Xp11.23
ODF2,-0.015987685,ODF2,Approved symbol,ODF2,outer dense fiber of sperm tails 2,HGNC:8114,9q34.11
OSBPL10,-0.015986941,OSBPL10,Approved symbol,OSBPL10,oxysterol binding protein like 10,HGNC:16395,3p23
PTP4A3,-0.015986885,PTP4A3,Approved symbol,PTP4A3,protein tyrosine phosphatase 4A3,HGNC:9636,8q24.3
ITGAV,-0.015982821,ITGAV,Approved symbol,ITGAV,integrin subunit alpha V,HGNC:6150,2q32.1
AC096579.13,-0.015982319,AC096579.13,Unmatched,AC096579.13,,,
PDGFRB,-0.015981275,PDGFRB,Approved symbol,PDGFRB,platelet derived growth factor receptor beta,HGNC:8804,5q32
PSMB9,-0.015978024,PSMB9,Approved symbol,PSMB9,proteasome 20S subunit beta 9,HGNC:9546,6p21.32
ANKRD36C,-0.015976603,ANKRD36C,Approved symbol,ANKRD36C,ankyrin repeat domain 36C,HGNC:32946,2q11.1
RP11-588K22.2,-0.01597652,RP11-588K22.2,Unmatched,RP11-588K22.2,,,
AC034220.3,0.015975338,AC034220.3,Unmatched,AC034220.3,,,
TAGLN2,-0.015973186,TAGLN2,Approved symbol,TAGLN2,transgelin 2,HGNC:11554,1q23.2
NAMPT,-0.015972548,NAMPT,Approved symbol,NAMPT,nicotinamide phosphoribosyltransferase,HGNC:30092,7q22.3
GATA6-AS1,0.015970835,GATA6-AS1,Approved symbol,GATA6-AS1,GATA6 antisense RNA 1 (head to head),HGNC:48840,18q11.2
TNFRSF1B,-0.015970593,TNFRSF1B,Approved symbol,TNFRSF1B,TNF receptor superfamily member 1B,HGNC:11917,1p36.22
ENDOV,0.015970319,ENDOV,Approved symbol,ENDOV,endonuclease V,HGNC:26640,17q25.3
KCNJ6,0.015968415,KCNJ6,Approved symbol,KCNJ6,potassium inwardly rectifying channel subfamily J member 6,HGNC:6267,21q22.13
KIF26B,-0.015968052,KIF26B,Approved symbol,KIF26B,kinesin family member 26B,HGNC:25484,1q44
WWC2,-0.015966653,WWC2,Approved symbol,WWC2,WW and C2 domain containing 2,HGNC:24148,4q35.1
CCL18,-0.015965804,CCL18,Approved symbol,CCL18,C-C motif chemokine ligand 18,HGNC:10616,17q12
TPRG1,-0.015961445,TPRG1,Approved symbol,TPRG1,tumor protein p63 regulated 1,HGNC:24759,3q28
OLIG2,-0.015958437,OLIG2,Approved symbol,OLIG2,oligodendrocyte transcription factor 2,HGNC:9398,21q22.11
CCL2,-0.015958,CCL2,Approved symbol,CCL2,C-C motif chemokine ligand 2,HGNC:10618,17q12
HIC2,0.015955682,HIC2,Approved symbol,HIC2,HIC ZBTB transcriptional repressor 2,HGNC:18595,22q11.21
MLK4,0.015952261,MLK4,Alias symbol,MAP3K21,mitogen-activated protein kinase kinase kinase 21,HGNC:29798,1q42.2
RND1,-0.015949881,RND1,Approved symbol,RND1,Rho family GTPase 1,HGNC:18314,12q13.12
NDUFA6-AS1,0.015948881,NDUFA6-AS1,Previous symbol,NDUFA6-DT,NDUFA6 divergent transcript,HGNC:45273,22q13.2
SLC12A4,-0.015948511,SLC12A4,Approved symbol,SLC12A4,solute carrier family 12 member 4,HGNC:10913,16q22.1
MCHR1,-0.015946789,MCHR1,Approved symbol,MCHR1,melanin concentrating hormone receptor 1,HGNC:4479,22q13.2
RP11-396M11.1,-0.015945804,RP11-396M11.1,Unmatched,RP11-396M11.1,,,
IGHV4-34,-0.015944578,IGHV4-34,Approved symbol,IGHV4-34,immunoglobulin heavy variable 4-34,HGNC:5650,14q32.33
NCAPH,-0.015944301,NCAPH,Approved symbol,NCAPH,non-SMC condensin I complex subunit H,HGNC:1112,2q11.2
KCNJ8,-0.015940822,KCNJ8,Approved symbol,KCNJ8,potassium inwardly rectifying channel subfamily J member 8,HGNC:6269,12p12.1
MR1,-0.01593953,MR1,Approved symbol,MR1,"major histocompatibility complex, class I-related",HGNC:4975,1q25.3
CEACAM19,0.015933803,CEACAM19,Approved symbol,CEACAM19,CEA cell adhesion molecule 19,HGNC:31951,19q13.31
LAMC2,-0.015929055,LAMC2,Approved symbol,LAMC2,laminin subunit gamma 2,HGNC:6493,1q25.3
CNN2,-0.015923356,CNN2,Approved symbol,CNN2,calponin 2,HGNC:2156,19p13.3
FUT11,-0.015923314,FUT11,Approved symbol,FUT11,fucosyltransferase 11,HGNC:19233,10q22.2
FCGR1B,-0.015921457,FCGR1B,Approved symbol,FCGR1B,Fc fragment of IgG receptor Ib,HGNC:3614,1p11.2
ENPP7P4,0.015920764,ENPP7P4,Approved symbol,ENPP7P4,ectonucleotide pyrophosphatase/phosphodiesterase 7 pseudogene 4,HGNC:48687,3q21.2
TXNIP,0.015919963,TXNIP,Approved symbol,TXNIP,thioredoxin interacting protein,HGNC:16952,1q21.1
SLC22A2,-0.015913672,SLC22A2,Approved symbol,SLC22A2,solute carrier family 22 member 2,HGNC:10966,6q25.3
XBP1,-0.015907705,XBP1,Approved symbol,XBP1,X-box binding protein 1,HGNC:12801,22q12.1
TMEM203,0.015905363,TMEM203,Approved symbol,TMEM203,transmembrane protein 203,HGNC:28217,9q34.3
C18orf54,-0.015902148,C18orf54,Approved symbol,C18orf54,chromosome 18 open reading frame 54,HGNC:13796,18q21.2
SEC14L1,-0.015901024,SEC14L1,Approved symbol,SEC14L1,SEC14 like lipid binding 1,HGNC:10698,17q25.2-q25.3
FPGS,-0.015900964,FPGS,Approved symbol,FPGS,folylpolyglutamate synthase,HGNC:3824,9q34.11
NPY4R,0.015896727,NPY4R,Approved symbol,NPY4R,neuropeptide Y receptor Y4,HGNC:9329,10q11.22
DEFB1,0.015896597,DEFB1,Approved symbol,DEFB1,defensin beta 1,HGNC:2766,8p23.1
PAEP,-0.015892474,PAEP,Approved symbol,PAEP,progestagen associated endometrial protein,HGNC:8573,9q34.3
CXCL10,-0.015891558,CXCL10,Approved symbol,CXCL10,C-X-C motif chemokine ligand 10,HGNC:10637,4q21.1
REG4,-0.015888551,REG4,Approved symbol,REG4,regenerating family member 4,HGNC:22977,1p12
AC096670.3,0.015884567,AC096670.3,Unmatched,AC096670.3,,,
AC105402.3,0.015880713,AC105402.3,Unmatched,AC105402.3,,,
ITGB3,-0.015879465,ITGB3,Approved symbol,ITGB3,integrin subunit beta 3,HGNC:6156,17q21.32
PTGES,-0.015879186,PTGES,Approved symbol,PTGES,prostaglandin E synthase,HGNC:9599,9q34.11
GBP2,-0.015879036,GBP2,Approved symbol,GBP2,guanylate binding protein 2,HGNC:4183,1p22.2
KIF23,-0.015878188,KIF23,Approved symbol,KIF23,kinesin family member 23,HGNC:6392,15q23
UGT2A3,0.015874881,UGT2A3,Approved symbol,UGT2A3,UDP glucuronosyltransferase family 2 member A3,HGNC:28528,4q13.2
NLRC5,-0.015873112,NLRC5,Approved symbol,NLRC5,NLR family CARD domain containing 5,HGNC:29933,16q13
MGP,-0.015869032,MGP,Approved symbol,MGP,matrix Gla protein,HGNC:7060,12p12.3
COA5,0.015867982,COA5,Approved symbol,COA5,cytochrome c oxidase assembly factor 5,HGNC:33848,2q11.2
LMO2,-0.01586326,LMO2,Approved symbol,LMO2,LIM domain only 2,HGNC:6642,11p13
COL6A5,-0.015855854,COL6A5,Approved symbol,COL6A5,collagen type VI alpha 5 chain,HGNC:26674,3q22.1
CLSPN,-0.015855524,CLSPN,Approved symbol,CLSPN,claspin,HGNC:19715,1p34.3
IFIT3,-0.015854218,IFIT3,Approved symbol,IFIT3,interferon induced protein with tetratricopeptide repeats 3,HGNC:5411,10q23.31
EPB41L2,-0.015850676,EPB41L2,Approved symbol,EPB41L2,erythrocyte membrane protein band 4.1 like 2,HGNC:3379,6q23.1-q23.2
PF4,-0.015848424,PF4,Approved symbol,PF4,platelet factor 4,HGNC:8861,4q13.3
CTB-43E15.3,-0.015846929,CTB-43E15.3,Unmatched,CTB-43E15.3,,,
GBP1,-0.015843437,GBP1,Approved symbol,GBP1,guanylate binding protein 1,HGNC:4182,1p22.2
FGF10,-0.015843138,FGF10,Approved symbol,FGF10,fibroblast growth factor 10,HGNC:3666,5p12
LINC00654,0.015837982,LINC00654,Approved symbol,LINC00654,long intergenic non-protein coding RNA 654,HGNC:27154,20p12.3
SDK1,-0.015837256,SDK1,Approved symbol,SDK1,sidekick cell adhesion molecule 1,HGNC:19307,7p22.2
CDC14A,0.015836676,CDC14A,Approved symbol,CDC14A,cell division cycle 14A,HGNC:1718,1p21.2
RP11-416O18.1,-0.01583525,RP11-416O18.1,Unmatched,RP11-416O18.1,,,
CTC-558O2.1,0.015835159,CTC-558O2.1,Unmatched,CTC-558O2.1,,,
COQ5,0.015835005,COQ5,Approved symbol,COQ5,"coenzyme Q5, methyltransferase",HGNC:28722,12q24.31
DDX39A,-0.015833539,DDX39A,Approved symbol,DDX39A,DExD-box helicase 39A,HGNC:17821,19p13.12
MAML1,0.015832425,MAML1,Approved symbol,MAML1,mastermind like transcriptional coactivator 1,HGNC:13632,5q35.3
ANKRD36BP2,-0.015829876,ANKRD36BP2,Approved symbol,ANKRD36BP2,ankyrin repeat domain 36B pseudogene 2,HGNC:33607,2p11.2
EDEM1,-0.015824834,EDEM1,Approved symbol,EDEM1,ER degradation enhancing alpha-mannosidase like protein 1,HGNC:18967,3p26.1
CEACAM16,0.015821837,CEACAM16,Approved symbol,CEACAM16,"CEA cell adhesion molecule 16, tectorial membrane component",HGNC:31948,19q13.31-q13.32
CTDSP1,0.01581803,CTDSP1,Approved symbol,CTDSP1,CTD small phosphatase 1,HGNC:21614,2q35
ISG20,-0.01581792,ISG20,Approved symbol,ISG20,interferon stimulated exonuclease gene 20,HGNC:6130,15q26.1
EIF5A2,-0.015817369,EIF5A2,Approved symbol,EIF5A2,eukaryotic translation initiation factor 5A2,HGNC:3301,3q26.2
AC019100.3,-0.015813223,AC019100.3,Unmatched,AC019100.3,,,
YEATS2,-0.015810985,YEATS2,Approved symbol,YEATS2,YEATS domain containing 2,HGNC:25489,3q27.1
RP11-485G4.2,0.015809693,RP11-485G4.2,Unmatched,RP11-485G4.2,,,
GCG,0.015808139,GCG,Approved symbol,GCG,glucagon,HGNC:4191,2q24.2
NDUFAF4P3,0.015805137,NDUFAF4P3,Approved symbol,NDUFAF4P3,NADH:ubiquinone oxidoreductase complex assembly factor 4 pseudogene 3,HGNC:44542,3p22.2
ANXA5,-0.015803133,ANXA5,Approved symbol,ANXA5,annexin A5,HGNC:543,4q27
DENND4C,0.015795856,DENND4C,Approved symbol,DENND4C,DENN domain containing 4C,HGNC:26079,9p22.1
POMT1,0.015788746,POMT1,Approved symbol,POMT1,protein O-mannosyltransferase 1,HGNC:9202,9q34.13
AQP5,-0.015785638,AQP5,Approved symbol,AQP5,aquaporin 5,HGNC:638,12q13.12
AC098614.2,-0.015785591,AC098614.2,Unmatched,AC098614.2,,,
MCFD2,-0.015784787,MCFD2,Approved symbol,MCFD2,"multiple coagulation factor deficiency 2, ER cargo receptor complex subunit",HGNC:18451,2p21
CTD-2334D19.1,-0.015784779,CTD-2334D19.1,Unmatched,CTD-2334D19.1,,,
CELF5,0.015784726,CELF5,Approved symbol,CELF5,CUGBP Elav-like family member 5,HGNC:14058,19p13.3
TMEM106A,-0.015784375,TMEM106A,Approved symbol,TMEM106A,transmembrane protein 106A,HGNC:28288,17q21.31
RP4-714D9.5,0.015782775,RP4-714D9.5,Unmatched,RP4-714D9.5,,,
AC092652.1,0.015777697,AC092652.1,Unmatched,AC092652.1,,,
ATAD2,-0.015777124,ATAD2,Approved symbol,ATAD2,ATPase family AAA domain containing 2,HGNC:30123,8q24.13
IFNG,-0.015777118,IFNG,Approved symbol,IFNG,interferon gamma,HGNC:5438,12q15
P2RY6,-0.015775612,P2RY6,Approved symbol,P2RY6,pyrimidinergic receptor P2Y6,HGNC:8543,11q13.4
ALDH9A1,0.01576638,ALDH9A1,Approved symbol,ALDH9A1,aldehyde dehydrogenase 9 family member A1,HGNC:412,1q24.1
AC093673.5,-0.015765979,AC093673.5,Unmatched,AC093673.5,,,
HSP90B2P,-0.01575743,HSP90B2P,Approved symbol,HSP90B2P,"heat shock protein 90 beta family member 2, pseudogene",HGNC:12099,15q26.3
LDHAP2,-0.015757013,LDHAP2,Approved symbol,LDHAP2,lactate dehydrogenase A pseudogene 2,HGNC:6537,1q42.3
IL17B,-0.015754639,IL17B,Approved symbol,IL17B,interleukin 17B,HGNC:5982,5q32
SBSPON,-0.015754243,SBSPON,Approved symbol,SBSPON,somatomedin B and thrombospondin type 1 domain containing,HGNC:30362,8q21.11
TSHZ1,0.015748799,TSHZ1,Approved symbol,TSHZ1,teashirt zinc finger homeobox 1,HGNC:10669,18q22.3
HIF1A,-0.015746902,HIF1A,Approved symbol,HIF1A,hypoxia inducible factor 1 subunit alpha,HGNC:4910,14q23.2
S1PR2,-0.015744716,S1PR2,Approved symbol,S1PR2,sphingosine-1-phosphate receptor 2,HGNC:3169,19p13.2
TXNDC5,-0.015741711,TXNDC5,Approved symbol,TXNDC5,thioredoxin domain containing 5,HGNC:21073,6p24.3
ECI1,0.015738172,ECI1,Approved symbol,ECI1,enoyl-CoA delta isomerase 1,HGNC:2703,16p13.3
IGKJ3,-0.015734934,IGKJ3,Approved symbol,IGKJ3,immunoglobulin kappa joining 3,HGNC:5721,2p11.2
AF064860.5,0.015734095,AF064860.5,Unmatched,AF064860.5,,,
WNK3,-0.015732741,WNK3,Approved symbol,WNK3,WNK lysine deficient protein kinase 3,HGNC:14543,Xp11.22
THADA,-0.015732663,THADA,Approved symbol,THADA,THADA armadillo repeat containing,HGNC:19217,2p21
FAM92B,-0.01572167,FAM92B,Previous symbol,CIBAR2,CBY1 interacting BAR domain containing 2,HGNC:24781,16q24.1
STK3,-0.015720617,STK3,Approved symbol,STK3,serine/threonine kinase 3,HGNC:11406,8q22.2
PSME2,-0.015718615,PSME2,Approved symbol,PSME2,proteasome activator subunit 2,HGNC:9569,14q12
ICAM5,-0.015718211,ICAM5,Approved symbol,ICAM5,intercellular adhesion molecule 5,HGNC:5348,19p13.2
GINS4,-0.015717142,GINS4,Approved symbol,GINS4,GINS complex subunit 4,HGNC:28226,8p11.21
IGF1R,0.01571419,IGF1R,Approved symbol,IGF1R,insulin like growth factor 1 receptor,HGNC:5465,15q26.3
NGEF,0.015712884,NGEF,Approved symbol,NGEF,neuronal guanine nucleotide exchange factor,HGNC:7807,2q37.1
FAM98C,0.015712217,FAM98C,Approved symbol,FAM98C,family with sequence similarity 98 member C,HGNC:27119,19q13.2
NR6A1,0.015710117,NR6A1,Approved symbol,NR6A1,nuclear receptor subfamily 6 group A member 1,HGNC:7985,9q33.3
GAL3ST1,0.015710018,GAL3ST1,Approved symbol,GAL3ST1,galactose-3-O-sulfotransferase 1,HGNC:24240,22q12.2
AKAP7,0.015709723,AKAP7,Approved symbol,AKAP7,A-kinase anchoring protein 7,HGNC:377,6q23.2
IGHD3-16,-0.015709374,IGHD3-16,Approved symbol,IGHD3-16,immunoglobulin heavy diversity 3-16,HGNC:5496,14q32.33
RASGRP4,-0.015707067,RASGRP4,Approved symbol,RASGRP4,RAS guanyl releasing protein 4,HGNC:18958,19q13.2
ATG4B,0.015702417,ATG4B,Approved symbol,ATG4B,autophagy related 4B cysteine peptidase,HGNC:20790,2q37.3
SULT1A2,0.015700384,SULT1A2,Approved symbol,SULT1A2,sulfotransferase family 1A member 2,HGNC:11454,16p11.2
KCNE4,-0.015697816,KCNE4,Approved symbol,KCNE4,potassium voltage-gated channel subfamily E regulatory subunit 4,HGNC:6244,2q36.1
A4GALT,-0.015694695,A4GALT,Approved symbol,A4GALT,"alpha 1,4-galactosyltransferase (P blood group)",HGNC:18149,22q13.2
RP11-223C24.1,-0.015694188,RP11-223C24.1,Unmatched,RP11-223C24.1,,,
RP11-91K11.2,0.015680443,RP11-91K11.2,Unmatched,RP11-91K11.2,,,
MYO7A,-0.015680059,MYO7A,Approved symbol,MYO7A,myosin VIIA,HGNC:7606,11q13.5
PSME2P2,-0.015675758,PSME2P2,Approved symbol,PSME2P2,proteasome activator subunit 2 pseudogene 2,HGNC:30160,13q14.2
BHLHE22,-0.015675336,BHLHE22,Approved symbol,BHLHE22,basic helix-loop-helix family member e22,HGNC:11963,8q12.3
IL1RAP,-0.015674941,IL1RAP,Approved symbol,IL1RAP,interleukin 1 receptor accessory protein,HGNC:5995,3q28
CYYR1,-0.015672142,CYYR1,Approved symbol,CYYR1,cysteine and tyrosine rich 1,HGNC:16274,21q21.3
SAA1,-0.015669787,SAA1,Approved symbol,SAA1,serum amyloid A1,HGNC:10513,11p15.1
SAA2,-0.01566966,SAA2,Approved symbol,SAA2,serum amyloid A2,HGNC:10514,11p15.1
AC093818.1,-0.015669346,AC093818.1,Unmatched,AC093818.1,,,
CD274,-0.015662014,CD274,Approved symbol,CD274,CD274 molecule,HGNC:17635,9p24.1
IGJCOR18,-0.015661789,IGJCOR18,Unmatched,IGJCOR18,,,
KRT6A,-0.015660695,KRT6A,Approved symbol,KRT6A,keratin 6A,HGNC:6443,12q13.13
RP1-170O19.14,0.015656622,RP1-170O19.14,Unmatched,RP1-170O19.14,,,
ZSWIM5,0.01565385,ZSWIM5,Approved symbol,ZSWIM5,zinc finger SWIM-type containing 5,HGNC:29299,1p34.1
PTPRE,-0.015650195,PTPRE,Approved symbol,PTPRE,protein tyrosine phosphatase receptor type E,HGNC:9669,10q26.2
CMBL,0.015648387,CMBL,Approved symbol,CMBL,carboxymethylenebutenolidase homolog,HGNC:25090,5p15.2
CYB5R2,-0.015647875,CYB5R2,Approved symbol,CYB5R2,cytochrome b5 reductase 2,HGNC:24376,11p15.4
IGDCC4,-0.015647591,IGDCC4,Approved symbol,IGDCC4,immunoglobulin superfamily DCC subclass member 4,HGNC:13770,15q22.31
SHANK3,-0.015634284,SHANK3,Approved symbol,SHANK3,SH3 and multiple ankyrin repeat domains 3,HGNC:14294,22q13.33
HTRA3,-0.015631975,HTRA3,Approved symbol,HTRA3,HtrA serine peptidase 3,HGNC:30406,4p16.1
ALDOB,-0.015627983,ALDOB,Approved symbol,ALDOB,"aldolase, fructose-bisphosphate B",HGNC:417,9q31.1
NCAPG,-0.015622943,NCAPG,Approved symbol,NCAPG,non-SMC condensin I complex subunit G,HGNC:24304,4p15.31
EDIL3,0.015619228,EDIL3,Approved symbol,EDIL3,EGF like repeats and discoidin domains 3,HGNC:3173,5q14.3
RP11-20B7.1,-0.015614801,RP11-20B7.1,Unmatched,RP11-20B7.1,,,
BCL2L11,0.015611063,BCL2L11,Approved symbol,BCL2L11,BCL2 like 11,HGNC:994,2q13
SFMBT2,-0.015607293,SFMBT2,Approved symbol,SFMBT2,Scm like with four mbt domains 2,HGNC:20256,10p14
SH3RF3,-0.015606842,SH3RF3,Approved symbol,SH3RF3,SH3 domain containing ring finger 3,HGNC:24699,2q13
TKT,-0.015604933,TKT,Approved symbol,TKT,transketolase,HGNC:11834,3p21.1
RP11-531A24.3,0.015599453,RP11-531A24.3,Unmatched,RP11-531A24.3,,,
DCHS1,-0.015590254,DCHS1,Approved symbol,DCHS1,dachsous cadherin-related 1,HGNC:13681,11p15.4
TP53TG1,0.015587836,TP53TG1,Approved symbol,TP53TG1,TP53 target 1,HGNC:17026,7q21.12
CTC-338M12.5,0.015587835,CTC-338M12.5,Unmatched,CTC-338M12.5,,,
KIF18B,-0.015586133,KIF18B,Approved symbol,KIF18B,kinesin family member 18B,HGNC:27102,17q21.31
OAZ2,-0.015581886,OAZ2,Approved symbol,OAZ2,ornithine decarboxylase antizyme 2,HGNC:8096,15q22.31
FOSL1,-0.015573623,FOSL1,Approved symbol,FOSL1,"FOS like 1, AP-1 transcription factor subunit",HGNC:13718,11q13.1
LRRC53,0.015572693,LRRC53,Approved symbol,LRRC53,leucine rich repeat containing 53,HGNC:25255,1p31.1
NUDT16L1,0.015568297,NUDT16L1,Approved symbol,NUDT16L1,nudix hydrolase 16 like 1,HGNC:28154,16p13.3
LBX2-AS1,0.01556639,LBX2-AS1,Approved symbol,LBX2-AS1,LBX2 antisense RNA 1,HGNC:25136,2p13.1
KIF20A,-0.015561666,KIF20A,Approved symbol,KIF20A,kinesin family member 20A,HGNC:9787,5q31.2
BEAN1,-0.015558053,BEAN1,Approved symbol,BEAN1,brain expressed associated with NEDD4 1,HGNC:24160,16q21
DDAH2,0.015553058,DDAH2,Approved symbol,DDAH2,dimethylarginine dimethylaminohydrolase 2,HGNC:2716,6p21.33
KLHDC2,0.015551537,KLHDC2,Approved symbol,KLHDC2,kelch domain containing 2,HGNC:20231,14q21.3
PTTG1,-0.015548534,PTTG1,Approved symbol,PTTG1,"PTTG1 regulator of sister chromatid separation, securin",HGNC:9690,5q33.3
NFKBIZ,-0.015547988,NFKBIZ,Approved symbol,NFKBIZ,NFKB inhibitor zeta,HGNC:29805,3q12.3
SOX17,-0.015542791,SOX17,Approved symbol,SOX17,SRY-box transcription factor 17,HGNC:18122,8q11.23
CLEC4D,-0.015542452,CLEC4D,Approved symbol,CLEC4D,C-type lectin domain family 4 member D,HGNC:14554,12p13.31
AC013268.5,0.015540688,AC013268.5,Unmatched,AC013268.5,,,
ANLN,-0.015537059,ANLN,Approved symbol,ANLN,anillin actin binding protein,HGNC:14082,7p14.2
MLC1,-0.015536835,MLC1,Approved symbol,MLC1,modulator of VRAC current 1,HGNC:17082,22q13.33
TSHZ2,-0.015536011,TSHZ2,Approved symbol,TSHZ2,teashirt zinc finger homeobox 2,HGNC:13010,20q13.2
TM4SF18,-0.015533641,TM4SF18,Approved symbol,TM4SF18,transmembrane 4 L six family member 18,HGNC:25181,3q25.1
AGTRAP,-0.015532519,AGTRAP,Approved symbol,AGTRAP,angiotensin II receptor associated protein,HGNC:13539,1p36.22
RP13-497K6.1,0.015531759,RP13-497K6.1,Unmatched,RP13-497K6.1,,,
LPPR1,0.015529397,LPPR1,Alias symbol,PLPPR1,phospholipid phosphatase related 1,HGNC:25993,9q31.1
AC079325.6,-0.015529072,AC079325.6,Unmatched,AC079325.6,,,
SYNE2,0.015528087,SYNE2,Approved symbol,SYNE2,spectrin repeat containing nuclear envelope protein 2,HGNC:17084,14q23.2
NUSAP1,-0.015526181,NUSAP1,Approved symbol,NUSAP1,nucleolar and spindle associated protein 1,HGNC:18538,15q14
PAQR5,0.01552216,PAQR5,Approved symbol,PAQR5,progestin and adipoQ receptor family member 5,HGNC:29645,15q23
MT1DP,0.015521856,MT1DP,Approved symbol,MT1DP,"metallothionein 1D, pseudogene",HGNC:7396,16q13
SUV39H1,-0.015518455,SUV39H1,Approved symbol,SUV39H1,suppressor of variegation 3-9 homolog 1,HGNC:11479,Xp11.23
ERI1,-0.015517901,ERI1,Approved symbol,ERI1,exoribonuclease 1,HGNC:23994,8p23.1
TAF4,0.015516496,TAF4,Approved symbol,TAF4,TATA-box binding protein associated factor 4,HGNC:11537,20q13.33
LINC00323,-0.015511602,LINC00323,Approved symbol,LINC00323,long intergenic non-protein coding RNA 323,HGNC:19720,21q22.2
ARFGAP3,-0.015510333,ARFGAP3,Approved symbol,ARFGAP3,ADP ribosylation factor GTPase activating protein 3,HGNC:661,22q13.2
C15orf27,-0.015507577,C15orf27,Previous symbol,TMEM266,transmembrane protein 266,HGNC:26763,15q24.2
SDR16C5,-0.015506968,SDR16C5,Approved symbol,SDR16C5,short chain dehydrogenase/reductase family 16C member 5,HGNC:30311,8q12.1
HPRT1,-0.015504582,HPRT1,Approved symbol,HPRT1,hypoxanthine phosphoribosyltransferase 1,HGNC:5157,Xq26.2-q26.3
SH3TC2,-0.015492394,SH3TC2,Approved symbol,SH3TC2,SH3 domain and tetratricopeptide repeats 2,HGNC:29427,5q32
FBXO5,-0.015483155,FBXO5,Approved symbol,FBXO5,F-box protein 5,HGNC:13584,6q25.2
CCNB1,-0.015478354,CCNB1,Approved symbol,CCNB1,cyclin B1,HGNC:1579,5q13.2
WNT5A,-0.015477159,WNT5A,Approved symbol,WNT5A,Wnt family member 5A,HGNC:12784,3p14.3
POLR3G,-0.015471301,POLR3G,Approved symbol,POLR3G,RNA polymerase III subunit G,HGNC:30075,5q14.3
RP11-598F7.6,-0.01546944,RP11-598F7.6,Unmatched,RP11-598F7.6,,,
DPY19L1,-0.01546747,DPY19L1,Approved symbol,DPY19L1,dpy-19 like C-mannosyltransferase 1,HGNC:22205,7p14.2
CYP2J2,0.01546701,CYP2J2,Approved symbol,CYP2J2,cytochrome P450 family 2 subfamily J member 2,HGNC:2634,1p32.1
CYP2S1,0.015464578,CYP2S1,Approved symbol,CYP2S1,cytochrome P450 family 2 subfamily S member 1,HGNC:15654,19q13.2
UBTFL6,-0.015463203,UBTFL6,Approved symbol,UBTFL6,UBTF like 6 (pseudogene),HGNC:35406,2q11.2
RP5-884M6.1,-0.015457101,RP5-884M6.1,Unmatched,RP5-884M6.1,,,
ATP5G2,0.015455246,ATP5G2,Previous symbol,ATP5MC2,ATP synthase membrane subunit c locus 2,HGNC:842,12q13.13
FAM47E-STBD1,0.015449461,FAM47E-STBD1,Approved symbol,FAM47E-STBD1,FAM47E-STBD1 readthrough,HGNC:44667,4q21.1
CLDN14,-0.015447949,CLDN14,Approved symbol,CLDN14,claudin 14,HGNC:2035,21q22.13
HSD17B2,0.015445921,HSD17B2,Approved symbol,HSD17B2,hydroxysteroid 17-beta dehydrogenase 2,HGNC:5211,16q23.3
BTG3,0.015435685,BTG3,Approved symbol,BTG3,BTG anti-proliferation factor 3,HGNC:1132,21q21.1
SPATS2,-0.015432074,SPATS2,Approved symbol,SPATS2,spermatogenesis associated serine rich 2,HGNC:18650,12q13.12
TTC17,0.01543014,TTC17,Approved symbol,TTC17,tetratricopeptide repeat domain 17,HGNC:25596,11p12-p11.2
SLC35B1,-0.015425553,SLC35B1,Approved symbol,SLC35B1,solute carrier family 35 member B1,HGNC:20798,17q21.33
CRABP2,-0.015424034,CRABP2,Approved symbol,CRABP2,cellular retinoic acid binding protein 2,HGNC:2339,1q23.1
FCGR2A,-0.01542342,FCGR2A,Approved symbol,FCGR2A,Fc fragment of IgG receptor IIa,HGNC:3616,1q23.3
LFNG,0.015422507,LFNG,Approved symbol,LFNG,LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase,HGNC:6560,7p22.3
RP11-395G23.3,0.015418055,RP11-395G23.3,Unmatched,RP11-395G23.3,,,
PCSK9,-0.015417942,PCSK9,Approved symbol,PCSK9,proprotein convertase subtilisin/kexin type 9,HGNC:20001,1p32.3
TM4SF19,-0.015416691,TM4SF19,Approved symbol,TM4SF19,transmembrane 4 L six family member 19,HGNC:25167,3q29
ZNF219,0.015416544,ZNF219,Approved symbol,ZNF219,zinc finger protein 219,HGNC:13011,14q11
IGHV3OR16-11,-0.015414667,IGHV3OR16-11,Approved symbol,IGHV3OR16-11,immunoglobulin heavy variable 3/OR16-11 (pseudogene),HGNC:5635,16p11.2
KLK6,-0.01540733,KLK6,Approved symbol,KLK6,kallikrein related peptidase 6,HGNC:6367,19q13.41
PDLIM4,-0.015405875,PDLIM4,Approved symbol,PDLIM4,PDZ and LIM domain 4,HGNC:16501,5q31.1
GLMN,-0.015405578,GLMN,Approved symbol,GLMN,"glomulin, FKBP associated protein",HGNC:14373,1p22.1
HSD3B7,-0.015396996,HSD3B7,Approved symbol,HSD3B7,"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7",HGNC:18324,16p11.2
NUP93,-0.01539632,NUP93,Approved symbol,NUP93,nucleoporin 93,HGNC:28958,16q13
VSTM1,-0.01539114,VSTM1,Approved symbol,VSTM1,V-set and transmembrane domain containing 1,HGNC:29455,19q13.42
USP2-AS1,0.015389269,USP2-AS1,Approved symbol,USP2-AS1,USP2 antisense RNA 1 (head to head),HGNC:48673,11q23.3
RP11-77K12.5,0.015388502,RP11-77K12.5,Unmatched,RP11-77K12.5,,,
GRHL3,-0.015388496,GRHL3,Approved symbol,GRHL3,grainyhead like transcription factor 3,HGNC:25839,1p36.11
RIMS1,-0.015386039,RIMS1,Approved symbol,RIMS1,regulating synaptic membrane exocytosis 1,HGNC:17282,6q13
ASIC5,0.015384628,ASIC5,Approved symbol,ASIC5,acid sensing ion channel subunit family member 5,HGNC:17537,4q32.1
E2F5,-0.015383271,E2F5,Approved symbol,E2F5,E2F transcription factor 5,HGNC:3119,8q21.2
NPC1,-0.015381605,NPC1,Approved symbol,NPC1,NPC intracellular cholesterol transporter 1,HGNC:7897,18q11.2
ANGPTL4,-0.015372582,ANGPTL4,Approved symbol,ANGPTL4,angiopoietin like 4,HGNC:16039,19p13.2
CD70,-0.015370695,CD70,Approved symbol,CD70,CD70 molecule,HGNC:11937,19p13.3
ZC4H2,0.015369452,ZC4H2,Approved symbol,ZC4H2,zinc finger C4H2-type containing,HGNC:24931,Xq11.2
RPS6,0.015366179,RPS6,Approved symbol,RPS6,ribosomal protein S6,HGNC:10429,9p22.1
MYH7B,0.015356496,MYH7B,Approved symbol,MYH7B,myosin heavy chain 7B,HGNC:15906,20q11.22
LRIG2,0.015355069,LRIG2,Approved symbol,LRIG2,leucine rich repeats and immunoglobulin like domains 2,HGNC:20889,1p13.2
PRKG2,0.015351232,PRKG2,Approved symbol,PRKG2,protein kinase cGMP-dependent 2,HGNC:9416,4q21.21
GLT1D1,-0.015350136,GLT1D1,Approved symbol,GLT1D1,glycosyltransferase 1 domain containing 1,HGNC:26483,12q24.33
MTRNR2L9,0.015348752,MTRNR2L9,Approved symbol,MTRNR2L9,MT-RNR2 like 9,HGNC:37166,6q11.1
CLEC5A,-0.015346749,CLEC5A,Approved symbol,CLEC5A,C-type lectin domain containing 5A,HGNC:2054,7q34
AC105402.4,0.015344452,AC105402.4,Unmatched,AC105402.4,,,
GAB2,0.015342419,GAB2,Approved symbol,GAB2,GRB2 associated binding protein 2,HGNC:14458,11q14.1
ACVR1,-0.01534207,ACVR1,Approved symbol,ACVR1,activin A receptor type 1,HGNC:171,2q24.1
LAMA1,0.015340547,LAMA1,Approved symbol,LAMA1,laminin subunit alpha 1,HGNC:6481,18p11.31
SEC11C,-0.015340134,SEC11C,Approved symbol,SEC11C,"SEC11 homolog C, signal peptidase complex subunit",HGNC:23400,18q21.32
RP11-290F20.1,-0.015338276,RP11-290F20.1,Unmatched,RP11-290F20.1,,,
RP11-498D10.6,0.015337814,RP11-498D10.6,Unmatched,RP11-498D10.6,,,
UCN3,0.015334551,UCN3,Approved symbol,UCN3,urocortin 3,HGNC:17781,10p15.1
AMOTL2,-0.015321052,AMOTL2,Approved symbol,AMOTL2,angiomotin like 2,HGNC:17812,3q22.2
RP4-725G10.3,-0.015320563,RP4-725G10.3,Unmatched,RP4-725G10.3,,,
CTA-126B4.7,-0.015313964,CTA-126B4.7,Unmatched,CTA-126B4.7,,,
RP11-367J11.3,0.015313776,RP11-367J11.3,Unmatched,RP11-367J11.3,,,
RP11-121M22.1,0.015313382,RP11-121M22.1,Unmatched,RP11-121M22.1,,,
KBTBD2,-0.015312977,KBTBD2,Approved symbol,KBTBD2,kelch repeat and BTB domain containing 2,HGNC:21751,7p14.3
ZNF446,0.015308546,ZNF446,Approved symbol,ZNF446,zinc finger protein 446,HGNC:21036,19q13.43
ZNF385C,0.015306129,ZNF385C,Approved symbol,ZNF385C,zinc finger protein 385C,HGNC:33722,17q21.2
RALGPS2,-0.015304439,RALGPS2,Approved symbol,RALGPS2,Ral GEF with PH domain and SH3 binding motif 2,HGNC:30279,1q25.2
HSPA13,-0.015301208,HSPA13,Approved symbol,HSPA13,heat shock protein family A (Hsp70) member 13,HGNC:11375,21q11.2
DARS,-0.015300158,DARS,Previous symbol,DARS1,aspartyl-tRNA synthetase 1,HGNC:2678,2q21.3
CENPW,-0.015295026,CENPW,Approved symbol,CENPW,centromere protein W,HGNC:21488,6q22.32
MT3,0.015292925,MT3,Approved symbol,MT3,metallothionein 3,HGNC:7408,16q13
SYTL1,-0.015291132,SYTL1,Approved symbol,SYTL1,synaptotagmin like 1,HGNC:15584,1p36.11
LINC00922,-0.015288328,LINC00922,Approved symbol,LINC00922,long intergenic non-protein coding RNA 922,HGNC:27545,16q21
HIST1H2BJ,-0.015280231,HIST1H2BJ,Previous symbol,H2BC11,H2B clustered histone 11,HGNC:4761,6p22.1
ITGA1,-0.015280229,ITGA1,Approved symbol,ITGA1,integrin subunit alpha 1,HGNC:6134,5q11.2
PADI1,0.015278571,PADI1,Approved symbol,PADI1,peptidyl arginine deiminase 1,HGNC:18367,1p36.13
RP11-66B24.4,0.015274874,RP11-66B24.4,Unmatched,RP11-66B24.4,,,
ATP6V1C2,0.015274374,ATP6V1C2,Approved symbol,ATP6V1C2,ATPase H+ transporting V1 subunit C2,HGNC:18264,2p25.1
RP11-181E10.3,-0.015273741,RP11-181E10.3,Unmatched,RP11-181E10.3,,,
RP11-6J21.2,-0.015272302,RP11-6J21.2,Unmatched,RP11-6J21.2,,,
PECR,0.015271924,PECR,Approved symbol,PECR,peroxisomal trans-2-enoyl-CoA reductase,HGNC:18281,2q35
PSAT1,-0.015269806,PSAT1,Approved symbol,PSAT1,phosphoserine aminotransferase 1,HGNC:19129,9q21.2
MEDAG,-0.015269148,MEDAG,Approved symbol,MEDAG,mesenteric estrogen dependent adipogenesis,HGNC:25926,13q12.3
TMEM133,0.015267141,TMEM133,Previous symbol,ARHGAP42,Rho GTPase activating protein 42,HGNC:26545,11q22.1
ZDHHC8P1,0.015261242,ZDHHC8P1,Approved symbol,ZDHHC8P1,ZDHHC8 pseudogene 1,HGNC:26461,22q11.23
CYP27B1,-0.01526089,CYP27B1,Approved symbol,CYP27B1,cytochrome P450 family 27 subfamily B member 1,HGNC:2606,12q14.1
VOPP1,-0.015260492,VOPP1,Approved symbol,VOPP1,VOPP1 WW domain binding protein,HGNC:34518,7p11.2
NXN,-0.015249577,NXN,Approved symbol,NXN,nucleoredoxin,HGNC:18008,17p13.3
LHFP,-0.015248897,LHFP,Previous symbol,LHFPL6,LHFPL tetraspan subfamily member 6,HGNC:6586,13q13.3-q14.11
SIAH1,0.01524427,SIAH1,Approved symbol,SIAH1,siah E3 ubiquitin protein ligase 1,HGNC:10857,16q12.1
CD300C,-0.015241345,CD300C,Approved symbol,CD300C,CD300c molecule,HGNC:19320,17q25.1
PIAS3,-0.015240356,PIAS3,Approved symbol,PIAS3,protein inhibitor of activated STAT 3,HGNC:16861,1q21.1
XYLT1,0.015238775,XYLT1,Approved symbol,XYLT1,xylosyltransferase 1,HGNC:15516,16p12.3
IFITM9P,-0.015238189,IFITM9P,Approved symbol,IFITM9P,interferon induced transmembrane protein 9 pseudogene,HGNC:33972,11q13.3
ZNF469,-0.015235896,ZNF469,Approved symbol,ZNF469,zinc finger protein 469,HGNC:23216,16q24.2
IGKJ4,-0.015232601,IGKJ4,Approved symbol,IGKJ4,immunoglobulin kappa joining 4,HGNC:5722,2p11.2
PARP14,-0.015229989,PARP14,Approved symbol,PARP14,poly(ADP-ribose) polymerase family member 14,HGNC:29232,3q21.1
S100A11,-0.015229571,S100A11,Approved symbol,S100A11,S100 calcium binding protein A11,HGNC:10488,1q21.3
ABCC8,0.015229065,ABCC8,Approved symbol,ABCC8,ATP binding cassette subfamily C member 8,HGNC:59,11p15.1
UBTD1,-0.015225966,UBTD1,Approved symbol,UBTD1,ubiquitin domain containing 1,HGNC:25683,10q24.1-q24.2
ZNF615,0.015224164,ZNF615,Approved symbol,ZNF615,zinc finger protein 615,HGNC:24740,19q13.41
NUAK1,-0.015223793,NUAK1,Approved symbol,NUAK1,NUAK family kinase 1,HGNC:14311,12q23.3
ZNF438,-0.015221462,ZNF438,Approved symbol,ZNF438,zinc finger protein 438,HGNC:21029,10p11.23
TEK,-0.015219725,TEK,Approved symbol,TEK,TEK receptor tyrosine kinase,HGNC:11724,9p21.2
PAX6,0.015214214,PAX6,Approved symbol,PAX6,paired box 6,HGNC:8620,11p13
ROPN1L,-0.015213341,ROPN1L,Approved symbol,ROPN1L,rhophilin associated tail protein 1 like,HGNC:24060,5p15.2
C1orf112,-0.015213113,C1orf112,Approved symbol,C1orf112,chromosome 1 open reading frame 112,HGNC:25565,1q24.2
CPNE5,-0.015212946,CPNE5,Approved symbol,CPNE5,copine 5,HGNC:2318,6p21.2
AC115522.3,-0.015212046,AC115522.3,Unmatched,AC115522.3,,,
CENPA,-0.015210335,CENPA,Approved symbol,CENPA,centromere protein A,HGNC:1851,2p23.3
NUDT9,0.015208581,NUDT9,Approved symbol,NUDT9,nudix hydrolase 9,HGNC:8056,4q22.1
PGRMC1,0.01520716,PGRMC1,Approved symbol,PGRMC1,progesterone receptor membrane component 1,HGNC:16090,Xq24
C1S,-0.015206948,C1S,Approved symbol,C1S,complement C1s,HGNC:1247,12p13.31
NT5DC3,0.015200419,NT5DC3,Approved symbol,NT5DC3,5'-nucleotidase domain containing 3,HGNC:30826,12q23.3
RUFY4,-0.015198007,RUFY4,Approved symbol,RUFY4,RUN and FYVE domain containing 4,HGNC:24804,2q35
PRSS1,-0.015195727,PRSS1,Approved symbol,PRSS1,serine protease 1,HGNC:9475,7q34
RP5-1031D4.2,-0.015194399,RP5-1031D4.2,Unmatched,RP5-1031D4.2,,,
USHBP1,-0.01519366,USHBP1,Approved symbol,USHBP1,USH1 protein network component harmonin binding protein 1,HGNC:24058,19p13.11
ABHD15,0.015193458,ABHD15,Approved symbol,ABHD15,abhydrolase domain containing 15,HGNC:26971,17q11.2
SOCS1,-0.015192421,SOCS1,Approved symbol,SOCS1,suppressor of cytokine signaling 1,HGNC:19383,16p13.13
RP11-230B22.1,0.0151899,RP11-230B22.1,Unmatched,RP11-230B22.1,,,
CCL1,-0.015187675,CCL1,Approved symbol,CCL1,C-C motif chemokine ligand 1,HGNC:10609,17q12
CD177,0.015186022,CD177,Approved symbol,CD177,CD177 molecule,HGNC:30072,19q13.31
FOXQ1,-0.015184987,FOXQ1,Approved symbol,FOXQ1,forkhead box Q1,HGNC:20951,6p25.3
PTGES3P1,-0.01518029,PTGES3P1,Approved symbol,PTGES3P1,prostaglandin E synthase 3 pseudogene 1,HGNC:43824,1p22.2
DERL3,-0.015179075,DERL3,Approved symbol,DERL3,derlin 3,HGNC:14236,22q11.23
DLGAP5,-0.015178264,DLGAP5,Approved symbol,DLGAP5,DLG associated protein 5,HGNC:16864,14q22.3
SOWAHA,0.015177957,SOWAHA,Approved symbol,SOWAHA,sosondowah ankyrin repeat domain family member A,HGNC:27033,5q31.1
RP11-326I11.5,-0.015175301,RP11-326I11.5,Unmatched,RP11-326I11.5,,,
XPOT,-0.015175185,XPOT,Approved symbol,XPOT,exportin for tRNA,HGNC:12826,12q14.2
C11orf84,-0.015170475,C11orf84,Previous symbol,SPINDOC,spindlin interactor and repressor of chromatin binding,HGNC:25115,11q13.1
SKIL,-0.015170333,SKIL,Approved symbol,SKIL,SKI like proto-oncogene,HGNC:10897,3q26.2
SYT12,-0.015168752,SYT12,Approved symbol,SYT12,synaptotagmin 12,HGNC:18381,11q13.2
SPDL1,-0.015166722,SPDL1,Approved symbol,SPDL1,spindle apparatus coiled-coil protein 1,HGNC:26010,5q35.1
CKS2,-0.015165618,CKS2,Approved symbol,CKS2,CDC28 protein kinase regulatory subunit 2,HGNC:2000,9q22.2
PLA2G7,-0.015165151,PLA2G7,Approved symbol,PLA2G7,phospholipase A2 group VII,HGNC:9040,6p12.3
PLXND1,-0.015164761,PLXND1,Approved symbol,PLXND1,plexin D1,HGNC:9107,3q22.1
NRIP1,0.015164676,NRIP1,Approved symbol,NRIP1,nuclear receptor interacting protein 1,HGNC:8001,21q11.2-q21.1
STARD4,-0.015161693,STARD4,Approved symbol,STARD4,StAR related lipid transfer domain containing 4,HGNC:18058,5q22.1
RP4-798A17.5,0.015161237,RP4-798A17.5,Unmatched,RP4-798A17.5,,,
SPCS3,-0.015153886,SPCS3,Approved symbol,SPCS3,signal peptidase complex subunit 3,HGNC:26212,4q34.2
DHFRL1,0.015153758,DHFRL1,Previous symbol,DHFR2,dihydrofolate reductase 2,HGNC:27309,3q11.2
FOXJ3,0.015152329,FOXJ3,Approved symbol,FOXJ3,forkhead box J3,HGNC:29178,1p34.2
HSPB8,-0.015150788,HSPB8,Approved symbol,HSPB8,heat shock protein family B (small) member 8,HGNC:30171,12q24.23
FAM3B,-0.015150697,FAM3B,Approved symbol,FAM3B,FAM3 metabolism regulating signaling molecule B,HGNC:1253,21q22.3
PCGF2,0.015150288,PCGF2,Approved symbol,PCGF2,polycomb group ring finger 2,HGNC:12929,17q12
CTSB,-0.015143011,CTSB,Approved symbol,CTSB,cathepsin B,HGNC:2527,8p23.1
CD34,-0.015139553,CD34,Approved symbol,CD34,CD34 molecule,HGNC:1662,1q32.2
RP11-513M16.8,0.015138803,RP11-513M16.8,Unmatched,RP11-513M16.8,,,
CDV3,-0.015138351,CDV3,Approved symbol,CDV3,CDV3 homolog,HGNC:26928,3q22.1
ROS1,0.01513725,ROS1,Approved symbol,ROS1,"ROS proto-oncogene 1, receptor tyrosine kinase",HGNC:10261,6q22.1
FBN1,-0.01513625,FBN1,Approved symbol,FBN1,fibrillin 1,HGNC:3603,15q21.1
PSMA3,-0.015135347,PSMA3,Approved symbol,PSMA3,proteasome 20S subunit alpha 3,HGNC:9532,14q23.1
NRP2,-0.015131476,NRP2,Approved symbol,NRP2,neuropilin 2,HGNC:8005,2q33.3
PPM1F,-0.015130026,PPM1F,Approved symbol,PPM1F,"protein phosphatase, Mg2+/Mn2+ dependent 1F",HGNC:19388,22q11.22
AC144652.1,-0.015129847,AC144652.1,Unmatched,AC144652.1,,,
LIN52,-0.015128786,LIN52,Approved symbol,LIN52,lin-52 DREAM MuvB core complex component,HGNC:19856,14q24.3
IGKV3-15,-0.015126481,IGKV3-15,Approved symbol,IGKV3-15,immunoglobulin kappa variable 3-15,HGNC:5816,2p11.2
FBXO6,-0.015120729,FBXO6,Approved symbol,FBXO6,F-box protein 6,HGNC:13585,1p36.22
NFE2L3,-0.015114317,NFE2L3,Approved symbol,NFE2L3,"nuclear factor, erythroid 2 like 3",HGNC:7783,7p15.2
IGHV1-24,-0.015113723,IGHV1-24,Approved symbol,IGHV1-24,immunoglobulin heavy variable 1-24,HGNC:5551,14q32.33
CLEC14A,-0.015111738,CLEC14A,Approved symbol,CLEC14A,C-type lectin domain containing 14A,HGNC:19832,14q21.1
SLC7A11,-0.015102899,SLC7A11,Approved symbol,SLC7A11,solute carrier family 7 member 11,HGNC:11059,4q28.3
MYO3B,-0.015100556,MYO3B,Approved symbol,MYO3B,myosin IIIB,HGNC:15576,2q31.1
IL22,-0.015095748,IL22,Approved symbol,IL22,interleukin 22,HGNC:14900,12q15
GAPDHP14,-0.015094717,GAPDHP14,Approved symbol,GAPDHP14,glyceraldehyde-3-phosphate dehydrogenase pseudogene 14,HGNC:4160,21q21.3
AGTPBP1,-0.015091684,AGTPBP1,Approved symbol,AGTPBP1,ATP/GTP binding protein 1,HGNC:17258,9q21.33
TMEM230,0.015089624,TMEM230,Approved symbol,TMEM230,transmembrane protein 230,HGNC:15876,20p13-p12.3
PIR,-0.015083801,PIR,Approved symbol,PIR,pirin,HGNC:30048,Xp22.2
RHBDD1,-0.015082148,RHBDD1,Approved symbol,RHBDD1,rhomboid domain containing 1,HGNC:23081,2q36.3
RP11-288H12.4,0.01508075,RP11-288H12.4,Unmatched,RP11-288H12.4,,,
RP11-253E3.3,-0.015080613,RP11-253E3.3,Unmatched,RP11-253E3.3,,,
TRIM5,-0.015080227,TRIM5,Approved symbol,TRIM5,tripartite motif containing 5,HGNC:16276,11p15.4
KCND3,-0.015079468,KCND3,Approved symbol,KCND3,potassium voltage-gated channel subfamily D member 3,HGNC:6239,1p13.2
AC013460.1,-0.015077175,AC013460.1,Unmatched,AC013460.1,,,
TNFAIP6,-0.015073811,TNFAIP6,Approved symbol,TNFAIP6,TNF alpha induced protein 6,HGNC:11898,2q23.3
TSEN15,-0.015073041,TSEN15,Approved symbol,TSEN15,tRNA splicing endonuclease subunit 15,HGNC:16791,1q25.3
ARPC1B,-0.015071462,ARPC1B,Approved symbol,ARPC1B,actin related protein 2/3 complex subunit 1B,HGNC:704,7q22.1
GFER,0.015070506,GFER,Approved symbol,GFER,"growth factor, augmenter of liver regeneration",HGNC:4236,16p13.3
LRRC25,-0.015069491,LRRC25,Approved symbol,LRRC25,leucine rich repeat containing 25,HGNC:29806,19p13.11
VMO1,-0.015069255,VMO1,Approved symbol,VMO1,vitelline membrane outer layer 1 homolog,HGNC:30387,17p13.2
CRLF3,-0.01506737,CRLF3,Approved symbol,CRLF3,cytokine receptor like factor 3,HGNC:17177,17q11.2
CCSAP,-0.015066845,CCSAP,Approved symbol,CCSAP,"centriole, cilia and spindle associated protein",HGNC:29578,1q42.13
C6orf123,0.015061416,C6orf123,Previous symbol,LINC01558,long intergenic non-protein coding RNA 1558,HGNC:21235,6q27
ZNF112,0.01506116,ZNF112,Approved symbol,ZNF112,zinc finger protein 112,HGNC:12892,19q13.31
IYD,0.015059762,IYD,Approved symbol,IYD,iodotyrosine deiodinase,HGNC:21071,6q25.1
MZB1,-0.015057582,MZB1,Approved symbol,MZB1,marginal zone B and B1 cell specific protein,HGNC:30125,5q31.2
TMED6,0.015055254,TMED6,Approved symbol,TMED6,transmembrane p24 trafficking protein 6,HGNC:28331,16q22.1
IGLL5,-0.015054857,IGLL5,Approved symbol,IGLL5,immunoglobulin lambda like polypeptide 5,HGNC:38476,22q11.22
RP11-299H21.1,0.015053693,RP11-299H21.1,Unmatched,RP11-299H21.1,,,
RP3-462E2.5,0.015047022,RP3-462E2.5,Unmatched,RP3-462E2.5,,,
RP1-317E23.3,0.015044481,RP1-317E23.3,Unmatched,RP1-317E23.3,,,
IGLV1-40,-0.01504385,IGLV1-40,Approved symbol,IGLV1-40,immunoglobulin lambda variable 1-40,HGNC:5877,22q11.22
TNIP3,-0.015043287,TNIP3,Approved symbol,TNIP3,TNFAIP3 interacting protein 3,HGNC:19315,4q27
ASF1A,0.015041958,ASF1A,Approved symbol,ASF1A,anti-silencing function 1A histone chaperone,HGNC:20995,6q22.31
C11orf96,-0.015038438,C11orf96,Approved symbol,C11orf96,chromosome 11 open reading frame 96,HGNC:38675,11p11.2
MLH1,-0.015037894,MLH1,Approved symbol,MLH1,mutL homolog 1,HGNC:7127,3p22.2
FHL5,-0.015035474,FHL5,Approved symbol,FHL5,four and a half LIM domains 5,HGNC:17371,6q16.1
CLEC12A,-0.015034768,CLEC12A,Approved symbol,CLEC12A,C-type lectin domain family 12 member A,HGNC:31713,12p13.31
PPIL6,0.015034467,PPIL6,Approved symbol,PPIL6,peptidylprolyl isomerase like 6,HGNC:21557,6q21
BAMBI,0.015034433,BAMBI,Approved symbol,BAMBI,BMP and activin membrane bound inhibitor,HGNC:30251,10p12.1
PCSK1N,0.0150315,PCSK1N,Approved symbol,PCSK1N,proprotein convertase subtilisin/kexin type 1 inhibitor,HGNC:17301,Xp11.23
LDHAP7,-0.01503122,LDHAP7,Approved symbol,LDHAP7,lactate dehydrogenase A pseudogene 7,HGNC:23144,2p11.2
UBLCP1,-0.015029414,UBLCP1,Approved symbol,UBLCP1,ubiquitin like domain containing CTD phosphatase 1,HGNC:28110,5q33.3
FGF7,-0.015029035,FGF7,Approved symbol,FGF7,fibroblast growth factor 7,HGNC:3685,15q21.2
B9D1,-0.01502578,B9D1,Approved symbol,B9D1,B9 domain containing 1,HGNC:24123,17p11.2
POLE2,-0.015021705,POLE2,Approved symbol,POLE2,"DNA polymerase epsilon 2, accessory subunit",HGNC:9178,14q21.3
KIAA1456,0.015020685,KIAA1456,Previous symbol,TRMT9B,tRNA methyltransferase 9B (putative),HGNC:26725,8p22
KLK10,-0.015020016,KLK10,Approved symbol,KLK10,kallikrein related peptidase 10,HGNC:6358,19q13.41
KRTAP5-2,-0.01501684,KRTAP5-2,Approved symbol,KRTAP5-2,keratin associated protein 5-2,HGNC:23597,11p15.5
FLT1,-0.015013969,FLT1,Approved symbol,FLT1,fms related receptor tyrosine kinase 1,HGNC:3763,13q12.3
NGLY1,0.015010756,NGLY1,Approved symbol,NGLY1,N-glycanase 1,HGNC:17646,3p24.2
PIK3AP1,-0.015010159,PIK3AP1,Approved symbol,PIK3AP1,phosphoinositide-3-kinase adaptor protein 1,HGNC:30034,10q24.1
BEX1,0.015009704,BEX1,Approved symbol,BEX1,brain expressed X-linked 1,HGNC:1036,Xq22.1
SYF2,0.015003959,SYF2,Approved symbol,SYF2,SYF2 pre-mRNA splicing factor,HGNC:19824,1p36.11
LAMP5,-0.01499466,LAMP5,Approved symbol,LAMP5,lysosomal associated membrane protein family member 5,HGNC:16097,20p12.2
AC009014.3,0.014990094,AC009014.3,Unmatched,AC009014.3,,,
COL4A4,-0.014989484,COL4A4,Approved symbol,COL4A4,collagen type IV alpha 4 chain,HGNC:2206,2q36.3
RP11-290F24.6,0.014988268,RP11-290F24.6,Unmatched,RP11-290F24.6,,,
CTD-3088G3.8,-0.014984688,CTD-3088G3.8,Unmatched,CTD-3088G3.8,,,
ACVR2A,0.014984349,ACVR2A,Approved symbol,ACVR2A,activin A receptor type 2A,HGNC:173,2q22.3-q23.1
SLC25A34,0.014983732,SLC25A34,Approved symbol,SLC25A34,solute carrier family 25 member 34,HGNC:27653,1p36.21
GIPC2,0.014983197,GIPC2,Approved symbol,GIPC2,GIPC PDZ domain containing family member 2,HGNC:18177,1p31.1
RP11-157D23.2,-0.014982554,RP11-157D23.2,Unmatched,RP11-157D23.2,,,
LY6D,-0.014982543,LY6D,Approved symbol,LY6D,lymphocyte antigen 6 family member D,HGNC:13348,8q24.3
IGHV2-26,-0.014980747,IGHV2-26,Approved symbol,IGHV2-26,immunoglobulin heavy variable 2-26,HGNC:5575,14q32.33
PRAM1,-0.014980095,PRAM1,Approved symbol,PRAM1,PML-RARA regulated adaptor molecule 1,HGNC:30091,19p13.2
PTGFR,-0.014974987,PTGFR,Approved symbol,PTGFR,prostaglandin F receptor,HGNC:9600,1p31.1
AC145676.2,-0.014974541,AC145676.2,Unmatched,AC145676.2,,,
NLRC4,-0.014972418,NLRC4,Approved symbol,NLRC4,NLR family CARD domain containing 4,HGNC:16412,2p22.3
DISC1,-0.014971803,DISC1,Approved symbol,DISC1,DISC1 scaffold protein,HGNC:2888,1q42.2
RP11-79H23.3,-0.014971305,DNAJC24,Approved symbol,DNAJC24,DnaJ heat shock protein family (Hsp40) member C24,HGNC:26979,11p13
DNAJC24,-0.014969069,SHROOM1,Approved symbol,SHROOM1,shroom family member 1,HGNC:24084,5q31.1
SHROOM1,0.014967214,IGKV3-20,Approved symbol,IGKV3-20,immunoglobulin kappa variable 3-20,HGNC:5817,2p11.2
IGKV3-20,-0.014967121,KIRREL,Previous symbol,KIRREL1,kirre like nephrin family adhesion molecule 1,HGNC:15734,1q23.1
KIRREL,-0.014961284,RP11-792D21.2,Unmatched,KIRREL,,,
RP11-792D21.2,-0.014960588,AF127936.7,Unmatched,RP11-792D21.2,,,
AF127936.7,0.014958232,FNDC4,Approved symbol,FNDC4,fibronectin type III domain containing 4,HGNC:20239,2p23.3
FNDC4,-0.014956789,CCDC88B,Approved symbol,CCDC88B,coiled-coil domain containing 88B,HGNC:26757,11q13.1
CCDC88B,-0.014956054,RP11-71G12.1,Unmatched,CCDC88B,,,
RP11-71G12.1,-0.014949041,E2F7,Approved symbol,E2F7,E2F transcription factor 7,HGNC:23820,12q21.2
E2F7,-0.014947645,TPX2,Approved symbol,TPX2,TPX2 microtubule nucleation factor,HGNC:1249,20q11.21
TPX2,-0.014944693,VRK1,Approved symbol,VRK1,VRK serine/threonine kinase 1,HGNC:12718,14q32.2
VRK1,-0.014941287,NUP188,Approved symbol,NUP188,nucleoporin 188,HGNC:17859,9q34.11
NUP188,-0.014936778,CENPI,Approved symbol,CENPI,centromere protein I,HGNC:3968,Xq22.1
CENPI,-0.014936542,NUAK2,Approved symbol,NUAK2,NUAK family kinase 2,HGNC:29558,1q32.1
NUAK2,0.014936131,CPS1,Approved symbol,CPS1,carbamoyl-phosphate synthase 1,HGNC:2323,2q34
CPS1,-0.01493591,IGKV2-26,Approved symbol,IGKV2-26,immunoglobulin kappa variable 2-26 (pseudogene),HGNC:5782,2p11.2
IGKV2-26,-0.014933149,FEZ2,Approved symbol,FEZ2,fasciculation and elongation protein zeta 2,HGNC:3660,2p22.2
FEZ2,0.014931517,ITGB1BP2,Approved symbol,ITGB1BP2,integrin subunit beta 1 binding protein 2,HGNC:6154,Xq13.1
ITGB1BP2,-0.014929727,RP11-661A12.14,Unmatched,ITGB1BP2,,,
RP11-661A12.14,0.014929154,TSTD1,Approved symbol,TSTD1,thiosulfate sulfurtransferase like domain containing 1,HGNC:35410,1q23.3
TSTD1,0.014929107,OXTR,Approved symbol,OXTR,oxytocin receptor,HGNC:8529,3p25.3
OXTR,-0.014919138,ASPM,Approved symbol,ASPM,assembly factor for spindle microtubules,HGNC:19048,1q31.3
ASPM,-0.014915223,LAMB2,Approved symbol,LAMB2,laminin subunit beta 2,HGNC:6487,3p21.31
LAMB2,-0.01490725,LAMB2,Previous symbol,LAMC1,laminin subunit gamma 1,HGNC:6492,1q25.3
GJA1,-0.01490693,GJA1,Approved symbol,GJA1,gap junction protein alpha 1,HGNC:4274,6q22.31
ASPG,0.014906213,ASPG,Approved symbol,ASPG,asparaginase,HGNC:20123,14q32.33
CCDC19,-0.014901289,CCDC19,Previous symbol,CFAP45,cilia and flagella associated protein 45,HGNC:17229,1q23.2
HSPA12B,-0.014899003,HSPA12B,Approved symbol,HSPA12B,heat shock protein family A (Hsp70) member 12B,HGNC:16193,20p13
KIF1A,0.014898179,KIF1A,Approved symbol,KIF1A,kinesin family member 1A,HGNC:888,2q37.3
TAF1B,-0.014896253,TAF1B,Approved symbol,TAF1B,"TATA-box binding protein associated factor, RNA polymerase I subunit B",HGNC:11533,2p25.1
AC005262.3,-0.01489403,AC005262.3,Unmatched,AC005262.3,,,
FBXO16,-0.014889422,FBXO16,Approved symbol,FBXO16,F-box protein 16,HGNC:13618,8p21.1
CLCN1,-0.014884315,CLCN1,Approved symbol,CLCN1,chloride voltage-gated channel 1,HGNC:2019,7q34
NDST4,0.014883769,NDST4,Approved symbol,NDST4,N-deacetylase and N-sulfotransferase 4,HGNC:20779,4q26
LYPD1,-0.014882994,LYPD1,Approved symbol,LYPD1,LY6/PLAUR domain containing 1,HGNC:28431,2q21.2
USP18,-0.014881228,USP18,Approved symbol,USP18,ubiquitin specific peptidase 18,HGNC:12616,22q11.2
PREB,-0.01487878,PREB,Approved symbol,PREB,prolactin regulatory element binding,HGNC:9356,2p23.3
TMCC2,-0.014870705,TMCC2,Approved symbol,TMCC2,transmembrane and coiled-coil domain family 2,HGNC:24239,1q32.1
ZNF763,0.014866202,ZNF763,Approved symbol,ZNF763,zinc finger protein 763,HGNC:27614,19p13.2
LAP3,-0.01486516,LAP3,Approved symbol,LAP3,leucine aminopeptidase 3,HGNC:18449,4p15.32
RP11-16E12.2,-0.014861996,RP11-16E12.2,Unmatched,RP11-16E12.2,,,
CENPE,-0.014860529,CENPE,Approved symbol,CENPE,centromere protein E,HGNC:1856,4q24
LINC00865,0.014859186,LINC00865,Approved symbol,LINC00865,long intergenic non-protein coding RNA 865,HGNC:45170,10q23.31
SBF2-AS1,0.014852741,SBF2-AS1,Approved symbol,SBF2-AS1,SBF2 antisense RNA 1,HGNC:27438,11p15.4
AP001007.1,0.014849108,AP001007.1,Unmatched,AP001007.1,,,
ANK3,0.014846777,ANK3,Approved symbol,ANK3,ankyrin 3,HGNC:494,10q21.2
DMRTA1,0.014845941,DMRTA1,Approved symbol,DMRTA1,DMRT like family A1,HGNC:13826,9p21.3
MRPS25,0.014843489,MRPS25,Approved symbol,MRPS25,mitochondrial ribosomal protein S25,HGNC:14511,3p25.1
SRPR,-0.014843317,SRPR,Previous symbol,SRPRA,SRP receptor subunit alpha,HGNC:11307,11q24.2
RBBP8NL,0.014842158,RBBP8NL,Approved symbol,RBBP8NL,RBBP8 N-terminal like,HGNC:16144,20q13.33
FKBP15,-0.01484124,FKBP15,Approved symbol,FKBP15,FKBP prolyl isomerase 15,HGNC:23397,9q32
SNHG18,0.014839338,SNHG18,Approved symbol,SNHG18,small nucleolar RNA host gene 18,HGNC:49007,5p15.31
NHSL2,-0.014828812,NHSL2,Approved symbol,NHSL2,NHS like 2,HGNC:33737,Xq13.1
RECQL4,-0.014827764,RECQL4,Approved symbol,RECQL4,RecQ like helicase 4,HGNC:9949,8q24.3
RP11-168F9.2,0.01482426,RP11-168F9.2,Unmatched,RP11-168F9.2,,,
PI3,-0.014821622,PI3,Approved symbol,PI3,peptidase inhibitor 3,HGNC:8947,20q13.12
RP11-579D7.4,0.014819341,RP11-579D7.4,Unmatched,RP11-579D7.4,,,
MKI67,-0.014818093,MKI67,Approved symbol,MKI67,marker of proliferation Ki-67,HGNC:7107,10q26.2
TRIM52-AS1,0.014815128,TRIM52-AS1,Approved symbol,TRIM52-AS1,TRIM52 antisense RNA 1 (head to head),HGNC:49006,5q35.3
RP11-809C18.4,0.014814144,RP11-809C18.4,Unmatched,RP11-809C18.4,,,
TAPT1-AS1,0.014813825,TAPT1-AS1,Approved symbol,TAPT1-AS1,TAPT1 antisense RNA 1 (head to head),HGNC:26832,4p15.32
TTC6,0.014812497,TTC6,Approved symbol,TTC6,tetratricopeptide repeat domain 6,HGNC:19739,14q21.1
RP11-112H10.4,-0.014810107,RP11-112H10.4,Unmatched,RP11-112H10.4,,,
CCDC148,-0.01480907,CCDC148,Approved symbol,CCDC148,coiled-coil domain containing 148,HGNC:25191,2q24.1
DAB1,-0.014806822,DAB1,Approved symbol,DAB1,DAB adaptor protein 1,HGNC:2661,1p32.2
SLC45A2,0.01480665,SLC45A2,Approved symbol,SLC45A2,solute carrier family 45 member 2,HGNC:16472,5p13.2
PODXL,-0.014802847,PODXL,Approved symbol,PODXL,podocalyxin like,HGNC:9171,7q32.3
RP11-182J1.1,0.014800662,RP11-182J1.1,Unmatched,RP11-182J1.1,,,
CHAC1,-0.014799814,CHAC1,Approved symbol,CHAC1,ChaC glutathione specific gamma-glutamylcyclotransferase 1,HGNC:28680,15q15.1
USP21,0.014798372,USP21,Approved symbol,USP21,ubiquitin specific peptidase 21,HGNC:12620,1q23.3
FAM225A,-0.014795379,FAM225A,Approved symbol,FAM225A,family with sequence similarity 225 member A,HGNC:27855,9q32
KIFC1,-0.014794668,KIFC1,Approved symbol,KIFC1,kinesin family member C1,HGNC:6389,6p21.32
BEST1,-0.014789456,BEST1,Approved symbol,BEST1,bestrophin 1,HGNC:12703,11q12.3
GRHL1,-0.014782095,GRHL1,Approved symbol,GRHL1,grainyhead like transcription factor 1,HGNC:17923,2p25.1
ZDHHC22,0.014778614,ZDHHC22,Approved symbol,ZDHHC22,zinc finger DHHC-type palmitoyltransferase 22,HGNC:20106,14q24.3
IGKV1D-33,-0.014778123,IGKV1D-33,Approved symbol,IGKV1D-33,immunoglobulin kappa variable 1D-33,HGNC:5753,2p11.2
KIAA1549L,-0.014774226,KIAA1549L,Approved symbol,KIAA1549L,KIAA1549 like,HGNC:24836,11p13
TTYH3,-0.014771862,TTYH3,Approved symbol,TTYH3,tweety family member 3,HGNC:22222,7p22.3
TRAPPC6A,0.014768999,TRAPPC6A,Approved symbol,TRAPPC6A,trafficking protein particle complex 6A,HGNC:23069,19q13.32
BCAT1,-0.014767209,BCAT1,Approved symbol,BCAT1,branched chain amino acid transaminase 1,HGNC:976,12p12.1
IGHV3-15,-0.014763883,IGHV3-15,Approved symbol,IGHV3-15,immunoglobulin heavy variable 3-15,HGNC:5582,14q32.33
KRT16,-0.014754726,KRT16,Approved symbol,KRT16,keratin 16,HGNC:6423,17q21.2
CDK20,0.014750315,CDK20,Approved symbol,CDK20,cyclin dependent kinase 20,HGNC:21420,9q22.1
RP11-275I4.2,-0.014748574,RP11-275I4.2,Unmatched,RP11-275I4.2,,,
AC007952.5,-0.014747318,AC007952.5,Unmatched,AC007952.5,,,
SLC6A14,-0.01474564,SLC6A14,Approved symbol,SLC6A14,solute carrier family 6 member 14,HGNC:11047,Xq23
HSD17B7,-0.014745529,HSD17B7,Approved symbol,HSD17B7,hydroxysteroid 17-beta dehydrogenase 7,HGNC:5215,1q23.3
C5AR2,-0.014738054,C5AR2,Approved symbol,C5AR2,complement component 5a receptor 2,HGNC:4527,19q13.32
RASAL1,-0.014736312,RASAL1,Approved symbol,RASAL1,RAS protein activator like 1,HGNC:9873,12q24.13
PHF7,0.014736035,PHF7,Approved symbol,PHF7,PHD finger protein 7,HGNC:18458,3p21.1
PRDM1,-0.014734884,PRDM1,Approved symbol,PRDM1,PR/SET domain 1,HGNC:9346,6q21
CSMD2,-0.014733895,CSMD2,Approved symbol,CSMD2,CUB and Sushi multiple domains 2,HGNC:19290,1p35.1
FMO2,-0.014729221,FMO2,Approved symbol,FMO2,flavin containing dimethylaniline monoxygenase 2,HGNC:3770,1q24.3
KDR,-0.014729187,KDR,Approved symbol,KDR,kinase insert domain receptor,HGNC:6307,4q12
EMILIN2,-0.014727204,EMILIN2,Approved symbol,EMILIN2,elastin microfibril interfacer 2,HGNC:19881,18p11.32-p11.31
DCSTAMP,-0.014725712,DCSTAMP,Approved symbol,DCSTAMP,dendrocyte expressed seven transmembrane protein,HGNC:18549,8q22.3
CTC-297N7.5,0.014725652,CTC-297N7.5,Unmatched,CTC-297N7.5,,,
CEBPE,-0.014723686,CEBPE,Approved symbol,CEBPE,CCAAT enhancer binding protein epsilon,HGNC:1836,14q11.2
TMPRSS13,-0.014722066,TMPRSS13,Approved symbol,TMPRSS13,transmembrane serine protease 13,HGNC:29808,11q23.3
CRMP1,-0.014721192,CRMP1,Approved symbol,CRMP1,collapsin response mediator protein 1,HGNC:2365,4p16.2
FICD,-0.014717946,FICD,Approved symbol,FICD,FIC domain protein adenylyltransferase,HGNC:18416,12q23.3
FAM83D,-0.014717416,FAM83D,Approved symbol,FAM83D,family with sequence similarity 83 member D,HGNC:16122,20q11.23
SAP30L,0.014715372,SAP30L,Approved symbol,SAP30L,SAP30 like,HGNC:25663,5q33.2
P2RX7,-0.014713673,P2RX7,Approved symbol,P2RX7,purinergic receptor P2X 7,HGNC:8537,12q24.31
AARS,-0.014713253,AARS,Previous symbol,AARS1,alanyl-tRNA synthetase 1,HGNC:20,16q22.1
CCDC121,0.014711329,CCDC121,Approved symbol,CCDC121,coiled-coil domain containing 121,HGNC:25833,2p23.3
IRF1,-0.014710713,IRF1,Approved symbol,IRF1,interferon regulatory factor 1,HGNC:6116,5q31.1
RP11-94A24.1,-0.01470745,RP11-94A24.1,Unmatched,RP11-94A24.1,,,
SPAG4,-0.014706109,SPAG4,Approved symbol,SPAG4,sperm associated antigen 4,HGNC:11214,20q11.22
MLLT4-AS1,0.014703707,MLLT4-AS1,Previous symbol,AFDN-DT,AFDN divergent transcript,HGNC:21236,6q27
MARS,-0.014702237,MARS,Previous symbol,MARS1,methionyl-tRNA synthetase 1,HGNC:6898,12q13.3
LINC00211,-0.014696903,LINC00211,Approved symbol,LINC00211,long intergenic non-protein coding RNA 211,HGNC:37459,2p22.2
SPATA12,-0.014695407,SPATA12,Approved symbol,SPATA12,spermatogenesis associated 12,HGNC:23221,3p14.3
RNF135,0.014692479,RNF135,Approved symbol,RNF135,ring finger protein 135,HGNC:21158,17q11.2
DNAJB9,-0.014690591,DNAJB9,Approved symbol,DNAJB9,DnaJ heat shock protein family (Hsp40) member B9,HGNC:6968,7q31.1
NPM2,0.014689085,NPM2,Approved symbol,NPM2,nucleophosmin/nucleoplasmin 2,HGNC:7930,8p21.3
RNASE2,-0.014686165,RNASE2,Approved symbol,RNASE2,ribonuclease A family member 2,HGNC:10045,14q11.2
DUOX2,-0.014680907,DUOX2,Approved symbol,DUOX2,dual oxidase 2,HGNC:13273,15q21.1
PANX1,-0.014678557,PANX1,Approved symbol,PANX1,pannexin 1,HGNC:8599,11q21
STON2,0.014677645,STON2,Approved symbol,STON2,stonin 2,HGNC:30652,14q31.1
S100A12,-0.014677276,S100A12,Approved symbol,S100A12,S100 calcium binding protein A12,HGNC:10489,1q21.3
SGOL1,-0.014669629,SGOL1,Previous symbol,SGO1,shugoshin 1,HGNC:25088,3p24.3
DCUN1D5,-0.014662548,DCUN1D5,Approved symbol,DCUN1D5,defective in cullin neddylation 1 domain containing 5,HGNC:28409,11q22.3
RP11-47I22.3,-0.014661211,RP11-47I22.3,Unmatched,RP11-47I22.3,,,
SYT4,0.014658324,SYT4,Approved symbol,SYT4,synaptotagmin 4,HGNC:11512,18q12.3
LIF,-0.014656549,LIF,Approved symbol,LIF,LIF interleukin 6 family cytokine,HGNC:6596,22q12.2
SLC1A4,-0.014655099,SLC1A4,Approved symbol,SLC1A4,solute carrier family 1 member 4,HGNC:10942,2p14
RASIP1,-0.014654053,RASIP1,Approved symbol,RASIP1,Ras interacting protein 1,HGNC:24716,19q13.33
CPT1C,-0.01465258,CPT1C,Approved symbol,CPT1C,carnitine palmitoyltransferase 1C,HGNC:18540,19q13.33
GRAMD1B,-0.014641229,GRAMD1B,Approved symbol,GRAMD1B,GRAM domain containing 1B,HGNC:29214,11q24.1
AVPR1B,0.014638406,AVPR1B,Approved symbol,AVPR1B,arginine vasopressin receptor 1B,HGNC:896,1q32.1
CRB2,0.014638168,CRB2,Approved symbol,CRB2,crumbs cell polarity complex component 2,HGNC:18688,9q33.3
MAP2K1,-0.014634306,MAP2K1,Approved symbol,MAP2K1,mitogen-activated protein kinase kinase 1,HGNC:6840,15q22.31
HEY1,0.014628799,HEY1,Approved symbol,HEY1,hes related family bHLH transcription factor with YRPW motif 1,HGNC:4880,8q21.13
TBC1D8,-0.01462879,TBC1D8,Approved symbol,TBC1D8,TBC1 domain family member 8,HGNC:17791,2q11.2
MTATP6P1,0.014623866,MTATP6P1,Approved symbol,MTATP6P1,MT-ATP6 pseudogene 1,HGNC:44575,1p36.33
MAML2,0.014620667,MAML2,Approved symbol,MAML2,mastermind like transcriptional coactivator 2,HGNC:16259,11q21
CHDH,0.014616793,CHDH,Approved symbol,CHDH,choline dehydrogenase,HGNC:24288,3p21.1
INSIG1,-0.014615998,INSIG1,Approved symbol,INSIG1,insulin induced gene 1,HGNC:6083,7q36.3
DHH,-0.014613895,DHH,Approved symbol,DHH,desert hedgehog signaling molecule,HGNC:2865,12q13.12
DUOX1,-0.014613557,DUOX1,Approved symbol,DUOX1,dual oxidase 1,HGNC:3062,15q21.1
SLC17A9,-0.014608556,SLC17A9,Approved symbol,SLC17A9,solute carrier family 17 member 9,HGNC:16192,20q13.33
FKBP14,-0.014604435,FKBP14,Approved symbol,FKBP14,FKBP prolyl isomerase 14,HGNC:18625,7p14.3
FTH1P22,-0.014602909,FTH1P22,Approved symbol,FTH1P22,ferritin heavy chain 1 pseudogene 22,HGNC:37640,1p13.1
RP11-75C9.1,0.014602455,RP11-75C9.1,Unmatched,RP11-75C9.1,,,
SLC25A32,-0.01460184,SLC25A32,Approved symbol,SLC25A32,solute carrier family 25 member 32,HGNC:29683,8q22.3
FBXW4,0.014599839,FBXW4,Approved symbol,FBXW4,F-box and WD repeat domain containing 4,HGNC:10847,10q24.32
IL24,-0.014596814,IL24,Approved symbol,IL24,interleukin 24,HGNC:11346,1q32.1
GNB4,-0.014595605,GNB4,Approved symbol,GNB4,G protein subunit beta 4,HGNC:20731,3q26.33
ABHD14B,0.014594011,ABHD14B,Approved symbol,ABHD14B,abhydrolase domain containing 14B,HGNC:28235,3p21.2
CYP2R1,0.01459374,CYP2R1,Approved symbol,CYP2R1,cytochrome P450 family 2 subfamily R member 1,HGNC:20580,11p15.2
HAL,-0.014589843,HAL,Approved symbol,HAL,histidine ammonia-lyase,HGNC:4806,12q23.1
GRINA,-0.014589565,GRINA,Approved symbol,GRINA,glutamate ionotropic receptor NMDA type subunit associated protein 1,HGNC:4589,8q24.3
RALGPS1,0.014588454,RALGPS1,Approved symbol,RALGPS1,Ral GEF with PH domain and SH3 binding motif 1,HGNC:16851,9q33.3
CASC10,-0.014584949,CASC10,Previous symbol,MIR1915HG,MIR1915 host gene,HGNC:31448,10p12.31
MRPL34,0.014584476,MRPL34,Approved symbol,MRPL34,mitochondrial ribosomal protein L34,HGNC:14488,19p13.11
ANKH,0.014581641,ANKH,Approved symbol,ANKH,ANKH inorganic pyrophosphate transport regulator,HGNC:15492,5p15.2
ZSCAN9,0.014581373,ZSCAN9,Approved symbol,ZSCAN9,zinc finger and SCAN domain containing 9,HGNC:12984,6p22.1
DEFB4B,-0.014575457,DEFB4B,Approved symbol,DEFB4B,defensin beta 4B,HGNC:30193,8p23.1
FOLH1,-0.01457521,FOLH1,Approved symbol,FOLH1,folate hydrolase 1,HGNC:3788,11p11.12
FBXO31,0.014574827,FBXO31,Approved symbol,FBXO31,F-box protein 31,HGNC:16510,16q24.2
AKR1D1,-0.014574286,AKR1D1,Approved symbol,AKR1D1,aldo-keto reductase family 1 member D1,HGNC:388,7q33
IGSF5,0.014574015,IGSF5,Approved symbol,IGSF5,immunoglobulin superfamily member 5,HGNC:5952,21q22.2
ADAMTSL1,0.014572193,ADAMTSL1,Approved symbol,ADAMTSL1,ADAMTS like 1,HGNC:14632,9p22.2-p22.1
SGOL2,-0.014571564,SGOL2,Previous symbol,SGO2,shugoshin 2,HGNC:30812,2q33.1
RP11-80B9.4,0.014565411,RP11-80B9.4,Unmatched,RP11-80B9.4,,,
THBS2,-0.014560213,THBS2,Approved symbol,THBS2,thrombospondin 2,HGNC:11786,6q27
TXNDC15,-0.014560016,TXNDC15,Approved symbol,TXNDC15,thioredoxin domain containing 15,HGNC:20652,5q31.1
C21orf49,0.014559877,C21orf49,Previous symbol,C21orf62-AS1,C21orf62 antisense RNA 1,HGNC:1290,21q22.11
NUP107,-0.014553392,NUP107,Approved symbol,NUP107,nucleoporin 107,HGNC:29914,12q15
SERPINA10,0.014550308,SERPINA10,Approved symbol,SERPINA10,serpin family A member 10,HGNC:15996,14q32.13
PTPN2,-0.014547249,PTPN2,Approved symbol,PTPN2,protein tyrosine phosphatase non-receptor type 2,HGNC:9650,18p11.21
LINC00704,0.014545052,LINC00704,Previous symbol,MANCR,mitotically associated long non coding RNA,HGNC:44678,10p15.1
CDC6,-0.014542358,CDC6,Approved symbol,CDC6,cell division cycle 6,HGNC:1744,17q21.2
AC104699.1,-0.014541004,AC104699.1,Unmatched,AC104699.1,,,
CDKN3,-0.014537875,CDKN3,Approved symbol,CDKN3,cyclin dependent kinase inhibitor 3,HGNC:1791,14q22.2
RUNDC3B,0.014536362,RUNDC3B,Approved symbol,RUNDC3B,RUN domain containing 3B,HGNC:30286,7q21.12
RP11-554A11.4,-0.014535985,RP11-554A11.4,Unmatched,RP11-554A11.4,,,
RP11-420L9.5,-0.014535647,RP11-420L9.5,Unmatched,RP11-420L9.5,,,
CIB2,0.014531728,CIB2,Approved symbol,CIB2,calcium and integrin binding family member 2,HGNC:24579,15q25.1
ST3GAL1,-0.014531281,ST3GAL1,Approved symbol,ST3GAL1,"ST3 beta-galactoside alpha-2,3-sialyltransferase 1",HGNC:10862,8q24.22
ZNF813,0.014529563,ZNF813,Approved symbol,ZNF813,zinc finger protein 813,HGNC:33257,19q13.42
ABCA5,0.014529483,ABCA5,Approved symbol,ABCA5,ATP binding cassette subfamily A member 5,HGNC:35,17q24.3
CCP110,-0.014528447,CCP110,Approved symbol,CCP110,centriolar coiled-coil protein 110,HGNC:24342,16p12.3
AC093391.2,-0.014525049,AC093391.2,Unmatched,AC093391.2,,,
OLR1,-0.014521299,OLR1,Approved symbol,OLR1,oxidized low density lipoprotein receptor 1,HGNC:8133,12p13.2
ME1,-0.014520329,ME1,Approved symbol,ME1,malic enzyme 1,HGNC:6983,6q14.2
NMI,-0.014519996,NMI,Approved symbol,NMI,N-myc and STAT interactor,HGNC:7854,2q23.3
CPEB3,0.014517848,CPEB3,Approved symbol,CPEB3,cytoplasmic polyadenylation element binding protein 3,HGNC:21746,10q23.32
PPIB,-0.014516493,PPIB,Approved symbol,PPIB,peptidylprolyl isomerase B,HGNC:9255,15q22.31
BUB1,-0.014516124,BUB1,Approved symbol,BUB1,BUB1 mitotic checkpoint serine/threonine kinase,HGNC:1148,2q13
CHPT1,0.014512689,CHPT1,Approved symbol,CHPT1,choline phosphotransferase 1,HGNC:17852,12q23.2
AC123023.1,-0.014512393,AC123023.1,Unmatched,AC123023.1,,,
RP11-57H14.4,0.014511024,RP11-57H14.4,Unmatched,RP11-57H14.4,,,
CYR61,-0.014508272,CYR61,Previous symbol,CCN1,cellular communication network factor 1,HGNC:2654,1p22.3
ORC1,-0.014507967,ORC1,Approved symbol,ORC1,origin recognition complex subunit 1,HGNC:8487,1p32.3
CTD-2132N18.2,0.014505067,CTD-2132N18.2,Unmatched,CTD-2132N18.2,,,
XRCC2,-0.014502515,XRCC2,Approved symbol,XRCC2,X-ray repair cross complementing 2,HGNC:12829,7q36.1
POM121L9P,-0.014489864,POM121L9P,Approved symbol,POM121L9P,"POM121 transmembrane nucleoporin like 9, pseudogene",HGNC:30080,22q11.23
SLC25A26,0.014488876,SLC25A26,Approved symbol,SLC25A26,solute carrier family 25 member 26,HGNC:20661,3p14.1
HMGN3-AS1,0.014487098,HMGN3-AS1,Approved symbol,HMGN3-AS1,HMGN3 antisense RNA 1,HGNC:48984,6q14.1
TMEM165,-0.014484643,TMEM165,Approved symbol,TMEM165,transmembrane protein 165,HGNC:30760,4q12
DNA2,-0.014484461,DNA2,Approved symbol,DNA2,DNA replication helicase/nuclease 2,HGNC:2939,10q21.3
SLFN12,-0.014484111,SLFN12,Approved symbol,SLFN12,schlafen family member 12,HGNC:25500,17q12
NAP1L2,0.01447863,NAP1L2,Approved symbol,NAP1L2,nucleosome assembly protein 1 like 2,HGNC:7638,Xq13.2
RP11-426C22.4,-0.014473237,RP11-426C22.4,Unmatched,RP11-426C22.4,,,
LINC01023,0.014472361,LINC01023,Approved symbol,LINC01023,long intergenic non-protein coding RNA 1023,HGNC:49004,5q21.3
SEMA6B,-0.014472311,SEMA6B,Approved symbol,SEMA6B,semaphorin 6B,HGNC:10739,19p13.3
ST13,0.014470568,ST13,Approved symbol,ST13,ST13 Hsp70 interacting protein,HGNC:11343,22q13.2
JAK2,-0.014467312,JAK2,Approved symbol,JAK2,Janus kinase 2,HGNC:6192,9p24.1
RAP2B,-0.014465851,RAP2B,Approved symbol,RAP2B,"RAP2B, member of RAS oncogene family",HGNC:9862,3q25.2
SLC39A14,0.014463908,SLC39A14,Approved symbol,SLC39A14,solute carrier family 39 member 14,HGNC:20858,8p21.3
CSRP2BP,0.014461707,CSRP2BP,Previous symbol,KAT14,lysine acetyltransferase 14,HGNC:15904,20p11.23
BMP8B,0.014461403,BMP8B,Approved symbol,BMP8B,bone morphogenetic protein 8b,HGNC:1075,1p34.2
PDGFB,-0.014460908,PDGFB,Approved symbol,PDGFB,platelet derived growth factor subunit B,HGNC:8800,22q13.1
NAMPTL,-0.014458407,NAMPTL,Previous symbol,NAMPTP1,nicotinamide phosphoribosyltransferase pseudogene 1,HGNC:17633,10p11.21
TMEM45A,-0.014450839,TMEM45A,Approved symbol,TMEM45A,transmembrane protein 45A,HGNC:25480,3q12.2
IGHD3-3,-0.014450005,IGHD3-3,Approved symbol,IGHD3-3,immunoglobulin heavy diversity 3-3,HGNC:5498,14q32.33
SRCIN1,0.014449616,SRCIN1,Approved symbol,SRCIN1,SRC kinase signaling inhibitor 1,HGNC:29506,17q12
AC121251.1,-0.01444596,AC121251.1,Unmatched,AC121251.1,,,
MT1X,0.014441138,MT1X,Approved symbol,MT1X,metallothionein 1X,HGNC:7405,16q13
RPS18P9,0.014439588,RPS18P9,Approved symbol,RPS18P9,ribosomal protein S18 pseudogene 9,HGNC:36483,6q25.1
KIAA1377,0.01443933,KIAA1377,Previous symbol,CEP126,centrosomal protein 126,HGNC:29264,11q22.1
PARD3B,0.014438984,PARD3B,Approved symbol,PARD3B,par-3 family cell polarity regulator beta,HGNC:14446,2q33.3
CTC-428G20.3,0.014438793,CTC-428G20.3,Unmatched,CTC-428G20.3,,,
PALLD,-0.014438457,PALLD,Approved symbol,PALLD,"palladin, cytoskeletal associated protein",HGNC:17068,4q32.3
PTPN1,-0.01443625,PTPN1,Approved symbol,PTPN1,protein tyrosine phosphatase non-receptor type 1,HGNC:9642,20q13.13
DHRS4,0.014432841,DHRS4,Approved symbol,DHRS4,dehydrogenase/reductase 4,HGNC:16985,14q11.2
SFXN4,0.014428757,SFXN4,Approved symbol,SFXN4,sideroflexin 4,HGNC:16088,10q26.11
UCN2,-0.01442504,UCN2,Approved symbol,UCN2,urocortin 2,HGNC:18414,3p21.31
DNAJC10,-0.014422749,DNAJC10,Approved symbol,DNAJC10,DnaJ heat shock protein family (Hsp40) member C10,HGNC:24637,2q32.1
FOXC1,-0.014421165,FOXC1,Approved symbol,FOXC1,forkhead box C1,HGNC:3800,6p25.3
GRAMD2,-0.01441867,GRAMD2,Previous symbol,GRAMD2A,GRAM domain containing 2A,HGNC:27287,15q23
RP11-84D1.1,-0.014416885,RP11-84D1.1,Unmatched,RP11-84D1.1,,,
RP11-1246C19.1,0.01441291,RP11-1246C19.1,Unmatched,RP11-1246C19.1,,,
RP11-586D19.1,-0.014411467,RP11-586D19.1,Unmatched,RP11-586D19.1,,,
ZC3H12A,-0.014409183,ZC3H12A,Approved symbol,ZC3H12A,zinc finger CCCH-type containing 12A,HGNC:26259,1p34.3
DIO3OS,0.014407778,DIO3OS,Approved symbol,DIO3OS,DIO3 opposite strand upstream RNA,HGNC:20348,14q32.31
COL15A1,-0.014403065,COL15A1,Approved symbol,COL15A1,collagen type XV alpha 1 chain,HGNC:2192,9q22.33
NUTM2D,0.014402925,NUTM2D,Approved symbol,NUTM2D,NUT family member 2D,HGNC:23447,10q23.2
CTD-2014B16.3,0.014400082,CTD-2014B16.3,Unmatched,CTD-2014B16.3,,,
CCL4L2,-0.014398774,CCL4L2,Approved symbol,CCL4L2,C-C motif chemokine ligand 4 like 2,HGNC:24066,17q12
2-Mar,0.014398627,2-Mar,Unmatched,2-Mar,,,
IGHV3-22,-0.014397443,IGHV3-22,Approved symbol,IGHV3-22,immunoglobulin heavy variable 3-22 (pseudogene),HGNC:5587,14q32.33
INPP4B,-0.01438611,INPP4B,Approved symbol,INPP4B,inositol polyphosphate-4-phosphatase type II B,HGNC:6075,4q31.21
KCNC1,0.014385879,KCNC1,Approved symbol,KCNC1,potassium voltage-gated channel subfamily C member 1,HGNC:6233,11p15.1
STK32B,-0.014385452,STK32B,Approved symbol,STK32B,serine/threonine kinase 32B,HGNC:14217,4p16.2
INSR,0.014385329,INSR,Approved symbol,INSR,insulin receptor,HGNC:6091,19p13.2
HSP90B1,-0.014384986,HSP90B1,Approved symbol,HSP90B1,heat shock protein 90 beta family member 1,HGNC:12028,12q23.3
PAG1,0.01437931,PAG1,Approved symbol,PAG1,phosphoprotein membrane anchor with glycosphingolipid microdomains 1,HGNC:30043,8q21.13
TMEM14B,0.014378065,TMEM14B,Approved symbol,TMEM14B,transmembrane protein 14B,HGNC:21384,6p24.2
CDK1,-0.014375841,CDK1,Approved symbol,CDK1,cyclin dependent kinase 1,HGNC:1722,10q21.2
EWSR1,-0.014374995,EWSR1,Approved symbol,EWSR1,EWS RNA binding protein 1,HGNC:3508,22q12.2
SH2B1,0.014374515,SH2B1,Approved symbol,SH2B1,SH2B adaptor protein 1,HGNC:30417,16p11.2
NOVA1-AS1,0.01436833,NOVA1-AS1,Previous symbol,LINC02588,long intergenic non-protein coding RNA 2588,HGNC:19827,14q12
SLAMF9,-0.014367469,SLAMF9,Approved symbol,SLAMF9,SLAM family member 9,HGNC:18430,1q23.2
MMRN2,-0.014365178,MMRN2,Approved symbol,MMRN2,multimerin 2,HGNC:19888,10q23.2
DEFB4A,-0.014364297,DEFB4A,Approved symbol,DEFB4A,defensin beta 4A,HGNC:2767,8p23.1
ANKRD9,0.014358637,ANKRD9,Approved symbol,ANKRD9,ankyrin repeat domain 9,HGNC:20096,14q32.31
REG3A,-0.01435687,REG3A,Approved symbol,REG3A,regenerating family member 3 alpha,HGNC:8601,2p12
CALCRL,-0.014354757,CALCRL,Approved symbol,CALCRL,calcitonin receptor like receptor,HGNC:16709,2q32.1
GPX8,-0.014352793,GPX8,Approved symbol,GPX8,glutathione peroxidase 8 (putative),HGNC:33100,5q11.2
PACRG,0.014351135,PACRG,Approved symbol,PACRG,parkin coregulated,HGNC:19152,6q26
RP11-290F5.1,-0.014344491,RP11-290F5.1,Unmatched,RP11-290F5.1,,,
SLAMF7,-0.014342812,SLAMF7,Approved symbol,SLAMF7,SLAM family member 7,HGNC:21394,1q23.3
S100A7,-0.014339771,S100A7,Approved symbol,S100A7,S100 calcium binding protein A7,HGNC:10497,1q21.3
LDB2,-0.014339645,LDB2,Approved symbol,LDB2,LIM domain binding 2,HGNC:6533,4p15.32
FCER1G,-0.014333591,FCER1G,Approved symbol,FCER1G,Fc fragment of IgE receptor Ig,HGNC:3611,1q23.3
HNRNPH3,0.01433071,HNRNPH3,Approved symbol,HNRNPH3,heterogeneous nuclear ribonucleoprotein H3,HGNC:5043,10q21.3
LMBRD1,0.014322059,LMBRD1,Approved symbol,LMBRD1,LMBR1 domain containing 1,HGNC:23038,6q13
BUB1B,-0.014321403,BUB1B,Approved symbol,BUB1B,BUB1 mitotic checkpoint serine/threonine kinase B,HGNC:1149,15q15.1
RP11-524D16__A.3,-0.014320999,RP11-524D16__A.3,Unmatched,RP11-524D16__A.3,,,
MGAM,-0.014319273,MGAM,Approved symbol,MGAM,maltase-glucoamylase,HGNC:7043,7q34
ITIH3,-0.014316315,ITIH3,Approved symbol,ITIH3,inter-alpha-trypsin inhibitor heavy chain 3,HGNC:6168,3p21.1
PAPPA,-0.014315913,PAPPA,Approved symbol,PAPPA,pappalysin 1,HGNC:8602,9q33.1
ZBED5-AS1,0.014313579,ZBED5-AS1,Approved symbol,ZBED5-AS1,ZBED5 antisense RNA 1,HGNC:48646,11p15.4
PLN,-0.014311523,PLN,Approved symbol,PLN,phospholamban,HGNC:9080,6q22.31
BRCA1,-0.014311175,BRCA1,Approved symbol,BRCA1,BRCA1 DNA repair associated,HGNC:1100,17q21.31
IFIT5,-0.014306058,IFIT5,Approved symbol,IFIT5,interferon induced protein with tetratricopeptide repeats 5,HGNC:13328,10q23.31
HINFP,0.014304242,HINFP,Approved symbol,HINFP,histone H4 transcription factor,HGNC:17850,11q23.3
FOXP2,0.014302989,FOXP2,Approved symbol,FOXP2,forkhead box P2,HGNC:13875,7q31.1
KCNN3,-0.014300699,KCNN3,Approved symbol,KCNN3,potassium calcium-activated channel subfamily N member 3,HGNC:6292,1q21.3
RP11-678G14.2,0.014297884,RP11-678G14.2,Unmatched,RP11-678G14.2,,,
FGF14,0.014297485,FGF14,Approved symbol,FGF14,fibroblast growth factor 14,HGNC:3671,13q33.1
SMARCE1,0.014296058,SMARCE1,Approved symbol,SMARCE1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1",HGNC:11109,17q21.2
OLIG1,-0.014284868,OLIG1,Approved symbol,OLIG1,oligodendrocyte transcription factor 1,HGNC:16983,21q22.11
RP4-669H2.1,0.014281498,RP4-669H2.1,Unmatched,RP4-669H2.1,,,
KRT14,0.014281005,KRT14,Approved symbol,KRT14,keratin 14,HGNC:6416,17q21.2
AC012456.4,-0.014276406,AC012456.4,Unmatched,AC012456.4,,,
THSD1,-0.014275959,THSD1,Approved symbol,THSD1,thrombospondin type 1 domain containing 1,HGNC:17754,13q14.3
SPARC,-0.014275558,SPARC,Approved symbol,SPARC,secreted protein acidic and cysteine rich,HGNC:11219,5q33.1
LYPD5,-0.014274599,LYPD5,Approved symbol,LYPD5,LY6/PLAUR domain containing 5,HGNC:26397,19q13.31
ENPP7P11,0.014269511,ENPP7P11,Approved symbol,ENPP7P11,ectonucleotide pyrophosphatase/phosphodiesterase 7 pseudogene 11,HGNC:48694,4p16.1
RP11-18I14.10,0.014265113,RP11-18I14.10,Unmatched,RP11-18I14.10,,,
RXRG,0.014259163,RXRG,Approved symbol,RXRG,retinoid X receptor gamma,HGNC:10479,1q23.3
IQGAP3,-0.014257579,IQGAP3,Approved symbol,IQGAP3,IQ motif containing GTPase activating protein 3,HGNC:20669,1q22
STXBP5L,0.014256869,STXBP5L,Approved symbol,STXBP5L,syntaxin binding protein 5 like,HGNC:30757,3q13.33
MLTK,-0.014256695,MLTK,Alias symbol,MAP3K20,mitogen-activated protein kinase kinase kinase 20,HGNC:17797,2q31.1
ANXA2P2,-0.014254756,ANXA2P2,Approved symbol,ANXA2P2,annexin A2 pseudogene 2,HGNC:539,9p13.3
CAMSAP1,-0.014251421,CAMSAP1,Approved symbol,CAMSAP1,calmodulin regulated spectrin associated protein 1,HGNC:19946,9q34.3
AC072052.7,0.014244377,AC072052.7,Unmatched,AC072052.7,,,
SLC19A3,0.014244127,SLC19A3,Approved symbol,SLC19A3,solute carrier family 19 member 3,HGNC:16266,2q36.3
IGKV3D-15,-0.014234609,IGKV3D-15,Approved symbol,IGKV3D-15,immunoglobulin kappa variable 3D-15,HGNC:5824,2p11.2
PPP6R1,-0.014234576,PPP6R1,Approved symbol,PPP6R1,protein phosphatase 6 regulatory subunit 1,HGNC:29195,19q13.42
CDCA4,-0.014232803,CDCA4,Approved symbol,CDCA4,cell division cycle associated 4,HGNC:14625,14q32.33
IGHJ6,-0.014230414,IGHJ6,Approved symbol,IGHJ6,immunoglobulin heavy joining 6,HGNC:5540,14q32.33
TCF19,-0.01422891,TCF19,Approved symbol,TCF19,transcription factor 19,HGNC:11629,6p21.33
CCAT1,-0.014226242,CCAT1,Approved symbol,CCAT1,colon cancer associated transcript 1,HGNC:45128,8q24.21
ILF3-AS1,0.014225291,ILF3-AS1,Previous symbol,ILF3-DT,ILF3 divergent transcript,HGNC:27115,19p13.2
FOXM1,-0.014223406,FOXM1,Approved symbol,FOXM1,forkhead box M1,HGNC:3818,12p13.33
APOBEC1,-0.014223203,APOBEC1,Approved symbol,APOBEC1,apolipoprotein B mRNA editing enzyme catalytic subunit 1,HGNC:604,12p13.31
ARHGEF3,-0.014221653,ARHGEF3,Approved symbol,ARHGEF3,Rho guanine nucleotide exchange factor 3,HGNC:683,3p14.3
TPST2,-0.014203667,TPST2,Approved symbol,TPST2,tyrosylprotein sulfotransferase 2,HGNC:12021,22q12.1
IGHV5-51,-0.014201908,IGHV5-51,Approved symbol,IGHV5-51,immunoglobulin heavy variable 5-51,HGNC:5659,14q32.33
RP11-709B3.2,-0.014198321,RP11-709B3.2,Unmatched,RP11-709B3.2,,,
AC012358.8,0.014197437,AC012358.8,Unmatched,AC012358.8,,,
HM13,-0.014196253,HM13,Approved symbol,HM13,histocompatibility minor 13,HGNC:16435,20q11.21
RHOJ,-0.014192419,RHOJ,Approved symbol,RHOJ,ras homolog family member J,HGNC:688,14q23.2
FKBP10,-0.014189838,FKBP10,Approved symbol,FKBP10,FKBP prolyl isomerase 10,HGNC:18169,17q21.2
PARPBP,-0.01418637,PARPBP,Approved symbol,PARPBP,PARP1 binding protein,HGNC:26074,12q23.2
CHSY3,-0.014184243,CHSY3,Approved symbol,CHSY3,chondroitin sulfate synthase 3,HGNC:24293,5q23.3
ABCG5,-0.014183018,ABCG5,Approved symbol,ABCG5,ATP binding cassette subfamily G member 5,HGNC:13886,2p21
RP11-312O7.2,-0.014178526,RP11-312O7.2,Unmatched,RP11-312O7.2,,,
SAMD14,-0.014177688,SAMD14,Approved symbol,SAMD14,sterile alpha motif domain containing 14,HGNC:27312,17q21.33
PLK4,-0.014172952,PLK4,Approved symbol,PLK4,polo like kinase 4,HGNC:11397,4q28.1
ACSL1,-0.014172582,ACSL1,Approved symbol,ACSL1,acyl-CoA synthetase long chain family member 1,HGNC:3569,4q35.1
SKA3,-0.014171527,SKA3,Approved symbol,SKA3,spindle and kinetochore associated complex subunit 3,HGNC:20262,13q12.11
AFAP1-AS1,-0.014169549,AFAP1-AS1,Approved symbol,AFAP1-AS1,AFAP1 antisense RNA 1,HGNC:28141,4p16.1
RP11-815J4.4,0.014159155,RP11-815J4.4,Unmatched,RP11-815J4.4,,,
PDLIM7,-0.014155287,PDLIM7,Approved symbol,PDLIM7,PDZ and LIM domain 7,HGNC:22958,5q35.3
LRRC32,-0.014154568,LRRC32,Approved symbol,LRRC32,leucine rich repeat containing 32,HGNC:4161,11q13.5
GAS1,-0.014154533,GAS1,Approved symbol,GAS1,growth arrest specific 1,HGNC:4165,9q21.33
SLCO4A1,-0.014146166,SLCO4A1,Approved symbol,SLCO4A1,solute carrier organic anion transporter family member 4A1,HGNC:10953,20q13.33
ABCA7,-0.014145425,ABCA7,Approved symbol,ABCA7,ATP binding cassette subfamily A member 7,HGNC:37,19p13.3
C15orf40,0.014140355,C15orf40,Approved symbol,C15orf40,chromosome 15 open reading frame 40,HGNC:28443,15q25.2
ELL2,-0.014135135,ELL2,Approved symbol,ELL2,elongation factor for RNA polymerase II 2,HGNC:17064,5q15
DDX19B,0.014133548,DDX19B,Approved symbol,DDX19B,DEAD-box helicase 19B,HGNC:2742,16q22.1
ALKBH7,0.014131419,ALKBH7,Approved symbol,ALKBH7,alkB homolog 7,HGNC:21306,19p13.3
APBA2,-0.014126333,APBA2,Approved symbol,APBA2,amyloid beta precursor protein binding family A member 2,HGNC:579,15q13.1
C1orf131,0.014124386,C1orf131,Approved symbol,C1orf131,chromosome 1 open reading frame 131,HGNC:25332,1q42.2
AC008268.2,-0.014121503,AC008268.2,Unmatched,AC008268.2,,,
HINT2,0.014116174,HINT2,Approved symbol,HINT2,histidine triad nucleotide binding protein 2,HGNC:18344,9p13.3
TRIM69,-0.014114894,TRIM69,Approved symbol,TRIM69,tripartite motif containing 69,HGNC:17857,15q15-q21
COLGALT1,-0.014107892,COLGALT1,Approved symbol,COLGALT1,collagen beta(1-O)galactosyltransferase 1,HGNC:26182,19p13.11
PAPSS1,-0.014104472,PAPSS1,Approved symbol,PAPSS1,3'-phosphoadenosine 5'-phosphosulfate synthase 1,HGNC:8603,4q25
IGHV1-69,-0.014104123,IGHV1-69,Approved symbol,IGHV1-69,immunoglobulin heavy variable 1-69,HGNC:5558,14q32.33
MRPL16,0.014100907,MRPL16,Approved symbol,MRPL16,mitochondrial ribosomal protein L16,HGNC:14476,11q12.1
COL5A2,-0.014100906,COL5A2,Approved symbol,COL5A2,collagen type V alpha 2 chain,HGNC:2210,2q32.2
SHISA5,-0.014100361,SHISA5,Approved symbol,SHISA5,shisa family member 5,HGNC:30376,3p21.31
ASS1P5,-0.014099303,ASS1P5,Approved symbol,ASS1P5,argininosuccinate synthetase 1 pseudogene 5,HGNC:768,Xq23
RP4-730K3.3,-0.01409801,RP4-730K3.3,Unmatched,RP4-730K3.3,,,
SLCO3A1,-0.014095979,SLCO3A1,Approved symbol,SLCO3A1,solute carrier organic anion transporter family member 3A1,HGNC:10952,15q26.1
CCNB1IP1,0.014093219,CCNB1IP1,Approved symbol,CCNB1IP1,cyclin B1 interacting protein 1,HGNC:19437,14q11.2
IGHJ2P,-0.014089197,IGHJ2P,Approved symbol,IGHJ2P,immunoglobulin heavy joining 2P (pseudogene),HGNC:5535,14q32.33
MAP7D1,-0.01408395,MAP7D1,Approved symbol,MAP7D1,MAP7 domain containing 1,HGNC:25514,1p34.3
MT2A,0.01407943,MT2A,Approved symbol,MT2A,metallothionein 2A,HGNC:7406,16q13
SND1,-0.01407926,SND1,Approved symbol,SND1,staphylococcal nuclease and tudor domain containing 1,HGNC:30646,7q32.1
COLEC10,-0.014075362,COLEC10,Approved symbol,COLEC10,collectin subfamily member 10,HGNC:2220,8q24.12
SRD5A3,-0.014071609,SRD5A3,Approved symbol,SRD5A3,steroid 5 alpha-reductase 3,HGNC:25812,4q12
DNAJB11,-0.014070191,DNAJB11,Approved symbol,DNAJB11,DnaJ heat shock protein family (Hsp40) member B11,HGNC:14889,3q27.3
IGHJ3P,-0.014066195,IGHJ3P,Approved symbol,IGHJ3P,immunoglobulin heavy joining 3P (pseudogene),HGNC:5537,14q32.33
MEIOB,0.014065235,MEIOB,Approved symbol,MEIOB,meiosis specific with OB-fold,HGNC:28569,16p13.3
AQP7,0.014062409,AQP7,Approved symbol,AQP7,aquaporin 7,HGNC:640,9p13.3
CLC,-0.014062305,CLC,Approved symbol,CLC,Charcot-Leyden crystal galectin,HGNC:2014,19q13.2
DDC,0.014060872,DDC,Approved symbol,DDC,dopa decarboxylase,HGNC:2719,7p12.2-p12.1
CETN3,0.014049085,CETN3,Approved symbol,CETN3,centrin 3,HGNC:1868,5q14.3
KCNA2,-0.014047926,KCNA2,Approved symbol,KCNA2,potassium voltage-gated channel subfamily A member 2,HGNC:6220,1p13.3
LINS,-0.014045913,LINS,Previous symbol,LINS1,lines homolog 1,HGNC:30922,15q26.3
KLRG2,0.014044517,KLRG2,Approved symbol,KLRG2,killer cell lectin like receptor G2,HGNC:24778,7q34
ECEL1,-0.014042186,ECEL1,Approved symbol,ECEL1,endothelin converting enzyme like 1,HGNC:3147,2q37.1
SYVN1,-0.014040721,SYVN1,Approved symbol,SYVN1,synoviolin 1,HGNC:20738,11q13.1
C4BPA,-0.014038662,C4BPA,Approved symbol,C4BPA,complement component 4 binding protein alpha,HGNC:1325,1q32.2
DOCK4,-0.014031661,DOCK4,Approved symbol,DOCK4,dedicator of cytokinesis 4,HGNC:19192,7q31.1
SBNO2,-0.014025131,SBNO2,Approved symbol,SBNO2,strawberry notch homolog 2,HGNC:29158,19p13.3
RBM19,-0.014024043,RBM19,Approved symbol,RBM19,RNA binding motif protein 19,HGNC:29098,12q24.13-q24.21
GBP1P1,-0.014023992,GBP1P1,Approved symbol,GBP1P1,guanylate binding protein 1 pseudogene 1,HGNC:39561,1p22.2
RP11-44K6.2,-0.014023757,RP11-44K6.2,Unmatched,RP11-44K6.2,,,
AC092580.4,-0.014023543,AC092580.4,Unmatched,AC092580.4,,,
LILRB3,-0.014019046,LILRB3,Approved symbol,LILRB3,leukocyte immunoglobulin like receptor B3,HGNC:6607,19q13.42
GPR119,0.014006394,GPR119,Approved symbol,GPR119,G protein-coupled receptor 119,HGNC:19060,Xq26.1
TCHP,-0.014004157,TCHP,Approved symbol,TCHP,trichoplein keratin filament binding,HGNC:28135,12q24.11
CKAP2,-0.01400078,CKAP2,Approved symbol,CKAP2,cytoskeleton associated protein 2,HGNC:1990,13q14.3
RNF144B,-0.013995185,RNF144B,Approved symbol,RNF144B,ring finger protein 144B,HGNC:21578,6p22.3
RPS3A,0.013994997,RPS3A,Approved symbol,RPS3A,ribosomal protein S3A,HGNC:10421,4q31.3
CYP2C9,-0.013992907,CYP2C9,Approved symbol,CYP2C9,cytochrome P450 family 2 subfamily C member 9,HGNC:2623,10q23.33
BHLHE40,-0.013990682,BHLHE40,Approved symbol,BHLHE40,basic helix-loop-helix family member e40,HGNC:1046,3p26.1
IRAK4,-0.013989134,IRAK4,Approved symbol,IRAK4,interleukin 1 receptor associated kinase 4,HGNC:17967,12q12
AC079602.1,0.0139862,AC079602.1,Unmatched,AC079602.1,,,
SERPINB2,-0.013986012,SERPINB2,Approved symbol,SERPINB2,serpin family B member 2,HGNC:8584,18q21.33-q22.1
RP3-393E18.2,-0.013985431,RP3-393E18.2,Unmatched,RP3-393E18.2,,,
STC2,-0.013974006,STC2,Approved symbol,STC2,stanniocalcin 2,HGNC:11374,5q35.2
AC016735.2,-0.013973591,AC016735.2,Alias symbol,LINC02590,long intergenic non-protein coding RNA 2590,HGNC:53861,2p21
CCDC163P,-0.013972642,CCDC163P,Previous symbol,CCDC163,coiled-coil domain containing 163,HGNC:27003,1p34.1
IGSF6,-0.013971496,IGSF6,Approved symbol,IGSF6,immunoglobulin superfamily member 6,HGNC:5953,16p12.2
GLIPR2,0.013960664,GLIPR2,Approved symbol,GLIPR2,GLI pathogenesis related 2,HGNC:18007,9p13.3
ACACB,0.013959708,ACACB,Approved symbol,ACACB,acetyl-CoA carboxylase beta,HGNC:85,12q24.11
MUC16,-0.013957699,MUC16,Approved symbol,MUC16,"mucin 16, cell surface associated",HGNC:15582,19p13.2
SULT2B1,-0.013956504,SULT2B1,Approved symbol,SULT2B1,sulfotransferase family 2B member 1,HGNC:11459,19q13.33
SEZ6,0.013953889,SEZ6,Approved symbol,SEZ6,seizure related 6 homolog,HGNC:15955,17q11.2
MEI1,-0.013952047,MEI1,Approved symbol,MEI1,meiotic double-stranded break formation protein 1,HGNC:28613,22q13.2
CKAP2L,-0.01394937,CKAP2L,Approved symbol,CKAP2L,cytoskeleton associated protein 2 like,HGNC:26877,2q14.1
NOC3L,-0.013947255,NOC3L,Approved symbol,NOC3L,NOC3 like DNA replication regulator,HGNC:24034,10q23.33
NOTUM,-0.013946417,NOTUM,Approved symbol,NOTUM,"notum, palmitoleoyl-protein carboxylesterase",HGNC:27106,17q25.3
C20orf112,0.013944777,C20orf112,Previous symbol,NOL4L,nucleolar protein 4 like,HGNC:16106,20q11.21
AFAP1L2,-0.013941845,AFAP1L2,Approved symbol,AFAP1L2,actin filament associated protein 1 like 2,HGNC:25901,10q25.3
IGHV3-23,-0.01393601,IGHV3-23,Approved symbol,IGHV3-23,immunoglobulin heavy variable 3-23,HGNC:5588,14q32.33
TMEM101,0.013931498,TMEM101,Approved symbol,TMEM101,transmembrane protein 101,HGNC:28653,17q21.31
BACE2,-0.013928328,BACE2,Approved symbol,BACE2,beta-secretase 2,HGNC:934,21q22.2-q22.3
DHRSX,0.01392672,DHRSX,Approved symbol,DHRSX,dehydrogenase/reductase X-linked,HGNC:18399,Xp22.33 and Yp11.2
PPP4R4,-0.013924096,PPP4R4,Approved symbol,PPP4R4,protein phosphatase 4 regulatory subunit 4,HGNC:23788,14q32.2
IGHV1-45,-0.013923477,IGHV1-45,Approved symbol,IGHV1-45,immunoglobulin heavy variable 1-45,HGNC:5553,14q32.33
FGF2,-0.013923149,FGF2,Approved symbol,FGF2,fibroblast growth factor 2,HGNC:3676,4q28.1
AQP11,0.013922587,AQP11,Approved symbol,AQP11,aquaporin 11,HGNC:19940,11q14.1
RP4-794H19.1,0.013922322,RP4-794H19.1,Unmatched,RP4-794H19.1,,,
VWA5B2,0.013914809,VWA5B2,Approved symbol,VWA5B2,von Willebrand factor A domain containing 5B2,HGNC:25144,3q27.1
AURKA,-0.013913242,AURKA,Approved symbol,AURKA,aurora kinase A,HGNC:11393,20q13.2
IL37,0.013911797,IL37,Approved symbol,IL37,interleukin 37,HGNC:15563,2q14.1
AGPAT4,-0.013907554,AGPAT4,Approved symbol,AGPAT4,1-acylglycerol-3-phosphate O-acyltransferase 4,HGNC:20885,6q26
HEXIM1,0.013907456,HEXIM1,Approved symbol,HEXIM1,HEXIM P-TEFb complex subunit 1,HGNC:24953,17q21.31
KIF3A,-0.013898816,KIF3A,Approved symbol,KIF3A,kinesin family member 3A,HGNC:6319,5q31.1
STAT1,-0.013897291,STAT1,Approved symbol,STAT1,signal transducer and activator of transcription 1,HGNC:11362,2q32.2
NCK2,0.01389705,NCK2,Approved symbol,NCK2,NCK adaptor protein 2,HGNC:7665,2q12.2
SRM,-0.013897039,SRM,Approved symbol,SRM,spermidine synthase,HGNC:11296,1p36.22
CRISPLD1,-0.01389572,CRISPLD1,Approved symbol,CRISPLD1,cysteine rich secretory protein LCCL domain containing 1,HGNC:18206,8q21.13
DUSP7,-0.013894925,DUSP7,Approved symbol,DUSP7,dual specificity phosphatase 7,HGNC:3073,3p21.2
LATS2,-0.013894522,LATS2,Approved symbol,LATS2,large tumor suppressor kinase 2,HGNC:6515,13q12.11
MAGI2,0.013894083,MAGI2,Approved symbol,MAGI2,"membrane associated guanylate kinase, WW and PDZ domain containing 2",HGNC:18957,7q21.11
PDIA4,-0.013891954,PDIA4,Approved symbol,PDIA4,protein disulfide isomerase family A member 4,HGNC:30167,7q36.1
KNSTRN,-0.013887639,KNSTRN,Approved symbol,KNSTRN,kinetochore localized astrin (SPAG5) binding protein,HGNC:30767,15q15.1
CCNA2,-0.013887553,CCNA2,Approved symbol,CCNA2,cyclin A2,HGNC:1578,4q27
CITED2,0.01388107,CITED2,Approved symbol,CITED2,Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2,HGNC:1987,6q24.1
ANXA2P1,-0.013879644,ANXA2P1,Approved symbol,ANXA2P1,annexin A2 pseudogene 1,HGNC:538,4q31.3
TNNC1,0.013878909,TNNC1,Approved symbol,TNNC1,"troponin C1, slow skeletal and cardiac type",HGNC:11943,3p21.1
HNF1A,0.013873224,HNF1A,Approved symbol,HNF1A,HNF1 homeobox A,HGNC:11621,12q24.31
FOXP1,0.013869363,FOXP1,Approved symbol,FOXP1,forkhead box P1,HGNC:3823,3p13
IGHV3-41,-0.013867552,IGHV3-41,Approved symbol,IGHV3-41,immunoglobulin heavy variable 3-41 (pseudogene),HGNC:5602,14q32.33
PLVAP,-0.013865686,PLVAP,Approved symbol,PLVAP,plasmalemma vesicle associated protein,HGNC:13635,19p13.11
RP3-467K16.4,-0.013864774,RP3-467K16.4,Unmatched,RP3-467K16.4,,,
EXO1,-0.013860206,EXO1,Approved symbol,EXO1,exonuclease 1,HGNC:3511,1q43
HOMER1,-0.013858455,HOMER1,Approved symbol,HOMER1,homer scaffold protein 1,HGNC:17512,5q14.1
PLEKHF1,-0.013857972,PLEKHF1,Approved symbol,PLEKHF1,pleckstrin homology and FYVE domain containing 1,HGNC:20764,19q12
TRNAU1AP,-0.013854918,TRNAU1AP,Approved symbol,TRNAU1AP,tRNA selenocysteine 1 associated protein 1,HGNC:30813,1p35.3
SST,0.013850997,SST,Approved symbol,SST,somatostatin,HGNC:11329,3q27.3
GEN1,-0.013849081,GEN1,Approved symbol,GEN1,GEN1 Holliday junction 5' flap endonuclease,HGNC:26881,2p24.2
DMGDH,0.013847552,DMGDH,Approved symbol,DMGDH,dimethylglycine dehydrogenase,HGNC:24475,5q14.1
DPP6,0.013843652,DPP6,Approved symbol,DPP6,dipeptidyl peptidase like 6,HGNC:3010,7q36.2
SLC25A21-AS1,0.013843123,SLC25A21-AS1,Approved symbol,SLC25A21-AS1,SLC25A21 antisense RNA 1,HGNC:44298,14q13.3
OSCAR,-0.013839844,OSCAR,Approved symbol,OSCAR,osteoclast associated Ig-like receptor,HGNC:29960,19q13.42
CTC-558O2.2,0.013838125,CTC-558O2.2,Unmatched,CTC-558O2.2,,,
IGKV4-1,-0.013837797,IGKV4-1,Approved symbol,IGKV4-1,immunoglobulin kappa variable 4-1,HGNC:5834,2p11.2
FOXS1,-0.013837015,FOXS1,Approved symbol,FOXS1,forkhead box S1,HGNC:3735,20q11.21
SLCO4C1,0.013836095,SLCO4C1,Approved symbol,SLCO4C1,solute carrier organic anion transporter family member 4C1,HGNC:23612,5q21.1
DEFA5,-0.013834279,DEFA5,Approved symbol,DEFA5,defensin alpha 5,HGNC:2764,8p23.1
MTHFD2,-0.013828747,MTHFD2,Approved symbol,MTHFD2,"methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase",HGNC:7434,2p13.1
RP11-81N13.1,0.013827427,RP11-81N13.1,Unmatched,RP11-81N13.1,,,
DKK1,-0.013827402,DKK1,Approved symbol,DKK1,dickkopf WNT signaling pathway inhibitor 1,HGNC:2891,10q21.1
RP11-64C12.3,0.013825804,RP11-64C12.3,Unmatched,RP11-64C12.3,,,
MUC5AC,-0.013817043,MUC5AC,Approved symbol,MUC5AC,"mucin 5AC, oligomeric mucus/gel-forming",HGNC:7515,11p15.5
ZNF493,0.013812892,ZNF493,Approved symbol,ZNF493,zinc finger protein 493,HGNC:23708,19p12
RP11-211G23.2,-0.013812757,RP11-211G23.2,Unmatched,RP11-211G23.2,,,
FZD4,-0.013804851,FZD4,Approved symbol,FZD4,frizzled class receptor 4,HGNC:4042,11q14.2
MT1P3,0.013800987,MT1P3,Approved symbol,MT1P3,metallothionein 1 pseudogene 3,HGNC:16120,20q11.22
ELAC1,0.013794256,ELAC1,Approved symbol,ELAC1,elaC ribonuclease Z 1,HGNC:14197,18q21.2
PKD1L3,-0.013793001,PKD1L3,Approved symbol,PKD1L3,"polycystin 1 like 3, transient receptor potential channel interacting",HGNC:21716,16q22.2
RP11-541N10.3,0.013790167,RP11-541N10.3,Unmatched,RP11-541N10.3,,,
RPS18,0.01378836,RPS18,Approved symbol,RPS18,ribosomal protein S18,HGNC:10401,6p21.32
TFE3,-0.013788194,TFE3,Approved symbol,TFE3,transcription factor binding to IGHM enhancer 3,HGNC:11752,Xp11.23
SERPINB8,-0.013786024,SERPINB8,Approved symbol,SERPINB8,serpin family B member 8,HGNC:8952,18q22.1
TMEM237,-0.013783872,TMEM237,Approved symbol,TMEM237,transmembrane protein 237,HGNC:14432,2q33.1
LDHA,-0.013778813,LDHA,Approved symbol,LDHA,lactate dehydrogenase A,HGNC:6535,11p15.1
ZNF608,0.013778741,ZNF608,Approved symbol,ZNF608,zinc finger protein 608,HGNC:29238,5q23.2
RDH11,-0.013777856,RDH11,Approved symbol,RDH11,retinol dehydrogenase 11,HGNC:17964,14q24.1
CHEK1,-0.01377608,CHEK1,Approved symbol,CHEK1,checkpoint kinase 1,HGNC:1925,11q24.2
FAM124A,-0.013772742,FAM124A,Approved symbol,FAM124A,family with sequence similarity 124 member A,HGNC:26413,13q14.3
RP11-800A3.4,0.013771102,RP11-800A3.4,Unmatched,RP11-800A3.4,,,
NUP37,-0.013768034,NUP37,Approved symbol,NUP37,nucleoporin 37,HGNC:29929,12q23.2
KTN1-AS1,0.013767299,KTN1-AS1,Approved symbol,KTN1-AS1,KTN1 antisense RNA 1,HGNC:19842,14q22.3
USP15,-0.013765209,USP15,Approved symbol,USP15,ubiquitin specific peptidase 15,HGNC:12613,12q14.1
VRK2,-0.013764676,VRK2,Approved symbol,VRK2,VRK serine/threonine kinase 2,HGNC:12719,2p16.1
STRADB,0.01376202,STRADB,Approved symbol,STRADB,STE20 related adaptor beta,HGNC:13205,2q33.1
RP11-798K3.2,0.013756252,RP11-798K3.2,Unmatched,RP11-798K3.2,,,
ASB13,0.013753843,ASB13,Approved symbol,ASB13,ankyrin repeat and SOCS box containing 13,HGNC:19765,10p15.1
FILIP1,-0.013750226,FILIP1,Approved symbol,FILIP1,filamin A interacting protein 1,HGNC:21015,6q14.1
RP11-738O11.13,0.013748303,RP11-738O11.13,Unmatched,RP11-738O11.13,,,
C6,0.013742598,C6,Approved symbol,C6,complement C6,HGNC:1339,5p13.1
GTF2E2,-0.013742324,GTF2E2,Approved symbol,GTF2E2,general transcription factor IIE subunit 2,HGNC:4651,8p12
RP11-536K7.3,-0.013741504,RP11-536K7.3,Unmatched,RP11-536K7.3,,,
ZFAND2B,0.013739923,ZFAND2B,Approved symbol,ZFAND2B,zinc finger AN1-type containing 2B,HGNC:25206,2q35
SLC2A5,-0.01373478,SLC2A5,Approved symbol,SLC2A5,solute carrier family 2 member 5,HGNC:11010,1p36.23
ZNF124,0.013734008,ZNF124,Approved symbol,ZNF124,zinc finger protein 124,HGNC:12907,1q44
NID1,-0.013731281,NID1,Approved symbol,NID1,nidogen 1,HGNC:7821,1q42.3
IGHV3OR16-7,-0.013724646,IGHV3OR16-7,Approved symbol,IGHV3OR16-7,immunoglobulin heavy variable 3/OR16-7 (pseudogene),HGNC:5642,16p11.2
KCNE1,-0.013722618,KCNE1,Approved symbol,KCNE1,potassium voltage-gated channel subfamily E regulatory subunit 1,HGNC:6240,21q22.12
ZNF821,0.013711433,ZNF821,Approved symbol,ZNF821,zinc finger protein 821,HGNC:28043,16q22.2
CT62,0.013704819,CT62,Approved symbol,CT62,cancer/testis associated 62,HGNC:27286,15q23
C9orf40,0.013704474,C9orf40,Approved symbol,C9orf40,chromosome 9 open reading frame 40,HGNC:23433,9q21.13
SLC46A2,-0.013703412,SLC46A2,Approved symbol,SLC46A2,solute carrier family 46 member 2,HGNC:16055,9q32
AC084809.2,0.013703087,AC084809.2,Unmatched,AC084809.2,,,
TSTD3,0.013699376,TSTD3,Approved symbol,TSTD3,thiosulfate sulfurtransferase like domain containing 3,HGNC:40910,6q16.2
SIDT2,0.013696732,SIDT2,Approved symbol,SIDT2,SID1 transmembrane family member 2,HGNC:24272,11q23.3
ZCCHC14,0.013696118,ZCCHC14,Approved symbol,ZCCHC14,zinc finger CCHC-type containing 14,HGNC:24134,16q24.2
MAP1LC3A,0.013690294,MAP1LC3A,Approved symbol,MAP1LC3A,microtubule associated protein 1 light chain 3 alpha,HGNC:6838,20q11.22
PMM1,0.013686821,PMM1,Approved symbol,PMM1,phosphomannomutase 1,HGNC:9114,22q13.2
SIGLEC9,-0.013685915,SIGLEC9,Approved symbol,SIGLEC9,sialic acid binding Ig like lectin 9,HGNC:10878,19q13.3-q13.4
LINC00937,-0.013683983,LINC00937,Approved symbol,LINC00937,long intergenic non-protein coding RNA 937,HGNC:48629,12p13.31
IGHV3-21,-0.01367448,IGHV3-21,Approved symbol,IGHV3-21,immunoglobulin heavy variable 3-21,HGNC:5586,14q32.33
CDCA8,-0.013674297,CDCA8,Approved symbol,CDCA8,cell division cycle associated 8,HGNC:14629,1p34.3
CACNG4,0.013674047,CACNG4,Approved symbol,CACNG4,calcium voltage-gated channel auxiliary subunit gamma 4,HGNC:1408,17q24.2
RPS10P7,0.013672308,RPS10P7,Approved symbol,RPS10P7,ribosomal protein S10 pseudogene 7,HGNC:36423,1q32.1
AC129778.7,-0.013672264,AC129778.7,Unmatched,AC129778.7,,,
NPR1,-0.013669184,NPR1,Approved symbol,NPR1,natriuretic peptide receptor 1,HGNC:7943,1q21.3
SNAI3-AS1,-0.01366334,SNAI3-AS1,Approved symbol,SNAI3-AS1,SNAI3 antisense RNA 1,HGNC:28327,16q24.2
TWIST1,-0.013662571,TWIST1,Approved symbol,TWIST1,twist family bHLH transcription factor 1,HGNC:12428,7p21.1
RAB17,0.013662436,RAB17,Approved symbol,RAB17,"RAB17, member RAS oncogene family",HGNC:16523,2q37.3
CXCR2P1,-0.013660027,CXCR2P1,Approved symbol,CXCR2P1,C-X-C motif chemokine receptor 2 pseudogene 1,HGNC:6028,2q35
DIAPH3,-0.013659457,DIAPH3,Approved symbol,DIAPH3,diaphanous related formin 3,HGNC:15480,13q21.2
AC137932.6,-0.013658897,AC137932.6,Unmatched,AC137932.6,,,
CORO1C,-0.013654235,CORO1C,Approved symbol,CORO1C,coronin 1C,HGNC:2254,12q24.11
RTP4,-0.013654202,RTP4,Approved symbol,RTP4,receptor transporter protein 4,HGNC:23992,3q27.3
CHCHD10,0.013653755,CHCHD10,Approved symbol,CHCHD10,coiled-coil-helix-coiled-coil-helix domain containing 10,HGNC:15559,22q11.23
ZNF395,0.01365335,ZNF395,Approved symbol,ZNF395,zinc finger protein 395,HGNC:18737,8p21.1
PTPN12,-0.013648872,PTPN12,Approved symbol,PTPN12,protein tyrosine phosphatase non-receptor type 12,HGNC:9645,7q11.23
GMDS-AS1,0.013646604,GMDS-AS1,Previous symbol,GMDS-DT,GMDS divergent transcript,HGNC:48993,6p25.3-p25.2
NOS3,-0.013646221,NOS3,Approved symbol,NOS3,nitric oxide synthase 3,HGNC:7876,7q36.1
RP11-153M7.3,-0.013645995,RP11-153M7.3,Unmatched,RP11-153M7.3,,,
APOL4,-0.013643333,APOL4,Approved symbol,APOL4,apolipoprotein L4,HGNC:14867,22q12.3
SGMS1,-0.013641536,SGMS1,Approved symbol,SGMS1,sphingomyelin synthase 1,HGNC:29799,10q11.23
SORL1,0.013639616,SORL1,Approved symbol,SORL1,sortilin related receptor 1,HGNC:11185,11q24.1
RP11-436F9.1,0.013634998,RP11-436F9.1,Unmatched,RP11-436F9.1,,,
CTD-3195I5.1,0.013630097,CTD-3195I5.1,Unmatched,CTD-3195I5.1,,,
WDR92,0.013622082,WDR92,Approved symbol,WDR92,WD repeat domain 92,HGNC:25176,2p14
RP11-415C15.3,0.013621299,RP11-415C15.3,Unmatched,RP11-415C15.3,,,
PRDX4,-0.013616834,PRDX4,Approved symbol,PRDX4,peroxiredoxin 4,HGNC:17169,Xp22.11
MPST,0.013611837,MPST,Approved symbol,MPST,mercaptopyruvate sulfurtransferase,HGNC:7223,22q12.3
MELK,-0.013611687,MELK,Approved symbol,MELK,maternal embryonic leucine zipper kinase,HGNC:16870,9p13.2
SPTBN5,-0.013611538,SPTBN5,Approved symbol,SPTBN5,"spectrin beta, non-erythrocytic 5",HGNC:15680,15q21
SPC24,-0.013609931,SPC24,Approved symbol,SPC24,SPC24 component of NDC80 kinetochore complex,HGNC:26913,19p13.2
CALR,-0.013606716,CALR,Approved symbol,CALR,calreticulin,HGNC:1455,19p13.13
TAPT1,0.013604882,TAPT1,Approved symbol,TAPT1,transmembrane anterior posterior transformation 1,HGNC:26887,4p15.32
CTA-217C2.1,-0.013602692,CTA-217C2.1,Unmatched,CTA-217C2.1,,,
ART3,-0.013601074,ART3,Approved symbol,ART3,ADP-ribosyltransferase 3 (inactive),HGNC:725,4q21.1
RNU6-1161P,-0.013600584,RNU6-1161P,Approved symbol,RNU6-1161P,"RNA, U6 small nuclear 1161, pseudogene",HGNC:48124,22q13.31
RP11-44F14.1,-0.013589169,RP11-44F14.1,Unmatched,RP11-44F14.1,,,
PHF20,-0.01358708,PHF20,Approved symbol,PHF20,PHD finger protein 20,HGNC:16098,20q11.22-q11.23
CTD-2132N18.4,0.013584552,CTD-2132N18.4,Unmatched,CTD-2132N18.4,,,
KIAA0355,0.013579406,KIAA0355,Previous symbol,GARRE1,granule associated Rac and RHOG effector 1,HGNC:29016,19q13.11
RSPO3,-0.013574874,RSPO3,Approved symbol,RSPO3,R-spondin 3,HGNC:20866,6q22.33
DECR2,0.013572428,DECR2,Approved symbol,DECR2,"2,4-dienoyl-CoA reductase 2",HGNC:2754,16p13.3
IGKV1-5,-0.013571578,IGKV1-5,Approved symbol,IGKV1-5,immunoglobulin kappa variable 1-5,HGNC:5741,2p11.2
IQCD,-0.013570092,IQCD,Approved symbol,IQCD,IQ motif containing D,HGNC:25168,12q24.13
ALDH4A1,-0.013565789,ALDH4A1,Approved symbol,ALDH4A1,aldehyde dehydrogenase 4 family member A1,HGNC:406,1p36.13
NARF,-0.013562289,NARF,Approved symbol,NARF,nuclear prelamin A recognition factor,HGNC:29916,17q25.3
MYEOV,-0.013560649,MYEOV,Approved symbol,MYEOV,myeloma overexpressed,HGNC:7563,11q13.3
RASGEF1B,-0.013560306,RASGEF1B,Approved symbol,RASGEF1B,RasGEF domain family member 1B,HGNC:24881,4q21.21
HLA-DQB1,-0.013556735,HLA-DQB1,Approved symbol,HLA-DQB1,"major histocompatibility complex, class II, DQ beta 1",HGNC:4944,6p21.32
UBE2T,-0.013555622,UBE2T,Approved symbol,UBE2T,ubiquitin conjugating enzyme E2 T,HGNC:25009,1q32.1
AC009061.1,0.013555076,AC009061.1,Unmatched,AC009061.1,,,
TBCD,-0.013546618,TBCD,Approved symbol,TBCD,tubulin folding cofactor D,HGNC:11581,17q25.3
EML1,-0.013542093,EML1,Approved symbol,EML1,EMAP like 1,HGNC:3330,14q32.2
EFNA5,0.013535147,EFNA5,Approved symbol,EFNA5,ephrin A5,HGNC:3225,5q21.3
RBFOX1,0.013524218,RBFOX1,Approved symbol,RBFOX1,RNA binding fox-1 homolog 1,HGNC:18222,16p13.3
SLC5A4,-0.013523685,SLC5A4,Approved symbol,SLC5A4,solute carrier family 5 member 4,HGNC:11039,22q12.3
RP11-467L13.5,-0.013517778,RP11-467L13.5,Unmatched,RP11-467L13.5,,,
CACNA1E,-0.01351012,CACNA1E,Approved symbol,CACNA1E,calcium voltage-gated channel subunit alpha1 E,HGNC:1392,1q25.3
RP11-424I19.2,-0.013509505,RP11-424I19.2,Unmatched,RP11-424I19.2,,,
FZD1,0.013508503,FZD1,Approved symbol,FZD1,frizzled class receptor 1,HGNC:4038,7q21.13
UBE2C,-0.01350849,UBE2C,Approved symbol,UBE2C,ubiquitin conjugating enzyme E2 C,HGNC:15937,20q13.12
LINC00842,0.013504698,LINC00842,Approved symbol,LINC00842,long intergenic non-protein coding RNA 842,HGNC:44989,10q11.22
TAP1,-0.013490523,TAP1,Approved symbol,TAP1,"transporter 1, ATP binding cassette subfamily B member",HGNC:43,6p21.32
WDSUB1,0.013486894,WDSUB1,Approved symbol,WDSUB1,"WD repeat, sterile alpha motif and U-box domain containing 1",HGNC:26697,2q24.2
RP11-170L3.7,-0.013484807,RP11-170L3.7,Unmatched,RP11-170L3.7,,,
SYT2,0.013482004,SYT2,Approved symbol,SYT2,synaptotagmin 2,HGNC:11510,1q32.1
TRIM16,-0.013472093,TRIM16,Approved symbol,TRIM16,tripartite motif containing 16,HGNC:17241,17p12
ZNF30,0.013470162,ZNF30,Approved symbol,ZNF30,zinc finger protein 30,HGNC:13090,19q13.13
PLCB1,-0.013469967,PLCB1,Approved symbol,PLCB1,phospholipase C beta 1,HGNC:15917,20p12.3
PSMB2,-0.013467612,PSMB2,Approved symbol,PSMB2,proteasome 20S subunit beta 2,HGNC:9539,1p34.3
PYURF,0.01346681,PYURF,Approved symbol,PYURF,PIGY upstream reading frame,HGNC:44317,4q22.1
SDF2L1,-0.013466298,SDF2L1,Approved symbol,SDF2L1,stromal cell derived factor 2 like 1,HGNC:10676,22q11.21
GRIN2D,-0.013466186,GRIN2D,Approved symbol,GRIN2D,glutamate ionotropic receptor NMDA type subunit 2D,HGNC:4588,19q13.33
SMIM8,0.013464931,SMIM8,Approved symbol,SMIM8,small integral membrane protein 8,HGNC:21401,6q15
RP1-39G22.7,0.013462262,RP1-39G22.7,Unmatched,RP1-39G22.7,,,
RRNAD1,0.013460202,RRNAD1,Approved symbol,RRNAD1,ribosomal RNA adenine dimethylase domain containing 1,HGNC:24273,1q23.1
COL6A1,-0.013458123,COL6A1,Approved symbol,COL6A1,collagen type VI alpha 1 chain,HGNC:2211,21q22.3
RP1-50J22.4,-0.013458076,RP1-50J22.4,Unmatched,RP1-50J22.4,,,
FAM19A2,0.013455203,FAM19A2,Previous symbol,TAFA2,TAFA chemokine like family member 2,HGNC:21589,12q14.1
KIF11,-0.013455009,KIF11,Approved symbol,KIF11,kinesin family member 11,HGNC:6388,10q23.33
PILRA,-0.013447327,PILRA,Approved symbol,PILRA,paired immunoglobin like type 2 receptor alpha,HGNC:20396,7q22.1
RP11-419I17.1,0.013446006,RP11-419I17.1,Unmatched,RP11-419I17.1,,,
IGHV3OR16-15,-0.013443737,IGHV3OR16-15,Approved symbol,IGHV3OR16-15,immunoglobulin heavy variable 3/OR16-15 (pseudogene),HGNC:5639,16p11.2
SUMO3,0.0134405,SUMO3,Approved symbol,SUMO3,small ubiquitin like modifier 3,HGNC:11124,21q22.3
LINC00114,-0.013439636,LINC00114,Approved symbol,LINC00114,long intergenic non-protein coding RNA 114,HGNC:1265,21q22.2
TP73,-0.013439323,TP73,Approved symbol,TP73,tumor protein p73,HGNC:12003,1p36.32
LINC00707,-0.01343919,LINC00707,Approved symbol,LINC00707,long intergenic non-protein coding RNA 707,HGNC:44691,10p14
CHST13,0.013436375,CHST13,Approved symbol,CHST13,carbohydrate sulfotransferase 13,HGNC:21755,3q21.3
IGHV3-73,-0.013435441,IGHV3-73,Approved symbol,IGHV3-73,immunoglobulin heavy variable 3-73,HGNC:5623,14q32.33
PRSS3P1,-0.013432724,PRSS3P1,Approved symbol,PRSS3P1,PRSS3 pseudogene 1,HGNC:43787,7q34
COL1A2,-0.013432459,COL1A2,Approved symbol,COL1A2,collagen type I alpha 2 chain,HGNC:2198,7q21.3
LGMN,0.013431169,LGMN,Approved symbol,LGMN,legumain,HGNC:9472,14q32.12
RP11-531H8.2,-0.0134291,RP11-531H8.2,Unmatched,RP11-531H8.2,,,
ZMAT4,0.013423812,ZMAT4,Approved symbol,ZMAT4,zinc finger matrin-type 4,HGNC:25844,8p11.21
UBE2S,-0.013423444,UBE2S,Approved symbol,UBE2S,ubiquitin conjugating enzyme E2 S,HGNC:17895,19q13.42
TCIRG1,-0.013423285,TCIRG1,Approved symbol,TCIRG1,"T cell immune regulator 1, ATPase H+ transporting V0 subunit a3",HGNC:11647,11q13.2
EGFL7,-0.01342262,EGFL7,Approved symbol,EGFL7,EGF like domain multiple 7,HGNC:20594,9q34.3
VPS51,0.013419577,VPS51,Approved symbol,VPS51,VPS51 subunit of GARP complex,HGNC:1172,11q13.1
CTC-303L1.1,0.013418492,CTC-303L1.1,Unmatched,CTC-303L1.1,,,
VAC14,-0.013417089,VAC14,Approved symbol,VAC14,VAC14 component of PIKFYVE complex,HGNC:25507,16q22.1-q22.2
SMC4,-0.013412125,SMC4,Approved symbol,SMC4,structural maintenance of chromosomes 4,HGNC:14013,3q25.33
CTC-510F12.4,-0.013402532,CTC-510F12.4,Unmatched,CTC-510F12.4,,,
ARHGAP11A,-0.013400703,ARHGAP11A,Approved symbol,ARHGAP11A,Rho GTPase activating protein 11A,HGNC:15783,15q13.3
MEIS3,-0.013400281,MEIS3,Approved symbol,MEIS3,Meis homeobox 3,HGNC:29537,19q13.32
ABCB1,0.013393831,ABCB1,Approved symbol,ABCB1,ATP binding cassette subfamily B member 1,HGNC:40,7q21.12
IGHM,-0.013392589,IGHM,Approved symbol,IGHM,immunoglobulin heavy constant mu,HGNC:5541,14q32.33
NLRP6,-0.013392157,NLRP6,Approved symbol,NLRP6,NLR family pyrin domain containing 6,HGNC:22944,11p15.5
MYCN,-0.013391569,MYCN,Approved symbol,MYCN,"MYCN proto-oncogene, bHLH transcription factor",HGNC:7559,2p24.3
MMP14,-0.013386176,MMP14,Approved symbol,MMP14,matrix metallopeptidase 14,HGNC:7160,14q11.2
IGKV3-11,-0.013386044,IGKV3-11,Approved symbol,IGKV3-11,immunoglobulin kappa variable 3-11,HGNC:5815,2p11.2
TFAP2E,-0.013385827,TFAP2E,Approved symbol,TFAP2E,transcription factor AP-2 epsilon,HGNC:30774,1p34.3
MASP1,-0.013385147,MASP1,Approved symbol,MASP1,mannan binding lectin serine peptidase 1,HGNC:6901,3q27.3
ARHGAP28,-0.013384281,ARHGAP28,Approved symbol,ARHGAP28,Rho GTPase activating protein 28,HGNC:25509,18p11.31
POC1A,-0.013383512,POC1A,Approved symbol,POC1A,POC1 centriolar protein A,HGNC:24488,3p21.2
CLCF1,-0.013380115,CLCF1,Approved symbol,CLCF1,cardiotrophin like cytokine factor 1,HGNC:17412,11q13.2
PSME4,-0.013378546,PSME4,Approved symbol,PSME4,proteasome activator subunit 4,HGNC:20635,2p16.2
TANGO6,-0.013373235,TANGO6,Approved symbol,TANGO6,transport and golgi organization 6 homolog,HGNC:25749,16q22.1
PDCD4-AS1,0.013371707,PDCD4-AS1,Approved symbol,PDCD4-AS1,PDCD4 antisense RNA 1,HGNC:27425,10q25.2
APOBEC3A,-0.013369079,APOBEC3A,Approved symbol,APOBEC3A,apolipoprotein B mRNA editing enzyme catalytic subunit 3A,HGNC:17343,22q13.1
CTC-205M6.5,-0.013368758,CTC-205M6.5,Unmatched,CTC-205M6.5,,,
CNTFR,0.013366812,CNTFR,Approved symbol,CNTFR,ciliary neurotrophic factor receptor,HGNC:2170,9p13.3
SOD2,-0.013363287,SOD2,Approved symbol,SOD2,superoxide dismutase 2,HGNC:11180,6q25.3
SDC3,-0.013361096,SDC3,Approved symbol,SDC3,syndecan 3,HGNC:10660,1p35.2
NRG1,-0.013360237,NRG1,Approved symbol,NRG1,neuregulin 1,HGNC:7997,8p12
ITGA11,-0.013360204,ITGA11,Approved symbol,ITGA11,integrin subunit alpha 11,HGNC:6136,15q23
RPL5,0.013356074,RPL5,Approved symbol,RPL5,ribosomal protein L5,HGNC:10360,1p22.1
RP11-449P15.2,0.01335215,RP11-449P15.2,Unmatched,RP11-449P15.2,,,
SOGA2,-0.013350555,SOGA2,Previous symbol,MTCL1,microtubule crosslinking factor 1,HGNC:29121,18p11.22
CTSL,-0.01334964,CTSL,Approved symbol,CTSL,cathepsin L,HGNC:2537,9q21.33
TSPAN18,-0.013337614,TSPAN18,Approved symbol,TSPAN18,tetraspanin 18,HGNC:20660,11p11.2
G6PD,-0.013335643,G6PD,Approved symbol,G6PD,glucose-6-phosphate dehydrogenase,HGNC:4057,Xq28
C9orf24,0.013329222,C9orf24,Approved symbol,C9orf24,chromosome 9 open reading frame 24,HGNC:19919,9p13.3
NOS2P1,-0.013329184,NOS2P1,Approved symbol,NOS2P1,nitric oxide synthase 2 pseudogene 1,HGNC:7875,17q11.2
BCL3,-0.013324883,BCL3,Approved symbol,BCL3,BCL3 transcription coactivator,HGNC:998,19q13.32
EXTL3,-0.01332441,EXTL3,Approved symbol,EXTL3,exostosin like glycosyltransferase 3,HGNC:3518,8p21.1
IGHV3-30,-0.013323149,IGHV3-30,Approved symbol,IGHV3-30,immunoglobulin heavy variable 3-30,HGNC:5591,14q32.33
TINF2,-0.013310475,TINF2,Approved symbol,TINF2,TERF1 interacting nuclear factor 2,HGNC:11824,14q12
DIMT1,-0.013309313,DIMT1,Approved symbol,DIMT1,DIMT1 rRNA methyltransferase and ribosome maturation factor,HGNC:30217,5q12.1
SLC25A30-AS1,0.013309134,SLC25A30-AS1,Approved symbol,SLC25A30-AS1,SLC25A30 antisense RNA 1,HGNC:42795,13q14.13
RP11-218I7.2,0.013307867,RP11-218I7.2,Unmatched,RP11-218I7.2,,,
ST18,0.013306561,ST18,Approved symbol,ST18,ST18 C2H2C-type zinc finger transcription factor,HGNC:18695,8q11.23
RNF167,0.013305295,RNF167,Approved symbol,RNF167,ring finger protein 167,HGNC:24544,17p13.2
ASCC3,-0.013305075,ASCC3,Approved symbol,ASCC3,activating signal cointegrator 1 complex subunit 3,HGNC:18697,6q16.3
SLC35G2,-0.013303958,SLC35G2,Approved symbol,SLC35G2,solute carrier family 35 member G2,HGNC:28480,3q22.3
VASN,-0.013300978,VASN,Approved symbol,VASN,vasorin,HGNC:18517,16p13.3
TGFB3,-0.013299833,TGFB3,Approved symbol,TGFB3,transforming growth factor beta 3,HGNC:11769,14q24.3
TOR3A,-0.013295234,TOR3A,Approved symbol,TOR3A,torsin family 3 member A,HGNC:11997,1q25.2
CACNA1A,0.01329133,CACNA1A,Approved symbol,CACNA1A,calcium voltage-gated channel subunit alpha1 A,HGNC:1388,19p13.13
SGK223,0.013291175,LGALS2,Approved symbol,LGALS2,galectin 2,HGNC:6562,22q13.1
LGALS2,0.013291121,LGALS2,Previous symbol,LGALS3,galectin 3,HGNC:6563,14q22.3
RP11-253M7.1,-0.013289237,RP11-253M7.1,Unmatched,RP11-253M7.1,,,
CENPV,0.01328898,CENPV,Approved symbol,CENPV,centromere protein V,HGNC:29920,17p11.2
ASS1P1,-0.013287424,ASS1P1,Approved symbol,ASS1P1,argininosuccinate synthetase 1 pseudogene 1,HGNC:759,6p22.3
RP11-24F11.2,-0.013285849,RP11-24F11.2,Unmatched,RP11-24F11.2,,,
DEFA6,-0.013283131,DEFA6,Approved symbol,DEFA6,defensin alpha 6,HGNC:2765,8p23.1
CIT,-0.013275287,CIT,Approved symbol,CIT,citron rho-interacting serine/threonine kinase,HGNC:1985,12q24.23
HNRNPUL2,0.013268799,HNRNPUL2,Approved symbol,HNRNPUL2,heterogeneous nuclear ribonucleoprotein U like 2,HGNC:25451,11q12.3
MIR146A,-0.013268579,MIR146A,Approved symbol,MIR146A,microRNA 146a,HGNC:31533,5q33.3
TK1,-0.013268354,TK1,Approved symbol,TK1,thymidine kinase 1,HGNC:11830,17q25.3
HIF1AN,0.013266654,HIF1AN,Approved symbol,HIF1AN,hypoxia inducible factor 1 subunit alpha inhibitor,HGNC:17113,10q24.31
AF186192.5,0.013265819,AF186192.5,Unmatched,AF186192.5,,,
IGKV1D-16,-0.013262914,IGKV1D-16,Approved symbol,IGKV1D-16,immunoglobulin kappa variable 1D-16,HGNC:5748,2p11.2
ASUN,-0.013260582,ASUN,Previous symbol,INTS13,integrator complex subunit 13,HGNC:20174,12p11.23
BCL2L10,0.013259854,BCL2L10,Approved symbol,BCL2L10,BCL2 like 10,HGNC:993,15q21.2
CASP1,-0.013255901,CASP1,Approved symbol,CASP1,caspase 1,HGNC:1499,11q22.3
IGHV1-18,-0.013247608,IGHV1-18,Approved symbol,IGHV1-18,immunoglobulin heavy variable 1-18,HGNC:5549,14q32.33
FEZ1,-0.013246727,FEZ1,Approved symbol,FEZ1,fasciculation and elongation protein zeta 1,HGNC:3659,11q24.2
CHRNA3,0.013245254,CHRNA3,Approved symbol,CHRNA3,cholinergic receptor nicotinic alpha 3 subunit,HGNC:1957,15q25.1
H2AFZ,-0.013238096,H2AFZ,Previous symbol,H2AZ1,H2A.Z variant histone 1,HGNC:4741,4q23
AP000695.6,-0.013236963,AP000695.6,Unmatched,AP000695.6,,,
TMED4,0.013236235,TMED4,Approved symbol,TMED4,transmembrane p24 trafficking protein 4,HGNC:22301,7p13
SLC6A19,0.013235823,SLC6A19,Approved symbol,SLC6A19,solute carrier family 6 member 19,HGNC:27960,5p15.33
B3GNT1,0.013233885,B3GNT1,Previous symbol,B4GAT1,"beta-1,4-glucuronyltransferase 1",HGNC:15685,11q13.2
RP11-473L15.2,-0.01323106,B3GNT1,Previous symbol,B3GNT2,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2",HGNC:15629,2p15
LAMC1,-0.013230254,LAMC1,Approved symbol,LAMC1,laminin subunit gamma 1,HGNC:6492,1q25.3
TRAM1,-0.013228088,TRAM1,Approved symbol,TRAM1,translocation associated membrane protein 1,HGNC:20568,8q13.3
ESCO2,-0.013226949,ESCO2,Approved symbol,ESCO2,establishment of sister chromatid cohesion N-acetyltransferase 2,HGNC:27230,8p21.1
ANXA2,-0.013221961,ANXA2,Approved symbol,ANXA2,annexin A2,HGNC:537,15q22.2
KIF22,0.013221598,KIF22,Approved symbol,KIF22,kinesin family member 22,HGNC:6391,16p11.2
MXRA5,-0.013220377,MXRA5,Approved symbol,MXRA5,matrix remodeling associated 5,HGNC:7539,Xp22.33
PPM1J,-0.013217047,PPM1J,Approved symbol,PPM1J,"protein phosphatase, Mg2+/Mn2+ dependent 1J",HGNC:20785,1p13.2
CLCA3P,-0.013215035,CLCA3P,Approved symbol,CLCA3P,"chloride channel accessory 3, pseudogene",HGNC:2017,1p22.3
PRR11,-0.013212875,PRR11,Approved symbol,PRR11,proline rich 11,HGNC:25619,17q22
DLGAP1-AS1,-0.013209746,DLGAP1-AS1,Approved symbol,DLGAP1-AS1,DLGAP1 antisense RNA 1,HGNC:31676,18p11.31
RP11-800A18.4,-0.01320789,RP11-800A18.4,Unmatched,RP11-800A18.4,,,
CA10,0.01320514,CA10,Approved symbol,CA10,carbonic anhydrase 10,HGNC:1369,17q21.33-q22
ACTC1,-0.013204781,ACTC1,Approved symbol,ACTC1,actin alpha cardiac muscle 1,HGNC:143,15q14
IGKV1-33,-0.013203934,IGKV1-33,Approved symbol,IGKV1-33,immunoglobulin kappa variable 1-33,HGNC:5737,2p11.2
MIR31HG,-0.01318612,MIR31HG,Approved symbol,MIR31HG,MIR31 host gene,HGNC:37187,9p21.3
TPK1,-0.013181948,TPK1,Approved symbol,TPK1,thiamin pyrophosphokinase 1,HGNC:17358,7q35
HMMR,-0.01318176,HMMR,Approved symbol,HMMR,hyaluronan mediated motility receptor,HGNC:5012,5q34
ACTN1,-0.013174723,ACTN1,Approved symbol,ACTN1,actinin alpha 1,HGNC:163,14q24.1
HIF1A-AS1,-0.013173543,HIF1A-AS1,Approved symbol,HIF1A-AS1,HIF1A antisense RNA 1,HGNC:43014,14q23.2
ADAMTS5,-0.013170423,ADAMTS5,Approved symbol,ADAMTS5,ADAM metallopeptidase with thrombospondin type 1 motif 5,HGNC:221,21q21.3
C2CD4B,-0.013169502,C2CD4B,Approved symbol,C2CD4B,C2 calcium dependent domain containing 4B,HGNC:33628,15q22.2
AQP3,-0.01316679,AQP3,Approved symbol,AQP3,aquaporin 3 (Gill blood group),HGNC:636,9p13.3
KCNMB2,0.013165358,KCNMB2,Approved symbol,KCNMB2,potassium calcium-activated channel subfamily M regulatory beta subunit 2,HGNC:6286,3q26.32
IPO9,-0.013159056,IPO9,Approved symbol,IPO9,importin 9,HGNC:19425,1q32.1
KRT23,-0.013151673,KRT23,Approved symbol,KRT23,keratin 23,HGNC:6438,17q21.2
AC007228.11,0.013142352,AC007228.11,Unmatched,AC007228.11,,,
WASF1,-0.013141983,WASF1,Approved symbol,WASF1,WASP family member 1,HGNC:12732,6q21
GPX7,-0.013133093,GPX7,Approved symbol,GPX7,glutathione peroxidase 7,HGNC:4559,1p32.3
RP11-334L9.1,-0.013131995,RP11-334L9.1,Unmatched,RP11-334L9.1,,,
SLC6A1,-0.013127294,SLC6A1,Approved symbol,SLC6A1,solute carrier family 6 member 1,HGNC:11042,3p25.3
HYAL2,-0.013125473,HYAL2,Approved symbol,HYAL2,hyaluronidase 2,HGNC:5321,3p21.31
DTD1,-0.013123476,DTD1,Approved symbol,DTD1,D-aminoacyl-tRNA deacylase 1,HGNC:16219,20p11.23
H19,-0.013118965,H19,Approved symbol,H19,H19 imprinted maternally expressed transcript,HGNC:4713,11p15.5
TMEM220,0.013114278,TMEM220,Approved symbol,TMEM220,transmembrane protein 220,HGNC:33757,17p13.1
LEMD1,-0.013101139,LEMD1,Approved symbol,LEMD1,LEM domain containing 1,HGNC:18725,1q32.1
RP11-676J12.6,-0.013098667,RP11-676J12.6,Unmatched,RP11-676J12.6,,,
POT1,-0.013098331,POT1,Approved symbol,POT1,protection of telomeres 1,HGNC:17284,7q31.33
MBIP,0.01309477,MBIP,Approved symbol,MBIP,MAP3K12 binding inhibitory protein 1,HGNC:20427,14q13.3
LRRTM2,-0.013087001,LRRTM2,Approved symbol,LRRTM2,leucine rich repeat transmembrane neuronal 2,HGNC:19409,5q31.2
LYAR,-0.013085023,LYAR,Approved symbol,LYAR,Ly1 antibody reactive,HGNC:26021,4p16.3
RP5-850O15.4,0.013082248,RP5-850O15.4,Unmatched,RP5-850O15.4,,,
RP13-1032I1.7,0.013081507,RP13-1032I1.7,Unmatched,RP13-1032I1.7,,,
TPTE2P5,0.013078183,TPTE2P5,Approved symbol,TPTE2P5,transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 pseudogene 5,HGNC:42356,13q14.11
RP11-624L4.1,0.01307425,RP11-624L4.1,Unmatched,RP11-624L4.1,,,
EDN2,0.013064485,EDN2,Approved symbol,EDN2,endothelin 2,HGNC:3177,1p34.2
CSMD3,0.013064084,CSMD3,Approved symbol,CSMD3,CUB and Sushi multiple domains 3,HGNC:19291,8q23.3
GRB7,0.013063207,GRB7,Approved symbol,GRB7,growth factor receptor bound protein 7,HGNC:4567,17q12
COL1A1,-0.013059313,COL1A1,Approved symbol,COL1A1,collagen type I alpha 1 chain,HGNC:2197,17q21.33
CTA-293F17.1,0.013058246,CTA-293F17.1,Unmatched,CTA-293F17.1,,,
RP11-867O8.5,0.013056616,RP11-867O8.5,Unmatched,RP11-867O8.5,,,
FAM155B,0.013053797,FAM155B,Approved symbol,FAM155B,family with sequence similarity 155 member B,HGNC:30701,Xq13.1
GAS5-AS1,0.013043928,GAS5-AS1,Approved symbol,GAS5-AS1,GAS5 antisense RNA 1,HGNC:44119,1q25.1
LCN2,-0.013043792,LCN2,Approved symbol,LCN2,lipocalin 2,HGNC:6526,9q34.11
RP11-88H9.2,-0.013042012,RP11-88H9.2,Unmatched,RP11-88H9.2,,,
C17orf107,-0.013041416,C17orf107,Approved symbol,C17orf107,chromosome 17 open reading frame 107,HGNC:37238,17p13.2
UBA6,-0.013040817,UBA6,Approved symbol,UBA6,ubiquitin like modifier activating enzyme 6,HGNC:25581,4q13.2
SKA2,-0.013037781,SKA2,Approved symbol,SKA2,spindle and kinetochore associated complex subunit 2,HGNC:28006,17q23.2
ERO1L,-0.013036926,ERO1L,Previous symbol,ERO1A,endoplasmic reticulum oxidoreductase 1 alpha,HGNC:13280,14q22.1
ZNF799,0.013033332,ZNF799,Approved symbol,ZNF799,zinc finger protein 799,HGNC:28071,19p13.2
CDHR5,0.013032812,CDHR5,Approved symbol,CDHR5,cadherin related family member 5,HGNC:7521,11p15.5
KIF12,0.013031709,KIF12,Approved symbol,KIF12,kinesin family member 12,HGNC:21495,9q32
CDH22,0.013029271,CDH22,Approved symbol,CDH22,cadherin 22,HGNC:13251,20q13.12
LLGL1,-0.013028611,LLGL1,Approved symbol,LLGL1,LLGL scribble cell polarity complex component 1,HGNC:6628,17p11.2
CTD-2006K23.1,-0.013020793,CTD-2006K23.1,Unmatched,CTD-2006K23.1,,,
GLYATL1,-0.013020659,GLYATL1,Approved symbol,GLYATL1,glycine-N-acyltransferase like 1,HGNC:30519,11q12.1
DPAGT1,-0.013018196,DPAGT1,Approved symbol,DPAGT1,dolichyl-phosphate N-acetylglucosaminephosphotransferase 1,HGNC:2995,11q23.3
RPL15,0.013012638,RPL15,Approved symbol,RPL15,ribosomal protein L15,HGNC:10306,3p24.2
RAB23,-0.013012348,RAB23,Approved symbol,RAB23,"RAB23, member RAS oncogene family",HGNC:14263,6p12.1-p11.2
ITSN2,-0.013006634,ITSN2,Approved symbol,ITSN2,intersectin 2,HGNC:6184,2p23.3
GYG1,-0.013005555,GYG1,Approved symbol,GYG1,glycogenin 1,HGNC:4699,3q24
CYP4F12,0.013003267,CYP4F12,Approved symbol,CYP4F12,cytochrome P450 family 4 subfamily F member 12,HGNC:18857,19p13.12
HYOU1,-0.012994238,HYOU1,Approved symbol,HYOU1,hypoxia up-regulated 1,HGNC:16931,11q23.3
KIF20B,-0.012981165,KIF20B,Approved symbol,KIF20B,kinesin family member 20B,HGNC:7212,10q23.31
TLR4,-0.012976142,TLR4,Approved symbol,TLR4,toll like receptor 4,HGNC:11850,9q33.1
ASS1P6,-0.012965436,ASS1P6,Approved symbol,ASS1P6,argininosuccinate synthetase 1 pseudogene 6,HGNC:769,Yq11.21
CLPB,-0.012963803,CLPB,Approved symbol,CLPB,caseinolytic mitochondrial matrix peptidase chaperone subunit B,HGNC:30664,11q13.4
RP11-680F8.1,0.012960683,RP11-680F8.1,Unmatched,RP11-680F8.1,,,
R3HDM1,-0.012960105,R3HDM1,Approved symbol,R3HDM1,R3H domain containing 1,HGNC:9757,2q21.3
GZMH,-0.012950243,GZMH,Approved symbol,GZMH,granzyme H,HGNC:4710,14q12
NCS1,-0.012950149,NCS1,Approved symbol,NCS1,neuronal calcium sensor 1,HGNC:3953,9q34.11
MLF1,0.012936602,MLF1,Approved symbol,MLF1,myeloid leukemia factor 1,HGNC:7125,3q25.32
SEMA5A,0.0129343,SEMA5A,Approved symbol,SEMA5A,semaphorin 5A,HGNC:10736,5p15.31
JAK1,-0.012930924,JAK1,Approved symbol,JAK1,Janus kinase 1,HGNC:6190,1p31.3
RP11-112J1.3,0.012930619,RP11-112J1.3,Unmatched,RP11-112J1.3,,,
MANF,-0.012929357,MANF,Approved symbol,MANF,mesencephalic astrocyte derived neurotrophic factor,HGNC:15461,3p21.2
RABL5,-0.012923545,RABL5,Previous symbol,IFT22,intraflagellar transport 22,HGNC:21895,7q22.1
ZP3,0.012918936,ZP3,Approved symbol,ZP3,zona pellucida glycoprotein 3,HGNC:13189,7q11.23
SNORD125,-0.012914525,SNORD125,Approved symbol,SNORD125,"small nucleolar RNA, C/D box 125",HGNC:33564,22q12.2
ECT2,-0.012908776,ECT2,Approved symbol,ECT2,epithelial cell transforming 2,HGNC:3155,3q26.31
KIF4A,-0.012907086,KIF4A,Approved symbol,KIF4A,kinesin family member 4A,HGNC:13339,Xq13.1
BRI3,0.012904999,BRI3,Approved symbol,BRI3,brain protein I3,HGNC:1109,7q21.3
IGKV3D-20,-0.012895814,IGKV3D-20,Approved symbol,IGKV3D-20,immunoglobulin kappa variable 3D-20,HGNC:5825,2p11.2
PRC1,-0.012886785,PRC1,Approved symbol,PRC1,protein regulator of cytokinesis 1,HGNC:9341,15q26.1
BET1,-0.012884335,BET1,Approved symbol,BET1,Bet1 golgi vesicular membrane trafficking protein,HGNC:14562,7q21.3
BRD3,0.01288271,BRD3,Approved symbol,BRD3,bromodomain containing 3,HGNC:1104,9q34.2
SMG9,-0.012880802,SMG9,Approved symbol,SMG9,SMG9 nonsense mediated mRNA decay factor,HGNC:25763,19q13.31
RP11-209E8.1,0.012879363,RP11-209E8.1,Unmatched,RP11-209E8.1,,,
MAP3K6,-0.012878435,MAP3K6,Approved symbol,MAP3K6,mitogen-activated protein kinase kinase kinase 6,HGNC:6858,1p36.11
RP11-277P12.20,-0.012871868,RP11-277P12.20,Unmatched,RP11-277P12.20,,,
BHLHA15,-0.012871477,BHLHA15,Approved symbol,BHLHA15,basic helix-loop-helix family member a15,HGNC:22265,7q21.3
SASH1,-0.012869384,SASH1,Approved symbol,SASH1,SAM and SH3 domain containing 1,HGNC:19182,6q24.3-q25.1
NAP1L5,-0.012867865,NAP1L5,Approved symbol,NAP1L5,nucleosome assembly protein 1 like 5,HGNC:19968,4q22.1
CEP112,-0.012866004,CEP112,Approved symbol,CEP112,centrosomal protein 112,HGNC:28514,17q24.1
RP11-434H6.6,-0.012861832,RP11-434H6.6,Unmatched,RP11-434H6.6,,,
PKMP1,-0.012855333,PKMP1,Approved symbol,PKMP1,pyruvate kinase M1/2 pseudogene 1,HGNC:44243,1p13.2
IGKV6D-21,-0.012852712,IGKV6D-21,Approved symbol,IGKV6D-21,immunoglobulin kappa variable 6D-21 (non-functional),HGNC:5837,2p11.2
LDHB,-0.012850632,LDHB,Approved symbol,LDHB,lactate dehydrogenase B,HGNC:6541,12p12.1
FAM47E,0.012845311,FAM47E,Approved symbol,FAM47E,family with sequence similarity 47 member E,HGNC:34343,4q21.1
CDIPT,0.012833803,CDIPT,Approved symbol,CDIPT,CDP-diacylglycerol--inositol 3-phosphatidyltransferase,HGNC:1769,16p11.2
APOLD1,-0.012832642,APOLD1,Approved symbol,APOLD1,apolipoprotein L domain containing 1,HGNC:25268,12p13.1
KCNB2,0.012830141,KCNB2,Approved symbol,KCNB2,potassium voltage-gated channel subfamily B member 2,HGNC:6232,8q21.11
ALDH3B2,-0.012829979,ALDH3B2,Approved symbol,ALDH3B2,aldehyde dehydrogenase 3 family member B2,HGNC:411,11q13.2
APLNR,-0.012825408,APLNR,Approved symbol,APLNR,apelin receptor,HGNC:339,11q12.1
PHGDH,-0.012824317,PHGDH,Approved symbol,PHGDH,phosphoglycerate dehydrogenase,HGNC:8923,1p12
CLN5,0.012816691,CLN5,Approved symbol,CLN5,CLN5 intracellular trafficking protein,HGNC:2076,13q22.3
CCL26,-0.012810002,CCL26,Approved symbol,CCL26,C-C motif chemokine ligand 26,HGNC:10625,7q11.23
RP11-39C10.1,-0.012808966,RP11-39C10.1,Unmatched,RP11-39C10.1,,,
RP11-431K24.1,-0.012804894,RP11-431K24.1,Unmatched,RP11-431K24.1,,,
NAGS,0.012804401,NAGS,Approved symbol,NAGS,N-acetylglutamate synthase,HGNC:17996,17q21.31
ADRA2A,-0.012802615,ADRA2A,Approved symbol,ADRA2A,adrenoceptor alpha 2A,HGNC:281,10q25.2
UBE2O,-0.012798736,UBE2O,Approved symbol,UBE2O,ubiquitin conjugating enzyme E2 O,HGNC:29554,17q25.1
DUS2,-0.012792834,DUS2,Approved symbol,DUS2,dihydrouridine synthase 2,HGNC:26014,16q22.1
ADAR,-0.012791048,ADAR,Approved symbol,ADAR,adenosine deaminase RNA specific,HGNC:225,1q21.3
CCL3L1,-0.012785247,CCL3L1,Approved symbol,CCL3L1,C-C motif chemokine ligand 3 like 1,HGNC:10628,17q12 alternate reference locus
C2CD4C,-0.012783678,C2CD4C,Approved symbol,C2CD4C,C2 calcium dependent domain containing 4C,HGNC:29417,19p13.3
NPY,0.01278264,NPY,Approved symbol,NPY,neuropeptide Y,HGNC:7955,7p15.3
PRPF4,-0.012776549,PRPF4,Approved symbol,PRPF4,pre-mRNA processing factor 4,HGNC:17349,9q32
CXCL16,-0.012775188,CXCL16,Approved symbol,CXCL16,C-X-C motif chemokine ligand 16,HGNC:16642,17p13.2
RP11-143K11.1,0.012773805,RP11-143K11.1,Unmatched,RP11-143K11.1,,,
CATSPERB,-0.012772578,CATSPERB,Approved symbol,CATSPERB,cation channel sperm associated auxiliary subunit beta,HGNC:20500,14q32.12
MAP1A,-0.012768929,MAP1A,Approved symbol,MAP1A,microtubule associated protein 1A,HGNC:6835,15q15.3
C5orf34,-0.012768872,C5orf34,Approved symbol,C5orf34,chromosome 5 open reading frame 34,HGNC:24738,5p12
CYB5R4,-0.012767891,CYB5R4,Approved symbol,CYB5R4,cytochrome b5 reductase 4,HGNC:20147,6q14.2
ZNF415,0.012763026,ZNF415,Approved symbol,ZNF415,zinc finger protein 415,HGNC:20636,19q13.42
MKLN1-AS2,-0.01276206,MKLN1-AS2,Previous symbol,MKLN1-AS,MKLN1 antisense RNA,HGNC:40374,7q32.3
TRAFD1,-0.012760352,TRAFD1,Approved symbol,TRAFD1,TRAF-type zinc finger domain containing 1,HGNC:24808,12q24.13
WBSCR27,0.012759139,WBSCR27,Previous symbol,METTL27,methyltransferase like 27,HGNC:19068,7q11.23
RP11-517B11.7,0.012755213,RP11-517B11.7,Unmatched,RP11-517B11.7,,,
ABCG2,0.012751311,ABCG2,Approved symbol,ABCG2,ATP binding cassette subfamily G member 2 (Junior blood group),HGNC:74,4q22.1
ZNF253,0.012749111,ZNF253,Approved symbol,ZNF253,zinc finger protein 253,HGNC:13497,19p13.11
PAXIP1-AS1,0.012741996,PAXIP1-AS1,Previous symbol,PAXIP1-DT,PAXIP1 divergent transcript,HGNC:27328,7q36.2
PSAT1P3,-0.012738839,PSAT1P3,Approved symbol,PSAT1P3,phosphoserine aminotransferase 1 pseudogene 3,HGNC:43989,1p31.1
INMT,-0.01273632,INMT,Approved symbol,INMT,indolethylamine N-methyltransferase,HGNC:6069,7p14.3
SFRP2,-0.01273387,SFRP2,Approved symbol,SFRP2,secreted frizzled related protein 2,HGNC:10777,4q31.3
IGKV3D-7,-0.012732591,IGKV3D-7,Approved symbol,IGKV3D-7,immunoglobulin kappa variable 3D-7,HGNC:5829,2p11.2
STAC,-0.012730469,STAC,Approved symbol,STAC,SH3 and cysteine rich domain,HGNC:11353,3p22.3-p22.2
P4HA3,-0.012727562,P4HA3,Approved symbol,P4HA3,prolyl 4-hydroxylase subunit alpha 3,HGNC:30135,11q13.4
RP11-801F7.1,0.012726374,RP11-801F7.1,Unmatched,RP11-801F7.1,,,
CHRNA9,-0.012722237,CHRNA9,Approved symbol,CHRNA9,cholinergic receptor nicotinic alpha 9 subunit,HGNC:14079,4p14
CCNE1,-0.012721584,CCNE1,Approved symbol,CCNE1,cyclin E1,HGNC:1589,19q12
BMP2K,0.012717447,BMP2K,Approved symbol,BMP2K,BMP2 inducible kinase,HGNC:18041,4q21.21
MMP2,-0.012716308,MMP2,Approved symbol,MMP2,matrix metallopeptidase 2,HGNC:7166,16q12.2
RP1-161P9.5,0.012716046,RP1-161P9.5,Unmatched,RP1-161P9.5,,,
AP001046.6,-0.01271537,AP001046.6,Unmatched,AP001046.6,,,
NMUR2,-0.012706932,NMUR2,Approved symbol,NMUR2,neuromedin U receptor 2,HGNC:16454,5q33.1
RUNDC3A,0.012705199,RUNDC3A,Approved symbol,RUNDC3A,RUN domain containing 3A,HGNC:16984,17q21.31
AC097724.3,0.01270446,AC097724.3,Unmatched,AC097724.3,,,
GNG4,0.012700839,GNG4,Approved symbol,GNG4,G protein subunit gamma 4,HGNC:4407,1q42.3
PLBD2,-0.012700108,PLBD2,Approved symbol,PLBD2,phospholipase B domain containing 2,HGNC:27283,12q24.13
MIR1249,-0.012698297,MIR1249,Approved symbol,MIR1249,microRNA 1249,HGNC:35315,22q13.31
ENTPD7,-0.012695163,ENTPD7,Approved symbol,ENTPD7,ectonucleoside triphosphate diphosphohydrolase 7,HGNC:19745,10q24.2
RP11-757F18.5,0.01269194,RP11-757F18.5,Unmatched,RP11-757F18.5,,,
PTRF,-0.012684037,PTRF,Previous symbol,CAVIN1,caveolae associated protein 1,HGNC:9688,17q21.2
LILRA6,-0.012683501,LILRA6,Approved symbol,LILRA6,leukocyte immunoglobulin like receptor A6,HGNC:15495,19q13.42
B3GNT9,-0.012678435,B3GNT9,Approved symbol,B3GNT9,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9",HGNC:28714,16q22.1
KIAA1147,0.012678069,KIAA1147,Previous symbol,DENND11,DENN domain containing 11,HGNC:29472,7q34
ABCG8,-0.012676895,ABCG8,Approved symbol,ABCG8,ATP binding cassette subfamily G member 8,HGNC:13887,2p21
MKRN9P,0.01267646,MKRN9P,Approved symbol,MKRN9P,"makorin ring finger protein 9, pseudogene",HGNC:7116,12q21.32
AC011298.2,0.012673726,AC011298.2,Unmatched,AC011298.2,,,
DNASE2,-0.012671832,DNASE2,Approved symbol,DNASE2,"deoxyribonuclease 2, lysosomal",HGNC:2960,19p13.13
NVL,0.012668973,NVL,Approved symbol,NVL,nuclear VCP like,HGNC:8070,1q42.11
SMC2,-0.012668946,SMC2,Approved symbol,SMC2,structural maintenance of chromosomes 2,HGNC:14011,9q31.1
AC103563.5,-0.012667322,AC103563.5,Unmatched,AC103563.5,,,
ZNF358,0.012666039,ZNF358,Approved symbol,ZNF358,zinc finger protein 358,HGNC:16838,19p13.2
HKDC1,-0.012662541,HKDC1,Approved symbol,HKDC1,hexokinase domain containing 1,HGNC:23302,10q22.1
S100A11P1,-0.012662421,S100A11P1,Approved symbol,S100A11P1,S100A11 pseudogene 1,HGNC:10491,7q22.1
CCT8P1,0.012658095,CCT8P1,Approved symbol,CCT8P1,chaperonin containing TCP1 subunit 8 pseudogene 1,HGNC:35144,1q21.1
FDPS,-0.012654983,FDPS,Approved symbol,FDPS,farnesyl diphosphate synthase,HGNC:3631,1q22
ACOX2,0.012654661,ACOX2,Approved symbol,ACOX2,acyl-CoA oxidase 2,HGNC:120,3p14.3
PCOLCE,-0.012652219,PCOLCE,Approved symbol,PCOLCE,procollagen C-endopeptidase enhancer,HGNC:8738,7q22.1
SERPINE2,-0.012652054,SERPINE2,Approved symbol,SERPINE2,serpin family E member 2,HGNC:8951,2q36.1
SRGAP2C,-0.012649478,SRGAP2C,Approved symbol,SRGAP2C,SLIT-ROBO Rho GTPase activating protein 2C,HGNC:30584,1p11.2
DIRC3,-0.01264809,DIRC3,Approved symbol,DIRC3,disrupted in renal carcinoma 3,HGNC:17805,2q35
ZFPM2,-0.012643188,ZFPM2,Approved symbol,ZFPM2,"zinc finger protein, FOG family member 2",HGNC:16700,8q23
SFTA2,-0.012641626,SFTA2,Approved symbol,SFTA2,surfactant associated 2,HGNC:18386,6p21.33
CEBPB,-0.012641061,CEBPB,Approved symbol,CEBPB,CCAAT enhancer binding protein beta,HGNC:1834,20q13.13
RP11-321F8.4,-0.012639419,RP11-321F8.4,Unmatched,RP11-321F8.4,,,
VCP,-0.01263867,VCP,Approved symbol,VCP,valosin containing protein,HGNC:12666,9p13.3
UBE2J1,-0.01263764,UBE2J1,Approved symbol,UBE2J1,ubiquitin conjugating enzyme E2 J1,HGNC:17598,6q15
TMEM99,0.012636057,TMEM99,Approved symbol,TMEM99,transmembrane protein 99 (putative),HGNC:28305,17q21.2
C1orf127,0.01263394,C1orf127,Approved symbol,C1orf127,chromosome 1 open reading frame 127,HGNC:26730,1p36.22
RP11-527N22.1,0.012631065,RP11-527N22.1,Unmatched,RP11-527N22.1,,,
HSPA6,-0.012624365,HSPA6,Approved symbol,HSPA6,heat shock protein family A (Hsp70) member 6,HGNC:5239,1q23.3
SSR1,-0.01262188,SSR1,Approved symbol,SSR1,signal sequence receptor subunit 1,HGNC:11323,6p24.3
GCLM,-0.012615552,GCLM,Approved symbol,GCLM,glutamate-cysteine ligase modifier subunit,HGNC:4312,1p22.1
IGHD2-2,-0.012613274,IGHD2-2,Approved symbol,IGHD2-2,immunoglobulin heavy diversity 2-2,HGNC:5490,14q32.33
ZNF207,-0.012611306,ZNF207,Approved symbol,ZNF207,zinc finger protein 207,HGNC:12998,17q11.2
LCN6,-0.012608591,LCN6,Approved symbol,LCN6,lipocalin 6,HGNC:17337,9q34.3
INCENP,-0.012608516,INCENP,Approved symbol,INCENP,inner centromere protein,HGNC:6058,11q12.3
PDK4,0.012608126,PDK4,Approved symbol,PDK4,pyruvate dehydrogenase kinase 4,HGNC:8812,7q21.3
MTFR1L,0.012601296,MTFR1L,Approved symbol,MTFR1L,mitochondrial fission regulator 1 like,HGNC:28836,1p36.11
DKFZP761J1410,-0.012599434,DKFZP761J1410,Unmatched,DKFZP761J1410,,,
AEBP1,-0.012592568,AEBP1,Approved symbol,AEBP1,AE binding protein 1,HGNC:303,7p13
P4HB,-0.012589861,P4HB,Approved symbol,P4HB,prolyl 4-hydroxylase subunit beta,HGNC:8548,17q25.3
PLS3,-0.012588896,PLS3,Approved symbol,PLS3,plastin 3,HGNC:9091,Xq23
IGHV1-8,-0.012586841,IGHV1-8,Approved symbol,IGHV1-8,immunoglobulin heavy variable 1-8,HGNC:5559,14q32.33 not on reference assembly
SPG7,0.012586417,SPG7,Approved symbol,SPG7,"SPG7 matrix AAA peptidase subunit, paraplegin",HGNC:11237,16q24.3
IGLV9-49,-0.012579408,IGLV9-49,Approved symbol,IGLV9-49,immunoglobulin lambda variable 9-49,HGNC:5933,22q11.22
CCNB2,-0.012576786,CCNB2,Approved symbol,CCNB2,cyclin B2,HGNC:1580,15q22.2
SFT2D2,0.01257489,SFT2D2,Approved symbol,SFT2D2,SFT2 domain containing 2,HGNC:25140,1q24.2
MIR29B1,-0.012572381,MIR29B1,Approved symbol,MIR29B1,microRNA 29b-1,HGNC:31619,7q32.3
LINC00839,-0.012571214,LINC00839,Approved symbol,LINC00839,long intergenic non-protein coding RNA 839,HGNC:28269,10q11.21
PRSS3P2,-0.012560573,PRSS3P2,Approved symbol,PRSS3P2,PRSS3 pseudogene 2,HGNC:43788,7q34 alternate reference locus
OSR1,0.012560344,OSR1,Approved symbol,OSR1,odd-skipped related transcription factor 1,HGNC:8111,2p24.1
RP11-48B3.4,0.012552441,RP11-48B3.4,Unmatched,RP11-48B3.4,,,
TTK,-0.012550941,TTK,Approved symbol,TTK,TTK protein kinase,HGNC:12401,6q14.1
P2RY4,0.012546749,P2RY4,Approved symbol,P2RY4,pyrimidinergic receptor P2Y4,HGNC:8542,Xq13.1
NR4A2,-0.012545148,NR4A2,Approved symbol,NR4A2,nuclear receptor subfamily 4 group A member 2,HGNC:7981,2q22-q23
BEX2,0.012543789,BEX2,Approved symbol,BEX2,brain expressed X-linked 2,HGNC:30933,Xq22.2
SPNS2,-0.012543368,SPNS2,Approved symbol,SPNS2,sphingolipid transporter 2,HGNC:26992,17p13.2
FAM129A,-0.012542209,FAM129A,Previous symbol,NIBAN1,niban apoptosis regulator 1,HGNC:16784,1q25.3
RACGAP1,-0.012532425,RACGAP1,Approved symbol,RACGAP1,Rac GTPase activating protein 1,HGNC:9804,12q13.12
KLHL30,-0.012531535,KLHL30,Approved symbol,KLHL30,kelch like family member 30,HGNC:24770,2q37.3
ME3,0.012528524,ME3,Approved symbol,ME3,malic enzyme 3,HGNC:6985,11q14.2
WRAP53,-0.012525596,WRAP53,Approved symbol,WRAP53,WD repeat containing antisense to TP53,HGNC:25522,17p13.1
SLC29A4,0.012524889,SLC29A4,Approved symbol,SLC29A4,solute carrier family 29 member 4,HGNC:23097,7p22.1
KLHDC3,0.012524036,KLHDC3,Approved symbol,KLHDC3,kelch domain containing 3,HGNC:20704,6p21.1
SCTR,0.012523328,SCTR,Approved symbol,SCTR,secretin receptor,HGNC:10608,2q14.2
CRNDE,-0.012514266,CRNDE,Approved symbol,CRNDE,colorectal neoplasia differentially expressed,HGNC:37078,16q12.2
CENPO,-0.012512818,CENPO,Approved symbol,CENPO,centromere protein O,HGNC:28152,2p23.3
STX18-AS1,0.012512646,STX18-AS1,Approved symbol,STX18-AS1,STX18 antisense RNA 1 (head to head),HGNC:48877,4p16.2
RP11-71H17.9,0.012505844,RP11-71H17.9,Unmatched,RP11-71H17.9,,,
ZNF766,0.012505357,ZNF766,Approved symbol,ZNF766,zinc finger protein 766,HGNC:28063,19q13.41
PITPNB,-0.012502546,PITPNB,Approved symbol,PITPNB,phosphatidylinositol transfer protein beta,HGNC:9002,22q12.1
RPN2,-0.012500768,RPN2,Approved symbol,RPN2,ribophorin II,HGNC:10382,20q11.23
RP11-750H9.5,-0.012498146,RP11-750H9.5,Unmatched,RP11-750H9.5,,,
IGHV4-28,-0.012496472,IGHV4-28,Approved symbol,IGHV4-28,immunoglobulin heavy variable 4-28,HGNC:5645,14q32.33
MBTD1,0.012492858,MBTD1,Approved symbol,MBTD1,mbt domain containing 1,HGNC:19866,17q21.33
SEC61A1,-0.012491128,SEC61A1,Approved symbol,SEC61A1,SEC61 translocon subunit alpha 1,HGNC:18276,3q21.3
AC097467.2,-0.012489578,AC097467.2,Unmatched,AC097467.2,,,
CTD-2256P15.4,0.012489558,CTD-2256P15.4,Unmatched,CTD-2256P15.4,,,
LETMD1,0.012488602,LETMD1,Approved symbol,LETMD1,LETM1 domain containing 1,HGNC:24241,12q13.12
PRSS33,-0.012485497,PRSS33,Approved symbol,PRSS33,serine protease 33,HGNC:30405,16p13.3
CNNM3,0.012482791,CNNM3,Approved symbol,CNNM3,cyclin and CBS domain divalent metal cation transport mediator 3,HGNC:104,2q11.2
NOS2,-0.012481154,NOS2,Approved symbol,NOS2,nitric oxide synthase 2,HGNC:7873,17q11.2
NEK2,-0.012475415,NEK2,Approved symbol,NEK2,NIMA related kinase 2,HGNC:7745,1q32.3
CHAC2,-0.012475195,CHAC2,Approved symbol,CHAC2,ChaC glutathione specific gamma-glutamylcyclotransferase 2,HGNC:32363,2p16.2
NDUFA4L2,-0.012475025,NDUFA4L2,Approved symbol,NDUFA4L2,NDUFA4 mitochondrial complex associated like 2,HGNC:29836,12q13.3
KRT2,-0.012473285,KRT2,Approved symbol,KRT2,keratin 2,HGNC:6439,12q13.13
PEX11G,0.01246829,PEX11G,Approved symbol,PEX11G,peroxisomal biogenesis factor 11 gamma,HGNC:20208,19p13.2
TPGS2,-0.012463493,TPGS2,Approved symbol,TPGS2,tubulin polyglutamylase complex subunit 2,HGNC:24561,18q12.2
MDM2,-0.012460346,MDM2,Approved symbol,MDM2,MDM2 proto-oncogene,HGNC:6973,12q15
CPLX2,0.012460167,CPLX2,Approved symbol,CPLX2,complexin 2,HGNC:2310,5q35.2
RP11-383J24.6,0.012457496,RP11-383J24.6,Unmatched,RP11-383J24.6,,,
RP11-380M21.2,0.012454621,RP11-380M21.2,Unmatched,RP11-380M21.2,,,
SPOCD1,-0.012452469,SPOCD1,Approved symbol,SPOCD1,SPOC domain containing 1,HGNC:26338,1p35.2
DNAJC27-AS1,0.012446131,DNAJC27-AS1,Approved symbol,DNAJC27-AS1,DNAJC27 antisense RNA 1,HGNC:42943,2p23.3
CTB-58E17.5,0.012446049,CTB-58E17.5,Unmatched,CTB-58E17.5,,,
PPP1R12A,-0.012445882,PPP1R12A,Approved symbol,PPP1R12A,protein phosphatase 1 regulatory subunit 12A,HGNC:7618,12q21.2-q21.31
RAB33B,-0.01243772,RAB33B,Approved symbol,RAB33B,"RAB33B, member RAS oncogene family",HGNC:16075,4q31.1
RTBDN,0.012437637,RTBDN,Approved symbol,RTBDN,retbindin,HGNC:30310,19p13.13
XRN2,-0.01243478,XRN2,Approved symbol,XRN2,5'-3' exoribonuclease 2,HGNC:12836,20p11.22
RP11-53O19.3,0.012429341,RP11-53O19.3,Unmatched,RP11-53O19.3,,,
STT3A,-0.012424388,STT3A,Approved symbol,STT3A,STT3 oligosaccharyltransferase complex catalytic subunit A,HGNC:6172,11q24.2
ITGA2,-0.012424006,ITGA2,Approved symbol,ITGA2,integrin subunit alpha 2,HGNC:6137,5q11.2
SEC24D,-0.012412455,SEC24D,Approved symbol,SEC24D,"SEC24 homolog D, COPII coat complex component",HGNC:10706,4q26
LDHAP4,-0.012411207,LDHAP4,Approved symbol,LDHAP4,lactate dehydrogenase A pseudogene 4,HGNC:6539,9p22.3
EFNA1,0.012410837,EFNA1,Approved symbol,EFNA1,ephrin A1,HGNC:3221,1q22
H2AFV,0.012410436,H2AFV,Previous symbol,H2AZ2,H2A.Z variant histone 2,HGNC:20664,7p13
ZNF793,0.012409026,ZNF793,Approved symbol,ZNF793,zinc finger protein 793,HGNC:33115,19q13.12
RP11-18B16.2,-0.012407071,RP11-18B16.2,Unmatched,RP11-18B16.2,,,
DHRS12,0.012406794,DHRS12,Approved symbol,DHRS12,dehydrogenase/reductase 12,HGNC:25832,13q14.3
ASS1P9,-0.012406629,ASS1P9,Approved symbol,ASS1P9,argininosuccinate synthetase 1 pseudogene 9,HGNC:772,5q11.2
DTYMK,-0.01240638,DTYMK,Approved symbol,DTYMK,deoxythymidylate kinase,HGNC:3061,2q37.3
DIRAS3,0.012404685,DIRAS3,Approved symbol,DIRAS3,DIRAS family GTPase 3,HGNC:687,1p31.3
LMNB1,-0.012403362,LMNB1,Approved symbol,LMNB1,lamin B1,HGNC:6637,5q23.2
PSMC2,-0.012394859,PSMC2,Approved symbol,PSMC2,"proteasome 26S subunit, ATPase 2",HGNC:9548,7q22.1
INPP5J,0.012394382,INPP5J,Approved symbol,INPP5J,inositol polyphosphate-5-phosphatase J,HGNC:8956,22q12.2
HOXA3,0.012380754,HOXA3,Approved symbol,HOXA3,homeobox A3,HGNC:5104,7p15.2
ATP11C,-0.012378937,ATP11C,Approved symbol,ATP11C,ATPase phospholipid transporting 11C,HGNC:13554,Xq27.1
MOCOS,-0.012377148,MOCOS,Approved symbol,MOCOS,molybdenum cofactor sulfurase,HGNC:18234,18q12.2
RPS24,0.012376592,RPS24,Approved symbol,RPS24,ribosomal protein S24,HGNC:10411,10q22.3
RP11-655M14.13,0.01237631,RP11-655M14.13,Unmatched,RP11-655M14.13,,,
CLNS1A,0.012373503,CLNS1A,Approved symbol,CLNS1A,chloride nucleotide-sensitive channel 1A,HGNC:2080,11q14.1
RP11-82L18.4,-0.012370615,RP11-82L18.4,Unmatched,RP11-82L18.4,,,
RP11-1029J19.5,-0.012370207,RP11-1029J19.5,Unmatched,RP11-1029J19.5,,,
XXbac-BPG181B23.7,0.012369987,XXbac-BPG181B23.7,Unmatched,XXbac-BPG181B23.7,,,
HTR1D,-0.012369393,HTR1D,Approved symbol,HTR1D,5-hydroxytryptamine receptor 1D,HGNC:5289,1p36.12
APOA1BP,0.012366662,APOA1BP,Previous symbol,NAXE,NAD(P)HX epimerase,HGNC:18453,1q22
CAMKK1,-0.012358628,CAMKK1,Approved symbol,CAMKK1,calcium/calmodulin dependent protein kinase kinase 1,HGNC:1469,17p13.2
IGLV7-43,-0.012355601,IGLV7-43,Approved symbol,IGLV7-43,immunoglobulin lambda variable 7-43,HGNC:5929,22q11.22
C1QTNF1,-0.012355559,C1QTNF1,Approved symbol,C1QTNF1,C1q and TNF related 1,HGNC:14324,17q25.3
AC004466.1,0.012353867,AC004466.1,Unmatched,AC004466.1,,,
OAS3,-0.012344077,OAS3,Approved symbol,OAS3,2'-5'-oligoadenylate synthetase 3,HGNC:8088,12q24.13
TET3,0.012343073,TET3,Approved symbol,TET3,tet methylcytosine dioxygenase 3,HGNC:28313,2p13.1
KCNK3,0.012341443,KCNK3,Approved symbol,KCNK3,potassium two pore domain channel subfamily K member 3,HGNC:6278,2p23.3
TRDN,0.012336009,TRDN,Approved symbol,TRDN,triadin,HGNC:12261,6q22.31
MITF,-0.012328632,MITF,Approved symbol,MITF,melanocyte inducing transcription factor,HGNC:7105,3p13
IGHV1-46,-0.012327206,IGHV1-46,Approved symbol,IGHV1-46,immunoglobulin heavy variable 1-46,HGNC:5554,14q32.33
MPZL3,0.012326426,MPZL3,Approved symbol,MPZL3,myelin protein zero like 3,HGNC:27279,11q23.3
RCN1,-0.012318641,RCN1,Approved symbol,RCN1,reticulocalbin 1,HGNC:9934,11p13
RP11-21L23.2,0.012317604,RP11-21L23.2,Unmatched,RP11-21L23.2,,,
VRTN,-0.012314925,VRTN,Approved symbol,VRTN,vertebrae development associated,HGNC:20223,14q24.3
SLC16A12,0.012310481,SLC16A12,Approved symbol,SLC16A12,solute carrier family 16 member 12,HGNC:23094,10q23.31
RP1-240K6.3,0.012309277,RP1-240K6.3,Unmatched,RP1-240K6.3,,,
TAAR3,-0.01230713,TAAR3,Previous symbol,TAAR3P,"trace amine associated receptor 3, pseudogene",HGNC:4513,6q23.2
DCBLD1,-0.012306986,DCBLD1,Approved symbol,DCBLD1,"discoidin, CUB and LCCL domain containing 1",HGNC:21479,6q22.1
CH25H,-0.012305616,CH25H,Approved symbol,CH25H,cholesterol 25-hydroxylase,HGNC:1907,10q23.31
WDR44,-0.012303689,WDR44,Approved symbol,WDR44,WD repeat domain 44,HGNC:30512,Xq24
IGHV6-1,-0.01230269,IGHV6-1,Approved symbol,IGHV6-1,immunoglobulin heavy variable 6-1,HGNC:5662,14q32.33
RP11-410D17.2,0.012300703,RP11-410D17.2,Unmatched,RP11-410D17.2,,,
RP11-411H5.1,-0.012298645,RP11-411H5.1,Unmatched,RP11-411H5.1,,,
MFSD2A,-0.012297501,MFSD2A,Approved symbol,MFSD2A,major facilitator superfamily domain containing 2A,HGNC:25897,1p34.2
KDM2A,-0.012296632,KDM2A,Approved symbol,KDM2A,lysine demethylase 2A,HGNC:13606,11q13.2
IGKV1OR-2,-0.012289817,IGKV1OR-2,Approved symbol,IGKV1OR-2,immunoglobulin kappa variable 1/OR-2 (pseudogene),HGNC:5761,9q13
CASR,0.012287841,CASR,Approved symbol,CASR,calcium sensing receptor,HGNC:1514,3q13.33-q21.1
LUM,-0.012287389,LUM,Approved symbol,LUM,lumican,HGNC:6724,12q21.33
LOX,-0.012285928,LOX,Approved symbol,LOX,lysyl oxidase,HGNC:6664,5q23.1
APMAP,-0.012277781,APMAP,Approved symbol,APMAP,adipocyte plasma membrane associated protein,HGNC:13238,20p11.21
ST7,-0.012273968,ST7,Approved symbol,ST7,suppression of tumorigenicity 7,HGNC:11351,7q31.2
PON3,0.012270662,PON3,Approved symbol,PON3,paraoxonase 3,HGNC:9206,7q21.3
LMAN1,-0.012269231,LMAN1,Approved symbol,LMAN1,"lectin, mannose binding 1",HGNC:6631,18q21.32
CA9,-0.012268889,CA9,Approved symbol,CA9,carbonic anhydrase 9,HGNC:1383,9p13.3
ROGDI,0.01226817,ROGDI,Approved symbol,ROGDI,rogdi atypical leucine zipper,HGNC:29478,16p13.3
PIK3R1,0.012266331,PIK3R1,Approved symbol,PIK3R1,phosphoinositide-3-kinase regulatory subunit 1,HGNC:8979,5q13.1
STAU2-AS1,0.012264977,STAU2-AS1,Approved symbol,STAU2-AS1,STAU2 antisense RNA 1,HGNC:44101,8q21.11
ENKUR,-0.012255702,ENKUR,Approved symbol,ENKUR,"enkurin, TRPC channel interacting protein",HGNC:28388,10p12.1
ACSF3,0.012250191,ACSF3,Approved symbol,ACSF3,acyl-CoA synthetase family member 3,HGNC:27288,16q24.3
CNIH2,0.012246987,CNIH2,Approved symbol,CNIH2,cornichon family AMPA receptor auxiliary protein 2,HGNC:28744,11q13.2
CHAF1A,-0.012244333,CHAF1A,Approved symbol,CHAF1A,chromatin assembly factor 1 subunit A,HGNC:1910,19p13.3
DOPEY1,0.012239339,DOPEY1,Previous symbol,DOP1A,DOP1 leucine zipper like protein A,HGNC:21194,6q14.1
SERPINH1,-0.012236352,SERPINH1,Approved symbol,SERPINH1,serpin family H member 1,HGNC:1546,11q13.5
SERPINB6,-0.012235954,SERPINB6,Approved symbol,SERPINB6,serpin family B member 6,HGNC:8950,6p25.2
SNRNP40,-0.012235345,SNRNP40,Approved symbol,SNRNP40,small nuclear ribonucleoprotein U5 subunit 40,HGNC:30857,1p35.2
RP1-30G7.2,-0.012233284,RP1-30G7.2,Unmatched,RP1-30G7.2,,,
SHC3,-0.012231368,SHC3,Approved symbol,SHC3,SHC adaptor protein 3,HGNC:18181,9q22.1
RP11-582J16.4,0.012230464,RP11-582J16.4,Unmatched,RP11-582J16.4,,,
SEC24A,-0.012226121,SEC24A,Approved symbol,SEC24A,"SEC24 homolog A, COPII coat complex component",HGNC:10703,5q31.1
GIT1,0.012225469,GIT1,Approved symbol,GIT1,GIT ArfGAP 1,HGNC:4272,17q11.2
PDIA6,-0.012223342,PDIA6,Approved symbol,PDIA6,protein disulfide isomerase family A member 6,HGNC:30168,2p25.1
NUCB2,-0.012216351,NUCB2,Approved symbol,NUCB2,nucleobindin 2,HGNC:8044,11p15.1
IGLV8-61,-0.012216024,IGLV8-61,Approved symbol,IGLV8-61,immunoglobulin lambda variable 8-61,HGNC:5931,22q11.22
TOPBP1,-0.012206378,TOPBP1,Approved symbol,TOPBP1,DNA topoisomerase II binding protein 1,HGNC:17008,3q22.1
CLGN,0.012204769,CLGN,Approved symbol,CLGN,calmegin,HGNC:2060,4q31.1
ODC1,-0.012204072,ODC1,Approved symbol,ODC1,ornithine decarboxylase 1,HGNC:8109,2p25.1
KCTD11,-0.012202592,KCTD11,Approved symbol,KCTD11,potassium channel tetramerization domain containing 11,HGNC:21302,17p13.1
CTB-36H16.2,0.012200539,CTB-36H16.2,Unmatched,CTB-36H16.2,,,
TNFRSF11B,-0.012195885,TNFRSF11B,Approved symbol,TNFRSF11B,TNF receptor superfamily member 11b,HGNC:11909,8q24.12
LIN9,-0.01219533,LIN9,Approved symbol,LIN9,lin-9 DREAM MuvB core complex component,HGNC:30830,1q42.12
MIR378A,0.012191557,MIR378A,Approved symbol,MIR378A,microRNA 378a,HGNC:31871,5q32
POLB,-0.012190495,POLB,Approved symbol,POLB,DNA polymerase beta,HGNC:9174,8p11.21
GPN3,-0.012181996,GPN3,Approved symbol,GPN3,GPN-loop GTPase 3,HGNC:30186,12q24.11
MAFA,0.012180568,MAFA,Approved symbol,MAFA,MAF bZIP transcription factor A,HGNC:23145,8q24.3
LDHAP3,-0.012175243,LDHAP3,Approved symbol,LDHAP3,lactate dehydrogenase A pseudogene 3,HGNC:6538,2p21
RP11-114H23.1,-0.012168891,RP11-114H23.1,Unmatched,RP11-114H23.1,,,
OSTC,-0.012167327,OSTC,Approved symbol,OSTC,oligosaccharyltransferase complex non-catalytic subunit,HGNC:24448,4q25
NCAPD3,-0.012164578,NCAPD3,Approved symbol,NCAPD3,non-SMC condensin II complex subunit D3,HGNC:28952,11q25
IGKV1D-12,-0.012159539,IGKV1D-12,Approved symbol,IGKV1D-12,immunoglobulin kappa variable 1D-12,HGNC:5746,2p11.2
SLC5A7,0.012150186,SLC5A7,Approved symbol,SLC5A7,solute carrier family 5 member 7,HGNC:14025,2q12.3
IGHV3-13,-0.012146738,IGHV3-13,Approved symbol,IGHV3-13,immunoglobulin heavy variable 3-13,HGNC:5581,14q32.33
TMEM185B,-0.012140968,TMEM185B,Approved symbol,TMEM185B,transmembrane protein 185B,HGNC:18896,2q14.2
LIMCH1,-0.012140387,LIMCH1,Approved symbol,LIMCH1,LIM and calponin homology domains 1,HGNC:29191,4p13
PGLYRP1,-0.012137613,PGLYRP1,Approved symbol,PGLYRP1,peptidoglycan recognition protein 1,HGNC:8904,19q13.32
SPTBN2,-0.01213508,SPTBN2,Approved symbol,SPTBN2,"spectrin beta, non-erythrocytic 2",HGNC:11276,11q13.2
SUSD5,-0.012130626,SUSD5,Approved symbol,SUSD5,sushi domain containing 5,HGNC:29061,3p22.3
RP11-138I1.3,0.012121574,RP11-138I1.3,Unmatched,RP11-138I1.3,,,
IGLV1-51,-0.012118541,IGLV1-51,Approved symbol,IGLV1-51,immunoglobulin lambda variable 1-51,HGNC:5882,22q11.22
DCLRE1B,-0.012117272,DCLRE1B,Approved symbol,DCLRE1B,DNA cross-link repair 1B,HGNC:17641,1p13.2
IL11,-0.012116846,IL11,Approved symbol,IL11,interleukin 11,HGNC:5966,19q13.42
ADAM9,-0.012108381,ADAM9,Approved symbol,ADAM9,ADAM metallopeptidase domain 9,HGNC:216,8p11.22
CISD2,-0.012102864,CISD2,Approved symbol,CISD2,CDGSH iron sulfur domain 2,HGNC:24212,4q24
MAP9,-0.012101345,MAP9,Approved symbol,MAP9,microtubule associated protein 9,HGNC:26118,4q32.1
TULP3,-0.01209984,TULP3,Approved symbol,TULP3,TUB like protein 3,HGNC:12425,12p13.33
C3orf36,-0.01209751,C3orf36,Approved symbol,C3orf36,chromosome 3 putative open reading frame 36,HGNC:26170,3q22.1
RP11-452D12.1,0.0120972,RP11-452D12.1,Unmatched,RP11-452D12.1,,,
FAM151B,-0.012095287,FAM151B,Approved symbol,FAM151B,family with sequence similarity 151 member B,HGNC:33716,5q14.1
CST3,0.012095085,CST3,Approved symbol,CST3,cystatin C,HGNC:2475,20p11.21
RP11-96B2.1,-0.012092559,RP11-96B2.1,Unmatched,RP11-96B2.1,,,
PLCXD3,0.012089301,PLCXD3,Approved symbol,PLCXD3,phosphatidylinositol specific phospholipase C X domain containing 3,HGNC:31822,5p13.1
HERPUD1,-0.012087822,HERPUD1,Approved symbol,HERPUD1,homocysteine inducible ER protein with ubiquitin like domain 1,HGNC:13744,16q13
NCAPG2,-0.012071388,NCAPG2,Approved symbol,NCAPG2,non-SMC condensin II complex subunit G2,HGNC:21904,7q36.3
CTD-2350C19.2,0.012071237,CTD-2350C19.2,Unmatched,CTD-2350C19.2,,,
FOSB,-0.012070353,FOSB,Approved symbol,FOSB,"FosB proto-oncogene, AP-1 transcription factor subunit",HGNC:3797,19q13.32
PPA1,-0.01206747,PPA1,Approved symbol,PPA1,inorganic pyrophosphatase 1,HGNC:9226,10q22.1
IGHV2-70,-0.012066821,IGHV2-70,Approved symbol,IGHV2-70,immunoglobulin heavy variable 2-70,HGNC:5577,14q32.33
HSPA5,-0.012066244,HSPA5,Approved symbol,HSPA5,heat shock protein family A (Hsp70) member 5,HGNC:5238,9q33.3
CSDC2,-0.012065498,CSDC2,Approved symbol,CSDC2,cold shock domain containing C2,HGNC:30359,22q13.2
C16orf45,-0.012063951,C16orf45,Previous symbol,BMERB1,bMERB domain containing 1,HGNC:19213,16p13.11
C6orf163,0.012052051,C6orf163,Approved symbol,C6orf163,chromosome 6 open reading frame 163,HGNC:21403,6q15
ZNF200,-0.012051031,ZNF200,Approved symbol,ZNF200,zinc finger protein 200,HGNC:12993,16p13.3
MNX1-AS2,0.012049693,MNX1-AS2,Approved symbol,MNX1-AS2,MNX1 antisense RNA 2,HGNC:40278,7q36.3
SIGLEC16,-0.012049203,SIGLEC16,Approved symbol,SIGLEC16,sialic acid binding Ig like lectin 16,HGNC:24851,19q13.33
RP11-10J5.1,-0.012048988,RP11-10J5.1,Unmatched,RP11-10J5.1,,,
OGDHL,0.012048921,OGDHL,Approved symbol,OGDHL,oxoglutarate dehydrogenase L,HGNC:25590,10q11.23
MT1XP1,0.012046388,MT1XP1,Approved symbol,MT1XP1,metallothionein 1X pseudogene 1,HGNC:7442,1p36.13
RP11-466P24.7,0.012044567,RP11-466P24.7,Unmatched,RP11-466P24.7,,,
RP11-783K16.5,-0.012027766,RP11-783K16.5,Unmatched,RP11-783K16.5,,,
ERCC6,0.012018175,ERCC6,Approved symbol,ERCC6,"ERCC excision repair 6, chromatin remodeling factor",HGNC:3438,10q11.23
PRSS22,-0.012007656,PRSS22,Approved symbol,PRSS22,serine protease 22,HGNC:14368,16p13.3
RP11-701P16.4,-0.011999353,RP11-701P16.4,Unmatched,RP11-701P16.4,,,
IGHV1-58,-0.011994614,IGHV1-58,Approved symbol,IGHV1-58,immunoglobulin heavy variable 1-58,HGNC:5555,14q32.33
MYO1H,-0.011994437,MYO1H,Approved symbol,MYO1H,myosin IH,HGNC:13879,12q24.11
AFG3L2P1,0.011990659,AFG3L2P1,Approved symbol,AFG3L2P1,AFG3 like AAA ATPase 2 pseudogene 1,HGNC:24169,8p11.1
AC006132.1,-0.011989242,AC006132.1,Unmatched,AC006132.1,,,
ACMSD,-0.011988995,ACMSD,Approved symbol,ACMSD,aminocarboxymuconate semialdehyde decarboxylase,HGNC:19288,2q21.3
RP4-625H18.2,-0.011986043,RP4-625H18.2,Unmatched,RP4-625H18.2,,,
ELFN1,-0.011984642,ELFN1,Approved symbol,ELFN1,extracellular leucine rich repeat and fibronectin type III domain containing 1,HGNC:33154,7p22.3
TM4SF5,0.011984582,TM4SF5,Approved symbol,TM4SF5,transmembrane 4 L six family member 5,HGNC:11857,17p13.2
TMEM79,0.011984291,TMEM79,Approved symbol,TMEM79,transmembrane protein 79,HGNC:28196,1q22
IGLV1-44,-0.011980913,IGLV1-44,Approved symbol,IGLV1-44,immunoglobulin lambda variable 1-44,HGNC:5879,22q11.22
IGKV2-40,-0.011980022,IGKV2-40,Approved symbol,IGKV2-40,immunoglobulin kappa variable 2-40,HGNC:5789,2p11.2
PELO,-0.011969253,PELO,Approved symbol,PELO,pelota mRNA surveillance and ribosome rescue factor,HGNC:8829,5q11.2
RB1,-0.011968849,RB1,Approved symbol,RB1,RB transcriptional corepressor 1,HGNC:9884,13q14.2
CATSPER1,-0.011964672,CATSPER1,Approved symbol,CATSPER1,cation channel sperm associated 1,HGNC:17116,11q13.1
TPRG1-AS1,-0.011964362,TPRG1-AS1,Approved symbol,TPRG1-AS1,TPRG1 antisense RNA 1,HGNC:42391,3q28
CSF2RBP1,-0.011963976,CSF2RBP1,Approved symbol,CSF2RBP1,CSF2RB pseudogene 1,HGNC:2437,22q12.3
ZWILCH,-0.011962826,ZWILCH,Approved symbol,ZWILCH,zwilch kinetochore protein,HGNC:25468,15q22.31
NCAPD2,-0.011960088,NCAPD2,Approved symbol,NCAPD2,non-SMC condensin I complex subunit D2,HGNC:24305,12p13.31
CRBN,0.011957337,CRBN,Approved symbol,CRBN,cereblon,HGNC:30185,3p26.2
STIL,-0.011956331,STIL,Approved symbol,STIL,STIL centriolar assembly protein,HGNC:10879,1p33
IL27,-0.011955227,IL27,Approved symbol,IL27,interleukin 27,HGNC:19157,16p12.1-p11.2
TRIM40,-0.011945013,TRIM40,Approved symbol,TRIM40,tripartite motif containing 40,HGNC:18736,6p22.1
NEU1,0.01193786,NEU1,Approved symbol,NEU1,neuraminidase 1,HGNC:7758,6p21.33
NACA,0.011935456,NACA,Approved symbol,NACA,nascent polypeptide associated complex subunit alpha,HGNC:7629,12q23-q24.1
PDZD3,0.011933761,PDZD3,Approved symbol,PDZD3,PDZ domain containing 3,HGNC:19891,11q23.3
RP11-451M19.3,0.01193254,RP11-451M19.3,Unmatched,RP11-451M19.3,,,
MATN2,0.011927277,MATN2,Approved symbol,MATN2,matrilin 2,HGNC:6908,8q22.1-q22.2
RP11-788H18.1,0.011926871,RP11-788H18.1,Unmatched,RP11-788H18.1,,,
RANGAP1,-0.011918347,RANGAP1,Approved symbol,RANGAP1,Ran GTPase activating protein 1,HGNC:9854,22q13.2
TRIB3,-0.011915794,TRIB3,Approved symbol,TRIB3,tribbles pseudokinase 3,HGNC:16228,20p13
ECM1,-0.011914345,ECM1,Approved symbol,ECM1,extracellular matrix protein 1,HGNC:3153,1q21.2
COL8A1,-0.011912263,COL8A1,Approved symbol,COL8A1,collagen type VIII alpha 1 chain,HGNC:2215,3q12.1
RP11-285F7.2,0.011906626,RP11-285F7.2,Unmatched,RP11-285F7.2,,,
AC009110.1,0.011896933,AC009110.1,Unmatched,AC009110.1,,,
OTX1,-0.011893641,OTX1,Approved symbol,OTX1,orthodenticle homeobox 1,HGNC:8521,2p15
ASS1,-0.01188853,ASS1,Approved symbol,ASS1,argininosuccinate synthase 1,HGNC:758,9q34.11
MMP8,-0.011887068,MMP8,Approved symbol,MMP8,matrix metallopeptidase 8,HGNC:7175,11q22.2
ASF1B,-0.011881983,ASF1B,Approved symbol,ASF1B,anti-silencing function 1B histone chaperone,HGNC:20996,19p13.12
TMC1,-0.011881008,TMC1,Approved symbol,TMC1,transmembrane channel like 1,HGNC:16513,9q21.13
IGKV2D-40,-0.011879312,IGKV2D-40,Approved symbol,IGKV2D-40,immunoglobulin kappa variable 2D-40,HGNC:5804,2p11.2
MZT1,-0.011878214,MZT1,Approved symbol,MZT1,mitotic spindle organizing protein 1,HGNC:33830,13q21.33
RP11-1149O23.3,-0.011877892,RP11-1149O23.3,Unmatched,RP11-1149O23.3,,,
U91328.19,0.01187735,U91328.19,Unmatched,U91328.19,,,
CTC-429P9.3,0.011866304,CTC-429P9.3,Unmatched,CTC-429P9.3,,,
HIAT1,-0.011858413,HIAT1,Previous symbol,MFSD14A,major facilitator superfamily domain containing 14A,HGNC:23363,1p21.2
RRAS2,0.011857437,RRAS2,Approved symbol,RRAS2,RAS related 2,HGNC:17271,11p15.2
IGKV1-9,-0.011847108,IGKV1-9,Approved symbol,IGKV1-9,immunoglobulin kappa variable 1-9,HGNC:5744,2p11.2
C9orf116,-0.01184563,C9orf116,Approved symbol,C9orf116,chromosome 9 open reading frame 116,HGNC:28435,9q34.3
AC007679.3,0.011843706,AC007679.3,Unmatched,AC007679.3,,,
DLGAP4,-0.011841671,DLGAP4,Approved symbol,DLGAP4,DLG associated protein 4,HGNC:24476,20q11.23
LINC00930,0.0118404,LINC00930,Approved symbol,LINC00930,long intergenic non-protein coding RNA 930,HGNC:48620,15q26.1
MFI2,0.0118376,MFI2,Previous symbol,MELTF,melanotransferrin,HGNC:7037,3q29
CCDC101,0.011831088,CCDC101,Previous symbol,SGF29,SAGA complex associated factor 29,HGNC:25156,16p11.2
DYNC1LI1,-0.011824933,DYNC1LI1,Approved symbol,DYNC1LI1,dynein cytoplasmic 1 light intermediate chain 1,HGNC:18745,3p22.3
HYAL3,-0.011824121,HYAL3,Approved symbol,HYAL3,hyaluronidase 3,HGNC:5322,3p21.31
KBTBD3,0.011821187,KBTBD3,Approved symbol,KBTBD3,kelch repeat and BTB domain containing 3,HGNC:22934,11q22.3
C12orf5,-0.011818321,C12orf5,Previous symbol,TIGAR,TP53 induced glycolysis regulatory phosphatase,HGNC:1185,12p13.32
ADAM17,-0.011812508,ADAM17,Approved symbol,ADAM17,ADAM metallopeptidase domain 17,HGNC:195,2p25.1
BACE1,-0.011812311,BACE1,Approved symbol,BACE1,beta-secretase 1,HGNC:933,11q23.3
CAV1,-0.011810537,CAV1,Approved symbol,CAV1,caveolin 1,HGNC:1527,7q31.2
ADAM1A,0.0118105,ADAM1A,Approved symbol,ADAM1A,ADAM metallopeptidase domain 1A (pseudogene),HGNC:187,12q24.12-q24.13
MSX2,-0.011806382,MSX2,Approved symbol,MSX2,msh homeobox 2,HGNC:7392,5q35.2
SOCS4,-0.011793942,SOCS4,Approved symbol,SOCS4,suppressor of cytokine signaling 4,HGNC:19392,14q22.3
RBBP8,-0.011793843,RBBP8,Approved symbol,RBBP8,"RB binding protein 8, endonuclease",HGNC:9891,18q11.2
SAA4,-0.011790126,SAA4,Approved symbol,SAA4,"serum amyloid A4, constitutive",HGNC:10516,11p15.1
ZNF525,0.011788639,ZNF525,Approved symbol,ZNF525,zinc finger protein 525,HGNC:29423,19q13.42
PDGFRL,-0.011784975,PDGFRL,Approved symbol,PDGFRL,platelet derived growth factor receptor like,HGNC:8805,8p22
MTRNR2L7,0.011778354,MTRNR2L7,Approved symbol,MTRNR2L7,MT-RNR2 like 7,HGNC:37164,10p11.21
RP11-571L19.8,0.011776402,RP11-571L19.8,Unmatched,RP11-571L19.8,,,
RP4-740C4.6,0.011776283,RP4-740C4.6,Unmatched,RP4-740C4.6,,,
IGHV3-49,-0.011775408,IGHV3-49,Approved symbol,IGHV3-49,immunoglobulin heavy variable 3-49,HGNC:5607,14q32.33
RP11-328M4.2,0.011775055,RP11-328M4.2,Unmatched,RP11-328M4.2,,,
CYP2C18,-0.011763092,CYP2C18,Approved symbol,CYP2C18,cytochrome P450 family 2 subfamily C member 18,HGNC:2620,10q23.33
TNFAIP8L3,0.011760852,TNFAIP8L3,Approved symbol,TNFAIP8L3,TNF alpha induced protein 8 like 3,HGNC:20620,15q21.2
FAM25C,-0.011760089,FAM25C,Approved symbol,FAM25C,family with sequence similarity 25 member C,HGNC:23586,10q11.22
KATNAL2,0.011753298,KATNAL2,Approved symbol,KATNAL2,katanin catalytic subunit A1 like 2,HGNC:25387,18q21.1
SLC18A1,0.011751048,SLC18A1,Approved symbol,SLC18A1,solute carrier family 18 member A1,HGNC:10934,8p21.3
ARHGAP31,-0.011741599,ARHGAP31,Approved symbol,ARHGAP31,Rho GTPase activating protein 31,HGNC:29216,3q13.32-q13.33
EIF3F,0.011739677,EIF3F,Approved symbol,EIF3F,eukaryotic translation initiation factor 3 subunit F,HGNC:3275,11p15.4
YIF1B,-0.011734914,YIF1B,Approved symbol,YIF1B,"Yip1 interacting factor homolog B, membrane trafficking protein",HGNC:30511,19q13.2
NUBP1,-0.011732367,NUBP1,Approved symbol,NUBP1,nucleotide binding protein 1,HGNC:8041,16p13.13
CCDC134,-0.011730905,CCDC134,Approved symbol,CCDC134,coiled-coil domain containing 134,HGNC:26185,22q13.2
GPR180,-0.011730601,GPR180,Approved symbol,GPR180,G protein-coupled receptor 180,HGNC:28899,13q32.1
IGKV2D-28,-0.011726778,IGKV2D-28,Approved symbol,IGKV2D-28,immunoglobulin kappa variable 2D-28,HGNC:5799,2p11.2
TPTE2P1,0.011713803,TPTE2P1,Approved symbol,TPTE2P1,transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 pseudogene 1,HGNC:35196,13q12.13
SLC25A48,-0.011709453,SLC25A48,Approved symbol,SLC25A48,solute carrier family 25 member 48,HGNC:30451,5q31.1
SEC61B,-0.011709151,SEC61B,Approved symbol,SEC61B,SEC61 translocon subunit beta,HGNC:16993,9q22.33
MAD2L1,-0.011708827,MAD2L1,Approved symbol,MAD2L1,mitotic arrest deficient 2 like 1,HGNC:6763,4q27
PLA2G2A,-0.011708822,PLA2G2A,Approved symbol,PLA2G2A,phospholipase A2 group IIA,HGNC:9031,1p36.13
AP001626.1,-0.01170688,AP001626.1,Alias symbol,LINC01671,long intergenic non-protein coding RNA 1671,HGNC:52459,21q22.3
POLD3,-0.011700604,POLD3,Approved symbol,POLD3,"DNA polymerase delta 3, accessory subunit",HGNC:20932,11q13.4
RP11-626P14.2,0.011698928,RP11-626P14.2,Unmatched,RP11-626P14.2,,,
BRINP3,0.011686189,BRINP3,Approved symbol,BRINP3,BMP/retinoic acid inducible neural specific 3,HGNC:22393,1q31.1
IGHV4-61,-0.011683038,IGHV4-61,Approved symbol,IGHV4-61,immunoglobulin heavy variable 4-61,HGNC:5655,14q32.33
DHRS4-AS1,0.01168253,DHRS4-AS1,Approved symbol,DHRS4-AS1,DHRS4 antisense RNA 1,HGNC:23175,14q11.2
MNT,-0.011676643,MNT,Approved symbol,MNT,MAX network transcriptional repressor,HGNC:7188,17p13.3
MTHFD1,-0.0116733,MTHFD1,Approved symbol,MTHFD1,"methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1",HGNC:7432,14q23.3
PFKP,-0.011669928,PFKP,Approved symbol,PFKP,"phosphofructokinase, platelet",HGNC:8878,10p15.2
PLCL2,0.011665855,PLCL2,Approved symbol,PLCL2,phospholipase C like 2,HGNC:9064,3p24.3
LINC00582,-0.011663453,LINC00582,Approved symbol,LINC00582,long intergenic non-protein coding RNA 582,HGNC:43842,1q42.2
AP4B1,-0.011653583,AP4B1,Approved symbol,AP4B1,adaptor related protein complex 4 subunit beta 1,HGNC:572,1p13.2
DACT2,0.011647813,DACT2,Approved symbol,DACT2,dishevelled binding antagonist of beta catenin 2,HGNC:21231,6q27
GMDS,-0.011636703,GMDS,Approved symbol,GMDS,"GDP-mannose 4,6-dehydratase",HGNC:4369,6p25.3
ZWINT,-0.011634184,ZWINT,Approved symbol,ZWINT,ZW10 interacting kinetochore protein,HGNC:13195,10q21.1
RP11-1260E13.2,0.011631455,RP11-1260E13.2,Unmatched,RP11-1260E13.2,,,
CYP4X1,-0.011628943,CYP4X1,Approved symbol,CYP4X1,cytochrome P450 family 4 subfamily X member 1,HGNC:20244,1p33
LINC00920,-0.011627493,LINC00920,Approved symbol,LINC00920,long intergenic non-protein coding RNA 920,HGNC:48611,16q21
TANK,-0.011627357,TANK,Approved symbol,TANK,TRAF family member associated NFKB activator,HGNC:11562,2q24.2
SIX1,-0.011607817,SIX1,Approved symbol,SIX1,SIX homeobox 1,HGNC:10887,14q23.1
RP11-67L2.2,0.011607379,RP11-67L2.2,Unmatched,RP11-67L2.2,,,
HAUS2,-0.011603897,HAUS2,Approved symbol,HAUS2,HAUS augmin like complex subunit 2,HGNC:25530,15q15.2
IGLV3-25,-0.011601708,IGLV3-25,Approved symbol,IGLV3-25,immunoglobulin lambda variable 3-25,HGNC:5908,22q11.22
RAPGEF3,-0.011598844,RAPGEF3,Approved symbol,RAPGEF3,Rap guanine nucleotide exchange factor 3,HGNC:16629,12q13.11
OTOP3,0.011597705,OTOP3,Approved symbol,OTOP3,otopetrin 3,HGNC:19658,17q25.1
PCSK5,0.011590541,PCSK5,Approved symbol,PCSK5,proprotein convertase subtilisin/kexin type 5,HGNC:8747,9q21.13
NPSR1-AS1,-0.011586903,NPSR1-AS1,Approved symbol,NPSR1-AS1,NPSR1 antisense RNA 1,HGNC:22128,7p14.3
RP11-24B19.4,0.011582694,RP11-24B19.4,Unmatched,RP11-24B19.4,,,
RP4-613B23.1,-0.011581865,RP4-613B23.1,Unmatched,RP4-613B23.1,,,
SEMA3E,0.011580236,SEMA3E,Approved symbol,SEMA3E,semaphorin 3E,HGNC:10727,7q21.11
NLRP7,-0.011577856,NLRP7,Approved symbol,NLRP7,NLR family pyrin domain containing 7,HGNC:22947,19q13.42
CHRNA7,0.011572508,CHRNA7,Approved symbol,CHRNA7,cholinergic receptor nicotinic alpha 7 subunit,HGNC:1960,15q13.3
CLLU1OS,-0.01157131,CLLU1OS,Previous symbol,CLLU1-AS1,CLLU1 antisense RNA 1,HGNC:24070,12q22
DKK2,-0.01156773,DKK2,Approved symbol,DKK2,dickkopf WNT signaling pathway inhibitor 2,HGNC:2892,4q25
KDELR3,-0.011566653,KDELR3,Approved symbol,KDELR3,KDEL endoplasmic reticulum protein retention receptor 3,HGNC:6306,22q13.1
BNIP3L,-0.011565996,BNIP3L,Approved symbol,BNIP3L,BCL2 interacting protein 3 like,HGNC:1085,8p21.2
ST8SIA2,0.01156586,ST8SIA2,Approved symbol,ST8SIA2,"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2",HGNC:10870,15q26.1
SLC24A5,0.011563697,SLC24A5,Approved symbol,SLC24A5,solute carrier family 24 member 5,HGNC:20611,15q21.1
EHBP1L1,-0.011559275,EHBP1L1,Approved symbol,EHBP1L1,EH domain binding protein 1 like 1,HGNC:30682,11q13.1
COL6A2,-0.011557356,COL6A2,Approved symbol,COL6A2,collagen type VI alpha 2 chain,HGNC:2212,21q22.3
ERRFI1,-0.011553328,ERRFI1,Approved symbol,ERRFI1,ERBB receptor feedback inhibitor 1,HGNC:18185,1p36.23
RP11-890B15.3,0.011552029,RP11-890B15.3,Unmatched,RP11-890B15.3,,,
AC026202.3,-0.011550621,AC026202.3,Unmatched,AC026202.3,,,
SIL1,-0.011536737,SIL1,Approved symbol,SIL1,SIL1 nucleotide exchange factor,HGNC:24624,5q31.2
ADHFE1,0.011534314,ADHFE1,Approved symbol,ADHFE1,alcohol dehydrogenase iron containing 1,HGNC:16354,8q13.1
NCALD,-0.011534022,NCALD,Approved symbol,NCALD,neurocalcin delta,HGNC:7655,8q22.3
RP11-400N9.1,0.011528746,RP11-400N9.1,Unmatched,RP11-400N9.1,,,
PSMD14,-0.011524463,PSMD14,Approved symbol,PSMD14,"proteasome 26S subunit, non-ATPase 14",HGNC:16889,2q24.2
RWDD2A,-0.011523908,RWDD2A,Approved symbol,RWDD2A,RWD domain containing 2A,HGNC:21385,6q14.1
PAQR4,-0.011523534,PAQR4,Approved symbol,PAQR4,progestin and adipoQ receptor family member 4,HGNC:26386,16p13.3
C7orf41,0.011522749,C7orf41,Previous symbol,MTURN,"maturin, neural progenitor differentiation regulator homolog",HGNC:25457,7p14.3
ASCL2,0.011517927,ASCL2,Approved symbol,ASCL2,achaete-scute family bHLH transcription factor 2,HGNC:739,11p15.5
MLK7-AS1,-0.011507274,MLK7-AS1,Previous symbol,MAP3K20-AS1,MAP3K20 antisense RNA 1,HGNC:27935,2q31.1
ZFP2,0.011507063,ZFP2,Approved symbol,ZFP2,ZFP2 zinc finger protein,HGNC:26138,5q35.3
NBN,-0.011505331,NBN,Approved symbol,NBN,nibrin,HGNC:7652,8q21.3
SSR3,-0.011498722,SSR3,Approved symbol,SSR3,signal sequence receptor subunit 3,HGNC:11325,3q25.31
AP000330.8,-0.011498047,AP000330.8,Unmatched,AP000330.8,,,
RP11-809N8.5,0.011496981,RP11-809N8.5,Unmatched,RP11-809N8.5,,,
C17orf72,-0.01149411,C17orf72,Previous symbol,PRR29,proline rich 29,HGNC:25673,17q23.3
DEPDC7,0.01149373,DEPDC7,Approved symbol,DEPDC7,DEP domain containing 7,HGNC:29899,11p13
FAM218A,0.011492546,FAM218A,Approved symbol,FAM218A,family with sequence similarity 218 member A,HGNC:26466,4q32.3
TNFRSF12A,-0.011491116,TNFRSF12A,Approved symbol,TNFRSF12A,TNF receptor superfamily member 12A,HGNC:18152,16p13.3
RAN,-0.011490372,RAN,Approved symbol,RAN,"RAN, member RAS oncogene family",HGNC:9846,12q24.33
LRFN5,-0.01148095,LRFN5,Approved symbol,LRFN5,leucine rich repeat and fibronectin type III domain containing 5,HGNC:20360,14q21.1
TMEM241,-0.01147578,TMEM241,Approved symbol,TMEM241,transmembrane protein 241,HGNC:31723,18q11.2
SCD,-0.011474164,SCD,Approved symbol,SCD,stearoyl-CoA desaturase,HGNC:10571,10q24.31
TFPI2,-0.011465785,TFPI2,Approved symbol,TFPI2,tissue factor pathway inhibitor 2,HGNC:11761,7q21.3
RP1-92O14.3,0.01146225,RP1-92O14.3,Unmatched,RP1-92O14.3,,,
CTB-50L17.14,-0.011459909,CTB-50L17.14,Unmatched,CTB-50L17.14,,,
DNM3,-0.01145978,DNM3,Approved symbol,DNM3,dynamin 3,HGNC:29125,1q24.3
RPL13A,0.011448736,RPL13A,Approved symbol,RPL13A,ribosomal protein L13a,HGNC:10304,19q13.33
PTCHD3P2,-0.01144811,PTCHD3P2,Approved symbol,PTCHD3P2,patched domain containing 3 pseudogene 2,HGNC:44946,2q31.1
SLC25A5P5,0.011444256,SLC25A5P5,Approved symbol,SLC25A5P5,solute carrier family 25 member 5 pseudogene 5,HGNC:511,7p14.3
ASS1P10,-0.011443053,ASS1P10,Approved symbol,ASS1P10,argininosuccinate synthetase 1 pseudogene 10,HGNC:760,5q32
RP13-15E13.1,0.011430146,RP13-15E13.1,Unmatched,RP13-15E13.1,,,
HP,-0.011427747,HP,Approved symbol,HP,haptoglobin,HGNC:5141,16q22.2
BTN2A1,-0.011422029,BTN2A1,Approved symbol,BTN2A1,butyrophilin subfamily 2 member A1,HGNC:1136,6p22.2
SLC22A4,0.011420029,SLC22A4,Approved symbol,SLC22A4,solute carrier family 22 member 4,HGNC:10968,5q31.1
PBK,-0.011417116,PBK,Approved symbol,PBK,PDZ binding kinase,HGNC:18282,8p21.1
IGKV3-7,-0.011410538,IGKV3-7,Approved symbol,IGKV3-7,immunoglobulin kappa variable 3-7 (non-functional),HGNC:5821,2p11.2
PTPRG,-0.011393044,PTPRG,Approved symbol,PTPRG,protein tyrosine phosphatase receptor type G,HGNC:9671,3p14.2
RP11-334E6.3,0.011391479,RP11-334E6.3,Unmatched,RP11-334E6.3,,,
SLC7A1,-0.011386871,SLC7A1,Approved symbol,SLC7A1,solute carrier family 7 member 1,HGNC:11057,13q12.3
MSI1,0.011382095,MSI1,Approved symbol,MSI1,musashi RNA binding protein 1,HGNC:7330,12q24.31
SLC5A1,-0.011381698,SLC5A1,Approved symbol,SLC5A1,solute carrier family 5 member 1,HGNC:11036,22q12.3
GABRA2,0.011377907,GABRA2,Approved symbol,GABRA2,gamma-aminobutyric acid type A receptor subunit alpha2,HGNC:4076,4p12
AL133373.1,-0.011377744,AL133373.1,Unmatched,AL133373.1,,,
RP11-475N22.4,-0.011374059,RP11-475N22.4,Unmatched,RP11-475N22.4,,,
CPSF3,-0.011364304,CPSF3,Approved symbol,CPSF3,cleavage and polyadenylation specific factor 3,HGNC:2326,2p25.1
OSGIN2,-0.011360603,OSGIN2,Approved symbol,OSGIN2,oxidative stress induced growth inhibitor family member 2,HGNC:1355,8q21.3
LINC00346,-0.01135579,LINC00346,Previous symbol,PRECSIT,p53 regulated carcinoma associated Stat3 activating long intergenic non-protein coding transcript,HGNC:27492,13q34
PARP16,0.011355563,PARP16,Approved symbol,PARP16,poly(ADP-ribose) polymerase family member 16,HGNC:26040,15q22.31
MROH7,0.011345074,MROH7,Approved symbol,MROH7,maestro heat like repeat family member 7,HGNC:24802,1p32.3
RP11-632F7.3,0.011337702,RP11-632F7.3,Unmatched,RP11-632F7.3,,,
AC104135.3,-0.011337587,AC104135.3,Unmatched,AC104135.3,,,
SPCS2P4,-0.011336818,SPCS2P4,Approved symbol,SPCS2P4,signal peptidase complex subunit 2 pseudogene 4,HGNC:45237,1p35.3
SRF,-0.011335735,SRF,Approved symbol,SRF,serum response factor,HGNC:11291,6p21.1
RP11-516A11.1,-0.011329575,RP11-516A11.1,Unmatched,RP11-516A11.1,,,
DEPDC1,-0.011322809,DEPDC1,Approved symbol,DEPDC1,DEP domain containing 1,HGNC:22949,1p31.3
CALHM3,-0.011321175,CALHM3,Approved symbol,CALHM3,calcium homeostasis modulator 3,HGNC:23458,10q24.33
TPM4,-0.011319659,TPM4,Approved symbol,TPM4,tropomyosin 4,HGNC:12013,19p13.12-p13.11
IGKV1-17,-0.011311692,IGKV1-17,Approved symbol,IGKV1-17,immunoglobulin kappa variable 1-17,HGNC:5733,2p11.2
DIAPH1,-0.011310245,DIAPH1,Approved symbol,DIAPH1,diaphanous related formin 1,HGNC:2876,5q31.3
CSE1L,-0.011305731,CSE1L,Approved symbol,CSE1L,chromosome segregation 1 like,HGNC:2431,20q13.13
DUOXA1,-0.011305361,DUOXA1,Approved symbol,DUOXA1,dual oxidase maturation factor 1,HGNC:26507,15q21.1
ATG7,-0.011302553,ATG7,Approved symbol,ATG7,autophagy related 7,HGNC:16935,3p25.3
UBE2H,-0.011294397,UBE2H,Approved symbol,UBE2H,ubiquitin conjugating enzyme E2 H,HGNC:12484,7q32.2
RBM20,0.01129032,RBM20,Approved symbol,RBM20,RNA binding motif protein 20,HGNC:27424,10q25.2
IGKV1-8,-0.011289484,IGKV1-8,Approved symbol,IGKV1-8,immunoglobulin kappa variable 1-8,HGNC:5743,2p11.2
BCORL1,0.011288337,BCORL1,Approved symbol,BCORL1,BCL6 corepressor like 1,HGNC:25657,Xq26.1
CTD-2186M15.3,0.011287142,CTD-2186M15.3,Unmatched,CTD-2186M15.3,,,
SPCS2,-0.011282686,SPCS2,Approved symbol,SPCS2,signal peptidase complex subunit 2,HGNC:28962,11q13.4
OXCT1,-0.011276976,OXCT1,Approved symbol,OXCT1,3-oxoacid CoA-transferase 1,HGNC:8527,5p13.1
IGLV3-10,-0.011276521,IGLV3-10,Approved symbol,IGLV3-10,immunoglobulin lambda variable 3-10,HGNC:5897,22q11.22
MYH16,-0.011274518,MYH16,Approved symbol,MYH16,myosin heavy chain 16 pseudogene,HGNC:31038,7q22.1
RP11-196I18.3,-0.011269894,RP11-196I18.3,Unmatched,RP11-196I18.3,,,
RP11-677M14.7,0.011267574,RP11-677M14.7,Unmatched,RP11-677M14.7,,,
AVPR1A,-0.011265143,AVPR1A,Approved symbol,AVPR1A,arginine vasopressin receptor 1A,HGNC:895,12q14.2
AKIRIN2,-0.011262003,AKIRIN2,Approved symbol,AKIRIN2,akirin 2,HGNC:21407,6q15
ULK3,0.011257382,ULK3,Approved symbol,ULK3,unc-51 like kinase 3,HGNC:19703,15q24.1
WASF3,0.011255599,WASF3,Approved symbol,WASF3,WASP family member 3,HGNC:12734,13q12.13
NEDD1,-0.011253504,NEDD1,Approved symbol,NEDD1,NEDD1 gamma-tubulin ring complex targeting factor,HGNC:7723,12q23.1
DTX3L,-0.011252664,DTX3L,Approved symbol,DTX3L,deltex E3 ubiquitin ligase 3L,HGNC:30323,3q21.1
FBXL19-AS1,-0.011249308,FBXL19-AS1,Approved symbol,FBXL19-AS1,FBXL19 antisense RNA 1,HGNC:27557,16p11.2
GOLT1B,-0.011248559,GOLT1B,Approved symbol,GOLT1B,golgi transport 1B,HGNC:20175,12p12.1
CAPN11,-0.011246737,CAPN11,Approved symbol,CAPN11,calpain 11,HGNC:1478,6p21.1
RP11-175O19.4,0.011245191,RP11-175O19.4,Unmatched,RP11-175O19.4,,,
AF186192.1,0.011244913,AF186192.1,Unmatched,AF186192.1,,,
FOXE3,0.011236959,FOXE3,Approved symbol,FOXE3,forkhead box E3,HGNC:3808,1p33
KIAA1683,0.011236852,KIAA1683,Previous symbol,IQCN,IQ motif containing N,HGNC:29350,19p13.11
EYA3,-0.011236073,EYA3,Approved symbol,EYA3,EYA transcriptional coactivator and phosphatase 3,HGNC:3521,1p35.3
IGHV3-7,-0.011226155,IGHV3-7,Approved symbol,IGHV3-7,immunoglobulin heavy variable 3-7,HGNC:5620,14q32.33
RPL22,0.011224778,RPL22,Approved symbol,RPL22,ribosomal protein L22,HGNC:10315,1p36.31
HOXA2,0.011221267,HOXA2,Approved symbol,HOXA2,homeobox A2,HGNC:5103,7p15.2
ACVR2B,0.011220621,ACVR2B,Approved symbol,ACVR2B,activin A receptor type 2B,HGNC:174,3p22.2
IGHV1OR15-6,-0.011220052,IGHV1OR15-6,Approved symbol,IGHV1OR15-6,immunoglobulin heavy variable 1/OR15-6 (pseudogene),HGNC:5568,15q11.2
TG,-0.011217192,TG,Approved symbol,TG,thyroglobulin,HGNC:11764,8q24.22
GS1-44D20.1,-0.011215443,GS1-44D20.1,Unmatched,GS1-44D20.1,,,
CBLN2,0.011214596,CBLN2,Approved symbol,CBLN2,cerebellin 2 precursor,HGNC:1544,18q22.3
RP11-336N8.2,-0.011211708,RP11-336N8.2,Unmatched,RP11-336N8.2,,,
C2orf68,0.011208762,C2orf68,Approved symbol,C2orf68,chromosome 2 open reading frame 68,HGNC:34353,2p11.2
SNTG2,-0.011207924,SNTG2,Approved symbol,SNTG2,syntrophin gamma 2,HGNC:13741,2p25.3
RP11-815J4.6,0.011200262,RP11-815J4.6,Unmatched,RP11-815J4.6,,,
RP11-219B17.1,0.011198854,RP11-219B17.1,Unmatched,RP11-219B17.1,,,
IGKV1-27,-0.011197163,IGKV1-27,Approved symbol,IGKV1-27,immunoglobulin kappa variable 1-27,HGNC:5735,2p11.2
MTND4P12,0.011195608,MTND4P12,Approved symbol,MTND4P12,MT-ND4 pseudogene 12,HGNC:42199,5q31.1
MTRNR2L12,0.01119485,MTRNR2L12,Approved symbol,MTRNR2L12,MT-RNR2 like 12,HGNC:37169,3q11.2
ANO4,0.011182234,ANO4,Approved symbol,ANO4,anoctamin 4,HGNC:23837,12q23.1
RNASEH1,-0.011179352,RNASEH1,Approved symbol,RNASEH1,ribonuclease H1,HGNC:18466,2p25.3
RP11-835E18.5,0.011176515,RNASEH1,Previous symbol,RNASEH1P1,ribonuclease H1 pseudogene 1,HGNC:10049,17p11.2
CTD-2105E13.15,0.011172576,RP11-835E18.5,Unmatched,CTD-2105E13.15,,,
VAMP2,0.011171791,CTD-2105E13.15,Unmatched,VAMP2,,,
C6orf106,-0.011148974,VAMP2,Approved symbol,VAMP2,vesicle associated membrane protein 2,HGNC:12643,17p13.1
ACTR3,-0.011146606,C6orf106,Previous symbol,ILRUN,inflammation and lipid regulator with UBA-like and NBR1-like domains,HGNC:21215,6p21.31
CCIN,-0.011146304,ACTR3,Approved symbol,ACTR3,actin related protein 3,HGNC:170,2q14.1
RP11-315O6.1,0.011144331,CCIN,Approved symbol,CCIN,calicin,HGNC:1568,9p13.3
CNTNAP3,-0.011138851,RP11-315O6.1,Unmatched,CNTNAP3,,,
POLR3GL,0.011125492,CNTNAP3,Approved symbol,CNTNAP3,contactin associated protein family member 3,HGNC:13834,9p12
PDZK1IP1,-0.011121627,POLR3GL,Approved symbol,POLR3GL,RNA polymerase III subunit GL,HGNC:28466,1q21.1
HABP2,-0.011114157,PDZK1IP1,Approved symbol,PDZK1IP1,PDZK1 interacting protein 1,HGNC:16887,1p33
CTD-2201E18.3,-0.011113596,HABP2,Approved symbol,HABP2,hyaluronan binding protein 2,HGNC:4798,10q25.3
LHX6,-0.011112956,CTD-2201E18.3,Unmatched,LHX6,,,
TBK1,-0.011112685,LHX6,Approved symbol,LHX6,LIM homeobox 6,HGNC:21735,9q33.2
RP11-216L13.19,0.011105387,TBK1,Approved symbol,TBK1,TANK binding kinase 1,HGNC:11584,12q14.2
RP11-424C20.2,-0.011103899,RP11-216L13.19,Unmatched,RP11-424C20.2,,,
PPIL1,-0.01109765,RP11-424C20.2,Unmatched,PPIL1,,,
PGK1,-0.011090257,PPIL1,Approved symbol,PPIL1,peptidylprolyl isomerase like 1,HGNC:9260,6p21.2
COL3A1,-0.011090015,PGK1,Approved symbol,PGK1,phosphoglycerate kinase 1,HGNC:8896,Xq21.1
IGHV4-39,-0.011086803,COL3A1,Approved symbol,COL3A1,collagen type III alpha 1 chain,HGNC:2201,2q32.2
AC133528.2,0.011086127,IGHV4-39,Approved symbol,IGHV4-39,immunoglobulin heavy variable 4-39,HGNC:5651,14q32.33
ANXA13,0.011085876,AC133528.2,Unmatched,ANXA13,,,
CYP27A1,0.011081348,ANXA13,Approved symbol,ANXA13,annexin A13,HGNC:536,8q24.13
DOCK9,-0.011078536,CYP27A1,Approved symbol,CYP27A1,cytochrome P450 family 27 subfamily A member 1,HGNC:2605,2q35
CDC25A,-0.011075552,DOCK9,Approved symbol,DOCK9,dedicator of cytokinesis 9,HGNC:14132,13q32.3
EDN1,0.011065794,CDC25A,Approved symbol,CDC25A,cell division cycle 25A,HGNC:1725,3p21.31
INTS7,-0.011062189,EDN1,Approved symbol,EDN1,endothelin 1,HGNC:3176,6p24.1
RBM38,0.011059565,INTS7,Approved symbol,INTS7,integrator complex subunit 7,HGNC:24484,1q32.3
EIF4A1P10,-0.011059107,RBM38,Approved symbol,RBM38,RNA binding motif protein 38,HGNC:15818,20q13.31
CERCAM,-0.011059028,EIF4A1P10,Approved symbol,EIF4A1P10,eukaryotic translation initiation factor 4A1 pseudogene 10,HGNC:37930,Xq21.31
IGLV3-1,-0.011057299,CERCAM,Approved symbol,CERCAM,cerebral endothelial cell adhesion molecule,HGNC:23723,9q34.11
CCL7,-0.011049306,IGLV3-1,Approved symbol,IGLV3-1,immunoglobulin lambda variable 3-1,HGNC:5896,22q11.22
RP11-267C16.1,-0.011045355,CCL7,Approved symbol,CCL7,C-C motif chemokine ligand 7,HGNC:10634,17q12
RP11-677M14.2,0.011044081,RP11-267C16.1,Unmatched,RP11-677M14.2,,,
ETFB,0.011036687,RP11-677M14.2,Unmatched,ETFB,,,
ZNF662,0.011020719,ETFB,Approved symbol,ETFB,electron transfer flavoprotein subunit beta,HGNC:3482,19q13.41
SLC5A11,0.01101679,ZNF662,Approved symbol,ZNF662,zinc finger protein 662,HGNC:31930,3p22.1
DLL4,-0.011016049,SLC5A11,Approved symbol,SLC5A11,solute carrier family 5 member 11,HGNC:23091,16p12.1
TSTA3,-0.01101545,DLL4,Approved symbol,DLL4,delta like canonical Notch ligand 4,HGNC:2910,15q15.1
FGFBP2,0.011007678,TSTA3,Previous symbol,GFUS,GDP-L-fucose synthase,HGNC:12390,8q24.3
PSMB8,-0.011007349,FGFBP2,Approved symbol,FGFBP2,fibroblast growth factor binding protein 2,HGNC:29451,4p15.32
MCOLN3,0.010998519,PSMB8,Approved symbol,PSMB8,proteasome 20S subunit beta 8,HGNC:9545,6p21.32
CTD-2319I12.2,-0.010996798,MCOLN3,Approved symbol,MCOLN3,mucolipin 3,HGNC:13358,1p22.3
CENPL,-0.010990668,CTD-2319I12.2,Unmatched,CENPL,,,
ASXL3,0.010986844,CENPL,Approved symbol,CENPL,centromere protein L,HGNC:17879,1q25.1
IGHV3OR16-13,-0.010980058,ASXL3,Approved symbol,ASXL3,ASXL transcriptional regulator 3,HGNC:29357,18q12.1
POP1,-0.010978645,IGHV3OR16-13,Approved symbol,IGHV3OR16-13,immunoglobulin heavy variable 3/OR16-13 (non-functional),HGNC:5637,16p11.2
CAMSAP2,-0.010976641,POP1,Approved symbol,POP1,"POP1 homolog, ribonuclease P/MRP subunit",HGNC:30129,8q22.2
C1QTNF6,-0.010974629,CAMSAP2,Approved symbol,CAMSAP2,calmodulin regulated spectrin associated protein family member 2,HGNC:29188,1q32.1
PTN,0.010974251,C1QTNF6,Approved symbol,C1QTNF6,C1q and TNF related 6,HGNC:14343,22q12.3
GPR110,-0.010973533,PTN,Approved symbol,PTN,pleiotrophin,HGNC:9630,7q33
SHKBP1,-0.010961566,GPR110,Previous symbol,ADGRF1,adhesion G protein-coupled receptor F1,HGNC:18990,6p12.3
RP11-397C18.2,-0.010956102,SHKBP1,Approved symbol,SHKBP1,SH3KBP1 binding protein 1,HGNC:19214,19q13.2
OR51E2,0.010949396,RP11-397C18.2,Unmatched,OR51E2,,,
CD164L2,-0.01094829,OR51E2,Approved symbol,OR51E2,olfactory receptor family 51 subfamily E member 2,HGNC:15195,11p15.4
CARD16,-0.010933773,CD164L2,Approved symbol,CD164L2,CD164 molecule like 2,HGNC:32043,1p36.11
CARM1P1,0.010918085,CARD16,Approved symbol,CARD16,caspase recruitment domain family member 16,HGNC:33701,11q22.3
SRP72,-0.010911358,CARM1P1,Approved symbol,CARM1P1,coactivator associated arginine methyltransferase 1 pseudogene 1,HGNC:23392,9p24.2
RPL13AP20,0.010910527,SRP72,Approved symbol,SRP72,signal recognition particle 72,HGNC:11303,4q12
IGKV1-6,-0.010910318,RPL13AP20,Approved symbol,RPL13AP20,ribosomal protein L13a pseudogene 20,HGNC:35709,12p13.1
HSPB7,-0.010907479,IGKV1-6,Approved symbol,IGKV1-6,immunoglobulin kappa variable 1-6,HGNC:5742,2p11.2
ZNF607,0.010903019,HSPB7,Approved symbol,HSPB7,heat shock protein family B (small) member 7,HGNC:5249,1p36.13
SLC25A15P3,0.010902724,ZNF607,Approved symbol,ZNF607,zinc finger protein 607,HGNC:28192,19q13.1
CTD-3064H18.1,0.010901408,SLC25A15P3,Approved symbol,SLC25A15P3,solute carrier family 25 member 15 pseudogene 3,HGNC:39844,13q12.13
PNPLA8,-0.010901044,CTD-3064H18.1,Unmatched,PNPLA8,,,
DUSP28,0.010895798,PNPLA8,Approved symbol,PNPLA8,patatin like phospholipase domain containing 8,HGNC:28900,7q31.1
CRKL,0.010894634,DUSP28,Approved symbol,DUSP28,dual specificity phosphatase 28,HGNC:33237,2q37.3
ASS1P2,-0.010891117,CRKL,Approved symbol,CRKL,"CRK like proto-oncogene, adaptor protein",HGNC:2363,22q11.21
PDE1C,-0.010889053,ASS1P2,Approved symbol,ASS1P2,argininosuccinate synthetase 1 pseudogene 2,HGNC:765,2p22.1
SETD7,-0.010888395,PDE1C,Approved symbol,PDE1C,phosphodiesterase 1C,HGNC:8776,7p14.3
PCSK2,0.010888233,SETD7,Approved symbol,SETD7,"SET domain containing 7, histone lysine methyltransferase",HGNC:30412,4q31.1
BACH1,-0.010883944,PCSK2,Approved symbol,PCSK2,proprotein convertase subtilisin/kexin type 2,HGNC:8744,20p12.1
OACYLP,-0.010883535,BACH1,Approved symbol,BACH1,BTB domain and CNC homolog 1,HGNC:935,21q21.3
SLC38A11,0.010883013,OACYLP,Approved symbol,OACYLP,"O-acyltransferase like, pseudogene",HGNC:44362,18q21.32
POLR3F,-0.010878745,SLC38A11,Approved symbol,SLC38A11,solute carrier family 38 member 11,HGNC:26836,2q24.3
GPRIN1,-0.010873213,POLR3F,Approved symbol,POLR3F,RNA polymerase III subunit F,HGNC:15763,20p11.23
LRRC3B,0.010871722,GPRIN1,Approved symbol,GPRIN1,G protein regulated inducer of neurite outgrowth 1,HGNC:24835,5q35.2
SEC61G,-0.010867122,LRRC3B,Approved symbol,LRRC3B,leucine rich repeat containing 3B,HGNC:28105,3p24.1
SEC13,-0.010862861,SEC61G,Approved symbol,SEC61G,SEC61 translocon subunit gamma,HGNC:18277,7p11.2
PGAM1,-0.010854106,SEC13,Approved symbol,SEC13,"SEC13 homolog, nuclear pore and COPII coat complex component",HGNC:10697,3p25.3
ZNF35,-0.010851018,PGAM1,Approved symbol,PGAM1,phosphoglycerate mutase 1,HGNC:8888,10q24.1
CTD-2292M16.8,0.010849968,ZNF35,Approved symbol,ZNF35,zinc finger protein 35,HGNC:13099,3p21.31
ARHGEF26-AS1,0.010846591,CTD-2292M16.8,Unmatched,ARHGEF26-AS1,,,
LRRTM1,0.010842097,ARHGEF26-AS1,Approved symbol,ARHGEF26-AS1,ARHGEF26 antisense RNA 1,HGNC:41048,3q25.2
RP11-384J4.2,0.010839496,LRRTM1,Approved symbol,LRRTM1,leucine rich repeat transmembrane neuronal 1,HGNC:19408,2p12
SHF,-0.010833312,RP11-384J4.2,Unmatched,SHF,,,
TREML3P,-0.010831127,SHF,Approved symbol,SHF,Src homology 2 domain containing F,HGNC:25116,15q21.1
RP4-676J13.2,-0.010827488,TREML3P,Approved symbol,TREML3P,"triggering receptor expressed on myeloid cells like 3, pseudogene",HGNC:30806,6p21.1
PGBD2,0.010827406,RP4-676J13.2,Unmatched,PGBD2,,,
AP1S3,-0.010823572,PGBD2,Approved symbol,PGBD2,piggyBac transposable element derived 2,HGNC:19399,1q
CTC-512J14.7,-0.010822901,AP1S3,Approved symbol,AP1S3,adaptor related protein complex 1 subunit sigma 3,HGNC:18971,2q36.1
SP6,-0.010822496,CTC-512J14.7,Unmatched,SP6,,,
HS6ST2,-0.010818469,SP6,Approved symbol,SP6,Sp6 transcription factor,HGNC:14530,17q21.32
RP1-35C21.1,0.010814374,HS6ST2,Approved symbol,HS6ST2,heparan sulfate 6-O-sulfotransferase 2,HGNC:19133,Xq26.2
DHRS4L2,0.010810677,RP1-35C21.1,Unmatched,DHRS4L2,,,
KIF24,-0.010794403,DHRS4L2,Approved symbol,DHRS4L2,dehydrogenase/reductase 4 like 2,HGNC:19731,14q11.2
SEMG1,-0.010794253,KIF24,Approved symbol,KIF24,kinesin family member 24,HGNC:19916,9p13.3
LINC01010,-0.010780199,SEMG1,Approved symbol,SEMG1,semenogelin 1,HGNC:10742,20q13.12
MKL1,-0.010775335,LINC01010,Approved symbol,LINC01010,long intergenic non-protein coding RNA 1010,HGNC:48978,6q23.2
ATF4,-0.010770903,MKL1,Previous symbol,MRTFA,myocardin related transcription factor A,HGNC:14334,22q13.1-q13.2
ASNS,-0.010763128,ATF4,Approved symbol,ATF4,activating transcription factor 4,HGNC:786,22q13.1
RP11-43N5.1,0.01075871,ASNS,Approved symbol,ASNS,asparagine synthetase (glutamine-hydrolyzing),HGNC:753,7q21.3
C19orf10,-0.010757906,RP11-43N5.1,Unmatched,C19orf10,,,
IGLV3-19,-0.010741918,C19orf10,Previous symbol,MYDGF,myeloid derived growth factor,HGNC:16948,19p13.3
RAP2C,-0.010740979,IGLV3-19,Approved symbol,IGLV3-19,immunoglobulin lambda variable 3-19,HGNC:5903,22q11.22
CFLAR,-0.010738838,RAP2C,Approved symbol,RAP2C,"RAP2C, member of RAS oncogene family",HGNC:21165,Xq26.2
AC104135.4,-0.010736361,CFLAR,Approved symbol,CFLAR,CASP8 and FADD like apoptosis regulator,HGNC:1876,2q33.1
ASS1P12,-0.010736139,ASS1P12,Approved symbol,ASS1P12,argininosuccinate synthetase 1 pseudogene 12,HGNC:762,9p21.1
SEPTIN9,-0.010735343,SEPTIN9,Approved symbol,SEPTIN9,septin 9,,
APPL1,0.010730634,APPL1,Approved symbol,APPL1,"adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1",HGNC:24035,3p14.3
RBMXL1,-0.010728505,RBMXL1,Approved symbol,RBMXL1,RBMX like 1,HGNC:25073,1p22.2
RP11-378A13.1,0.010723133,RP11-378A13.1,Unmatched,RP11-378A13.1,,,
SORD,-0.010722015,SORD,Approved symbol,SORD,sorbitol dehydrogenase,HGNC:11184,15q21.1
LRRC6,-0.010715223,LRRC6,Approved symbol,LRRC6,leucine rich repeat containing 6,HGNC:16725,8q24.22
SLC35F6,-0.010714439,SLC35F6,Approved symbol,SLC35F6,solute carrier family 35 member F6,HGNC:26055,2p23.3
ACTB,-0.010713259,ACTB,Approved symbol,ACTB,actin beta,HGNC:132,7p22.1
ITLN2,-0.010710807,ITLN2,Approved symbol,ITLN2,intelectin 2,HGNC:20599,1q23.3
ACPP,-0.010699774,ACPP,Previous symbol,ACP3,acid phosphatase 3,HGNC:125,3q22.1
IGLV1-41,-0.010699584,IGLV1-41,Approved symbol,IGLV1-41,immunoglobulin lambda variable 1-41 (pseudogene),HGNC:5878,22q11.22
UTP11L,-0.010698597,UTP11L,Previous symbol,UTP11,UTP11 small subunit processome component,HGNC:24329,1p34.3
CPE,0.010698478,CPE,Approved symbol,CPE,carboxypeptidase E,HGNC:2303,4q32.3
CTD-3074O7.12,0.010694548,CTD-3074O7.12,Unmatched,CTD-3074O7.12,,,
ACOXL,-0.010693521,ACOXL,Approved symbol,ACOXL,acyl-CoA oxidase like,HGNC:25621,2q13
KLK11,-0.010692129,KLK11,Approved symbol,KLK11,kallikrein related peptidase 11,HGNC:6359,19q13.41
TMPRSS3,-0.010691412,TMPRSS3,Approved symbol,TMPRSS3,transmembrane serine protease 3,HGNC:11877,21q22.3
MYRFL,-0.01068768,MYRFL,Approved symbol,MYRFL,myelin regulatory factor like,HGNC:26316,12q15
TMEM208,-0.010686749,TMEM208,Approved symbol,TMEM208,transmembrane protein 208,HGNC:25015,16q22.1
IGHV3-33,-0.010682617,IGHV3-33,Approved symbol,IGHV3-33,immunoglobulin heavy variable 3-33,HGNC:5596,14q32.33
SLC16A14,-0.010681981,SLC16A14,Approved symbol,SLC16A14,solute carrier family 16 member 14,HGNC:26417,2q36.3
MTRNR2L1,0.010681395,MTRNR2L1,Approved symbol,MTRNR2L1,MT-RNR2 like 1,HGNC:37155,17p11.2
PNLIPRP2,0.010678447,PNLIPRP2,Approved symbol,PNLIPRP2,pancreatic lipase related protein 2 (gene/pseudogene),HGNC:9157,10q25.3
RP11-1275H24.1,0.010676413,RP11-1275H24.1,Unmatched,RP11-1275H24.1,,,
GABRA4,-0.010675357,GABRA4,Approved symbol,GABRA4,gamma-aminobutyric acid type A receptor subunit alpha4,HGNC:4078,4p12
GNB2L1,0.010672445,GNB2L1,Previous symbol,RACK1,receptor for activated C kinase 1,HGNC:4399,5q35.3
SOX18,-0.010670306,SOX18,Approved symbol,SOX18,SRY-box transcription factor 18,HGNC:11194,20q13.33
MOSPD2,-0.01066893,MOSPD2,Approved symbol,MOSPD2,motile sperm domain containing 2,HGNC:28381,Xp22.2
ZNF775,0.010657656,ZNF775,Approved symbol,ZNF775,zinc finger protein 775,HGNC:28501,7q36.1
MROH6,-0.010655968,MROH6,Approved symbol,MROH6,maestro heat like repeat family member 6,HGNC:27814,8q24.3
ASS1P7,-0.010655823,ASS1P7,Approved symbol,ASS1P7,argininosuccinate synthetase 1 pseudogene 7,HGNC:770,3q26.32
GFRA3,0.010654627,GFRA3,Approved symbol,GFRA3,GDNF family receptor alpha 3,HGNC:4245,5q31.2
ASS1P11,-0.010650214,ASS1P11,Approved symbol,ASS1P11,argininosuccinate synthetase 1 pseudogene 11,HGNC:761,7p15.3
C1RL,-0.010649839,C1RL,Approved symbol,C1RL,complement C1r subcomponent like,HGNC:21265,12p13.31
AC009950.2,-0.010649252,AC009950.2,Unmatched,AC009950.2,,,
PKMP5,-0.010645555,PKMP5,Approved symbol,PKMP5,pyruvate kinase M1/2 pseudogene 5,HGNC:44247,6p25.1
TUBB2A,-0.010640389,TUBB2A,Approved symbol,TUBB2A,tubulin beta 2A class IIa,HGNC:12412,6p25.2
ULBP1,-0.01063862,ULBP1,Approved symbol,ULBP1,UL16 binding protein 1,HGNC:14893,6q25.1
AC091132.1,-0.010638608,AC091132.1,Unmatched,AC091132.1,,,
CLDN11,-0.010638189,CLDN11,Approved symbol,CLDN11,claudin 11,HGNC:8514,3q26.2
C1orf115,0.010635492,C1orf115,Approved symbol,C1orf115,chromosome 1 open reading frame 115,HGNC:25873,1q41
GSTM4,0.010631966,GSTM4,Approved symbol,GSTM4,glutathione S-transferase mu 4,HGNC:4636,1p13.3
RP11-675P14.1,0.010630547,RP11-675P14.1,Unmatched,RP11-675P14.1,,,
EEF1DP3,-0.010629565,EEF1DP3,Approved symbol,EEF1DP3,eukaryotic translation elongation factor 1 delta pseudogene 3,HGNC:30486,13q13.1
RP11-17M24.1,0.010624837,RP11-17M24.1,Unmatched,RP11-17M24.1,,,
CASP5,-0.010607822,CASP5,Approved symbol,CASP5,caspase 5,HGNC:1506,11q22.3
APIP,-0.010605261,APIP,Approved symbol,APIP,APAF1 interacting protein,HGNC:17581,11p13
RPS14,0.010599509,RPS14,Approved symbol,RPS14,ribosomal protein S14,HGNC:10387,5q33.1
APOL6,-0.010597078,APOL6,Approved symbol,APOL6,apolipoprotein L6,HGNC:14870,22q12.3
FAH,0.010592473,FAH,Approved symbol,FAH,fumarylacetoacetate hydrolase,HGNC:3579,15q25.1
PSMA1,-0.01058786,PSMA1,Approved symbol,PSMA1,proteasome 20S subunit alpha 1,HGNC:9530,11p15.2
PLA2G4D,-0.010581721,PLA2G4D,Approved symbol,PLA2G4D,phospholipase A2 group IVD,HGNC:30038,15q15.1
MTRNR2L10,0.010578334,MTRNR2L10,Approved symbol,MTRNR2L10,MT-RNR2 like 10,HGNC:37167,Xp11.21
PLEK2,-0.010576388,PLEK2,Approved symbol,PLEK2,pleckstrin 2,HGNC:19238,14q23.3-q24.1
HEPHL1,-0.010573985,HEPHL1,Approved symbol,HEPHL1,hephaestin like 1,HGNC:30477,11q21
RP11-750B16.1,0.010566263,RP11-750B16.1,Unmatched,RP11-750B16.1,,,
NPLOC4,-0.010559997,NPLOC4,Approved symbol,NPLOC4,"NPL4 homolog, ubiquitin recognition factor",HGNC:18261,17q25.3
HIST1H2BC,-0.010559815,HIST1H2BC,Previous symbol,H2BC4,H2B clustered histone 4,HGNC:4757,6p22.2
CASP10,-0.010546677,CASP10,Approved symbol,CASP10,caspase 10,HGNC:1500,2q33.1
REPS1,0.010540276,REPS1,Approved symbol,REPS1,RALBP1 associated Eps domain containing 1,HGNC:15578,6q24.1
CTD-2619J13.3,0.010531318,CTD-2619J13.3,Unmatched,CTD-2619J13.3,,,
AEN,-0.010529429,AEN,Approved symbol,AEN,apoptosis enhancing nuclease,HGNC:25722,15q26.1
RP11-423G4.7,0.010526525,RP11-423G4.7,Unmatched,RP11-423G4.7,,,
IRG1,-0.010509145,IRG1,Previous symbol,ACOD1,aconitate decarboxylase 1,HGNC:33904,13q22.3
RP11-7K24.3,-0.010508329,RP11-7K24.3,Unmatched,RP11-7K24.3,,,
TXLNA,-0.010506683,TXLNA,Approved symbol,TXLNA,taxilin alpha,HGNC:30685,1p35.2
COL2A1,0.010502639,COL2A1,Approved symbol,COL2A1,collagen type II alpha 1 chain,HGNC:2200,12q13.11
ZNF600,0.010499763,ZNF600,Approved symbol,ZNF600,zinc finger protein 600,HGNC:30951,19q13.42
SS18,-0.010497079,SS18,Approved symbol,SS18,SS18 subunit of BAF chromatin remodeling complex,HGNC:11340,18q11.2
LDLR,-0.010494093,LDLR,Approved symbol,LDLR,low density lipoprotein receptor,HGNC:6547,19p13.2
ZNF610,0.010487852,ZNF610,Approved symbol,ZNF610,zinc finger protein 610,HGNC:26687,19q13.41
PIM3,-0.01048768,PIM3,Approved symbol,PIM3,"Pim-3 proto-oncogene, serine/threonine kinase",HGNC:19310,22q13.33
TYSND1,0.010485655,TYSND1,Approved symbol,TYSND1,trypsin like peroxisomal matrix peptidase 1,HGNC:28531,10q22.1
DCP1B,0.010482834,DCP1B,Approved symbol,DCP1B,decapping mRNA 1B,HGNC:24451,12p13.33
S100A11P2,-0.010465869,S100A11P2,Approved symbol,S100A11P2,S100A11 pseudogene 2,HGNC:37840,7p14.2
MTRNR2L8,0.010463329,MTRNR2L8,Approved symbol,MTRNR2L8,MT-RNR2 like 8,HGNC:37165,11p15.4
SRP54,-0.010461553,SRP54,Approved symbol,SRP54,signal recognition particle 54,HGNC:11301,14q13.2
AC092569.2,0.010458568,AC092569.2,Unmatched,AC092569.2,,,
HYAL1,-0.010457131,HYAL1,Approved symbol,HYAL1,hyaluronidase 1,HGNC:5320,3p21.31
RP11-305L7.7,0.010441331,RP11-305L7.7,Unmatched,RP11-305L7.7,,,
HOXA5,0.010439337,HOXA5,Approved symbol,HOXA5,homeobox A5,HGNC:5106,7p15.2
KLHL13,0.010427839,KLHL13,Approved symbol,KLHL13,kelch like family member 13,HGNC:22931,Xq24
CRB1,0.010424201,CRB1,Approved symbol,CRB1,crumbs cell polarity complex component 1,HGNC:2343,1q31.3
ANXA3,-0.010422211,ANXA3,Approved symbol,ANXA3,annexin A3,HGNC:541,4q21.21
RPS15AP11,0.01041608,RPS15AP11,Approved symbol,RPS15AP11,ribosomal protein S15a pseudogene 11,HGNC:36707,1p34.1
TPD52L2,-0.010412418,TPD52L2,Approved symbol,TPD52L2,TPD52 like 2,HGNC:12007,20q13.33
LINC00670,0.010411524,LINC00670,Approved symbol,LINC00670,long intergenic non-protein coding RNA 670,HGNC:44338,17p12
MIR589,-0.010408518,MIR589,Approved symbol,MIR589,microRNA 589,HGNC:32845,7p22.1
IGHV3-74,-0.010384629,IGHV3-74,Approved symbol,IGHV3-74,immunoglobulin heavy variable 3-74,HGNC:5624,14q32.33
ZNF432,0.010382789,ZNF432,Approved symbol,ZNF432,zinc finger protein 432,HGNC:20810,19q13.41
SAT1,-0.010382672,SAT1,Approved symbol,SAT1,spermidine/spermine N1-acetyltransferase 1,HGNC:10540,Xp22.11
RP11-382M14.1,-0.01038241,RP11-382M14.1,Unmatched,RP11-382M14.1,,,
RP11-219C20.3,0.010378718,RP11-219C20.3,Unmatched,RP11-219C20.3,,,
MT1L,0.010377638,MT1L,Approved symbol,MT1L,"metallothionein 1L, pseudogene",HGNC:7404,16q13
ASRGL1,-0.01037572,ASRGL1,Approved symbol,ASRGL1,asparaginase and isoaspartyl peptidase 1,HGNC:16448,11q12.3
PGM3,-0.010370462,PGM3,Approved symbol,PGM3,phosphoglucomutase 3,HGNC:8907,6q14.1
IGLV3-22,-0.010369392,IGLV3-22,Approved symbol,IGLV3-22,immunoglobulin lambda variable 3-22,HGNC:5906,22q11.22
RNF208,0.010367808,RNF208,Approved symbol,RNF208,ring finger protein 208,HGNC:25420,9q34.3
SERPINB1,-0.010366215,SERPINB1,Approved symbol,SERPINB1,serpin family B member 1,HGNC:3311,6p25.2
ZNF697,-0.010365706,ZNF697,Approved symbol,ZNF697,zinc finger protein 697,HGNC:32034,1p12
RP11-887P2.3,-0.010362295,RP11-887P2.3,Unmatched,RP11-887P2.3,,,
YARS,-0.010359814,YARS,Previous symbol,YARS1,tyrosyl-tRNA synthetase 1,HGNC:12840,1p35.1
ZNFX1,-0.010359396,ZNFX1,Approved symbol,ZNFX1,zinc finger NFX1-type containing 1,HGNC:29271,20q13.13
MCM3AP,-0.010358866,MCM3AP,Approved symbol,MCM3AP,minichromosome maintenance complex component 3 associated protein,HGNC:6946,21q22.3
MTDH,-0.010358766,MTDH,Approved symbol,MTDH,metadherin,HGNC:29608,8q22.1
HAT1,-0.010357693,HAT1,Approved symbol,HAT1,histone acetyltransferase 1,HGNC:4821,2q31.1
OSER1-AS1,0.010353655,OSER1-AS1,Previous symbol,OSER1-DT,OSER1 divergent transcript,HGNC:48585,20q13.12
BID,-0.010344155,BID,Approved symbol,BID,BH3 interacting domain death agonist,HGNC:1050,22q11.21
RP11-10B2.1,0.010339669,RP11-10B2.1,Unmatched,RP11-10B2.1,,,
AC053503.4,0.010335173,AC053503.4,Unmatched,AC053503.4,,,
SIRT3,0.010331466,SIRT3,Approved symbol,SIRT3,sirtuin 3,HGNC:14931,11p15.5
TIPARP-AS1,0.010329787,TIPARP-AS1,Approved symbol,TIPARP-AS1,TIPARP antisense RNA 1,HGNC:41028,3q25.31
IGLV5-45,-0.010323621,IGLV5-45,Approved symbol,IGLV5-45,immunoglobulin lambda variable 5-45,HGNC:5924,22q11.22
WAC-AS1,0.010317474,WAC-AS1,Approved symbol,WAC-AS1,WAC antisense RNA 1 (head to head),HGNC:27347,10p12.1
PGM2,-0.010315556,PGM2,Approved symbol,PGM2,phosphoglucomutase 2,HGNC:8906,4p14
CD59,-0.010313968,CD59,Approved symbol,CD59,CD59 molecule (CD59 blood group),HGNC:1689,11p13
CSRNP3,0.010309337,CSRNP3,Approved symbol,CSRNP3,cysteine and serine rich nuclear protein 3,HGNC:30729,2q24.3
ART1,0.01030892,ART1,Approved symbol,ART1,ADP-ribosyltransferase 1,HGNC:723,11p15.4
AC012363.4,-0.010302136,AC012363.4,Unmatched,AC012363.4,,,
PRUNE2,-0.010292015,PRUNE2,Approved symbol,PRUNE2,prune homolog 2 with BCH domain,HGNC:25209,9q21.2
CCDC85A,0.010291609,CCDC85A,Approved symbol,CCDC85A,coiled-coil domain containing 85A,HGNC:29400,2p16.1
IARS,-0.010282656,IARS,Previous symbol,IARS1,isoleucyl-tRNA synthetase 1,HGNC:5330,9q22.31
COL4A2-AS1,0.010281464,COL4A2-AS1,Approved symbol,COL4A2-AS1,COL4A2 antisense RNA 1,HGNC:40156,13q34
RP11-809O17.1,-0.010274451,RP11-809O17.1,Unmatched,RP11-809O17.1,,,
HELZ2,-0.010264966,HELZ2,Approved symbol,HELZ2,helicase with zinc finger 2,HGNC:30021,20q13.33
CPEB4,-0.010263309,CPEB4,Approved symbol,CPEB4,cytoplasmic polyadenylation element binding protein 4,HGNC:21747,5q35.2
AC002055.4,-0.010262803,AC002055.4,Unmatched,AC002055.4,,,
CASP8,-0.01025965,CASP8,Approved symbol,CASP8,caspase 8,HGNC:1509,2q33.1
TECTB,-0.010258889,TECTB,Approved symbol,TECTB,tectorin beta,HGNC:11721,10q25.2
SMAD7,0.010257582,SMAD7,Approved symbol,SMAD7,SMAD family member 7,HGNC:6773,18q21.1
EIF2S1,-0.010255717,EIF2S1,Approved symbol,EIF2S1,eukaryotic translation initiation factor 2 subunit alpha,HGNC:3265,14q23.3
ING5,0.010254261,ING5,Approved symbol,ING5,inhibitor of growth family member 5,HGNC:19421,2q37.3
ZNF571-AS1,0.010252163,ZNF571-AS1,Approved symbol,ZNF571-AS1,ZNF571 antisense RNA 1,HGNC:44324,19q13.12
C14orf144,0.010250699,C14orf144,Previous symbol,LINC02691,long intergenic non-protein coding RNA 2691,HGNC:20358,14q32.33
RP11-768F21.1,-0.010249897,RP11-768F21.1,Unmatched,RP11-768F21.1,,,
IGLV2-14,-0.010248279,IGLV2-14,Approved symbol,IGLV2-14,immunoglobulin lambda variable 2-14,HGNC:5888,22q11.22
NANOGP7,-0.010245868,NANOGP7,Approved symbol,NANOGP7,Nanog homeobox pseudogene 7,HGNC:23105,14q32.12
RP4-657E11.10,0.010243018,RP4-657E11.10,Unmatched,RP4-657E11.10,,,
RP4-671G15.2,0.010229469,RP4-671G15.2,Unmatched,RP4-671G15.2,,,
PRKAR1A,-0.010227404,PRKAR1A,Approved symbol,PRKAR1A,protein kinase cAMP-dependent type I regulatory subunit alpha,HGNC:9388,17q24.2
TPO,-0.010227355,TPO,Approved symbol,TPO,thyroid peroxidase,HGNC:12015,2p25.3
ZNF577,0.010210201,ZNF577,Approved symbol,ZNF577,zinc finger protein 577,HGNC:28673,19q13.41
TMEM245,0.010209513,TMEM245,Approved symbol,TMEM245,transmembrane protein 245,HGNC:1363,9q31.3
AGPAT6,-0.010208315,AGPAT6,Previous symbol,GPAT4,glycerol-3-phosphate acyltransferase 4,HGNC:20880,8p11.21
BEND7,0.01020746,BEND7,Approved symbol,BEND7,BEN domain containing 7,HGNC:23514,10p13
DMAP1,0.010198939,DMAP1,Approved symbol,DMAP1,DNA methyltransferase 1 associated protein 1,HGNC:18291,1p34.1
SLC5A3,0.010198217,SLC5A3,Approved symbol,SLC5A3,solute carrier family 5 member 3,HGNC:11038,21q22.11
IGKV2D-29,-0.010195245,IGKV2D-29,Approved symbol,IGKV2D-29,immunoglobulin kappa variable 2D-29,HGNC:5800,2p11.2
SBSN,-0.010193364,SBSN,Approved symbol,SBSN,suprabasin,HGNC:24950,19q13.12
RIMS2,0.010190288,RIMS2,Approved symbol,RIMS2,regulating synaptic membrane exocytosis 2,HGNC:17283,8q22.3
IPO11,-0.010189319,IPO11,Approved symbol,IPO11,importin 11,HGNC:20628,5q12.1
GTF2IRD2B,0.010187168,GTF2IRD2B,Approved symbol,GTF2IRD2B,GTF2I repeat domain containing 2B,HGNC:33125,7q11.23
CCDC104,-0.010186384,CCDC104,Previous symbol,CFAP36,cilia and flagella associated protein 36,HGNC:30540,2p16.1
RP11-767N6.7,0.010180777,RP11-767N6.7,Unmatched,RP11-767N6.7,,,
DNAJC1,-0.010180312,DNAJC1,Approved symbol,DNAJC1,DnaJ heat shock protein family (Hsp40) member C1,HGNC:20090,10p12.31
PSME1,-0.010145753,PSME1,Approved symbol,PSME1,proteasome activator subunit 1,HGNC:9568,14q12
LACTB2,-0.010142613,LACTB2,Approved symbol,LACTB2,lactamase beta 2,HGNC:18512,8q13.3
FGF11,-0.01013751,FGF11,Approved symbol,FGF11,fibroblast growth factor 11,HGNC:3667,17p13.1
CHRM4,-0.010133423,CHRM4,Approved symbol,CHRM4,cholinergic receptor muscarinic 4,HGNC:1953,11p11.2
RP11-373D23.3,0.010132598,RP11-373D23.3,Unmatched,RP11-373D23.3,,,
CCRN4L,-0.010130631,CCRN4L,Previous symbol,NOCT,nocturnin,HGNC:14254,4q31.1
RPL11,0.010129837,RPL11,Approved symbol,RPL11,ribosomal protein L11,HGNC:10301,1p36.11
RP6-201G10.2,0.01012633,RP6-201G10.2,Unmatched,RP6-201G10.2,,,
KB-431C1.4,0.010126075,KB-431C1.4,Unmatched,KB-431C1.4,,,
GJB5,-0.010122319,GJB5,Approved symbol,GJB5,gap junction protein beta 5,HGNC:4287,1p34.3
CSRNP1,-0.010120698,CSRNP1,Approved symbol,CSRNP1,cysteine and serine rich nuclear protein 1,HGNC:14300,3p22.2
SLC30A7,-0.010120232,SLC30A7,Approved symbol,SLC30A7,solute carrier family 30 member 7,HGNC:19306,1p21.2
MAST4-AS1,0.010116623,MAST4-AS1,Approved symbol,MAST4-AS1,MAST4 antisense RNA 1,HGNC:40865,5q12.3
ADAMTS1,-0.010112071,ADAMTS1,Approved symbol,ADAMTS1,ADAM metallopeptidase with thrombospondin type 1 motif 1,HGNC:217,21q21.3
PIEZO1,-0.010101679,PIEZO1,Approved symbol,PIEZO1,piezo type mechanosensitive ion channel component 1,HGNC:28993,16q24.3
G0S2,-0.010100005,G0S2,Approved symbol,G0S2,G0/G1 switch 2,HGNC:30229,1q32.2
NUP50,-0.010099432,NUP50,Approved symbol,NUP50,nucleoporin 50,HGNC:8065,22q13.31
EEF2K,0.010088537,EEF2K,Approved symbol,EEF2K,eukaryotic elongation factor 2 kinase,HGNC:24615,16p12.2
RPN1,-0.010087151,RPN1,Approved symbol,RPN1,ribophorin I,HGNC:10381,3q21.3
EDEM2,-0.010085484,EDEM2,Approved symbol,EDEM2,ER degradation enhancing alpha-mannosidase like protein 2,HGNC:15877,20q11.22
C2orf61,-0.010080189,C2orf61,Previous symbol,STPG4,sperm-tail PG-rich repeat containing 4,HGNC:26850,2p21
CCDC93,0.010076833,CCDC93,Approved symbol,CCDC93,coiled-coil domain containing 93,HGNC:25611,2q14.1
ZNF329,0.010072328,ZNF329,Approved symbol,ZNF329,zinc finger protein 329,HGNC:14209,19q13.43
RPL30,0.010068817,RPL30,Approved symbol,RPL30,ribosomal protein L30,HGNC:10333,8q22.2
SLC36A4,-0.01006547,SLC36A4,Approved symbol,SLC36A4,solute carrier family 36 member 4,HGNC:19660,11q21
SEL1L3,-0.01006306,SEL1L3,Approved symbol,SEL1L3,SEL1L family member 3,HGNC:29108,4p15.2
MTRNR2L6,0.010060763,MTRNR2L6,Approved symbol,MTRNR2L6,MT-RNR2 like 6,HGNC:37163,7q34
GPD1,-0.010060489,GPD1,Approved symbol,GPD1,glycerol-3-phosphate dehydrogenase 1,HGNC:4455,12q13.12
ATP13A5,0.010058702,ATP13A5,Approved symbol,ATP13A5,ATPase 13A5,HGNC:31789,3q29
SNPH,-0.010056376,SNPH,Approved symbol,SNPH,syntaphilin,HGNC:15931,20p13
KLK12,-0.010056148,KLK12,Approved symbol,KLK12,kallikrein related peptidase 12,HGNC:6360,19q13.41
USP14,-0.010051618,USP14,Approved symbol,USP14,ubiquitin specific peptidase 14,HGNC:12612,18p11.32
DLGAP1-AS2,-0.010046393,DLGAP1-AS2,Approved symbol,DLGAP1-AS2,DLGAP1 antisense RNA 2,HGNC:28146,18p11.31
MUM1,0.010038462,MUM1,Previous symbol,IRF4,interferon regulatory factor 4,HGNC:6119,6p25.3
NUS1,-0.010032957,NUS1,Approved symbol,NUS1,NUS1 dehydrodolichyl diphosphate synthase subunit,HGNC:21042,6q22.1
RP11-475J5.4,0.010018253,RP11-475J5.4,Unmatched,RP11-475J5.4,,,
ERCC4,-0.010017868,ERCC4,Approved symbol,ERCC4,"ERCC excision repair 4, endonuclease catalytic subunit",HGNC:3436,16p13.12
SLC26A4,-0.010015507,SLC26A4,Approved symbol,SLC26A4,solute carrier family 26 member 4,HGNC:8818,7q22.3
IGHV4-31,-0.010012641,IGHV4-31,Approved symbol,IGHV4-31,immunoglobulin heavy variable 4-31,HGNC:5649,14q32.33 not on reference assembly
ZFP41,0.010011095,ZFP41,Approved symbol,ZFP41,ZFP41 zinc finger protein,HGNC:26786,8q24.3
RP11-708H21.4,0.010010396,RP11-708H21.4,Unmatched,RP11-708H21.4,,,
FZD10,-0.01001034,FZD10,Approved symbol,FZD10,frizzled class receptor 10,HGNC:4039,12q24.33
CDKN2D,-0.010003211,CDKN2D,Approved symbol,CDKN2D,cyclin dependent kinase inhibitor 2D,HGNC:1790,19p13.2
LINC00910,0.009999999,LINC00910,Approved symbol,LINC00910,long intergenic non-protein coding RNA 910,HGNC:44361,17q21.31
SLC7A14,0.009995414,SLC7A14,Approved symbol,SLC7A14,solute carrier family 7 member 14,HGNC:29326,3q26.2
ANKRD22,-0.009994515,ANKRD22,Approved symbol,ANKRD22,ankyrin repeat domain 22,HGNC:28321,10q23.31
SLC18A3,0.009989366,SLC18A3,Approved symbol,SLC18A3,solute carrier family 18 member A3,HGNC:10936,10q11.23
MYO1B,-0.009968993,MYO1B,Approved symbol,MYO1B,myosin IB,HGNC:7596,2q32.3
ZNF12,0.009961115,ZNF12,Approved symbol,ZNF12,zinc finger protein 12,HGNC:12902,7p22.1
IGHV1OR15-3,-0.009959853,IGHV1OR15-3,Approved symbol,IGHV1OR15-3,immunoglobulin heavy variable 1/OR15-3 (pseudogene),HGNC:5565,15q11.2
SMARCAL1,-0.009947807,SMARCAL1,Approved symbol,SMARCAL1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1",HGNC:11102,2q35
CDH12,0.009946073,CDH12,Approved symbol,CDH12,cadherin 12,HGNC:1751,5p14.3
DESI1,-0.009934742,DESI1,Approved symbol,DESI1,desumoylating isopeptidase 1,HGNC:24577,22q13.2
WDR65,-0.009929643,WDR65,Previous symbol,CFAP57,cilia and flagella associated protein 57,HGNC:26485,1p34.2
RP11-254I22.3,-0.009926579,RP11-254I22.3,Unmatched,RP11-254I22.3,,,
FHL2,-0.009925065,FHL2,Approved symbol,FHL2,four and a half LIM domains 2,HGNC:3703,2q12.2
MSGN1,-0.009923875,MSGN1,Approved symbol,MSGN1,mesogenin 1,HGNC:14907,2p24.2
CFLAR-AS1,0.009921125,CFLAR-AS1,Approved symbol,CFLAR-AS1,CFLAR antisense RNA 1,HGNC:14437,2q33.1
SQLE,-0.009918435,SQLE,Approved symbol,SQLE,squalene epoxidase,HGNC:11279,8q24.13
PRKAB2,0.009908502,PRKAB2,Approved symbol,PRKAB2,protein kinase AMP-activated non-catalytic subunit beta 2,HGNC:9379,1q21.1
IL7,-0.009904809,IL7,Approved symbol,IL7,interleukin 7,HGNC:6023,8q21.13
STS,-0.009902653,STS,Approved symbol,STS,steroid sulfatase,HGNC:11425,Xp22.31
AGO2,-0.009892791,AGO2,Approved symbol,AGO2,argonaute RISC catalytic component 2,HGNC:3263,8q24.3
HRK,0.009887676,HRK,Approved symbol,HRK,"harakiri, BCL2 interacting protein",HGNC:5185,12q24.22
FAM157B,-0.009887546,FAM157B,Approved symbol,FAM157B,family with sequence similarity 157 member B,HGNC:34080,9q34.3
RP11-466P24.2,-0.009885138,RP11-466P24.2,Unmatched,RP11-466P24.2,,,
PYGO2,0.009883536,PYGO2,Approved symbol,PYGO2,pygopus family PHD finger 2,HGNC:30257,1q21.3
CRTC1,0.009866984,CRTC1,Approved symbol,CRTC1,CREB regulated transcription coactivator 1,HGNC:16062,19p13.11
RP11-944C7.1,0.009856528,RP11-944C7.1,Unmatched,RP11-944C7.1,,,
MAFF,-0.009854315,MAFF,Approved symbol,MAFF,MAF bZIP transcription factor F,HGNC:6780,22q13.1
MT1HL1,0.009853796,MT1HL1,Approved symbol,MT1HL1,metallothionein 1H like 1,HGNC:31864,1q43
ARMCX3,-0.009847794,ARMCX3,Approved symbol,ARMCX3,armadillo repeat containing X-linked 3,HGNC:24065,Xq22.1
PDIA3,-0.009844846,PDIA3,Approved symbol,PDIA3,protein disulfide isomerase family A member 3,HGNC:4606,15q15.3
SPACA3,0.009836547,SPACA3,Approved symbol,SPACA3,sperm acrosome associated 3,HGNC:16260,17q11.2
SCUBE2,0.009835328,SCUBE2,Approved symbol,SCUBE2,"signal peptide, CUB domain and EGF like domain containing 2",HGNC:30425,11p15.4
SSR4,-0.00983093,SSR4,Approved symbol,SSR4,signal sequence receptor subunit 4,HGNC:11326,Xq28
IFNGR1,-0.009823952,IFNGR1,Approved symbol,IFNGR1,interferon gamma receptor 1,HGNC:5439,6q23.3
RP11-475J5.6,0.009818566,RP11-475J5.6,Unmatched,RP11-475J5.6,,,
FKBP5,-0.009816926,FKBP5,Approved symbol,FKBP5,FKBP prolyl isomerase 5,HGNC:3721,6p21.31
CTD-2245E15.3,-0.009815705,CTD-2245E15.3,Unmatched,CTD-2245E15.3,,,
C12orf23,-0.009809565,C12orf23,Previous symbol,TMEM263,transmembrane protein 263,HGNC:28281,12q23.3
TMEM39A,-0.009803819,TMEM39A,Approved symbol,TMEM39A,transmembrane protein 39A,HGNC:25600,3q13.33
ECHDC2,0.009801407,ECHDC2,Approved symbol,ECHDC2,enoyl-CoA hydratase domain containing 2,HGNC:23408,1p32.3
MTATP6P2,0.009799408,MTATP6P2,Approved symbol,MTATP6P2,MT-ATP6 pseudogene 2,HGNC:44576,5q21.1
RP3-510L9.1,0.009798924,RP3-510L9.1,Unmatched,RP3-510L9.1,,,
TBX20,-0.00979772,TBX20,Approved symbol,TBX20,T-box transcription factor 20,HGNC:11598,7p14.2
SRP68,-0.009785306,SRP68,Approved symbol,SRP68,signal recognition particle 68,HGNC:11302,17q25.1
UGGT2,-0.009777964,UGGT2,Approved symbol,UGGT2,UDP-glucose glycoprotein glucosyltransferase 2,HGNC:15664,13q32.1
SULT2A1,0.009775608,SULT2A1,Approved symbol,SULT2A1,sulfotransferase family 2A member 1,HGNC:11458,19q13.33
BMPR1B,0.009774042,BMPR1B,Approved symbol,BMPR1B,bone morphogenetic protein receptor type 1B,HGNC:1077,4q22.3
RP5-857K21.7,0.009766959,RP5-857K21.7,Unmatched,RP5-857K21.7,,,
CFL1P6,0.009762901,CFL1P6,Approved symbol,CFL1P6,cofilin 1 pseudogene 6,HGNC:34545,1p36.22
E2F3,-0.009760426,E2F3,Approved symbol,E2F3,E2F transcription factor 3,HGNC:3115,6p22.3
XXYLT1-AS2,-0.009760001,XXYLT1-AS2,Approved symbol,XXYLT1-AS2,XXYLT1 antisense RNA 2,HGNC:41154,3q29
ADAMTS13,0.009758743,ADAMTS13,Approved symbol,ADAMTS13,ADAM metallopeptidase with thrombospondin type 1 motif 13,HGNC:1366,9q34.2
GSG1L,0.009755462,GSG1L,Approved symbol,GSG1L,GSG1 like,HGNC:28283,16p12.1
IKBKG,-0.009754231,IKBKG,Approved symbol,IKBKG,inhibitor of nuclear factor kappa B kinase regulatory subunit gamma,HGNC:5961,Xq28
AC093847.1,0.009751702,AC093847.1,Unmatched,AC093847.1,,,
IGLV3-12,-0.009751174,IGLV3-12,Approved symbol,IGLV3-12,immunoglobulin lambda variable 3-12,HGNC:5898,22q11.22
PDIA3P,-0.00974226,PDIA3P,Previous symbol,PDIA3P1,protein disulfide isomerase family A member 3 pseudogene 1,HGNC:4607,1q21.1
TNFAIP1,-0.009738912,TNFAIP1,Approved symbol,TNFAIP1,TNF alpha induced protein 1,HGNC:11894,17q11.2
AF127577.8,0.009738237,AF127577.8,Unmatched,AF127577.8,,,
HKR1,0.009735913,HKR1,Previous symbol,ZNF875,zinc finger protein 875,HGNC:4928,19q13.12
ENC1,-0.009735892,ENC1,Approved symbol,ENC1,ectodermal-neural cortex 1,HGNC:3345,5q13.3
GAD1,-0.009730436,GAD1,Approved symbol,GAD1,glutamate decarboxylase 1,HGNC:4092,2q31.1
CACNA2D4,0.009722698,CACNA2D4,Approved symbol,CACNA2D4,calcium voltage-gated channel auxiliary subunit alpha2delta 4,HGNC:20202,12p13.33
AIF1L,-0.00971371,AIF1L,Approved symbol,AIF1L,allograft inflammatory factor 1 like,HGNC:28904,9q34.12-q34.13
PLA2G4E,-0.009704972,PLA2G4E,Approved symbol,PLA2G4E,phospholipase A2 group IVE,HGNC:24791,15q15.1
SLC30A4,0.009697089,SLC30A4,Approved symbol,SLC30A4,solute carrier family 30 member 4,HGNC:11015,15q21.1
FGF9,0.00969441,FGF9,Approved symbol,FGF9,fibroblast growth factor 9,HGNC:3687,13q12.11
SEMA3D,0.009692949,SEMA3D,Approved symbol,SEMA3D,semaphorin 3D,HGNC:10726,7q21.11
XPA,0.009690558,XPA,Approved symbol,XPA,"XPA, DNA damage recognition and repair factor",HGNC:12814,9q22.33
TGS1,-0.009689559,TGS1,Approved symbol,TGS1,trimethylguanosine synthase 1,HGNC:17843,8q12.1
RNF145,-0.009679321,RNF145,Approved symbol,RNF145,ring finger protein 145,HGNC:20853,5q33.3
AC011747.6,0.009678766,AC011747.6,Unmatched,AC011747.6,,,
OGFOD1,-0.009676502,OGFOD1,Approved symbol,OGFOD1,2-oxoglutarate and iron dependent oxygenase domain containing 1,HGNC:25585,16q13
ZNF250,0.009670884,ZNF250,Approved symbol,ZNF250,zinc finger protein 250,HGNC:13044,8q24.3
CHN2,0.00966703,CHN2,Approved symbol,CHN2,chimerin 2,HGNC:1944,7p14.3
GSTP1,-0.009658866,GSTP1,Approved symbol,GSTP1,glutathione S-transferase pi 1,HGNC:4638,11q13.2
ATP1A1OS,0.009658492,ATP1A1OS,Previous symbol,ATP1A1-AS1,ATP1A1 antisense RNA 1,HGNC:28262,1p13.1
HNRNPA1P33,0.009652163,HNRNPA1P33,Approved symbol,HNRNPA1P33,heterogeneous nuclear ribonucleoprotein A1 pseudogene 33,HGNC:44990,10q11.22
L3MBTL2,-0.009646937,L3MBTL2,Approved symbol,L3MBTL2,L3MBTL histone methyl-lysine binding protein 2,HGNC:18594,22q13.2
STAB2,0.009642137,STAB2,Approved symbol,STAB2,stabilin 2,HGNC:18629,12q23.3
CAPZA1,-0.009632551,CAPZA1,Approved symbol,CAPZA1,capping actin protein of muscle Z-line subunit alpha 1,HGNC:1488,1p13.2
PAAF1,0.009632041,PAAF1,Approved symbol,PAAF1,proteasomal ATPase associated factor 1,HGNC:25687,11q13.4
PLAUR,-0.009620218,PLAUR,Approved symbol,PLAUR,"plasminogen activator, urokinase receptor",HGNC:9053,19q13
CERK,0.009617841,CERK,Approved symbol,CERK,ceramide kinase,HGNC:19256,22q13.31
MMP24,0.009614657,MMP24,Approved symbol,MMP24,matrix metallopeptidase 24,HGNC:7172,20q11.22
RP11-352E6.2,0.009609752,RP11-352E6.2,Unmatched,RP11-352E6.2,,,
FOLR3,-0.009606138,FOLR3,Approved symbol,FOLR3,folate receptor gamma,HGNC:3795,11q13.4
PPT2,0.009603733,PPT2,Approved symbol,PPT2,palmitoyl-protein thioesterase 2,HGNC:9326,6p21.32
MT1CP,0.009593692,MT1CP,Approved symbol,MT1CP,"metallothionein 1C, pseudogene",HGNC:7395,16q13
PRSS27,-0.009585196,PRSS27,Approved symbol,PRSS27,serine protease 27,HGNC:15475,16p13.3
TMEM214,-0.009577022,TMEM214,Approved symbol,TMEM214,transmembrane protein 214,HGNC:25983,2p23.3
KB-1991G8.1,0.009553578,KB-1991G8.1,Unmatched,KB-1991G8.1,,,
OTUB2,-0.009549048,OTUB2,Approved symbol,OTUB2,"OTU deubiquitinase, ubiquitin aldehyde binding 2",HGNC:20351,14q32.12
WFDC12,-0.009543272,WFDC12,Approved symbol,WFDC12,WAP four-disulfide core domain 12,HGNC:16115,20q13.12
RP1-212P9.2,-0.009542013,RP1-212P9.2,Unmatched,RP1-212P9.2,,,
RP11-461G12.2,0.009540814,RP11-461G12.2,Unmatched,RP11-461G12.2,,,
IFI35,-0.009530875,IFI35,Approved symbol,IFI35,interferon induced protein 35,HGNC:5399,17q21.31
RP11-299G20.2,0.009529775,RP11-299G20.2,Unmatched,RP11-299G20.2,,,
MT1A,0.009528946,MT1A,Approved symbol,MT1A,metallothionein 1A,HGNC:7393,16q13
NOMO2,-0.009515603,NOMO2,Approved symbol,NOMO2,NODAL modulator 2,HGNC:22652,16p12.3
PUS7L,-0.009501748,PUS7L,Approved symbol,PUS7L,pseudouridine synthase 7 like,HGNC:25276,12q12
RP11-400K9.4,-0.009501459,RP11-400K9.4,Unmatched,RP11-400K9.4,,,
RP11-244O19.1,0.009489562,RP11-244O19.1,Unmatched,RP11-244O19.1,,,
ZNF33B,0.009484285,ZNF33B,Approved symbol,ZNF33B,zinc finger protein 33B,HGNC:13097,10q11.21
APOBEC3C,0.00947639,APOBEC3C,Approved symbol,APOBEC3C,apolipoprotein B mRNA editing enzyme catalytic subunit 3C,HGNC:17353,22q13.1
ZNF169,0.009461779,ZNF169,Approved symbol,ZNF169,zinc finger protein 169,HGNC:12957,9q22.32
IGLV1-47,-0.009458311,IGLV1-47,Approved symbol,IGLV1-47,immunoglobulin lambda variable 1-47,HGNC:5880,22q11.22
GALNT2,-0.009458303,GALNT2,Approved symbol,GALNT2,polypeptide N-acetylgalactosaminyltransferase 2,HGNC:4124,1q42.13
VAV2,0.009457587,VAV2,Approved symbol,VAV2,vav guanine nucleotide exchange factor 2,HGNC:12658,9q34.2
LRRC8E,-0.009453751,LRRC8E,Approved symbol,LRRC8E,leucine rich repeat containing 8 VRAC subunit E,HGNC:26272,19p13.2
RNF220,0.009436078,RNF220,Approved symbol,RNF220,ring finger protein 220,HGNC:25552,1p34.1
ZSWIM3,0.009435172,ZSWIM3,Approved symbol,ZSWIM3,zinc finger SWIM-type containing 3,HGNC:16157,20q13.12
RP11-357C3.3,0.00942216,RP11-357C3.3,Unmatched,RP11-357C3.3,,,
RP11-617D20.1,0.0094209,RP11-617D20.1,Unmatched,RP11-617D20.1,,,
RCC1,-0.009412998,RCC1,Approved symbol,RCC1,regulator of chromosome condensation 1,HGNC:1913,1p35.3
AC104024.1,-0.009410322,AC104024.1,Unmatched,AC104024.1,,,
CARHSP1,-0.009410189,CARHSP1,Approved symbol,CARHSP1,calcium regulated heat stable protein 1,HGNC:17150,16p13.2
FAM151A,0.009404081,FAM151A,Approved symbol,FAM151A,family with sequence similarity 151 member A,HGNC:25032,1p32.3
CCL20,-0.009403964,CCL20,Approved symbol,CCL20,C-C motif chemokine ligand 20,HGNC:10619,2q36.3
RANP1,-0.009402806,RANP1,Approved symbol,RANP1,RAN pseudogene 1,HGNC:21631,6p22.1
ZNF846,0.009400963,ZNF846,Approved symbol,ZNF846,zinc finger protein 846,HGNC:27260,19p13.2
CD207,0.009395743,CD207,Approved symbol,CD207,CD207 molecule,HGNC:17935,2p13.3
PDZK1,0.00939462,PDZK1,Approved symbol,PDZK1,PDZ domain containing 1,HGNC:8821,1q21.1
ELOVL3,-0.009390313,ELOVL3,Approved symbol,ELOVL3,ELOVL fatty acid elongase 3,HGNC:18047,10q24.32
IGKV1D-43,-0.009384948,IGKV1D-43,Approved symbol,IGKV1D-43,immunoglobulin kappa variable 1D-43,HGNC:5758,2p11.2
SCT,0.009383827,SCT,Approved symbol,SCT,secretin,HGNC:10607,11p15.5
TRIM45,0.009381026,TRIM45,Approved symbol,TRIM45,tripartite motif containing 45,HGNC:19018,1p13.1
RP5-1011O1.2,-0.00937817,RP5-1011O1.2,Unmatched,RP5-1011O1.2,,,
ZNF737,0.00937706,ZNF737,Approved symbol,ZNF737,zinc finger protein 737,HGNC:32468,19p12
IL36RN,-0.009364331,IL36RN,Approved symbol,IL36RN,interleukin 36 receptor antagonist,HGNC:15561,2q14.1
GS1-393G12.12,0.009364101,GS1-393G12.12,Unmatched,GS1-393G12.12,,,
CRIPAK,0.00935557,CRIPAK,Entry withdrawn,CRIPAK,,HGNC:26619,
TNFSF9,-0.009355112,TNFSF9,Approved symbol,TNFSF9,TNF superfamily member 9,HGNC:11939,19p13.3
PGM2L1,-0.009354654,PGM2L1,Approved symbol,PGM2L1,phosphoglucomutase 2 like 1,HGNC:20898,11q13.4
GMPPA,-0.00935416,GMPPA,Approved symbol,GMPPA,GDP-mannose pyrophosphorylase A,HGNC:22923,2q35
PNMA1,-0.009350322,PNMA1,Approved symbol,PNMA1,PNMA family member 1,HGNC:9158,14q24.3
PGAP1,0.009348232,PGAP1,Approved symbol,PGAP1,post-GPI attachment to proteins inositol deacylase 1,HGNC:25712,2q33.1
ING4,0.009340634,ING4,Approved symbol,ING4,inhibitor of growth family member 4,HGNC:19423,12p13.31
AK7,-0.009334375,AK7,Approved symbol,AK7,adenylate kinase 7,HGNC:20091,14q32.2
STAT3,-0.009330759,STAT3,Approved symbol,STAT3,signal transducer and activator of transcription 3,HGNC:11364,17q21.2
MAN1A2,-0.009330067,MAN1A2,Approved symbol,MAN1A2,mannosidase alpha class 1A member 2,HGNC:6822,1p12
RP11-140I16.3,0.009329308,RP11-140I16.3,Unmatched,RP11-140I16.3,,,
CABP4,-0.009327169,CABP4,Approved symbol,CABP4,calcium binding protein 4,HGNC:1386,11q13.2
NISCH,0.009318921,NISCH,Approved symbol,NISCH,nischarin,HGNC:18006,3p21.1
FOXN3-AS1,0.009317265,FOXN3-AS1,Approved symbol,FOXN3-AS1,FOXN3 antisense RNA 1,HGNC:44290,14q32.11
DDX60L,-0.00931647,DDX60L,Approved symbol,DDX60L,DExD/H-box 60 like,HGNC:26429,4q32.3
ZSCAN12P1,-0.009298328,ZSCAN12P1,Approved symbol,ZSCAN12P1,zinc finger and SCAN domain containing 12 pseudogene 1,HGNC:13850,6p22.1
HLA-E,-0.009295888,HLA-E,Approved symbol,HLA-E,"major histocompatibility complex, class I, E",HGNC:4962,6p22.1
RP11-545I5.3,0.009295187,RP11-545I5.3,Unmatched,RP11-545I5.3,,,
IL17C,-0.009285213,IL17C,Approved symbol,IL17C,interleukin 17C,HGNC:5983,16q24.2
CRYBB2,0.009278659,CRYBB2,Approved symbol,CRYBB2,crystallin beta B2,HGNC:2398,22q11.23
XXyac-YM21GA2.7,0.009273915,XXyac-YM21GA2.7,Unmatched,XXyac-YM21GA2.7,,,
RP5-1142J19.1,-0.009272165,RP5-1142J19.1,Unmatched,RP5-1142J19.1,,,
LINC00959,0.009271403,LINC00959,Previous symbol,C10orf143,chromosome 10 open reading frame 143,HGNC:48677,10q26.3
TRIM21,-0.009269514,TRIM21,Approved symbol,TRIM21,tripartite motif containing 21,HGNC:11312,11p15.4
ANXA4,-0.009268659,ANXA4,Approved symbol,ANXA4,annexin A4,HGNC:542,2p13.3
FAM53B,0.00926504,FAM53B,Approved symbol,FAM53B,family with sequence similarity 53 member B,HGNC:28968,10q26.13
CLIP1,-0.009254857,CLIP1,Approved symbol,CLIP1,CAP-Gly domain containing linker protein 1,HGNC:10461,12q24.31
AP001062.7,0.009251074,AP001062.7,Unmatched,AP001062.7,,,
RP11-1000B6.5,-0.009247099,RP11-1000B6.5,Unmatched,RP11-1000B6.5,,,
MPPED2,0.009243024,MPPED2,Approved symbol,MPPED2,metallophosphoesterase domain containing 2,HGNC:1180,11p14.1
SHH,-0.009241767,SHH,Approved symbol,SHH,sonic hedgehog signaling molecule,HGNC:10848,7q36.3
CRYBB3,0.009235791,CRYBB3,Approved symbol,CRYBB3,crystallin beta B3,HGNC:2400,22q11.23
AZGP1,-0.009232705,AZGP1,Approved symbol,AZGP1,"alpha-2-glycoprotein 1, zinc-binding",HGNC:910,7q22.1
MORF4L2,-0.00922518,MORF4L2,Approved symbol,MORF4L2,mortality factor 4 like 2,HGNC:16849,Xq22.2
C10orf82,0.009207034,C10orf82,Approved symbol,C10orf82,chromosome 10 open reading frame 82,HGNC:28500,10q25.3
CYP1B1,-0.009206829,CYP1B1,Approved symbol,CYP1B1,cytochrome P450 family 1 subfamily B member 1,HGNC:2597,2p22.2
DCX,0.009200906,DCX,Approved symbol,DCX,doublecortin,HGNC:2714,Xq23
CTD-2008A1.2,-0.009199947,CTD-2008A1.2,Unmatched,CTD-2008A1.2,,,
CCNC,-0.009189072,CCNC,Approved symbol,CCNC,cyclin C,HGNC:1581,6q16.2
IGKV2-30,-0.009187581,IGKV2-30,Approved symbol,IGKV2-30,immunoglobulin kappa variable 2-30,HGNC:5785,2p11.2
PLA2R1,0.009183612,PLA2R1,Approved symbol,PLA2R1,phospholipase A2 receptor 1,HGNC:9042,2q23-q24
PHKA2,0.009135937,PHKA2,Approved symbol,PHKA2,phosphorylase kinase regulatory subunit alpha 2,HGNC:8926,Xp22.13
CCDC170,-0.009135058,CCDC170,Approved symbol,CCDC170,coiled-coil domain containing 170,HGNC:21177,6q25.1
RPL6,0.009135028,RPL6,Approved symbol,RPL6,ribosomal protein L6,HGNC:10362,12q24.13
TAPBP,-0.009130428,TAPBP,Approved symbol,TAPBP,TAP binding protein,HGNC:11566,6p21.32
KCNK15,0.009126332,KCNK15,Approved symbol,KCNK15,potassium two pore domain channel subfamily K member 15,HGNC:13814,20q13.12
RP11-327F22.6,-0.009121528,RP11-327F22.6,Unmatched,RP11-327F22.6,,,
GLTSCR1L,0.009112723,GLTSCR1L,Previous symbol,BICRAL,BRD4 interacting chromatin remodeling complex associated protein like,HGNC:21111,6p21.1
HS3ST1,-0.009106847,HS3ST1,Approved symbol,HS3ST1,heparan sulfate-glucosamine 3-sulfotransferase 1,HGNC:5194,4p15.33
COL5A1,-0.009097396,COL5A1,Approved symbol,COL5A1,collagen type V alpha 1 chain,HGNC:2209,9q34.3
EPB41L4A-AS1,0.009095815,EPB41L4A-AS1,Approved symbol,EPB41L4A-AS1,EPB41L4A antisense RNA 1,HGNC:30749,5q22.1
RP11-155O18.6,0.009094649,RP11-155O18.6,Unmatched,RP11-155O18.6,,,
ZNF181,0.009088313,ZNF181,Approved symbol,ZNF181,zinc finger protein 181,HGNC:12971,19q13.11
RP11-506H20.1,-0.009085391,RP11-506H20.1,Unmatched,RP11-506H20.1,,,
ABCA8,0.009082301,ABCA8,Approved symbol,ABCA8,ATP binding cassette subfamily A member 8,HGNC:38,17q24.2
ITFG2,0.009073639,ITFG2,Approved symbol,ITFG2,integrin alpha FG-GAP repeat containing 2,HGNC:30879,12p13.33
RP11-69G7.1,0.009061054,RP11-69G7.1,Unmatched,RP11-69G7.1,,,
LRRTM4,0.009044304,LRRTM4,Approved symbol,LRRTM4,leucine rich repeat transmembrane neuronal 4,HGNC:19411,2p12
MRPS6,0.009030875,MRPS6,Approved symbol,MRPS6,mitochondrial ribosomal protein S6,HGNC:14051,21q22.11
CNKSR3,0.009029376,CNKSR3,Approved symbol,CNKSR3,CNKSR family member 3,HGNC:23034,6q25.2
C3orf65,0.00902193,C3orf65,Previous symbol,IGF2BP2-AS1,IGF2BP2 antisense RNA 1,HGNC:32674,3q27.2
BAZ1A,-0.009021258,BAZ1A,Approved symbol,BAZ1A,bromodomain adjacent to zinc finger domain 1A,HGNC:960,14q13.1-q13.2
ETV1,0.009020662,ETV1,Approved symbol,ETV1,ETS variant transcription factor 1,HGNC:3490,7p21.2
DNAJB6,-0.009019293,DNAJB6,Approved symbol,DNAJB6,DnaJ heat shock protein family (Hsp40) member B6,HGNC:14888,7q36.3
RP11-529E10.6,0.009015186,RP11-529E10.6,Unmatched,RP11-529E10.6,,,
SELK,-0.00901141,SELK,Alias symbol,SELENOK,selenoprotein K,HGNC:30394,3p21.1
AC005481.5,0.009009351,AC005481.5,Unmatched,AC005481.5,,,1q21.2
HIST2H2BF,-0.009008307,HIST2H2BF,Previous symbol,H2BC18,H2B clustered histone 18,HGNC:24700,1p35.1
RNF19B,-0.00900725,RNF19B,Approved symbol,RNF19B,ring finger protein 19B,HGNC:26886,1q21.2
MCL1,-0.009004576,MCL1,Approved symbol,MCL1,"MCL1 apoptosis regulator, BCL2 family member",HGNC:6943,18q11.2
MIB1,-0.008986681,MIB1,Approved symbol,MIB1,mindbomb E3 ubiquitin protein ligase 1,HGNC:21086,5q11.2
MCIDAS,-0.008984149,MCIDAS,Approved symbol,MCIDAS,multiciliate differentiation and DNA synthesis associated cell cycle protein,HGNC:40050,19q13.12
ZNF420,0.008966692,ZNF420,Approved symbol,ZNF420,zinc finger protein 420,HGNC:20649,3p21.31
KIF15,-0.008965938,KIF15,Approved symbol,KIF15,kinesin family member 15,HGNC:17273,13q21.33
BORA,-0.008964623,BORA,Approved symbol,BORA,BORA aurora kinase A activator,HGNC:24724,16p12.3
TMC5,-0.008963833,TMC5,Approved symbol,TMC5,transmembrane channel like 5,HGNC:22999,22q13.1
TMEM184B,-0.008952403,TMEM184B,Approved symbol,TMEM184B,transmembrane protein 184B,HGNC:1310,
CTB-36O1.7,0.008942614,CTB-36O1.7,Unmatched,CTB-36O1.7,,,1p35.1
PHC2,-0.008938198,PHC2,Approved symbol,PHC2,polyhomeotic homolog 2,HGNC:3183,16q22.2
HPR,-0.008926464,HPR,Approved symbol,HPR,haptoglobin-related protein,HGNC:5156,6q23.3
HBS1L,-0.008917672,HBS1L,Approved symbol,HBS1L,HBS1 like translational GTPase,HGNC:4834,4p16.1
S100P,-0.008917186,S100P,Approved symbol,S100P,S100 calcium binding protein P,HGNC:10504,22q11.23
FAM211B,0.008915785,FAM211B,Previous symbol,LRRC75B,leucine rich repeat containing 75B,HGNC:33155,14q11.2
PNP,-0.008912375,PNP,Approved symbol,PNP,purine nucleoside phosphorylase,HGNC:7892,2q11.2
RPL31,0.008910815,RPL31,Approved symbol,RPL31,ribosomal protein L31,HGNC:10334,
RP11-491F9.1,0.008906051,RP11-491F9.1,Unmatched,RP11-491F9.1,,,9q31.1
MRPL50,-0.008897289,MRPL50,Approved symbol,MRPL50,mitochondrial ribosomal protein L50,HGNC:16654,
RP11-767N6.2,0.008895128,RP11-767N6.2,Unmatched,RP11-767N6.2,,,6p21.2
TMEM217,-0.008893232,TMEM217,Approved symbol,TMEM217,transmembrane protein 217,HGNC:21238,5q11.2
CCNO,-0.008891811,CCNO,Approved symbol,CCNO,cyclin O,HGNC:18576,9p23
LURAP1L,-0.00889164,LURAP1L,Approved symbol,LURAP1L,leucine rich adaptor protein 1 like,HGNC:31452,5p13.1
C5orf51,-0.008890141,C5orf51,Approved symbol,C5orf51,chromosome 5 open reading frame 51,HGNC:27750,7q22.1
ZSCAN21,0.008874511,ZSCAN21,Approved symbol,ZSCAN21,zinc finger and SCAN domain containing 21,HGNC:13104,7p13
PGAM2,0.008874306,PGAM2,Approved symbol,PGAM2,phosphoglycerate mutase 2,HGNC:8889,17q21.33
DLX3,0.008870318,DLX3,Approved symbol,DLX3,distal-less homeobox 3,HGNC:2916,1q41
CAPN8,-0.008865318,CAPN8,Approved symbol,CAPN8,calpain 8,HGNC:1485,12p13.31
GAPDH,-0.008860139,GAPDH,Approved symbol,GAPDH,glyceraldehyde-3-phosphate dehydrogenase,HGNC:4141,
RP11-320M16.1,0.008856105,RP11-320M16.1,Unmatched,RP11-320M16.1,,,18q11.2
LAMA3,-0.008854172,LAMA3,Approved symbol,LAMA3,laminin subunit alpha 3,HGNC:6483,
AC002310.12,0.008848528,AC002310.12,Unmatched,AC002310.12,,,2p21
SRBD1,-0.008843783,SRBD1,Approved symbol,SRBD1,S1 RNA binding domain 1,HGNC:25521,4q32.2
TMA16,-0.008843109,TMA16,Approved symbol,TMA16,translation machinery associated 16 homolog,HGNC:25638,
AC129492.6,0.00884011,AC129492.6,Unmatched,AC129492.6,,,7p13
CAMK2B,0.008839893,CAMK2B,Approved symbol,CAMK2B,calcium/calmodulin dependent protein kinase II beta,HGNC:1461,12q21.2
SYT1,0.008808806,SYT1,Approved symbol,SYT1,synaptotagmin 1,HGNC:11509,2q11.2
CNGA3,0.00880716,CNGA3,Approved symbol,CNGA3,cyclic nucleotide gated channel subunit alpha 3,HGNC:2150,
AC004009.3,-0.008806821,AC004009.3,Unmatched,AC004009.3,,,1p36.33
VWA1,-0.0088054,VWA1,Approved symbol,VWA1,von Willebrand factor A domain containing 1,HGNC:30910,2q33.1
AOX1,-0.008805266,AOX1,Approved symbol,AOX1,aldehyde oxidase 1,HGNC:553,6q21
WISP3,-0.008802941,WISP3,Previous symbol,CCN6,cellular communication network factor 6,HGNC:12771,15q11.2
NDN,0.008800232,NDN,Approved symbol,NDN,"necdin, MAGE family member",HGNC:7675,
RP11-426C22.5,0.008786822,RP11-426C22.5,Unmatched,RP11-426C22.5,,,Xp11.21
RRAGB,0.008785749,RRAGB,Approved symbol,RRAGB,Ras related GTP binding B,HGNC:19901,17p13.1
DNAH2,-0.008784635,DNAH2,Approved symbol,DNAH2,dynein axonemal heavy chain 2,HGNC:2948,8q21.3
OTUD6B,-0.008784533,OTUD6B,Approved symbol,OTUD6B,OTU deubiquitinase 6B,HGNC:24281,2p16.2
ERLEC1,-0.008778868,ERLEC1,Approved symbol,ERLEC1,endoplasmic reticulum lectin 1,HGNC:25222,19q13.11
ZNF302,0.008774313,ZNF302,Approved symbol,ZNF302,zinc finger protein 302,HGNC:13848,17p11.2
EPN2,-0.008771847,EPN2,Approved symbol,EPN2,epsin 2,HGNC:18639,17q21.32
KPNB1,-0.008765946,KPNB1,Approved symbol,KPNB1,karyopherin subunit beta 1,HGNC:6400,Xq22.3
RP11-480I12.5,0.008761066,RP11-480I12.5,Alias symbol,TUBA5P,"tubulin alpha 5, pseudogene",HGNC:54799,1q32.1
MORC4,-0.008754182,MORC4,Approved symbol,MORC4,MORC family CW-type zinc finger 4,HGNC:23485,5q14.2
RPS23,0.008753906,RPS23,Approved symbol,RPS23,ribosomal protein S23,HGNC:10410,4q24
GSTCD,-0.008751055,GSTCD,Approved symbol,GSTCD,glutathione S-transferase C-terminal domain containing,HGNC:25806,17q25.3
MAFG,-0.008747166,MAFG,Approved symbol,MAFG,MAF bZIP transcription factor G,HGNC:6781,
RP11-111I12.1,-0.008740926,RP11-111I12.1,Unmatched,RP11-111I12.1,,,4p16.3
MYL5,0.008740078,MYL5,Approved symbol,MYL5,myosin light chain 5,HGNC:7586,
RP4-666F24.3,0.00873379,RP4-666F24.3,Unmatched,RP4-666F24.3,,,
RP11-576D8.4,-0.008704177,RP11-576D8.4,Unmatched,RP11-576D8.4,,,6q25.1
RAET1E,-0.008697574,RAET1E,Approved symbol,RAET1E,retinoic acid early transcript 1E,HGNC:16793,20p11.21
GZF1,-0.008694959,GZF1,Approved symbol,GZF1,GDNF inducible zinc finger protein 1,HGNC:15808,4q21.23
HPSE,-0.008687171,HPSE,Approved symbol,HPSE,heparanase,HGNC:5164,
hsa-mir-6723,0.008684608,hsa-mir-6723,Unmatched,hsa-mir-6723,,,3p21.31
MAP4,-0.008682196,MAP4,Approved symbol,MAP4,microtubule associated protein 4,HGNC:6862,
RP11-690D19.3,0.008667061,RP11-690D19.3,Unmatched,RP11-690D19.3,,,1p36.31
ZBTB48,0.008666294,ZBTB48,Approved symbol,ZBTB48,zinc finger and BTB domain containing 48,HGNC:4930,2p23.3
CGREF1,-0.008647498,CGREF1,Approved symbol,CGREF1,cell growth regulator with EF-hand domain 1,HGNC:16962,15q26.1
IDH2,-0.008645898,IDH2,Approved symbol,IDH2,isocitrate dehydrogenase (NADP(+)) 2,HGNC:5383,15q22.2
NPM1P47,-0.008643568,NPM1P47,Approved symbol,NPM1P47,nucleophosmin 1 pseudogene 47,HGNC:45226,17q21.31
TUBG1,-0.008640972,TUBG1,Approved symbol,TUBG1,tubulin gamma 1,HGNC:12417,
AC022532.1,0.008633515,AC022532.1,Unmatched,AC022532.1,,,
RP5-968D22.3,-0.008627192,RP5-968D22.3,Unmatched,RP5-968D22.3,,,3q13.2
TMPRSS7,0.008626833,TMPRSS7,Approved symbol,TMPRSS7,transmembrane serine protease 7,HGNC:30846,14q32.33
IGHV1-2,-0.008618064,IGHV1-2,Approved symbol,IGHV1-2,immunoglobulin heavy variable 1-2,HGNC:5550,Xq28
IRAK1,-0.008617314,IRAK1,Approved symbol,IRAK1,interleukin 1 receptor associated kinase 1,HGNC:6112,4q24
BDH2,0.008598821,BDH2,Approved symbol,BDH2,3-hydroxybutyrate dehydrogenase 2,HGNC:32389,10q23.2
ADIRF,0.008594983,ADIRF,Approved symbol,ADIRF,adipogenesis regulatory factor,HGNC:24043,
RP11-352D13.6,0.00859188,RP11-352D13.6,Unmatched,RP11-352D13.6,,,
CTD-2336O2.1,0.008585964,CTD-2336O2.1,Unmatched,CTD-2336O2.1,,,12q13.13
PCBP2,0.008562962,PCBP2,Approved symbol,PCBP2,poly(rC) binding protein 2,HGNC:8648,2p11.2
MTATP8P2,0.008560891,MTATP8P2,Approved symbol,MTATP8P2,MT-ATP8 pseudogene 2,HGNC:44572,Xp22.2
ACE2,-0.008560481,ACE2,Approved symbol,ACE2,angiotensin I converting enzyme 2,HGNC:13557,22q13.2
CYB5R3,-0.008551944,CYB5R3,Approved symbol,CYB5R3,cytochrome b5 reductase 3,HGNC:2873,11p15.5
PSMD13,-0.00854275,PSMD13,Approved symbol,PSMD13,"proteasome 26S subunit, non-ATPase 13",HGNC:9558,3q29
XXYLT1-AS1,0.008526259,XXYLT1-AS1,Approved symbol,XXYLT1-AS1,XXYLT1 antisense RNA 1,HGNC:41153,11p15.4
ZNF143,-0.008525543,ZNF143,Approved symbol,ZNF143,zinc finger protein 143,HGNC:12928,2q14.3
UGGT1,-0.008512207,UGGT1,Approved symbol,UGGT1,UDP-glucose glycoprotein glucosyltransferase 1,HGNC:15663,Xp22.12
MAP7D2,0.008501179,MAP7D2,Approved symbol,MAP7D2,MAP7 domain containing 2,HGNC:25899,14q21.2
C14orf28,0.008493473,C14orf28,Approved symbol,C14orf28,chromosome 14 open reading frame 28,HGNC:19834,13q32.1
DNAJC3,-0.008490675,DNAJC3,Approved symbol,DNAJC3,DnaJ heat shock protein family (Hsp40) member C3,HGNC:9439,5q35.2
BOD1,0.008489622,BOD1,Approved symbol,BOD1,biorientation of chromosomes in cell division 1,HGNC:25114,
RP11-341G23.4,0.008486976,RP11-341G23.4,Unmatched,RP11-341G23.4,,,8q12.1
SDCBP,-0.008481382,SDCBP,Approved symbol,SDCBP,syndecan binding protein,HGNC:10662,11q13.1
NAALADL1,0.008471714,NAALADL1,Approved symbol,NAALADL1,N-acetylated alpha-linked acidic dipeptidase like 1,HGNC:23536,1q21.3
SPRR1B,-0.008465812,SPRR1B,Approved symbol,SPRR1B,small proline rich protein 1B,HGNC:11260,3q25.31
SLC33A1,-0.008458975,SLC33A1,Approved symbol,SLC33A1,solute carrier family 33 member 1,HGNC:95,7q11.23
FZD9,-0.00845855,FZD9,Approved symbol,FZD9,frizzled class receptor 9,HGNC:4047,1q32.1
IKBKE,-0.008457218,IKBKE,Approved symbol,IKBKE,inhibitor of nuclear factor kappa B kinase subunit epsilon,HGNC:14552,1p31.3
L1TD1,-0.008432532,L1TD1,Approved symbol,L1TD1,LINE1 type transposase domain containing 1,HGNC:25595,16q13
MT1JP,0.008426974,MT1JP,Approved symbol,MT1JP,"metallothionein 1J, pseudogene",HGNC:7402,18q11.2
C18orf8,-0.008425174,C18orf8,Previous symbol,RMC1,regulator of MON1-CCZ1,HGNC:24326,18q12.1
DSG4,-0.008424708,DSG4,Approved symbol,DSG4,desmoglein 4,HGNC:21307,7p12.2
VWC2,0.00841777,VWC2,Approved symbol,VWC2,von Willebrand factor C domain containing 2,HGNC:30200,11q24.2
DCPS,-0.008414803,DCPS,Approved symbol,DCPS,"decapping enzyme, scavenger",HGNC:29812,
RP11-248B24.4,-0.008404919,RP11-248B24.4,Unmatched,RP11-248B24.4,,,1p36.21
FHAD1,-0.008389331,FHAD1,Approved symbol,FHAD1,forkhead associated phosphopeptide binding domain 1,HGNC:29408,5q35.3
TRIM7,-0.008381939,TRIM7,Approved symbol,TRIM7,tripartite motif containing 7,HGNC:16278,22q13.2
WBP2NL,0.008371512,WBP2NL,Approved symbol,WBP2NL,WBP2 N-terminal like,HGNC:28389,
RP1-134E15.3,-0.008368642,RP1-134E15.3,Unmatched,RP1-134E15.3,,,11q13.1
BATF2,-0.008368099,BATF2,Approved symbol,BATF2,basic leucine zipper ATF-like transcription factor 2,HGNC:25163,14q12
NOVA1,0.00835637,NOVA1,Approved symbol,NOVA1,NOVA alternative splicing regulator 1,HGNC:7886,2p14
PELI1,-0.008349844,PELI1,Approved symbol,PELI1,pellino E3 ubiquitin protein ligase 1,HGNC:8827,12p13.32
KCNA6,0.008319687,KCNA6,Approved symbol,KCNA6,potassium voltage-gated channel subfamily A member 6,HGNC:6225,
RP11-465B22.5,0.008319396,RP11-465B22.5,Unmatched,RP11-465B22.5,,,22q12.1
ASPHD2,-0.008317894,ASPHD2,Approved symbol,ASPHD2,aspartate beta-hydroxylase domain containing 2,HGNC:30437,
AC034243.1,0.008299178,AC034243.1,Unmatched,AC034243.1,,,17q24.2
ABCA9,0.008298531,ABCA9,Approved symbol,ABCA9,ATP binding cassette subfamily A member 9,HGNC:39,8p21.2
PPP2R2A,-0.008291622,PPP2R2A,Approved symbol,PPP2R2A,protein phosphatase 2 regulatory subunit Balpha,HGNC:9304,
AC125232.1,0.008281758,AC125232.1,Unmatched,AC125232.1,,,12q24.31
OASL,-0.008279146,OASL,Approved symbol,OASL,2'-5'-oligoadenylate synthetase like,HGNC:8090,
RP11-498D10.8,-0.008279118,RP11-498D10.8,Unmatched,RP11-498D10.8,,,11p13
CSTF3,-0.008277702,CSTF3,Approved symbol,CSTF3,cleavage stimulation factor subunit 3,HGNC:2485,17q22
GDPD1,0.008277634,GDPD1,Approved symbol,GDPD1,glycerophosphodiester phosphodiesterase domain containing 1,HGNC:20883,2q24.1
PKP4,-0.008270324,PKP4,Approved symbol,PKP4,plakophilin 4,HGNC:9026,3q11.2
MINA,-0.008269829,MINA,Previous symbol,RIOX2,ribosomal oxygenase 2,HGNC:19441,20q13.12
SEMG2,-0.008266584,SEMG2,Approved symbol,SEMG2,semenogelin 2,HGNC:10743,4p16.3
NAT8L,0.008264236,NAT8L,Approved symbol,NAT8L,N-acetyltransferase 8 like,HGNC:26742,15q23
TLE3,0.00826409,TLE3,Approved symbol,TLE3,"TLE family member 3, transcriptional corepressor",HGNC:11839,
AC104600.1,0.008256031,AC104600.1,Unmatched,AC104600.1,,,4q21.22
SEC31A,-0.008252454,SEC31A,Approved symbol,SEC31A,"SEC31 homolog A, COPII coat complex component",HGNC:17052,
RP3-467L1.6,0.008249964,RP3-467L1.6,Unmatched,RP3-467L1.6,,,2q36.3
TM4SF20,-0.008245891,TM4SF20,Approved symbol,TM4SF20,transmembrane 4 L six family member 20,HGNC:26230,5q31.3
PCDHGC3,-0.008241148,PCDHGC3,Approved symbol,PCDHGC3,"protocadherin gamma subfamily C, 3",HGNC:8716,
RP11-488L18.6,0.008236058,RP11-488L18.6,Unmatched,RP11-488L18.6,,,
AC013394.2,0.008235035,AC013394.2,Unmatched,AC013394.2,,,5q35.3
CANX,-0.008234497,CANX,Approved symbol,CANX,calnexin,HGNC:1473,1p34.2
FOXO6,0.008224023,FOXO6,Approved symbol,FOXO6,forkhead box O6,HGNC:24814,2p24.2
VSNL1,-0.008221044,VSNL1,Approved symbol,VSNL1,visinin like 1,HGNC:12722,20q13.31
PMEPA1,-0.008216008,PMEPA1,Approved symbol,PMEPA1,"prostate transmembrane protein, androgen induced 1",HGNC:14107,18p11.31
DLGAP1-AS5,-0.008215398,DLGAP1-AS5,Approved symbol,DLGAP1-AS5,DLGAP1 antisense RNA 5,HGNC:27586,
AC004893.11,0.008212911,AC004893.11,Unmatched,AC004893.11,,,10p12.31
ARL5B,-0.008205351,ARL5B,Approved symbol,ARL5B,ADP ribosylation factor like GTPase 5B,HGNC:23052,13q13.3
UFM1,-0.008196108,UFM1,Approved symbol,UFM1,ubiquitin fold modifier 1,HGNC:20597,12q12
CNTN1,0.008196064,CNTN1,Approved symbol,CNTN1,contactin 1,HGNC:2171,19q13.2
CEACAM6,-0.008181274,CEACAM6,Approved symbol,CEACAM6,CEA cell adhesion molecule 6,HGNC:1818,2p16.3
NRXN1,0.0081798,NRXN1,Approved symbol,NRXN1,neurexin 1,HGNC:8008,
RP11-274E7.2,-0.008179239,RP11-274E7.2,Unmatched,RP11-274E7.2,,,
CTD-2611O12.8,0.008177913,CTD-2611O12.8,Unmatched,CTD-2611O12.8,,,Xq28
NSDHL,-0.008172744,NSDHL,Approved symbol,NSDHL,NAD(P) dependent steroid dehydrogenase-like,HGNC:13398,11p15.5
TALDO1,-0.008170625,TALDO1,Approved symbol,TALDO1,transaldolase 1,HGNC:11559,1p22.3
LPAR3,-0.008156954,LPAR3,Approved symbol,LPAR3,lysophosphatidic acid receptor 3,HGNC:14298,13q12.3
POMP,-0.008155378,POMP,Approved symbol,POMP,proteasome maturation protein,HGNC:20330,14q24.3
SAMD15,-0.008151375,SAMD15,Approved symbol,SAMD15,sterile alpha motif domain containing 15,HGNC:18631,1p36.13
EPHA2,-0.008148491,EPHA2,Approved symbol,EPHA2,EPH receptor A2,HGNC:3386,22q12.2
CABP7,-0.008144816,CABP7,Approved symbol,CABP7,calcium binding protein 7,HGNC:20834,10q22.1
DDX21,-0.008137239,DDX21,Approved symbol,DDX21,DExD-box helicase 21,HGNC:2744,8q21.11
RPL7,0.00810383,RPL7,Approved symbol,RPL7,ribosomal protein L7,HGNC:10363,6p21.32
HSD17B8,0.008099173,HSD17B8,Approved symbol,HSD17B8,hydroxysteroid 17-beta dehydrogenase 8,HGNC:3554,5q31.2
TMEM173,-0.008094315,TMEM173,Previous symbol,STING1,stimulator of interferon response cGAMP interactor 1,HGNC:27962,1q23.3
SH2D1B,-0.008086231,SH2D1B,Approved symbol,SH2D1B,SH2 domain containing 1B,HGNC:30416,10q21.3
CCAR1,-0.008073302,CCAR1,Approved symbol,CCAR1,cell division cycle and apoptosis regulator 1,HGNC:24236,1q32.1
IL19,-0.008072144,IL19,Approved symbol,IL19,interleukin 19,HGNC:5990,2q24.2
GCA,-0.008070342,GCA,Approved symbol,GCA,grancalcin,HGNC:15990,Xq21.2
DACH2,0.008066639,DACH2,Approved symbol,DACH2,dachshund family transcription factor 2,HGNC:16814,3q22.2
KY,-0.00806337,KY,Approved symbol,KY,kyphoscoliosis peptidase,HGNC:26576,6p23
RPS4XP7,0.008060004,RPS4XP7,Approved symbol,RPS4XP7,ribosomal protein S4X pseudogene 7,HGNC:36885,9q21.13
ZFAND5,-0.008057706,ZFAND5,Approved symbol,ZFAND5,zinc finger AN1-type containing 5,HGNC:13008,2q32.3
TMEFF2,0.008053713,TMEFF2,Approved symbol,TMEFF2,transmembrane protein with EGF like and two follistatin like domains 2,HGNC:11867,6q14.2
MRAP2,-0.008050648,MRAP2,Approved symbol,MRAP2,melanocortin 2 receptor accessory protein 2,HGNC:21232,1p36.22
MTHFR,-0.008048526,MTHFR,Approved symbol,MTHFR,methylenetetrahydrofolate reductase,HGNC:7436,14q22.3
LINC00520,-0.008041618,LINC00520,Approved symbol,LINC00520,long intergenic non-protein coding RNA 520,HGNC:19843,
LA16c-325D7.1,-0.008039654,LA16c-325D7.1,Unmatched,LA16c-325D7.1,,,6p22.1
HLA-F,-0.00801804,HLA-F,Approved symbol,HLA-F,"major histocompatibility complex, class I, F",HGNC:4963,1p13.3
PSMA5,-0.008005162,PSMA5,Approved symbol,PSMA5,proteasome 20S subunit alpha 5,HGNC:9534,
RP11-612B6.2,0.007995138,RP11-612B6.2,Unmatched,RP11-612B6.2,,,9q31.1
GRIN3A,-0.007993906,GRIN3A,Approved symbol,GRIN3A,glutamate ionotropic receptor NMDA type subunit 3A,HGNC:16767,11q13.1
SNX32,0.007989467,SNX32,Approved symbol,SNX32,sorting nexin 32,HGNC:26423,19p13.11
ZNF506,0.007956314,ZNF506,Approved symbol,ZNF506,zinc finger protein 506,HGNC:23780,19p13.3
PLIN3,-0.007949963,PLIN3,Approved symbol,PLIN3,perilipin 3,HGNC:16893,12p13.32
CCND2,0.007947024,CCND2,Approved symbol,CCND2,cyclin D2,HGNC:1583,2p22.3
FAM98A,-0.00794621,FAM98A,Approved symbol,FAM98A,family with sequence similarity 98 member A,HGNC:24520,8q24.3
FAM83H-AS1,-0.007942753,FAM83H-AS1,Approved symbol,FAM83H-AS1,FAM83H antisense RNA 1 (head to head),HGNC:48720,4q21.1
CCNG2,-0.00793641,CCNG2,Approved symbol,CCNG2,cyclin G2,HGNC:1593,4q21.1
USO1,-0.007935992,USO1,Approved symbol,USO1,USO1 vesicle transport factor,HGNC:30904,4q13.3
EPGN,-0.007933599,EPGN,Approved symbol,EPGN,epithelial mitogen,HGNC:17470,11q23.3
RPS25,0.007931202,RPS25,Approved symbol,RPS25,ribosomal protein S25,HGNC:10413,11p15.4
NLRP14,-0.007923871,NLRP14,Approved symbol,NLRP14,NLR family pyrin domain containing 14,HGNC:22939,Xp11.4
MID1IP1,-0.007917407,MID1IP1,Approved symbol,MID1IP1,MID1 interacting protein 1,HGNC:20715,1q23.1
ETV3,-0.007905931,ETV3,Approved symbol,ETV3,ETS variant transcription factor 3,HGNC:3492,17p13.1
MYH13,-0.007891811,MYH13,Approved symbol,MYH13,myosin heavy chain 13,HGNC:7571,5p15.33
CEP72,-0.007891302,CEP72,Approved symbol,CEP72,centrosomal protein 72,HGNC:25547,3q25.31
TIPARP,-0.007889118,TIPARP,Approved symbol,TIPARP,TCDD inducible poly(ADP-ribose) polymerase,HGNC:23696,1q22
SSR2,-0.007885893,SSR2,Approved symbol,SSR2,signal sequence receptor subunit 2,HGNC:11324,
RP11-490H24.5,-0.007882399,RP11-490H24.5,Unmatched,RP11-490H24.5,,,19q13.42
GP6,0.007880632,GP6,Approved symbol,GP6,glycoprotein VI platelet,HGNC:14388,3p22.1
ENTPD3,-0.007878829,ENTPD3,Approved symbol,ENTPD3,ectonucleoside triphosphate diphosphohydrolase 3,HGNC:3365,20q13.13
KCNG1,0.007870802,KCNG1,Approved symbol,KCNG1,potassium voltage-gated channel modifier subfamily G member 1,HGNC:6248,17q22
YPEL2,-0.00786984,YPEL2,Approved symbol,YPEL2,yippee like 2,HGNC:18326,11p15.3
TEAD1,-0.007868811,TEAD1,Approved symbol,TEAD1,TEA domain transcription factor 1,HGNC:11714,Xp11.4
CXorf38,-0.007859259,CXorf38,Approved symbol,CXorf38,chromosome X open reading frame 38,HGNC:28589,12q15
RAP1B,-0.007847201,RAP1B,Approved symbol,RAP1B,"RAP1B, member of RAS oncogene family",HGNC:9857,9q34.2
SURF4,-0.007843014,SURF4,Approved symbol,SURF4,surfeit 4,HGNC:11476,2p23.1
XDH,-0.007837192,XDH,Approved symbol,XDH,xanthine dehydrogenase,HGNC:12805,
CTC-448F2.6,0.007833135,CTC-448F2.6,Unmatched,CTC-448F2.6,,,9q33.1
ASTN2,0.007830717,ASTN2,Approved symbol,ASTN2,astrotactin 2,HGNC:17021,6p22.1
TRIM26,-0.007813704,TRIM26,Approved symbol,TRIM26,tripartite motif containing 26,HGNC:12962,7p14.3
NPSR1,-0.007810765,NPSR1,Approved symbol,NPSR1,neuropeptide S receptor 1,HGNC:23631,7q21.2
SAMD9,-0.007809054,SAMD9,Approved symbol,SAMD9,sterile alpha motif domain containing 9,HGNC:1348,
RP11-152P17.2,-0.00777838,RP11-152P17.2,Unmatched,RP11-152P17.2,,,
RP3-460G2.2,0.007774568,RP3-460G2.2,Unmatched,RP3-460G2.2,,,8q24.13
DERL1,-0.007768557,DERL1,Approved symbol,DERL1,derlin 1,HGNC:28454,
AC025335.1,0.007761875,AC025335.1,Unmatched,AC025335.1,,,
RP11-57A19.2,0.00775794,RP11-57A19.2,Unmatched,RP11-57A19.2,,,
RP11-1348G14.4,0.007751813,RP11-1348G14.4,Unmatched,RP11-1348G14.4,,,
RP11-416I2.1,-0.007750842,RP11-416I2.1,Unmatched,RP11-416I2.1,,,Xq22.1
BEX4,0.007740838,BEX4,Approved symbol,BEX4,brain expressed X-linked 4,HGNC:25475,4q35.1
ENPP6,0.007728777,ENPP6,Approved symbol,ENPP6,ectonucleotide pyrophosphatase/phosphodiesterase 6,HGNC:23409,18q12.1
CCDC178,-0.00772815,CCDC178,Approved symbol,CCDC178,coiled-coil domain containing 178,HGNC:29588,15q26.1
ABHD2,-0.007728053,ABHD2,Approved symbol,ABHD2,"abhydrolase domain containing 2, acylglycerol lipase",HGNC:18717,22q11.1
TPTEP1,-0.007722261,TPTEP1,Approved symbol,TPTEP1,TPTE pseudogene 1,HGNC:43648,Xq22.1
DRP2,-0.007716091,DRP2,Approved symbol,DRP2,dystrophin related protein 2,HGNC:3032,Xp11.22
SHROOM4,-0.007706908,SHROOM4,Approved symbol,SHROOM4,shroom family member 4,HGNC:29215,12q13.3
R3HDM2,0.007706531,R3HDM2,Approved symbol,R3HDM2,R3H domain containing 2,HGNC:29167,1p31.1
C1orf173,0.00770587,C1orf173,Previous symbol,ERICH3,glutamate rich 3,HGNC:25346,17p13.1
NDEL1,-0.007705827,NDEL1,Approved symbol,NDEL1,nudE neurodevelopment protein 1 like 1,HGNC:17620,16q11.2
GPT2,-0.007700515,GPT2,Approved symbol,GPT2,glutamic--pyruvic transaminase 2,HGNC:18062,7p11.2
FKBP9L,-0.00769958,FKBP9L,Previous symbol,FKBP9P1,FKBP prolyl isomerase 9 pseudogene 1,HGNC:23568,3q13.33
GTF2E1,-0.007696087,GTF2E1,Approved symbol,GTF2E1,general transcription factor IIE subunit 1,HGNC:4650,
RP11-134K13.4,0.007692098,RP11-134K13.4,Unmatched,RP11-134K13.4,,,3q29
FYTTD1,-0.007664811,FYTTD1,Approved symbol,FYTTD1,forty-two-three domain containing 1,HGNC:25407,4q31.22
SLC10A7,-0.007663897,SLC10A7,Approved symbol,SLC10A7,solute carrier family 10 member 7,HGNC:23088,
RP4-758J18.10,-0.007659716,RP4-758J18.10,Unmatched,RP4-758J18.10,,,1q32.2-q32.3
RCOR3,0.007654884,RCOR3,Approved symbol,RCOR3,REST corepressor 3,HGNC:25594,7p14.3
GARS,-0.007652948,GARS,Previous symbol,GARS1,glycyl-tRNA synthetase 1,HGNC:4162,
RP11-51J9.6,0.007650089,RP11-51J9.6,Unmatched,RP11-51J9.6,,,7q32.1
FLNC,-0.007647843,FLNC,Approved symbol,FLNC,filamin C,HGNC:3756,15q25.1
PSMA4,-0.00763574,PSMA4,Approved symbol,PSMA4,proteasome 20S subunit alpha 4,HGNC:9533,1q24.3
MYOC,0.007633767,MYOC,Approved symbol,MYOC,myocilin,HGNC:7610,2q37.1
PSMD1,-0.007604104,PSMD1,Approved symbol,PSMD1,"proteasome 26S subunit, non-ATPase 1",HGNC:9554,12q24.11
IFT81,-0.007593109,IFT81,Approved symbol,IFT81,intraflagellar transport 81,HGNC:14313,10p12.1
LRRC37A6P,0.007592889,LRRC37A6P,Approved symbol,LRRC37A6P,"leucine rich repeat containing 37 member A6, pseudogene",HGNC:33746,7p12.3
UPP1,-0.007590917,UPP1,Approved symbol,UPP1,uridine phosphorylase 1,HGNC:12576,
RP11-690G19.3,0.007581264,RP11-690G19.3,Unmatched,RP11-690G19.3,,,6p25.2
BPHL,0.00758089,BPHL,Approved symbol,BPHL,biphenyl hydrolase like,HGNC:1094,4q35.2
F11,-0.007575016,F11,Approved symbol,F11,coagulation factor XI,HGNC:3529,10q26.13
NSMCE4A,0.007573251,NSMCE4A,Approved symbol,NSMCE4A,"NSE4 homolog A, SMC5-SMC6 complex component",HGNC:25935,
RP11-266L9.4,0.00756528,RP11-266L9.4,Unmatched,RP11-266L9.4,,,Xp11.23
RBM3,-0.007562597,RBM3,Approved symbol,RBM3,RNA binding motif protein 3,HGNC:9900,6q25.1
ULBP3,-0.007547624,ULBP3,Approved symbol,ULBP3,UL16 binding protein 3,HGNC:14895,4q25
SGMS2,-0.007524722,SGMS2,Approved symbol,SGMS2,sphingomyelin synthase 2,HGNC:28395,3q29
PAK2,-0.007509316,PAK2,Approved symbol,PAK2,p21 (RAC1) activated kinase 2,HGNC:8591,21q22.11
GART,-0.007507078,GART,Approved symbol,GART,"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase",HGNC:4163,1q42.2
SLC35F3,0.007505196,SLC35F3,Approved symbol,SLC35F3,solute carrier family 35 member F3,HGNC:23616,9q33.3
NEK6,-0.007502009,NEK6,Approved symbol,NEK6,NIMA related kinase 6,HGNC:7749,5q35.3
RASGEF1C,0.007498536,RASGEF1C,Approved symbol,RASGEF1C,RasGEF domain family member 1C,HGNC:27400,7q31
MET,-0.007486937,MET,Approved symbol,MET,"MET proto-oncogene, receptor tyrosine kinase",HGNC:7029,7q21.2
CDK6,0.007484906,CDK6,Approved symbol,CDK6,cyclin dependent kinase 6,HGNC:1777,19p13.3
R3HDM4,-0.007467692,R3HDM4,Approved symbol,R3HDM4,R3H domain containing 4,HGNC:28270,2p23.3
C2orf70,-0.007467428,C2orf70,Previous symbol,FAM166C,family with sequence similarity 166 member C,HGNC:27938,12q22
SOCS2-AS1,0.007467167,SOCS2-AS1,Approved symbol,SOCS2-AS1,SOCS2 antisense RNA 1,HGNC:27054,3q26.31
FNDC3B,-0.007449869,FNDC3B,Approved symbol,FNDC3B,fibronectin type III domain containing 3B,HGNC:24670,5q31.3
EIF4EBP3,0.00744214,EIF4EBP3,Approved symbol,EIF4EBP3,eukaryotic translation initiation factor 4E binding protein 3,HGNC:3290,12p13.32
C12orf4,-0.007429423,C12orf4,Approved symbol,C12orf4,chromosome 12 open reading frame 4,HGNC:1184,11q13.2
ADRBK1,-0.00741297,ADRBK1,Previous symbol,GRK2,G protein-coupled receptor kinase 2,HGNC:289,7q22.3
SLC26A4-AS1,-0.007388307,SLC26A4-AS1,Approved symbol,SLC26A4-AS1,SLC26A4 antisense RNA 1,HGNC:22385,
RP11-348N5.7,0.007382579,RP11-348N5.7,Unmatched,RP11-348N5.7,,,
RP11-247I13.3,0.007361599,RP11-247I13.3,Unmatched,RP11-247I13.3,,,16p12.1
SBK1,0.0073614,SBK1,Approved symbol,SBK1,SH3 domain binding kinase 1,HGNC:17699,
GS1-72M22.1,0.007358378,GS1-72M22.1,Unmatched,GS1-72M22.1,,,Xp22.3 and Yp13.3
IL3RA,-0.007344964,IL3RA,Approved symbol,IL3RA,interleukin 3 receptor subunit alpha,HGNC:6012,
RP11-484N16.1,-0.007338107,RP11-484N16.1,Unmatched,RP11-484N16.1,,,12q24.23
PEBP1,0.007332659,PEBP1,Approved symbol,PEBP1,phosphatidylethanolamine binding protein 1,HGNC:8630,
RP11-498C9.15,0.007331991,RP11-498C9.15,Unmatched,RP11-498C9.15,,,9p21.1
DNAJA1,-0.007327516,DNAJA1,Approved symbol,DNAJA1,DnaJ heat shock protein family (Hsp40) member A1,HGNC:5229,16q24.2
MVD,-0.007316228,MVD,Approved symbol,MVD,mevalonate diphosphate decarboxylase,HGNC:7529,
RP11-243A14.1,0.007290342,RP11-243A14.1,Unmatched,RP11-243A14.1,,,
AC103563.2,-0.007287284,AC103563.2,Unmatched,AC103563.2,,,
CTA-963H5.5,0.007286747,CTA-963H5.5,Unmatched,CTA-963H5.5,,,19q13.12
ZNF585B,0.00728525,ZNF585B,Approved symbol,ZNF585B,zinc finger protein 585B,HGNC:30948,19q13.31
ZNF285,0.007277258,ZNF285,Approved symbol,ZNF285,zinc finger protein 285,HGNC:13079,16q22.1
SNTB2,-0.007267455,SNTB2,Approved symbol,SNTB2,syntrophin beta 2,HGNC:11169,3p21.31
MST1R,-0.007266815,MST1R,Approved symbol,MST1R,macrophage stimulating 1 receptor,HGNC:7381,1q25.3
ZNF648,-0.007262748,ZNF648,Approved symbol,ZNF648,zinc finger protein 648,HGNC:18190,
CTD-2047H16.4,0.00726152,CTD-2047H16.4,Unmatched,CTD-2047H16.4,,,20p13
ATRN,0.007245111,ATRN,Approved symbol,ATRN,attractin,HGNC:885,8p21.2
ADAMDEC1,0.007244203,ADAMDEC1,Approved symbol,ADAMDEC1,ADAM like decysin 1,HGNC:16299,1p35.2
EIF3I,-0.007243453,EIF3I,Approved symbol,EIF3I,eukaryotic translation initiation factor 3 subunit I,HGNC:3272,13q12.13
MTMR6,-0.007227697,MTMR6,Approved symbol,MTMR6,myotubularin related protein 6,HGNC:7453,20q11.22
EIF2S2,-0.007224266,EIF2S2,Approved symbol,EIF2S2,eukaryotic translation initiation factor 2 subunit beta,HGNC:3266,
CTD-2350C19.1,0.007221515,CTD-2350C19.1,Unmatched,CTD-2350C19.1,,,2p13.1
SEMA4F,-0.007218721,SEMA4F,Approved symbol,SEMA4F,ssemaphorin 4F,HGNC:10734,21q22.3
TFF1,-0.007205017,TFF1,Approved symbol,TFF1,trefoil factor 1,HGNC:11755,4q31.21
HHIP-AS1,0.007176776,HHIP-AS1,Approved symbol,HHIP-AS1,HHIP antisense RNA 1,HGNC:44182,17q21.31
KANSL1-AS1,0.007171583,KANSL1-AS1,Approved symbol,KANSL1-AS1,KANSL1 antisense RNA 1,HGNC:43740,11p11.2
EXT2,-0.007152072,EXT2,Approved symbol,EXT2,exostosin glycosyltransferase 2,HGNC:3513,14q23.2
SGPP1,-0.007120277,SGPP1,Approved symbol,SGPP1,sphingosine-1-phosphate phosphatase 1,HGNC:17720,14q13.3
SLC25A21,0.007119147,SLC25A21,Approved symbol,SLC25A21,solute carrier family 25 member 21,HGNC:14411,14q22.3
EXOC5,-0.007110641,EXOC5,Approved symbol,EXOC5,exocyst complex component 5,HGNC:10696,
RP11-434B12.1,0.007107057,RP11-434B12.1,Unmatched,RP11-434B12.1,,,11p15.5
RIC8A,-0.007102629,RIC8A,Approved symbol,RIC8A,RIC8 guanine nucleotide exchange factor A,HGNC:29550,4q12
SPINK2,0.007096384,SPINK2,Approved symbol,SPINK2,serine peptidase inhibitor Kazal type 2,HGNC:11245,
RP13-131K19.7,0.007081018,RP13-131K19.7,Unmatched,RP13-131K19.7,,,3q21.3
ALDH1L1,-0.007076108,ALDH1L1,Approved symbol,ALDH1L1,aldehyde dehydrogenase 1 family member L1,HGNC:3978,21q21.1
CHODL,0.007069968,CHODL,Approved symbol,CHODL,chondrolectin,HGNC:17807,
RP11-655B23.1,-0.007065552,RP11-655B23.1,Unmatched,RP11-655B23.1,,,16q22.1
PSMB10,-0.007059551,PSMB10,Approved symbol,PSMB10,proteasome 20S subunit beta 10,HGNC:9538,Xq28
CETN2,-0.00705877,CETN2,Approved symbol,CETN2,centrin 2,HGNC:1867,19q13.42
ZNF761,0.00704908,ZNF761,Approved symbol,ZNF761,zinc finger protein 761,HGNC:23179,
RP11-115D19.1,-0.007043499,RP11-115D19.1,Unmatched,RP11-115D19.1,,,11q13.1
MIR192,0.007039063,MIR192,Approved symbol,MIR192,microRNA 192,HGNC:31562,1p34.3
TEKT2,0.007036862,TEKT2,Approved symbol,TEKT2,tektin 2,HGNC:11725,16p12.2
UBFD1,-0.00702573,UBFD1,Approved symbol,UBFD1,ubiquitin family domain containing 1,HGNC:30565,19q13.42
DNAAF3,-0.007022933,DNAAF3,Approved symbol,DNAAF3,dynein axonemal assembly factor 3,HGNC:30492,10p15.3
IDI1,-0.00702145,IDI1,Approved symbol,IDI1,isopentenyl-diphosphate delta isomerase 1,HGNC:5387,11p15.4
ADM,-0.007012156,ADM,Approved symbol,ADM,adrenomedullin,HGNC:259,3q13.11
ALCAM,-0.007010785,ALCAM,Approved symbol,ALCAM,activated leukocyte cell adhesion molecule,HGNC:400,2p25.2
RSAD2,-0.007003601,RSAD2,Approved symbol,RSAD2,radical S-adenosyl methionine domain containing 2,HGNC:30908,
RP11-819C21.1,0.007001744,RP11-819C21.1,Unmatched,RP11-819C21.1,,,16p12.3
ITPRIPL2,-0.006983648,ITPRIPL2,Approved symbol,ITPRIPL2,ITPRIP like 2,HGNC:27257,
CTD-2619J13.17,0.006955161,CTD-2619J13.17,Unmatched,CTD-2619J13.17,,,11q13.2
ACY3,-0.006928313,ACY3,Approved symbol,ACY3,aminoacylase 3,HGNC:24104,5q34
FBLL1,0.006918562,FBLL1,Approved symbol,FBLL1,fibrillarin like 1,HGNC:35458,3p21.2
PARP3,-0.006918502,PARP3,Approved symbol,PARP3,poly(ADP-ribose) polymerase family member 3,HGNC:273,10q23.33
IDE,-0.00691406,IDE,Approved symbol,IDE,insulin degrading enzyme,HGNC:5381,17q23.3
KCNH6,0.006910434,KCNH6,Approved symbol,KCNH6,potassium voltage-gated channel subfamily H member 6,HGNC:18862,15q26.1
RCCD1,0.00690963,RCCD1,Approved symbol,RCCD1,RCC1 domain containing 1,HGNC:30457,18q12.3
LINC00907,0.006890896,LINC00907,Approved symbol,LINC00907,long intergenic non-protein coding RNA 907,HGNC:44327,3q21.1
PDIA5,-0.006889202,PDIA5,Approved symbol,PDIA5,protein disulfide isomerase family A member 5,HGNC:24811,
AL121578.7,-0.006880544,AL121578.7,Unmatched,AL121578.7,,,16q23.1
WDR59,0.006860731,WDR59,Approved symbol,WDR59,WD repeat domain 59,HGNC:25706,5q31.1
LEAP2,0.006855804,LEAP2,Approved symbol,LEAP2,liver enriched antimicrobial peptide 2,HGNC:29571,1p34.1
POMGNT1,0.006834023,POMGNT1,Approved symbol,POMGNT1,"protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)",HGNC:19139,
AC084809.3,0.006833944,AC084809.3,Unmatched,AC084809.3,,,
CTD-2589M5.4,-0.006833285,CTD-2589M5.4,Unmatched,CTD-2589M5.4,,,10p13
TRDMT1,0.006833064,TRDMT1,Approved symbol,TRDMT1,tRNA aspartic acid methyltransferase 1,HGNC:2977,9p11.1
MEP1AP4,0.006813066,MEP1AP4,Approved symbol,MEP1AP4,meprin A subunit alpha pseudogene 4,HGNC:39138,8p21.3
TNFRSF10A,-0.00678813,TNFRSF10A,Approved symbol,TNFRSF10A,TNF receptor superfamily member 10a,HGNC:11904,Xp11.4
SYTL5,-0.006780813,SYTL5,Approved symbol,SYTL5,synaptotagmin like 5,HGNC:15589,6p21.2
MOCS1,0.006779417,MOCS1,Approved symbol,MOCS1,molybdenum cofactor synthesis 1,HGNC:7190,8p23.1
FDFT1,-0.006776233,FDFT1,Approved symbol,FDFT1,farnesyl-diphosphate farnesyltransferase 1,HGNC:3629,3p24.2
THRB-IT1,0.006772492,THRB-IT1,Approved symbol,THRB-IT1,THRB intronic transcript 1,HGNC:41390,3q25.22
SCARNA7,0.006769956,SCARNA7,Approved symbol,SCARNA7,small Cajal body-specific RNA 7,HGNC:32563,4q25
RPL34,0.00675542,RPL34,Approved symbol,RPL34,ribosomal protein L34,HGNC:10340,22q12.2
TCN2,0.006750231,TCN2,Approved symbol,TCN2,transcobalamin 2,HGNC:11653,9q22.33
CORO2A,-0.006723748,CORO2A,Approved symbol,CORO2A,coronin 2A,HGNC:2255,9q31.3
LRRC37A5P,0.006708538,LRRC37A5P,Approved symbol,LRRC37A5P,"leucine rich repeat containing 37 member A5, pseudogene",HGNC:23369,1p32.3
C1orf177,-0.006701838,C1orf177,Previous symbol,LEXM,lymphocyte expansion molecule,HGNC:26854,11q12.3
MTA2,-0.006693384,MTA2,Approved symbol,MTA2,metastasis associated 1 family member 2,HGNC:7411,7p14.3
NT5C3A,-0.006669844,NT5C3A,Approved symbol,NT5C3A,"5'-nucleotidase, cytosolic IIIA",HGNC:17820,22q12.3
HMGXB4,-0.006638491,HMGXB4,Approved symbol,HMGXB4,HMG-box containing 4,HGNC:5003,11p15.5
TRPM5,0.006633943,TRPM5,Approved symbol,TRPM5,transient receptor potential cation channel subfamily M member 5,HGNC:14323,12q24.31
MIR5188,-0.006629666,MIR5188,Approved symbol,MIR5188,microRNA 5188,HGNC:43502,20p11.23
SEC23B,-0.00662401,SEC23B,Approved symbol,SEC23B,"SEC23 homolog B, COPII coat complex component",HGNC:10702,4q27
BBS7,-0.006593766,BBS7,Approved symbol,BBS7,Bardet-Biedl syndrome 7,HGNC:18758,9q34.11
LRRC8A,-0.006584119,LRRC8A,Approved symbol,LRRC8A,leucine rich repeat containing 8 VRAC subunit A,HGNC:19027,9q21.11
CBWD5,-0.006574983,CBWD5,Approved symbol,CBWD5,COBW domain containing 5,HGNC:24584,
RP11-488C13.1,0.006572157,RP11-488C13.1,Unmatched,RP11-488C13.1,,,11q13.1
DNAJC4,0.006564048,DNAJC4,Approved symbol,DNAJC4,DnaJ heat shock protein family (Hsp40) member C4,HGNC:5271,19q13.43
ZSCAN18,0.006562669,ZSCAN18,Approved symbol,ZSCAN18,zinc finger and SCAN domain containing 18,HGNC:21037,3q24
PLSCR1,-0.006561541,PLSCR1,Approved symbol,PLSCR1,phospholipid scramblase 1,HGNC:9092,16q24.1
LINC01082,0.006556654,LINC01082,Approved symbol,LINC01082,long intergenic non-protein coding RNA 1082,HGNC:49125,17p13.2
PLD2,-0.006555495,PLD2,Approved symbol,PLD2,phospholipase D2,HGNC:9068,
RP11-242F4.2,0.006552456,RP11-242F4.2,Unmatched,RP11-242F4.2,,,9q34.11
TBC1D13,0.006548502,TBC1D13,Approved symbol,TBC1D13,TBC1 domain family member 13,HGNC:25571,19q13.43
ZNF773,0.006546185,ZNF773,Approved symbol,ZNF773,zinc finger protein 773,HGNC:30487,
RP11-267D19.2,-0.006532084,RP11-267D19.2,Unmatched,RP11-267D19.2,,,8q12.3
ASPH,-0.00653036,ASPH,Approved symbol,ASPH,aspartate beta-hydroxylase,HGNC:757,
2-Sep,-0.006518106,2-Sep,Unmatched,2-Sep,,,19p13.2
ZNF177,0.006509503,ZNF177,Approved symbol,ZNF177,zinc finger protein 177,HGNC:12966,12q21.31
TMTC2,-0.00649698,TMTC2,Approved symbol,TMTC2,transmembrane O-mannosyltransferase targeting cadherins 2,HGNC:25440,17q12
MLLT6,0.006491953,MLLT6,Approved symbol,MLLT6,"MLLT6, PHD finger containing",HGNC:7138,1q21.3
SHC1,-0.006478405,SHC1,Approved symbol,SHC1,SHC adaptor protein 1,HGNC:10840,4p16.3
SH3BP2,-0.006475735,SH3BP2,Approved symbol,SH3BP2,SH3 domain binding protein 2,HGNC:10825,20p11.21
ACSS1,0.006439799,ACSS1,Approved symbol,ACSS1,acyl-CoA synthetase short chain family member 1,HGNC:16091,
LL09NC01-139C3.1,0.00643571,LL09NC01-139C3.1,Unmatched,LL09NC01-139C3.1,,,7q31.32
CADPS2,-0.00643304,CADPS2,Approved symbol,CADPS2,calcium dependent secretion activator 2,HGNC:16018,2p11.2
IGKV2-29,-0.006432362,IGKV2-29,Approved symbol,IGKV2-29,immunoglobulin kappa variable 2-29,HGNC:5784,13q31.1
SLITRK1,0.006420687,SLITRK1,Approved symbol,SLITRK1,SLIT and NTRK like family member 1,HGNC:20297,9q22.33
ALG2,-0.006408952,ALG2,Approved symbol,ALG2,"ALG2 alpha-1,3/1,6-mannosyltransferase",HGNC:23159,7q22.1
ACTL6B,0.006390581,ACTL6B,Approved symbol,ACTL6B,actin like 6B,HGNC:160,3p21.31
TCAIM,-0.006381065,TCAIM,Approved symbol,TCAIM,"T cell activation inhibitor, mitochondrial",HGNC:25241,
CTD-3138B18.5,-0.006376647,CTD-3138B18.5,Unmatched,CTD-3138B18.5,,,1q25.1
GAS5,0.006369841,GAS5,Approved symbol,GAS5,growth arrest specific 5,HGNC:16355,
RP4-773N10.4,0.006344906,RP4-773N10.4,Unmatched,RP4-773N10.4,,,17q25.3
PYCR1,-0.006343996,PYCR1,Approved symbol,PYCR1,pyrroline-5-carboxylate reductase 1,HGNC:9721,7p21.2
DGKB,0.006334594,DGKB,Approved symbol,DGKB,diacylglycerol kinase beta,HGNC:2850,17q24.3
ABCA10,0.006333372,ABCA10,Approved symbol,ABCA10,ATP binding cassette subfamily A member 10,HGNC:30,17q21.2
TNS4,-0.006330362,TNS4,Approved symbol,TNS4,tensin 4,HGNC:24352,19q13.13
ZNF383,0.006305784,ZNF383,Approved symbol,ZNF383,zinc finger protein 383,HGNC:18609,
RP11-813F20.4,-0.006292496,RP11-813F20.4,Unmatched,RP11-813F20.4,,,Xq23
AMMECR1,-0.006287437,AMMECR1,Approved symbol,AMMECR1,AMMECR nuclear protein 1,HGNC:467,9p11.2
CNTNAP3B,-0.006286173,CNTNAP3B,Approved symbol,CNTNAP3B,contactin associated protein family member 3B,HGNC:32035,6q14.1
TPBG,-0.006285812,TPBG,Approved symbol,TPBG,trophoblast glycoprotein,HGNC:12004,1p13.3
GNAI3,-0.006271809,GNAI3,Approved symbol,GNAI3,G protein subunit alpha i3,HGNC:4387,2q24.2
TANC1,-0.006263569,TANC1,Approved symbol,TANC1,"tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1",HGNC:29364,10q21.1
UBE2D1,-0.006257803,UBE2D1,Approved symbol,UBE2D1,ubiquitin conjugating enzyme E2 D1,HGNC:12474,1q42.12
C1orf95,-0.006253135,C1orf95,Previous symbol,STUM,"stum, mechanosensory transduction mediator homolog",HGNC:30491,11q12.1
PATL1,-0.006235377,PATL1,Approved symbol,PATL1,"PAT1 homolog 1, processing body mRNA decay factor",HGNC:26721,14q32.33
IGHV4-4,-0.006232677,IGHV4-4,Approved symbol,IGHV4-4,immunoglobulin heavy variable 4-4,HGNC:5652,15q21.3
PRTG,-0.00622687,PRTG,Approved symbol,PRTG,protogenin,HGNC:26373,
RP5-1112D6.8,0.006220912,RP5-1112D6.8,Unmatched,RP5-1112D6.8,,,19q13.43
ZNF444,0.00621916,ZNF444,Approved symbol,ZNF444,zinc finger protein 444,HGNC:16052,19q13.12
ZNF571,0.006196778,ZNF571,Approved symbol,ZNF571,zinc finger protein 571,HGNC:25000,6p22.1
TRIM15,-0.006195698,TRIM15,Approved symbol,TRIM15,tripartite motif containing 15,HGNC:16284,
CTB-176F20.3,0.006195612,CTB-176F20.3,Unmatched,CTB-176F20.3,,,19p12
ZNF98,0.006181699,ZNF98,Approved symbol,ZNF98,zinc finger protein 98,HGNC:13174,17q23.3
SCN4A,0.006178067,SCN4A,Approved symbol,SCN4A,sodium voltage-gated channel alpha subunit 4,HGNC:10591,2p24.2
KCNS3,-0.006176704,KCNS3,Approved symbol,KCNS3,potassium voltage-gated channel modifier subfamily S member 3,HGNC:6302,16q12.2
LPCAT2,-0.006155395,LPCAT2,Approved symbol,LPCAT2,lysophosphatidylcholine acyltransferase 2,HGNC:26032,19p13.3
LRG1,-0.006155136,LRG1,Approved symbol,LRG1,leucine rich alpha-2-glycoprotein 1,HGNC:29480,22q11.21
C22orf39,0.006145886,C22orf39,Approved symbol,C22orf39,chromosome 22 open reading frame 39,HGNC:27012,4q32.3
MSMO1,-0.006136936,MSMO1,Approved symbol,MSMO1,methylsterol monooxygenase 1,HGNC:10545,
RP11-509E16.1,0.006113603,RP11-509E16.1,Unmatched,RP11-509E16.1,,,6p24.3
TFAP2A-AS1,-0.006112918,TFAP2A-AS1,Approved symbol,TFAP2A-AS1,TFAP2A antisense RNA 1,HGNC:40579,9q21.13
OSTF1,-0.006112511,OSTF1,Approved symbol,OSTF1,osteoclast stimulating factor 1,HGNC:8510,20p12.1
FLRT3,-0.006107437,FLRT3,Approved symbol,FLRT3,fibronectin leucine rich transmembrane protein 3,HGNC:3762,20p12.2
SNAP25,0.006063122,SNAP25,Approved symbol,SNAP25,synaptosome associated protein 25,HGNC:11132,17q12
CCL14,0.006059919,CCL14,Approved symbol,CCL14,C-C motif chemokine ligand 14,HGNC:10612,15q24.1
CD276,-0.00604993,CD276,Approved symbol,CD276,CD276 molecule,HGNC:19137,11q21
MTMR2,-0.006045456,MTMR2,Approved symbol,MTMR2,myotubularin related protein 2,HGNC:7450,2q21.3
UBXN4,-0.006036363,UBXN4,Approved symbol,UBXN4,UBX domain protein 4,HGNC:14860,
AC004257.3,0.0060354,AC004257.3,Unmatched,AC004257.3,,,3p24.3
SATB1,0.006008259,SATB1,Approved symbol,SATB1,SATB homeobox 1,HGNC:10541,7q22.1
CYP3A4,0.00600515,CYP3A4,Approved symbol,CYP3A4,cytochrome P450 family 3 subfamily A member 4,HGNC:2637,16q23.2
C16orf46,-0.006003976,C16orf46,Approved symbol,C16orf46,chromosome 16 open reading frame 46,HGNC:26525,16p13.3
C16orf89,0.006001077,C16orf89,Approved symbol,C16orf89,chromosome 16 open reading frame 89,HGNC:28687,18q11.2
CHST9,0.005984218,CHST9,Approved symbol,CHST9,carbohydrate sulfotransferase 9,HGNC:19898,12q24.31
B3GNT4,-0.005980543,B3GNT4,Approved symbol,B3GNT4,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4",HGNC:15683,16q23.1
GLG1,-0.005971194,GLG1,Approved symbol,GLG1,golgi glycoprotein 1,HGNC:4316,7q22.1
CYP3A7,0.005965536,CYP3A7,Approved symbol,CYP3A7,cytochrome P450 family 3 subfamily A member 7,HGNC:2640,10q22.2
SEC24C,-0.005963412,SEC24C,Approved symbol,SEC24C,"SEC24 homolog C, COPII coat complex component",HGNC:10705,
AC006116.27,0.00595728,AC006116.27,Unmatched,AC006116.27,,,22q12.1
SEZ6L,0.005956066,SEZ6L,Approved symbol,SEZ6L,seizure related 6 homolog like,HGNC:10763,
RP11-184A2.2,-0.005944136,RP11-184A2.2,Unmatched,RP11-184A2.2,,,2q32.2
INPP1,-0.005922174,INPP1,Approved symbol,INPP1,inositol polyphosphate-1-phosphatase,HGNC:6071,
RP11-527H14.2,-0.00592114,RP11-527H14.2,Unmatched,RP11-527H14.2,,,14q22.1
PSMC6,-0.005892005,PSMC6,Approved symbol,PSMC6,"proteasome 26S subunit, ATPase 6",HGNC:9553,
RP11-416N2.4,0.00588978,RP11-416N2.4,Unmatched,RP11-416N2.4,,,Xq21.1
MAGT1,-0.005887078,MAGT1,Approved symbol,MAGT1,magnesium transporter 1,HGNC:28880,1p36.32
MMEL1,0.005874547,MMEL1,Approved symbol,MMEL1,membrane metalloendopeptidase like 1,HGNC:14668,11q14.1
KCTD21,-0.005850438,KCTD21,Approved symbol,KCTD21,potassium channel tetramerization domain containing 21,HGNC:27452,6q23.3
MAP3K5,-0.005842511,MAP3K5,Approved symbol,MAP3K5,mitogen-activated protein kinase kinase kinase 5,HGNC:6857,12q14.1
RP11-359E19.2,-0.00584033,RP11-359E19.2,Alias symbol,LINC02866,long intergenic non-protein coding RNA 2866,HGNC:54518,8p11.21
C12orf61,-0.00582091,C12orf61,Previous symbol,LINC01465,long intergenic non-protein coding RNA 1465,HGNC:26364,
RP11-320N7.1,-0.005818269,RP11-320N7.1,Unmatched,RP11-320N7.1,,,2p25.3
TSSC1,-0.005804668,TSSC1,Previous symbol,EIPR1,EARP complex and GARP complex interacting protein 1,HGNC:12383,
CTD-3195I5.5,0.005797541,CTD-3195I5.5,Unmatched,CTD-3195I5.5,,,16p13.3
ZG16B,-0.005793605,ZG16B,Approved symbol,ZG16B,zymogen granule protein 16B,HGNC:30456,
RP11-532F6.5,0.00578357,RP11-532F6.5,Unmatched,RP11-532F6.5,,,21q22.11
SOD1,-0.005780144,SOD1,Approved symbol,SOD1,superoxide dismutase 1,HGNC:11179,6p21.31
MLN,-0.00577112,MLN,Approved symbol,MLN,motilin,HGNC:7141,19p13.3
DPP9,-0.005769438,DPP9,Approved symbol,DPP9,dipeptidyl peptidase 9,HGNC:18648,17q23.3
USP32,-0.005758867,USP32,Approved symbol,USP32,ubiquitin specific peptidase 32,HGNC:19143,
AL161915.1,0.005732699,AL161915.1,Unmatched,AL161915.1,,,7q11.23
GTF2IRD1,-0.005729916,GTF2IRD1,Approved symbol,GTF2IRD1,GTF2I repeat domain containing 1,HGNC:4661,1p36.11
SLC30A2,0.005724306,SLC30A2,Approved symbol,SLC30A2,solute carrier family 30 member 2,HGNC:11013,19q13.31
ZNF404,0.005712572,ZNF404,Approved symbol,ZNF404,zinc finger protein 404,HGNC:19417,9q34.2
DBH,0.0057066,DBH,Approved symbol,DBH,dopamine beta-hydroxylase,HGNC:2689,
RP5-857K21.11,0.00570571,RP5-857K21.11,Unmatched,RP5-857K21.11,,,11p11.2
KBTBD4,-0.0056901,KBTBD4,Approved symbol,KBTBD4,kelch repeat and BTB domain containing 4,HGNC:23761,
RP13-580F15.2,-0.005675835,RP13-580F15.2,Unmatched,RP13-580F15.2,,,7q22.1
CRYZP1,0.005675328,CRYZP1,Approved symbol,CRYZP1,crystallin zeta pseudogene 1,HGNC:2421,1q21.3
S100A16,-0.0056402,S100A16,Approved symbol,S100A16,S100 calcium binding protein A16,HGNC:20441,10q23.31
HTR7,0.005639013,HTR7,Approved symbol,HTR7,5-hydroxytryptamine receptor 7,HGNC:5302,2q24.2
ITGB6,-0.005631892,ITGB6,Approved symbol,ITGB6,integrin subunit beta 6,HGNC:6161,12q24.31
CDK2AP1,-0.00560742,CDK2AP1,Approved symbol,CDK2AP1,cyclin dependent kinase 2 associated protein 1,HGNC:14002,
RP11-286E11.2,0.005604183,RP11-286E11.2,Unmatched,RP11-286E11.2,,,22q13.1
GTPBP1,-0.005596404,GTPBP1,Approved symbol,GTPBP1,GTP binding protein 1,HGNC:4669,18q21.2
RAB27B,-0.005589676,RAB27B,Approved symbol,RAB27B,"RAB27B, member RAS oncogene family",HGNC:9767,
CTD-2196E14.3,0.005576777,CTD-2196E14.3,Unmatched,CTD-2196E14.3,,,19p13.3
AP3D1,-0.005574929,AP3D1,Approved symbol,AP3D1,adaptor related protein complex 3 subunit delta 1,HGNC:568,22q12.2
PATZ1,0.005570198,PATZ1,Approved symbol,PATZ1,POZ/BTB and AT hook containing zinc finger 1,HGNC:13071,12q21.1
TSPAN8,-0.005566218,TSPAN8,Approved symbol,TSPAN8,tetraspanin 8,HGNC:11855,1p34.2
CAP1,-0.005563226,CAP1,Approved symbol,CAP1,cyclase associated actin cytoskeleton regulatory protein 1,HGNC:20040,12p12.3
ERP27,-0.005554071,ERP27,Approved symbol,ERP27,endoplasmic reticulum protein 27,HGNC:26495,19p13.12
PODNL1,-0.005537908,PODNL1,Approved symbol,PODNL1,podocan like 1,HGNC:26275,19q13.11
ZNF599,0.005522401,ZNF599,Approved symbol,ZNF599,zinc finger protein 599,HGNC:26408,8q21.2
CA3,0.005511091,CA3,Approved symbol,CA3,carbonic anhydrase 3,HGNC:1374,7q32.2
CPA2,0.005494217,CPA2,Approved symbol,CPA2,carboxypeptidase A2,HGNC:2297,17q12
RPL23,0.005490734,RPL23,Approved symbol,RPL23,ribosomal protein L23,HGNC:10316,
RP11-46D6.1,-0.005484371,RP11-46D6.1,Unmatched,RP11-46D6.1,,,
CTC-251D13.1,0.005481501,CTC-251D13.1,Unmatched,CTC-251D13.1,,,19q13.33
LIN7B,0.005437118,LIN7B,Approved symbol,LIN7B,"lin-7 homolog B, crumbs cell polarity complex component",HGNC:17788,16p13.11
NPIPP1,0.005433193,NPIPP1,Approved symbol,NPIPP1,nuclear pore complex interacting protein pseudogene 1,HGNC:35407,14q21.1
TRAPPC6B,-0.005428468,TRAPPC6B,Approved symbol,TRAPPC6B,trafficking protein particle complex 6B,HGNC:23066,
AC135178.1,0.005424165,AC135178.1,Unmatched,AC135178.1,,,
RP11-313J2.1,0.005423026,RP11-313J2.1,Unmatched,RP11-313J2.1,,,12p13.33
ERC1,-0.005422598,ERC1,Approved symbol,ERC1,ELKS/RAB6-interacting/CAST family member 1,HGNC:17072,12q14.1
AGAP2-AS1,-0.005409685,AGAP2-AS1,Approved symbol,AGAP2-AS1,AGAP2 antisense RNA 1,HGNC:48633,
RP13-131K19.1,0.005399768,RP13-131K19.1,Unmatched,RP13-131K19.1,,,1q25.3
ARPC5,-0.005396731,ARPC5,Approved symbol,ARPC5,actin related protein 2/3 complex subunit 5,HGNC:708,11q13.4
DHCR7,-0.005396679,DHCR7,Approved symbol,DHCR7,7-dehydrocholesterol reductase,HGNC:2860,3q26.2
LRRIQ4,-0.005373616,LRRIQ4,Approved symbol,LRRIQ4,leucine rich repeats and IQ motif containing 4,HGNC:34298,5p12
HMGCS1,-0.005351068,HMGCS1,Approved symbol,HMGCS1,3-hydroxy-3-methylglutaryl-CoA synthase 1,HGNC:5007,8p21.3
XPO7,-0.005323176,XPO7,Approved symbol,XPO7,exportin 7,HGNC:14108,5q14.3
TMEM161B-AS1,0.005322818,TMEM161B-AS1,Approved symbol,TMEM161B-AS1,TMEM161B antisense RNA 1,HGNC:43839,15q26.1
SEMA4B,-0.005301475,SEMA4B,Approved symbol,SEMA4B,semaphorin 4B,HGNC:10730,Xp11.4
MIR1587,-0.00530059,MIR1587,Approved symbol,MIR1587,microRNA 1587,HGNC:41596,11p11.2
ARHGAP1,-0.005283569,ARHGAP1,Approved symbol,ARHGAP1,Rho GTPase activating protein 1,HGNC:673,8q21.13
SNX16,-0.005268816,SNX16,Approved symbol,SNX16,sorting nexin 16,HGNC:14980,
AP001187.1,0.00525837,AP001187.1,Unmatched,AP001187.1,,,15q22.2
MYO1E,-0.005257888,MYO1E,Approved symbol,MYO1E,myosin IE,HGNC:7599,4q35.2
KLKB1,0.005255589,KLKB1,Approved symbol,KLKB1,kallikrein B1,HGNC:6371,Xq21.1
HK2P1,-0.00525433,HK2P1,Approved symbol,HK2P1,hexokinase 2 pseudogene 1,HGNC:4924,1q21.3
ADAM15,-0.005252099,ADAM15,Approved symbol,ADAM15,ADAM metallopeptidase domain 15,HGNC:193,3p21.31
KLHL18,-0.005251632,KLHL18,Approved symbol,KLHL18,kelch like family member 18,HGNC:29120,8q21.2
RALYL,0.005227824,RALYL,Approved symbol,RALYL,RALY RNA binding protein like,HGNC:27036,8q24.3
ZNF252P-AS1,0.005224269,ZNF252P-AS1,Approved symbol,ZNF252P-AS1,ZNF252P antisense RNA 1,HGNC:27821,
AC096772.6,0.005221662,AC096772.6,Unmatched,AC096772.6,,,6q22.31
HDDC2,0.005215799,HDDC2,Approved symbol,HDDC2,HD domain containing 2,HGNC:21078,6q25.3
TFB1M,-0.005212966,TFB1M,Approved symbol,TFB1M,"transcription factor B1, mitochondrial",HGNC:17037,5p15.32
ADAMTS16,-0.005194781,ADAMTS16,Approved symbol,ADAMTS16,ADAM metallopeptidase with thrombospondin type 1 motif 16,HGNC:17108,16q21
SETD6,0.005188855,SETD6,Approved symbol,SETD6,"SET domain containing 6, protein lysine methyltransferase",HGNC:26116,11q13.1
PPP2R5B,-0.005156427,PPP2R5B,Approved symbol,PPP2R5B,protein phosphatase 2 regulatory subunit B'beta,HGNC:9310,12q14.1-q14.2
PPM1H,-0.005155526,PPM1H,Approved symbol,PPM1H,"protein phosphatase, Mg2+/Mn2+ dependent 1H",HGNC:18583,2q36.3
RNY4P19,-0.00515535,RNY4P19,Approved symbol,RNY4P19,RNY4 pseudogene 19,HGNC:34069,
CTD-2575K13.6,0.005150213,CTD-2575K13.6,Unmatched,CTD-2575K13.6,,,2q36.3
TRIP12,-0.005149946,TRIP12,Approved symbol,TRIP12,thyroid hormone receptor interactor 12,HGNC:12306,17q25.3
FASN,-0.005145761,FASN,Approved symbol,FASN,fatty acid synthase,HGNC:3594,12q22
VEZT,-0.005124439,VEZT,Approved symbol,VEZT,"vezatin, adherens junctions transmembrane protein",HGNC:18258,3q22.3
NCK1,-0.00512029,NCK1,Approved symbol,NCK1,NCK adaptor protein 1,HGNC:7664,7q21.13
CLDN12,-0.005116668,CLDN12,Approved symbol,CLDN12,claudin 12,HGNC:2034,Xq22.3
ATG4A,-0.00511225,ATG4A,Approved symbol,ATG4A,autophagy related 4A cysteine peptidase,HGNC:16489,6p22.2
HMGN4,-0.005103862,HMGN4,Approved symbol,HMGN4,high mobility group nucleosomal binding domain 4,HGNC:4989,22q11.21
DGCR11,-0.00509446,DGCR11,Approved symbol,DGCR11,DiGeorge syndrome critical region gene 11,HGNC:17226,10q23.33
EXOC6,-0.005074566,EXOC6,Approved symbol,EXOC6,exocyst complex component 6,HGNC:23196,1q42.2
TRIM67,0.005055205,TRIM67,Approved symbol,TRIM67,tripartite motif containing 67,HGNC:31859,
AC024592.9,-0.005053334,AC024592.9,Unmatched,AC024592.9,,,7q22.1
TRIM56,-0.005046531,TRIM56,Approved symbol,TRIM56,tripartite motif containing 56,HGNC:19028,3q25.1
SERP1,-0.005044006,SERP1,Approved symbol,SERP1,stress associated endoplasmic reticulum protein 1,HGNC:10759,2q37.3
LRRFIP1,-0.00503344,LRRFIP1,Approved symbol,LRRFIP1,LRR binding FLII interacting protein 1,HGNC:6702,
RP11-503C24.6,0.005027746,RP11-503C24.6,Unmatched,RP11-503C24.6,,,22q13.1
MICALL1,-0.005024608,MICALL1,Approved symbol,MICALL1,MICAL like 1,HGNC:29804,19q13.42
NLRP9,-0.005020219,NLRP9,Approved symbol,NLRP9,NLR family pyrin domain containing 9,HGNC:22941,8q21.13
PI15,-0.005015806,PI15,Approved symbol,PI15,peptidase inhibitor 15,HGNC:8946,19p13.2
ZNF700,0.004996735,ZNF700,Approved symbol,ZNF700,zinc finger protein 700,HGNC:25292,17p13.3
FAM57A,-0.004987914,FAM57A,Previous symbol,TLCD3A,TLC domain containing 3A,HGNC:29646,15q21.3
ALDH1A2,-0.004986499,ALDH1A2,Approved symbol,ALDH1A2,aldehyde dehydrogenase 1 family member A2,HGNC:15472,2q31.1
DHRS9,-0.004945553,DHRS9,Approved symbol,DHRS9,dehydrogenase/reductase 9,HGNC:16888,Xp11.22
MAGED1,-0.004944576,MAGED1,Approved symbol,MAGED1,MAGE family member D1,HGNC:6813,17p11.2
NT5M,0.004943532,NT5M,Approved symbol,NT5M,"5',3'-nucleotidase, mitochondrial",HGNC:15769,4q21.23
COQ2,-0.00493973,COQ2,Approved symbol,COQ2,"coenzyme Q2, polyprenyltransferase",HGNC:25223,
KB-1460A1.5,0.004917822,KB-1460A1.5,Unmatched,KB-1460A1.5,,,11q12.1
GIF,-0.004912579,GIF,Previous symbol,CBLIF,cobalamin binding intrinsic factor,HGNC:4268,2q31.1
ITGA6,-0.004911411,ITGA6,Approved symbol,ITGA6,integrin subunit alpha 6,HGNC:6142,
RP11-93B14.5,-0.004879076,RP11-93B14.5,Unmatched,RP11-93B14.5,,,2q11.2
TXNDC9,-0.004878003,TXNDC9,Approved symbol,TXNDC9,thioredoxin domain containing 9,HGNC:24110,
AC105344.2,-0.004870802,AC105344.2,Unmatched,AC105344.2,,,
CTD-2517O10.6,0.004863884,CTD-2517O10.6,Unmatched,CTD-2517O10.6,,,17q25.1
TMEM104,-0.004851353,TMEM104,Approved symbol,TMEM104,transmembrane protein 104,HGNC:25984,11q22.3
ZC3H12C,-0.004842061,ZC3H12C,Approved symbol,ZC3H12C,zinc finger CCCH-type containing 12C,HGNC:29362,
AC125421.1,-0.004841147,AC125421.1,Unmatched,AC125421.1,,,5q31.3
IGIP,0.004840904,IGIP,Approved symbol,IGIP,IgA inducing protein,HGNC:33847,
AC007036.6,-0.004808484,AC007036.6,Unmatched,AC007036.6,,,
AC068587.2,0.004806249,AC068587.2,Unmatched,AC068587.2,,,19q13.12
ZFP14,0.004804912,ZFP14,Approved symbol,ZFP14,ZFP14 zinc finger protein,HGNC:29312,9q34.11
PPP2R4,-0.004777984,PPP2R4,Previous symbol,PTPA,protein phosphatase 2 phosphatase activator,HGNC:9308,
RP11-439E19.9,0.00476322,RP11-439E19.9,Unmatched,RP11-439E19.9,,,7p14.3
RP9,0.00475046,RP9,Approved symbol,RP9,RP9 pre-mRNA splicing factor,HGNC:10288,2p23.2
PLB1,0.004749427,PLB1,Approved symbol,PLB1,phospholipase B1,HGNC:30041,14q32.12
TC2N,-0.00474553,TC2N,Approved symbol,TC2N,"tandem C2 domains, nuclear",HGNC:19859,
RP11-770J1.3,0.004723672,RP11-770J1.3,Unmatched,RP11-770J1.3,,,15q21.1-q21.2
GALK2,-0.0046909,GALK2,Approved symbol,GALK2,galactokinase 2,HGNC:4119,
GS1-122H1.2,-0.0046906,GS1-122H1.2,Unmatched,GS1-122H1.2,,,3p21.31
RHOA,-0.004685151,RHOA,Approved symbol,RHOA,ras homolog family member A,HGNC:667,13q14.13
TPT1-AS1,0.00466988,TPT1-AS1,Approved symbol,TPT1-AS1,TPT1 antisense RNA 1,HGNC:43686,6p21.33
GPANK1,0.00466276,GPANK1,Approved symbol,GPANK1,G-patch domain and ankyrin repeats 1,HGNC:13920,9p13.3
FAM214B,-0.004632637,FAM214B,Approved symbol,FAM214B,family with sequence similarity 214 member B,HGNC:25666,Xp11.3
UBA1,-0.004606205,UBA1,Approved symbol,UBA1,ubiquitin like modifier activating enzyme 1,HGNC:12469,6q14.3
TBX18,-0.004602432,TBX18,Approved symbol,TBX18,T-box transcription factor 18,HGNC:11595,9q21.33
ZCCHC6,-0.004600329,ZCCHC6,Previous symbol,TUT7,terminal uridylyl transferase 7,HGNC:25817,10q21.3
HERC4,-0.004587932,HERC4,Approved symbol,HERC4,HECT and RLD domain containing E3 ubiquitin protein ligase 4,HGNC:24521,13q34
PROZ,-0.004580151,PROZ,Approved symbol,PROZ,"protein Z, vitamin K dependent plasma glycoprotein",HGNC:9460,5q15
PCSK1,-0.004550698,PCSK1,Approved symbol,PCSK1,proprotein convertase subtilisin/kexin type 1,HGNC:8743,3q28
LEPREL1,-0.004519628,LEPREL1,Previous symbol,P3H2,prolyl 3-hydroxylase 2,HGNC:19317,5q33.2
GALNT10,-0.004507327,GALNT10,Approved symbol,GALNT10,polypeptide N-acetylgalactosaminyltransferase 10,HGNC:19873,3q29
LMLN,-0.004495917,LMLN,Approved symbol,LMLN,leishmanolysin like peptidase,HGNC:15991,17q24.2
PSMD12,-0.004485302,PSMD12,Approved symbol,PSMD12,"proteasome 26S subunit, non-ATPase 12",HGNC:9557,1q24.2
TBX19,0.004459522,TBX19,Approved symbol,TBX19,T-box transcription factor 19,HGNC:11596,18q12.2
CELF4,0.004453008,CELF4,Approved symbol,CELF4,CUGBP Elav-like family member 4,HGNC:14015,
RP11-188P20.3,0.00440123,RP11-188P20.3,Unmatched,RP11-188P20.3,,,17q25.3
TBC1D16,-0.004324271,TBC1D16,Approved symbol,TBC1D16,TBC1 domain family member 16,HGNC:28356,16q23.1
KARS,-0.004316543,KARS,Previous symbol,KARS1,lysyl-tRNA synthetase 1,HGNC:6215,14q22.2
GCH1,-0.004305629,GCH1,Approved symbol,GCH1,GTP cyclohydrolase 1,HGNC:4193,
RP6-149D17.1,0.004294247,RP6-149D17.1,Unmatched,RP6-149D17.1,,,1p33
AGBL4,-0.004280195,AGBL4,Approved symbol,AGBL4,ATP/GTP binding protein like 4,HGNC:25892,Xp22.33 and Yp11.32
PLCXD1,-0.004274816,PLCXD1,Approved symbol,PLCXD1,phosphatidylinositol specific phospholipase C X domain containing 1,HGNC:23148,6q16.3
GRIK2,0.004268476,GRIK2,Approved symbol,GRIK2,glutamate ionotropic receptor kainate type subunit 2,HGNC:4580,19q13.2
PIH1D2,-0.004268358,PIH1D2,Approved symbol,PIH1D2,PIH1 domain containing 2,HGNC:25210,3p22.1
CTNNB1,-0.004266489,CTNNB1,Approved symbol,CTNNB1,catenin beta 1,HGNC:2514,21q22.3
LSS,-0.004261311,LSS,Approved symbol,LSS,lanosterol synthase,HGNC:6708,1p13.3
GSTM3,0.004238262,GSTM3,Approved symbol,GSTM3,glutathione S-transferase mu 3,HGNC:4635,
RP11-395I6.3,0.004215637,RP11-395I6.3,Unmatched,RP11-395I6.3,,,22q13.2
MPPED1,0.004205767,MPPED1,Approved symbol,MPPED1,metallophosphoesterase domain containing 1,HGNC:1306,5p15.2
DAP,-0.004203981,DAP,Approved symbol,DAP,death associated protein,HGNC:2672,10q22.2
ECD,-0.004198585,ECD,Approved symbol,ECD,ecdysoneless cell cycle regulator,HGNC:17029,1p12
SEC22B,-0.004193278,SEC22B,Approved symbol,SEC22B,"SEC22 homolog B, vesicle trafficking protein",HGNC:10700,10p12
CACNB2,0.004158615,CACNB2,Approved symbol,CACNB2,calcium voltage-gated channel auxiliary subunit beta 2,HGNC:1402,Xp22.2
PIGA,-0.004142573,PIGA,Approved symbol,PIGA,phosphatidylinositol glycan anchor biosynthesis class A,HGNC:8957,1p35.1
TLR12P,0.004131212,TLR12P,Approved symbol,TLR12P,"toll like receptor 12, pseudogene",HGNC:31754,9q34.11
HMCN2,-0.004122132,HMCN2,Approved symbol,HMCN2,hemicentin 2,HGNC:21293,5q33.1
ZNF300P1,0.004119511,ZNF300P1,Approved symbol,ZNF300P1,zinc finger protein 300 pseudogene 1,HGNC:27032,7p14.3
CCDC129,-0.004112908,CCDC129,Previous symbol,ITPRID1,ITPR interacting domain containing 1,HGNC:27363,10q11.23-q21.1
PRKG1,-0.004077362,PRKG1,Approved symbol,PRKG1,protein kinase cGMP-dependent 1,HGNC:9414,7q21.12
ADAM22,0.004036953,ADAM22,Approved symbol,ADAM22,ADAM metallopeptidase domain 22,HGNC:201,10q25.3
TDRD1,-0.004034293,TDRD1,Approved symbol,TDRD1,tudor domain containing 1,HGNC:11712,10p15.1
GDI2,-0.004034226,GDI2,Approved symbol,GDI2,GDP dissociation inhibitor 2,HGNC:4227,21q22.3
HSF2BP,-0.004020847,HSF2BP,Approved symbol,HSF2BP,heat shock transcription factor 2 binding protein,HGNC:5226,5q31.3
YIPF5,-0.004000625,YIPF5,Approved symbol,YIPF5,Yip1 domain family member 5,HGNC:24877,
RP11-351I21.11,0.003995616,RP11-351I21.11,Unmatched,RP11-351I21.11,,,7p21.1
AGR2,-0.003995321,AGR2,Approved symbol,AGR2,"anterior gradient 2, protein disulphide isomerase family member",HGNC:328,7q36.1
CHPF2,-0.003995136,CHPF2,Approved symbol,CHPF2,chondroitin polymerizing factor 2,HGNC:29270,11p15.4
TRIM66,0.003978965,TRIM66,Approved symbol,TRIM66,tripartite motif containing 66,HGNC:29005,12q24.31
DYNLL1-AS1,-0.003948104,DYNLL1-AS1,Previous symbol,NRAV,negative regulator of antiviral response,HGNC:48588,7q11.23
VPS37D,0.003930729,VPS37D,Approved symbol,VPS37D,VPS37D subunit of ESCRT-I,HGNC:18287,1q24.2
BLZF1,-0.003927054,BLZF1,Approved symbol,BLZF1,basic leucine zipper nuclear factor 1,HGNC:1065,
RP5-1112D6.7,0.003916853,RP5-1112D6.7,Unmatched,RP5-1112D6.7,,,10q22.1
HK1,-0.003901539,HK1,Approved symbol,HK1,hexokinase 1,HGNC:4922,11q23.3
TREH,0.003901444,TREH,Approved symbol,TREH,trehalase,HGNC:12266,
RP11-466H18.1,0.003891906,RP11-466H18.1,Unmatched,RP11-466H18.1,,,14q32.2
GSKIP,-0.00388623,GSKIP,Approved symbol,GSKIP,GSK3B interacting protein,HGNC:20343,4p15.32
FGFBP1,-0.003883793,FGFBP1,Approved symbol,FGFBP1,fibroblast growth factor binding protein 1,HGNC:19695,1q22
SLC50A1,-0.003860507,SLC50A1,Approved symbol,SLC50A1,solute carrier family 50 member 1,HGNC:30657,17q11.2
PSMD11,-0.003856436,PSMD11,Approved symbol,PSMD11,"proteasome 26S subunit, non-ATPase 11",HGNC:9556,1q44
TRIM58,-0.003854944,TRIM58,Approved symbol,TRIM58,tripartite motif containing 58,HGNC:24150,2q37.3
HDLBP,-0.003848653,HDLBP,Approved symbol,HDLBP,high density lipoprotein binding protein,HGNC:4857,13q14.11
CYCSP34,0.003829787,CYCSP34,Approved symbol,CYCSP34,CYCS pseudogene 34,HGNC:24408,
RP11-97O12.6,0.003817517,RP11-97O12.6,Unmatched,RP11-97O12.6,,,13q22.2
LMO7,-0.003810376,LMO7,Approved symbol,LMO7,LIM domain 7,HGNC:6646,9p21.3
FOCAD,-0.003809248,FOCAD,Approved symbol,FOCAD,focadhesin,HGNC:23377,21q22.3
TFF2,-0.003756278,TFF2,Approved symbol,TFF2,trefoil factor 2,HGNC:11756,4q31.21
MMAA,-0.003749154,MMAA,Approved symbol,MMAA,metabolism of cobalamin associated A,HGNC:18871,Xp22.2
GRPR,-0.00373997,GRPR,Approved symbol,GRPR,gastrin releasing peptide receptor,HGNC:4609,17q11.2
ALDOC,0.003734853,ALDOC,Approved symbol,ALDOC,"aldolase, fructose-bisphosphate C",HGNC:418,
AC144521.1,0.003704905,AC144521.1,Unmatched,AC144521.1,,,
AP001610.9,-0.003702042,AP001610.9,Unmatched,AP001610.9,,,2p13.2
RAB11FIP5,-0.003686253,RAB11FIP5,Approved symbol,RAB11FIP5,RAB11 family interacting protein 5,HGNC:24845,12q24.31
TMED2,-0.003673613,TMED2,Approved symbol,TMED2,transmembrane p24 trafficking protein 2,HGNC:16996,10q23.33
FRA10AC1,0.003673274,FRA10AC1,Approved symbol,FRA10AC1,FRA10A associated CGG repeat 1,HGNC:1162,
AC005083.1,0.003649169,AC005083.1,Unmatched,AC005083.1,,,7q21.3-q22.1
BAIAP2L1,-0.00364902,BAIAP2L1,Approved symbol,BAIAP2L1,BAR/IMD domain containing adaptor protein 2 like 1,HGNC:21649,2p12
HK2,-0.003638748,HK2,Approved symbol,HK2,hexokinase 2,HGNC:4923,
RP11-1157N2__B.2,-0.003631886,RP11-1157N2__B.2,Unmatched,RP11-1157N2__B.2,,,19q13.42
EPS8L1,-0.003616545,EPS8L1,Approved symbol,EPS8L1,EPS8 like 1,HGNC:21295,9q34.13
CEL,0.003607233,CEL,Approved symbol,CEL,carboxyl ester lipase,HGNC:1848,19q13.33
FUT2,-0.003601332,FUT2,Approved symbol,FUT2,fucosyltransferase 2,HGNC:4013,1p22.2
LRRC8B,-0.00359166,LRRC8B,Approved symbol,LRRC8B,leucine rich repeat containing 8 VRAC subunit B,HGNC:30692,
RP11-459I19.1,0.003539748,RP11-459I19.1,Unmatched,RP11-459I19.1,,,1p36.13
CAPZB,-0.00353699,CAPZB,Approved symbol,CAPZB,capping actin protein of muscle Z-line subunit beta,HGNC:1491,
RP11-127B20.2,0.003522926,RP11-127B20.2,Unmatched,RP11-127B20.2,,,
RP11-519G16.5,-0.003496953,RP11-519G16.5,Unmatched,RP11-519G16.5,,,9p21.1
B4GALT1,-0.00349257,B4GALT1,Approved symbol,B4GALT1,"beta-1,4-galactosyltransferase 1",HGNC:924,7p14.3
WIPF3,-0.00346016,WIPF3,Approved symbol,WIPF3,WAS/WASL interacting protein family member 3,HGNC:22004,3q12.2
TFG,-0.003454642,TFG,Approved symbol,TFG,trafficking from ER to golgi regulator,HGNC:11758,6p24.3
TFAP2A,-0.003435843,TFAP2A,Approved symbol,TFAP2A,transcription factor AP-2 alpha,HGNC:11742,10q26.11
BAG3,-0.003420332,BAG3,Approved symbol,BAG3,BAG cochaperone 3,HGNC:939,2p23.3
ZNF512,0.003408048,ZNF512,Approved symbol,ZNF512,zinc finger protein 512,HGNC:29380,9q31.1
ERP44,-0.003401807,ERP44,Approved symbol,ERP44,endoplasmic reticulum protein 44,HGNC:18311,
RP11-109J4.1,-0.003396399,RP11-109J4.1,Unmatched,RP11-109J4.1,,,7q22.1
SMURF1,-0.003387066,SMURF1,Approved symbol,SMURF1,SMAD specific E3 ubiquitin protein ligase 1,HGNC:16807,
RP11-675F6.4,0.00337253,RP11-675F6.4,Unmatched,RP11-675F6.4,,,4p16.1
ALG1L3P,-0.003360233,ALG1L3P,Approved symbol,ALG1L3P,"ALG1 like 3, pseudogene",HGNC:44372,1p34.2
SLC2A1,-0.003358301,SLC2A1,Approved symbol,SLC2A1,solute carrier family 2 member 1,HGNC:11005,
RP11-100L22.1,0.003343932,RP11-100L22.1,Unmatched,RP11-100L22.1,,,15q23
CORO2B,0.003340141,CORO2B,Approved symbol,CORO2B,coronin 2B,HGNC:2256,3q23
SLC25A36,0.003319235,SLC25A36,Approved symbol,SLC25A36,solute carrier family 25 member 36,HGNC:25554,17p11.2
ZNF286B,0.003306606,ZNF286B,Approved symbol,ZNF286B,zinc finger protein 286B (pseudogene),HGNC:33241,19q13.43
ZNF667-AS1,0.003288196,ZNF667-AS1,Approved symbol,ZNF667-AS1,ZNF667 antisense RNA 1 (head to head),HGNC:44321,12p12.3
STRAP,-0.003268961,STRAP,Approved symbol,STRAP,serine/threonine kinase receptor associated protein,HGNC:30796,11q21
GPR83,0.003265245,GPR83,Approved symbol,GPR83,G protein-coupled receptor 83,HGNC:4523,21q21.1
RPL39P40,0.003258947,RPL39P40,Approved symbol,RPL39P40,ribosomal protein L39 pseudogene 40,HGNC:35823,3q27.1
PSMD2,-0.003252388,PSMD2,Approved symbol,PSMD2,"proteasome 26S subunit, non-ATPase 2",HGNC:9559,15q15.1
SRP14-AS1,0.003215337,SRP14-AS1,Approved symbol,SRP14-AS1,SRP14 antisense RNA1 (head to head),HGNC:48619,
AC091167.3,-0.003210837,AC091167.3,Unmatched,AC091167.3,,,4q21.22
PLAC8,-0.003176627,PLAC8,Approved symbol,PLAC8,placenta associated 8,HGNC:19254,2q32.2
SLC40A1,-0.003171135,SLC40A1,Approved symbol,SLC40A1,solute carrier family 40 member 1,HGNC:10909,Xp22.33
GYG2,-0.003169156,GYG2,Approved symbol,GYG2,glycogenin 2,HGNC:4700,4q21.21
FGF5,-0.00316799,FGF5,Approved symbol,FGF5,fibroblast growth factor 5,HGNC:3683,17q21.33
LRRC59,-0.003162904,LRRC59,Approved symbol,LRRC59,leucine rich repeat containing 59,HGNC:28817,11q23.1
IL18,-0.003118896,IL18,Approved symbol,IL18,interleukin 18,HGNC:5986,5q13.3
CRHBP,0.003095553,CRHBP,Approved symbol,CRHBP,corticotropin releasing hormone binding protein,HGNC:2356,13q34
F10,0.003088131,F10,Approved symbol,F10,coagulation factor X,HGNC:3528,3p22.3
CMTM6,-0.003075217,CMTM6,Approved symbol,CMTM6,CKLF like MARVEL transmembrane domain containing 6,HGNC:19177,Xp11.4
DYNLT3,-0.00307417,DYNLT3,Approved symbol,DYNLT3,dynein light chain Tctex-type 3,HGNC:11694,1q23.3
PVRL4,-0.003064394,PVRL4,Previous symbol,NECTIN4,nectin cell adhesion molecule 4,HGNC:19688,1q21.3
TPM3,-0.003035504,TPM3,Approved symbol,TPM3,tropomyosin 3,HGNC:12012,1q43
CHRM3,-0.003012046,CHRM3,Approved symbol,CHRM3,cholinergic receptor muscarinic 3,HGNC:1952,5q12.1
PART1,0.002991873,PART1,Approved symbol,PART1,prostate androgen-regulated transcript 1,HGNC:17263,7p12.3
IGFBP3,0.002963623,IGFBP3,Approved symbol,IGFBP3,insulin like growth factor binding protein 3,HGNC:5472,1q42.12
ACBD3,-0.002927758,ACBD3,Approved symbol,ACBD3,acyl-CoA binding domain containing 3,HGNC:15453,10q11.21
HNRNPF,-0.002910769,HNRNPF,Approved symbol,HNRNPF,heterogeneous nuclear ribonucleoprotein F,HGNC:5039,19p13.11
ZNF14,0.00290846,ZNF14,Approved symbol,ZNF14,zinc finger protein 14,HGNC:12924,16q22.1
NQO1,-0.002887031,NQO1,Approved symbol,NQO1,NAD(P)H quinone dehydrogenase 1,HGNC:2874,7p11.2
EGFR-AS1,0.002859312,EGFR-AS1,Approved symbol,EGFR-AS1,EGFR antisense RNA 1,HGNC:40207,7q34
C7orf55-LUC7L2,0.002754535,C7orf55-LUC7L2,Previous symbol,FMC1-LUC7L2,FMC1-LUC7L2 readthrough,HGNC:44671,11p15.3
PARVA,0.002729758,PARVA,Approved symbol,PARVA,parvin alpha,HGNC:14652,1p36.33
MTND1P23,0.00270687,MTND1P23,Approved symbol,MTND1P23,MT-ND1 pseudogene 23,HGNC:42092,5p15.33
ZDHHC11B,0.002701218,ZDHHC11B,Approved symbol,ZDHHC11B,zinc finger DHHC-type containing 11B,HGNC:32962,4p16.1
PPP2R2C,0.002697725,PPP2R2C,Approved symbol,PPP2R2C,protein phosphatase 2 regulatory subunit Bgamma,HGNC:9306,11q24.2
CDON,0.002671454,CDON,Approved symbol,CDON,"cell adhesion associated, oncogene regulated",HGNC:17104,2q37.1
ALPP,0.002669596,ALPP,Approved symbol,ALPP,"alkaline phosphatase, placental",HGNC:439,20q11.21
MAPRE1,-0.002643691,MAPRE1,Approved symbol,MAPRE1,microtubule associated protein RP/EB family member 1,HGNC:6890,
RP5-1112D6.4,0.002636917,RP5-1112D6.4,Unmatched,RP5-1112D6.4,,,11p15.4
ST5,-0.002616168,ST5,Previous symbol,DENND2B,DENN domain containing 2B,HGNC:11350,2q14.2
RALB,-0.002599087,RALB,Approved symbol,RALB,RAS like proto-oncogene B,HGNC:9840,1q21.2
HIST2H2BE,-0.002584082,HIST2H2BE,Previous symbol,H2BC21,H2B clustered histone 21,HGNC:4760,21q22.3
SLC37A1,-0.002572545,SLC37A1,Approved symbol,SLC37A1,solute carrier family 37 member 1,HGNC:11024,19q13.33
SEC1P,-0.002547969,SEC1P,Approved symbol,SEC1P,"secretory blood group 1, pseudogene",HGNC:44149,14q22.1
GNPNAT1,-0.00253832,GNPNAT1,Approved symbol,GNPNAT1,glucosamine-phosphate N-acetyltransferase 1,HGNC:19980,1p34.2
HYI,0.002525896,HYI,Approved symbol,HYI,hydroxypyruvate isomerase (putative),HGNC:26948,8p12
UNC5D,0.002495731,UNC5D,Approved symbol,UNC5D,unc-5 netrin receptor D,HGNC:18634,15q11.2
PWAR6,0.002473045,PWAR6,Approved symbol,PWAR6,Prader Willi/Angelman region RNA 6,HGNC:49129,
RP11-412H8.2,-0.00246666,RP11-412H8.2,Unmatched,RP11-412H8.2,,,6p11.2
LINC00680,0.00242023,LINC00680,Approved symbol,LINC00680,long intergenic non-protein coding RNA 680,HGNC:44417,19q13.32
CALM3,-0.002393697,CALM3,Approved symbol,CALM3,calmodulin 3,HGNC:1449,15q25.2
FAM154B,0.002373015,FAM154B,Previous symbol,SAXO2,stabilizer of axonemal microtubules 2,HGNC:33727,
RP4-635E18.8,-0.002327929,RP4-635E18.8,Unmatched,RP4-635E18.8,,,17p13.1
TNFSF13,-0.002320563,TNFSF13,Approved symbol,TNFSF13,TNF superfamily member 13,HGNC:11928,
RP11-698N11.4,-0.002313729,RP11-698N11.4,Unmatched,RP11-698N11.4,,,5q13.3
RNU6-658P,0.00230807,RNU6-658P,Approved symbol,RNU6-658P,"RNA, U6 small nuclear 658, pseudogene",HGNC:47621,3q22.1
NEK11,-0.002304065,NEK11,Approved symbol,NEK11,NIMA related kinase 11,HGNC:18593,13q12.2
PDX1,-0.002283279,PDX1,Approved symbol,PDX1,pancreatic and duodenal homeobox 1,HGNC:6107,9p21.1
ACO1,-0.002262926,ACO1,Approved symbol,ACO1,aconitase 1,HGNC:117,1q32.1
PPP1R12B,-0.002261088,PPP1R12B,Approved symbol,PPP1R12B,protein phosphatase 1 regulatory subunit 12B,HGNC:7619,
AC138517.1,-0.00224666,AC138517.1,Unmatched,AC138517.1,,,11q22.3
GRIA4,0.002239442,GRIA4,Approved symbol,GRIA4,glutamate ionotropic receptor AMPA type subunit 4,HGNC:4574,
RP11-635N19.1,0.002238827,RP11-635N19.1,Unmatched,RP11-635N19.1,,,
AC004490.1,0.002234756,AC004490.1,Unmatched,AC004490.1,,,4q35.2
MTNR1A,-0.002228725,MTNR1A,Approved symbol,MTNR1A,melatonin receptor 1A,HGNC:7463,16p13.3
DNASE1,0.002227623,DNASE1,Approved symbol,DNASE1,deoxyribonuclease 1,HGNC:2956,17q22
MSI2,-0.002174555,MSI2,Approved symbol,MSI2,musashi RNA binding protein 2,HGNC:18585,5q31.3
PCDHA4,0.002078628,PCDHA4,Approved symbol,PCDHA4,protocadherin alpha 4,HGNC:8670,3q25.32
C3orf55,-0.002076773,C3orf55,Previous symbol,SLC66A1L,solute carrier family 66 member 1 like,HGNC:25146,
AC090602.2,-0.002057816,AC090602.2,Unmatched,AC090602.2,,,9q34.3
SEC16A,-0.002055077,SEC16A,Approved symbol,SEC16A,"SEC16 homolog A, endoplasmic reticulum export factor",HGNC:29006,1q25.3
GLUL,-0.002039766,GLUL,Approved symbol,GLUL,glutamate-ammonia ligase,HGNC:4341,12p13.1
KIAA1467,0.002008992,KIAA1467,Previous symbol,FAM234B,family with sequence similarity 234 member B,HGNC:29288,7p13
YKT6,-0.001981928,YKT6,Approved symbol,YKT6,YKT6 v-SNARE homolog,HGNC:16959,12q24.11
MVK,-0.001973255,MVK,Approved symbol,MVK,mevalonate kinase,HGNC:7530,3p21.31
LARS2,-0.001967009,LARS2,Approved symbol,LARS2,"leucyl-tRNA synthetase 2, mitochondrial",HGNC:17095,5q33.3
CLINT1,-0.001966482,CLINT1,Approved symbol,CLINT1,clathrin interactor 1,HGNC:23186,7q34
TAS2R5,0.00193468,TAS2R5,Approved symbol,TAS2R5,taste 2 receptor member 5,HGNC:14912,1q21.1
NBPF12,0.001879653,NBPF12,Approved symbol,NBPF12,NBPF member 12,HGNC:24297,
AL031663.2,0.001860366,AL031663.2,Unmatched,AL031663.2,,,4q31.21
USP38,-0.001847833,USP38,Approved symbol,USP38,ubiquitin specific peptidase 38,HGNC:20067,
RP11-305L7.1,0.001838157,RP11-305L7.1,Unmatched,RP11-305L7.1,,,11q24.3
ADAMTS15,-0.001836209,ADAMTS15,Approved symbol,ADAMTS15,ADAM metallopeptidase with thrombospondin type 1 motif 15,HGNC:16305,20q12
TOP1,-0.001833554,TOP1,Approved symbol,TOP1,DNA topoisomerase I,HGNC:11986,1p36.12
DDOST,-0.001796279,DDOST,Approved symbol,DDOST,dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit,HGNC:2728,17q12
AP2B1,-0.001779702,AP2B1,Approved symbol,AP2B1,adaptor related protein complex 2 subunit beta 1,HGNC:563,9q32
ATP6V1G1,-0.001771664,ATP6V1G1,Approved symbol,ATP6V1G1,ATPase H+ transporting V1 subunit G1,HGNC:864,1p36.11
GALE,-0.001760932,GALE,Approved symbol,GALE,UDP-galactose-4-epimerase,HGNC:4116,10q22.3
SFTPD,0.001735765,SFTPD,Approved symbol,SFTPD,surfactant protein D,HGNC:10803,Xq26.2
GPC3,-0.001697792,GPC3,Approved symbol,GPC3,glypican 3,HGNC:4451,2q37.1
ALPPL2,-0.001686674,ALPPL2,Previous symbol,ALPG,"alkaline phosphatase, germ cell",HGNC:441,
RP11-448A19.1,0.001673576,RP11-448A19.1,Unmatched,RP11-448A19.1,,,6p22.2
HIST1H2BF,-0.001648716,HIST1H2BF,Previous symbol,H2BC7,H2B clustered histone 7,HGNC:4752,17q11.2
RHBDL3,-0.001643316,RHBDL3,Approved symbol,RHBDL3,rhomboid like 3,HGNC:16502,
RP4-614O4.12,0.00163436,RP4-614O4.12,Unmatched,RP4-614O4.12,,,
RP11-426L16.3,0.001600728,RP11-426L16.3,Unmatched,RP11-426L16.3,,,12q13.12
DDX23,-0.001587594,DDX23,Approved symbol,DDX23,DEAD-box helicase 23,HGNC:17347,
RP5-1085F17.3,0.001577853,RP5-1085F17.3,Unmatched,RP5-1085F17.3,,,16p13.3
CDIP1,0.001546302,CDIP1,Approved symbol,CDIP1,cell death inducing p53 target 1,HGNC:13234,6q25.3
ACAT2,-0.001538956,ACAT2,Approved symbol,ACAT2,acetyl-CoA acetyltransferase 2,HGNC:94,11q12.1
TNKS1BP1,-0.001537645,TNKS1BP1,Approved symbol,TNKS1BP1,tankyrase 1 binding protein 1,HGNC:19081,Xq27.3
SLITRK2,0.001532398,SLITRK2,Approved symbol,SLITRK2,SLIT and NTRK like family member 2,HGNC:13449,15q15.2
TMEM62,-0.001526831,TMEM62,Approved symbol,TMEM62,transmembrane protein 62,HGNC:26269,
RP11-356M20.1,0.001497474,RP11-356M20.1,Unmatched,RP11-356M20.1,,,22q12.3
CPSF1P1,0.001484351,CPSF1P1,Approved symbol,CPSF1P1,CPSF1 pseudogene 1,HGNC:19251,1p32.3
DHCR24,0.001456159,DHCR24,Approved symbol,DHCR24,24-dehydrocholesterol reductase,HGNC:2859,1q22
MST4,-0.001447243,MST4,Alias symbol,STK26,serine/threonine kinase 26,HGNC:18174,Xq26.2
MUC1,-0.0014323,MUC1,Approved symbol,MUC1,"mucin 1, cell surface associated",HGNC:7508,3q23
COPB2,-0.001421124,COPB2,Approved symbol,COPB2,COPI coat complex subunit beta 2,HGNC:2232,17q11.1
RPL34P31,0.0013185,RPL34P31,Approved symbol,RPL34P31,ribosomal protein L34 pseudogene 31,HGNC:36899,4q25
ELOVL6,0.001291673,ELOVL6,Approved symbol,ELOVL6,ELOVL fatty acid elongase 6,HGNC:15829,
RP4-800G7.1,0.00128667,RP4-800G7.1,Unmatched,RP4-800G7.1,,,5q14.1
AP3B1,-0.001261024,AP3B1,Approved symbol,AP3B1,adaptor related protein complex 3 subunit beta 1,HGNC:566,10q25.2
GUCY2GP,-0.001254896,GUCY2GP,Approved symbol,GUCY2GP,"guanylate cyclase 2G, pseudogene",HGNC:31863,19q13.2
KCNK6,-0.001227568,KCNK6,Approved symbol,KCNK6,potassium two pore domain channel subfamily K member 6,HGNC:6281,10p15.3
LINC00200,-0.001226977,LINC00200,Approved symbol,LINC00200,long intergenic non-protein coding RNA 200,HGNC:30974,
RP5-1074L1.4,0.001203166,RP5-1074L1.4,Unmatched,RP5-1074L1.4,,,6q24.3
STXBP5,-0.001149141,STXBP5,Approved symbol,STXBP5,syntaxin binding protein 5,HGNC:19665,Xq22.2
MORF4L2-AS1,0.001101986,MORF4L2-AS1,Approved symbol,MORF4L2-AS1,MORF4L2 antisense RNA 1,HGNC:27991,6p21.1
ADCY10P1,-0.001083411,ADCY10P1,Approved symbol,ADCY10P1,ADCY10 pseudogene 1,HGNC:44143,3q21.2
MUC13,-0.001064545,MUC13,Approved symbol,MUC13,"mucin 13, cell surface associated",HGNC:7511,19q13.2
CEACAM1,-0.001049809,CEACAM1,Approved symbol,CEACAM1,CEA cell adhesion molecule 1,HGNC:1814,3q22.1
ATP2C1,-0.001039547,ATP2C1,Approved symbol,ATP2C1,ATPase secretory pathway Ca2+ transporting 1,HGNC:13211,
RP11-163N6.2,-0.00103607,RP11-163N6.2,Unmatched,RP11-163N6.2,,,18q12.2-q12.3
LINC00669,-0.000982552,LINC00669,Previous symbol,MIR924HG,MIR924 host gene,HGNC:44332,9q21.2
GNA14,-0.000960768,GNA14,Approved symbol,GNA14,G protein subunit alpha 14,HGNC:4382,
AP000936.1,0.000858206,AP000936.1,Unmatched,AP000936.1,,,17q21.31
LSM12,-0.000824825,LSM12,Approved symbol,LSM12,LSM12 homolog,HGNC:26407,1p22.2
CCBL2,-0.000780399,CCBL2,Previous symbol,KYAT3,kynurenine aminotransferase 3,HGNC:33238,Xp22.33 and Yp11.32
LINC00685,-0.000730476,LINC00685,Approved symbol,LINC00685,long intergenic non-protein coding RNA 685,HGNC:27560,13q12.3
CYP51P2,-0.000667384,CYP51P2,Previous symbol,CYP51A1P2,cytochrome P450 family 51 subfamily A member 1 pseudogene 2,HGNC:20251,3p24.3
RAB5A,-0.000656115,RAB5A,Approved symbol,RAB5A,"RAB5A, member RAS oncogene family",HGNC:9783,20p11.21
ZNF337,0.000613926,ZNF337,Approved symbol,ZNF337,zinc finger protein 337,HGNC:15809,
RP11-1036E20.9,-0.000594243,RP11-1036E20.9,Unmatched,RP11-1036E20.9,,,17p12
TEKT3,-0.000549314,TEKT3,Approved symbol,TEKT3,tektin 3,HGNC:14293,15q21.1
SLC28A2,-0.00050049,SLC28A2,Approved symbol,SLC28A2,solute carrier family 28 member 2,HGNC:11002,19q13.2
CEACAM5,-0.000478469,CEACAM5,Approved symbol,CEACAM5,CEA cell adhesion molecule 5,HGNC:1817,11p14.2
SLC5A12,-0.000428119,SLC5A12,Approved symbol,SLC5A12,solute carrier family 5 member 12,HGNC:28750,2q31.1
GORASP2,0.000399095,GORASP2,Approved symbol,GORASP2,golgi reassembly stacking protein 2,HGNC:17500,19q13.31
CEACAM22P,0.000386698,CEACAM22P,Approved symbol,CEACAM22P,"CEA cell adhesion molecule 22, pseudogene",HGNC:38029,
AC002075.4,-0.000327627,AC002075.4,Unmatched,AC002075.4,,,6p21.33
POU5F1,0.000281401,POU5F1,Approved symbol,POU5F1,POU class 5 homeobox 1,HGNC:9221,
RP11-666G4.1,0.000191784,RP11-666G4.1,Unmatched,RP11-666G4.1,,,8q24.3
SLC45A4,0.000187375,SLC45A4,Approved symbol,SLC45A4,solute carrier family 45 member 4,HGNC:29196,1p34.2
RIMS3,0.000180437,RIMS3,Approved symbol,RIMS3,regulating synaptic membrane exocytosis 3,HGNC:21292,11q13.1
CAPN1,0.00015191,CAPN1,Approved symbol,CAPN1,calpain 1,HGNC:1476,1p13.3
TAF13,-0.000135229,TAF13,Approved symbol,TAF13,TATA-box binding protein associated factor 13,HGNC:11546,
RP11-425I13.3,6.62E-05,RP11-425I13.3,Unmatched,RP11-425I13.3,,,9q33.3
MIR600HG,-2.76E-05,MIR600HG,Approved symbol,MIR600HG,MIR600 host gene,HGNC:23642,12q24.31
SIRT4,-1.54E-05,SIRT4,Approved symbol,SIRT4,sirtuin 4,HGNC:14932,